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Supervisor:  Stephen F. Martin 
 
The diastereoselective formal syntheses of the corynanthe alkaloid hirsutine and 
oxindole alkaloid rhynchophylline are described. The general approach features the use 
of ring-closing metathesis (RCM) to construct an α,β-unsaturated lactam, which is 
subjected to 1,4-addition. The lithium enolate of ethyl-1,3-dithiolane-2-carboxylate was 
identified as the optimal nucleophile in these systems. A key feature of this approach is 
that the stereochemical outcome of the 1,4-addition can be effectively controlled by 
appropriately sequencing the indole Boc-protection step to give either the C(3)-H/C(15)-
H cis or C(3)-H/C(15)-H trans stereochemical relationship. As a result, we have 
developed a unified approach to both the “normal” and “pseudo” corynanthe alkaloids. 
This finding was highlighted through the synthesis of the complete carbon skeleton of the 
archetypal normal corynanthe alkaloid dihydrocorynantheol.  
An efficient synthesis of the tricyclic spiroindolinone ABC-fragment of the 
marine alkaloid citrinadin A has been achieved. The synthesis relies on a novel 
asymmetric oxidative rearrangement of an indole to an oxindole using a chiral auxiliary 
 vii 
on the indole nitrogen to achieve facial selectivity. The transformation proceeds via the 
epoxidation of the indole C(2),C(3) double bond using DMDO, followed by a silica gel-
mediated 1,2-epoxide rearrangement. Using this tactic, the spirooxindole of citrinadin A, 
which contains two adjacent quaternary centers, was formed in high yield and excellent 
diastereoselectivity. Efforts toward the fragment coupling of the tricyclic spiroindolinone 
with a 2,4,6-trisubstituted piperidine coupling partner are described. 
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Chapter 1: Syntheses of Corynanthe, pseudo-Corynanthe and Oxindole 
Alkaloids  
1.1 INTRODUCTION 
For thousands of years nature has been an indispensable source of biologically 
active extracts from which important therapies have been derived. The extensive use of 
medicinal plants has been documented in the ancient Chinese, Egyptian and Native 
American civilizations, and to this day native tribes of the Amazon continue to use plants 
from the rain forest for the treatment of a variety of diseases.1 It was not until 1805, 
however, that the first alkaloid was isolated in pure form. Sertürner’s discovery of 
morphine (1.1) represented the start of a new era, not just of alkaloid isolation chemistry 
but of organic chemistry as a whole.2 Along with morphine, perhaps the most well known 
alkaloids among the general public are strychnine (1.2) and quinine (1.3). The latter is 
readily available from the bark of the chinchona tree and was introduced to the Western 
civilization by South American Indians. Quinine has served as a ubiquitous treatment 
against malaria for over hundred years until the discovery of the synthetic drug 
chloroquine in the 1950’s. However; with the steady rise of chloroquine resistant strains 
of malaria, quinine is again becoming increasingly important for the treatment of this 




































Alkaloids have also found application in the treatment of cancer. The complex 
bis-indole alkaloid vinblastine (1.4) was first isolated from the Madagascar periwinkle, 
and after the initial discovery that 1.4 could effectively lower the count of white blood 
cells, Eli Lilly and Co. (Indianapolis, Indiana) began extensive biological evaluation of 
1.4 and closely related alkaloids. It was eventually discovered that 1.4 is an effective 
treatment for Hodgkin lymphoma, for which it eventually was commercially developed.      
Aside from their biological relevance, several classes of alkaloids feature complex 
and fascinating molecular architectures, which pose significant challenges to practitioners 
of synthetic organic chemistry. Two such classes are the corynantheine-heteroyohimboid 
alkaloids and the closely related oxindole alkaloids (Figure 1.2). The latter is 
biogenetically related to the corynanthe alkaloids via an oxidative rearrangement of the 
indole unit. The corynanthe class can be further divided into four sub-groups differing in 
the stereochemical configurations of the substituents around the D-ring. These sub-
groups are known as normal (C(3)-H α, C(15)-H α, C(20)-H β), pseudo (β, α, β), allo (α, 
α, α), epi-allo (β, α, α). For almost half a century, the corynanthe and oxindole alkaloids 
have served to inspire the development of new methodologies and synthetic strategies.3 
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Three such alkaloids, hirsutine (1.5) dihydrocorynantheol (1.6) and rhynchophylline (1.7) 








































Hirsutine (1.5) is one of the corynanthe-type alkaloids of the “pseudo” sub-type 
possessing the characteristic C(3)-H β,  C(15)-H α, C(20)-H β relative stereochemical 
configuration. It was first isolated by Shellard and co-workers in 1966 from the Asian 
plant Mitragyna hirsuta Havil.4 Further work demonstrated that this alkaloid is present in 
a variety of Mitragyna and Uncaria species (Rubiaceae).3 Corynanthe-type alkaloids 
represent one of the major constituents of the root bark of Uncaria rhynchophylla (Miq.), 
an important medicinal plant used in the Chinese “Kampo” medicine for the treatment of 
cardiovascular disorder such as hypertension with its symptoms of dizziness and 
headache. Hirsutine has more received increased attention due to the discovery by 
Takayama and co-workers that 1.5 possesses significant in vitro activity against the 
influenza A virus (subtype H3N2).5 With EC50 = 0.4–0.57 μg/mL, 1.5 is approximately 
11-20 times more potent than the clinically used ribavarin.  The challenge of devising 
efficient strategies for controlling the stereochemistry around the D-ring coupled with the 
important biological activity of 1.5 has been the driving force behind a number of partial, 
formal, and total syntheses of 1.5 over the past four decades (vide infra). 
1.2.2 Sakai’s Partial Synthesis of Hirsutine (1972) 
The first two syntheses of hirsutine (1.5) were both partial syntheses using other 
natural products as starting materials. In the early seventies, Sakai and co-workers 
investigated the conversion of oxindole alkaloids to their corresponding indole 
counterparts.6 While the biomimetic oxidative rearrangement of indoles to oxindoles had 
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already been extensively studied by Finch and Taylor7 the reverse transformation had not 
yet been reported. As shown in Scheme 1.1, Sakai and co-workers demonstrated that 
iminoethers such as 1.9, which were readily obtained from the corresponding oxindoles 
(iso-rhynchophylline (1.8) in this case), could be reduced by NaBH4 in acetic acid to 
afford 2,3-seco-indoles such as 1.10. Interestingly, alkylation of the oxindoles with 
Meerwein salt resulted in epimerization of the C7-spirocenter, however, this was of no 
consequence since this stereocenter was destroyed in the ensuing reduction. The 2,3-
seco-indoles were then subjected to an oxidative cyclization with Hg(OAc)2 to afford the 
corresponding indoles in approximately 25%. However, in the case of hirsutine a 










































1.2.3 Brown’s Biomimetic Partial Synthesis of Hirsutine (1974)  
The iridoid glucoside secologanine constitutes the biogenetic precursor to the vast 
majority of monoterpene indole alkaloids. This was exploited by Brown8 in his 
biomimetic partial synthesis of hirsutine (1.5) and related alkaloids as depicted in Scheme 
1.2. In this case, however, the dihydro analogue of secologanine 1.11 was employed, 
which underwent condensation with Nb-benzyltryptamine (1.12) to afford N4-benzyl-
18,19-dihydrovincoside (1.13). Following cleavage of the glucose group by the action of 
β-glucosidase to afford 1.14, the synthesis of hirsutine was completed by subjecting 1.14 
to diazomethane followed by hydrogenolysis. Hirsutine (1.5) was thus prepared in only 
four steps from dihydrosecologanine (1.11), although the yields and diastereomeric ratios 





































1.2.4 Wenkert’s Racemic Total Synthesis of Hirsutine (1980)  
The first total synthesis of hirsutine was accomplished by Wenkert9 and co-
workers. They developed an elegant and highly concise approach in which the first step 
involved the formation of a pyridinium salt by condensation of tryptophyl bromide (1.15) 
and pyridine derivative 1.16 (Scheme 1.3). The pyridinium ion 1.17 was then treated with 
the sodium enolate of dimethyl malonate to afford 1.18, which was not isolated but 
immediately exposed to benzene saturated with hydrochloride gas to affect a cyclization 
that produced tetracycle 1.19. While the yield was low for this transformation (27%), the 
majority of the unreacted starting material (60-70%) could be recovered and recycled. It 
is interesting to note that the cyclization of 1.18 proceeded in a regiospecific manner in 
spite of the fact that there are two enamines present in 1.18. This can be explained by the 
fact that one of the olefins in 1.18 constitutes a vinylogous amide, which is much less 
acid sensitive and therefore less prone to undergo cyclization with the tethered indole. 
Following the cyclization, the vinylogous amide function of 1.19 was reduced in a two-
step protocol commencing with O-alkylation with Meerwein salt followed by 
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hydrogenation of the tetrafluoroborate salt 1.20 to afford 1.21. The total synthesis of 1.5 
was then completed by partial reduction of the malonate with DIBAL followed by acid 
catalyzed methylation to form the vinylic carbonate of hirsutine. These last two 
















































































1.2.5 Brown’s Racemic Synthesis of Hirsutine (1984)  
The main challenge in devising an efficient synthesis of the corynanthe alkaloids 
is to control the relative stereochemistry of the C3, C15 and C20 stereocenters around the 
D-ring. Brown and co-workers10 envisioned accomplishing this task by setting the 
relative stereochemistry around a five-membered ring in which eclipsing 1,2-interactions 
would insure nearly complete diastereoselectivity. As depicted in Scheme 1.4 this would 
allow access to the synthetic dihydrosecologanine aglucone analogue 1.29.  Given the 
success in converting dihydro secologanine (1.11) into various indole alkaloids (vide 
supra) including hirsutine (1.5), Brown and co-workers anticipated an efficient entry into 
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Vinylogous Claisen condensation of hex-2-enoate (1.23) with dimethyl oxalate 
furnished the novel cylcopentene dimer 1.24 in 50% yield. This material exists in an 
equilibrium with cyclopentenone derivative 1.25, which underwent a highly 
diastereoselective Michael addition when exposed to dimethylmalonate and triethylamine 
to provide 1.26 in quantitative yield as a single stereoisomer. Hydrogenation over Raney 
nickel afforded diol 1.27, which was cleaved upon exposure to sodium periodate to 
furnish the secologanine analogue 1.29. Reductive amination with tryptamine furnished 
1.30 (50% yield), which was subjected to a one-pot ester hydrolysis/decarboxylation 
protocol followed by intramolecular stereoselective Pictet-Spengler reaction to afford 
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indoloquinolizidine 1.21 in 35% yield. The conversion of 1.21 to hirsutine (1.5) was 
accomplished using the procedure already described by Wenkert.9 While the synthesis is 
rather concise, it is not readily adapted to an enantioselective synthesis. This issue was 
eventually addressed by Brown and co-workers about six years later, resulting in the first 
enantioselective synthesis of hirsutine (vide infra).  
1.2.6 Brown’s Enantioselective Synthesis of Hirsutine (1990)  
Brown’s approach to the asymmetric synthesis of hirsutine was to employ an 
chiral malonate equivalent in the form of the ephedrine derived oxazepine 1.31. As 
depicted in Scheme 1.5, refluxing oxazepine 1.31 and cyclopentene dimer 1.23 in 
dichloromethane in the presence of triethylamine effected a thermodynamically 
controlled Michael addition, which set the two adjacent stereocenters on the cyclopentene 
ring with reasonable diastereoselectivity (85:15). After facile separation of diastereomers 
by silica gel chromatography, the desired isomer 1.32 could be isolated in 60% yield. 
With this material in hand, the researchers pressed forward toward the chiral 
secologanine analogue 1.29. The oxazepine chiral auxiliary needed to be replaced with a 
malonate while retaining the fidelity of the two newly created stereocenters. In order to 
accomplish this goal, Brown first established that it was necessary to elaborate the 
Michael adduct 1.32 to 1.33, in which the oxazepine had undergone ring-opening so as to 
render the cyclopentenone less sterically encumbered. Once the oxazepine ring had been 
opened, enone 1.33 could be reduced and further elaborated to 1.34 in preparation for the 
removal of the auxiliary. In the event, heating 1.34 in the presence of dimethylmalonate 
and triethylamine afforded cyclopentenone derivative 1.35 following acylation. This 
material was obtained in 25% yield over eight steps, and the enantiomeric excess was 
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found to be greater than 96%. Additionally, the auxiliary was easily recovered and 
recycled. 
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With cyclopentene derivative 1.35 in hand, only a few straightforward 
transformations remained to complete the synthesis of enantiopure dihydrosecologanine 
1.29. The completion of the first asymmetric synthesis of hirsutine (1.5) was then 
achieved using the same chemistry developed for the racemic synthesis. While the chiral 
asymmetric Michael addition is certainly an interesting tactic on its own merit, the 
drawback of its application to the asymmetric synthesis of hirsutine is that a rather long 
sequence of functional group transformations was required, resulting in a synthesis 
totaling 17 steps.  
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1.2.7 d’Angelo’s Racemic Formal Synthesis of Hirsutine (1992)  
The approach developed by d’Angelo11 relied on a 1,4-addition to introduce the 
C(15) substituent on the D-ring. It had been established earlier that α,β-unsaturated 
lactams structurally related to 1.41 were not reactive toward 1,4-addition of dialkyl 
malonates,12 and it was hypothesized that the conversion of the lactam to a thiolactam13 
would render it more susceptible toward 1,4-addition. Starting with the known 
indoloquinolizidine 1.38,14 a five step sequence furnished thiolactam 1.41 in good overall 
yield, setting the stage for the key 1,4-addition. The presence of the ethyl group in 1.41 
significantly reduced its reactivity toward 1,4-addition with dimethylmalonate. As a 
result the reaction required four days at room temperature to go to completion, which 
stands in stark contrast to the des-ethyl analogue (not shown), which only required 5 
hours. In spite of the poor reactivity, adduct 1.42 was obtained in 90% yield albeit as an 
inseparable mixture of C15 epimers (dr = 6:1). However, following desulfurization of the 
mixture, the two epimers 1.43 were readily separated by chromatography. The formal 
synthesis of 1.5 was then completed by removing the N-benzyl protecting group through 
dissolving metal reaction to afford 1.24 in a moderate yield of 35-40%. 
Indoloquinolizidine 1.24 had previously been converted to hirsutine (1.5) in two steps by 
Wenkert (vide supra). d’Angelo’s approach to 1.44, which was eight steps from 1.38 
(nine steps from tryptamine), provides an interesting solution the problem of the poor 
reactivity of α,β-unsaturated lactams in 1,4-additions. It also represents one of the first 
successful applications of a 1,4-addition to introduce the C(15)substituent in corynanthe 
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1.2.8 Lounasmaa’s Racemic Synthesis of Hirsutine (1997) 
In their ABD→ABCD approach to corynanthe alkaloids, Lounasmaa and co-
workers utilized the addition of dimethylmalonate to a vinylogous iminium ion as a key 
step (Scheme 1.7).15 The synthesis of the requisite substrate 1.48 commenced with the 
alkylation of 3-ethylpyridine (1.44) with tryptophyl bromide (1.15), and the resultant 
pyridinium ion was subjected to acid promoted addition of cyanide ion followed by 
reduction with sodium borohydride to afford 1.46 in good yield. Following acid-
catalyzed cyclization, the resultant indoloquinolizidine 1.47 then underwent an 
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interesting three step, one-pot transformation. The tertiary nitrogen was first oxidized 
with mCPBA. The N-oxide intermediate thus formed was subjected to a modified 
Polonovski reaction by the addition of trifluoroacetic anhydride, which generated a 
conjugated iminium ion that was trapped in situ with cyanide ion to afford 1.48 in a 
modest yield of 26%. This modified Polonovski protocol was extensively studied,16 and 
the regiochemistry of the iminium ion formation was found to be highly dependant on the 
nature of the substrate as well as on the specific reaction conditions used.   
Exposure of 1.48 to AgBF4 regenerated the conjugated iminium ion 1.49, to 
which sodium dimethylmalonate was added in a 1,4-sense to afford 1.50 in a moderate 
yield (44%). Following stereoselective hydrogenation of the tertiary olefin of 1.50, the 
synthesis was completed using the same endgame as described by Wenkert.9 
Lounasmaa’s synthesis avoided the use of protecting groups, and it is only eight steps 
from tryptophyl bromide. However; the low yields associated with the modified 
Polonovski reaction and the key addition to the vinylogous iminium ion detracts 
somewhat from the overall elegance of this approach. Additionally, the 
diastereoselectivity of the vinylogous iminium reaction as well as the ensuing 
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1.2.9 Lounasmaa’s Second Generation Racemic Synthesis of Hirsutine (1998) 
In 1998 Lounasmaa published a second generation synthesis of hirsutine, this time 
utilizing chemistry developed for their approach to geissoschizine and 
dihydrocorynantheol that employed a stereoselective Claisen rearrangement as a key 
step.17 The synthesis commenced with the four-step preparation of the diastereomeric 
allylic alcohols 1.53 in 24% overall yield from tryptophyl bromide (1.12). This 
represented a slight improvement over Ziegler and Sweeney’s approach to the same 
intermediate (five steps, 14% overall yield), which was used in their synthesis of 
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dihydrocorynantheol (vide infra).18 After introducing a substituted vinyl group via 1,4-
addition of 1.53 to methyl propiolate, the key Claisen rearrangement followed to deliver 
1.55 and 1.56, in a combined yield of 32% and a 5:4 ratio. Because of difficulties with 
separation, this mixture was treated with Boc2O, after which the stereoisomers were 
easily separated to afford the pure stereoisomer 1.57 in 40% yield. At this point, all that 
remained was the conversion of 1.57 to 1.58 followed by hydrogenation of the ethylidine 
group to complete the synthesis of 1.5. Unfortunately, virtually no diastereoselectivity 
was achieved in the latter transformation. 
The strength of Lounasmaa’s synthesis of hirsutine (1.5) was the key Claisen 
rearrangement, which allowed for the rapid installation the C15 appendage. However, 
while the synthesis was only nine steps, the low yield of the key step coupled with the 
need for three separations of almost equimolar mixtures of diastereomers makes this 











































































































1.2.10 Tietze’s Enantioselective Total Synthesis (1999) 
Perhaps the most interesting contribution came from the Tietze laboratory,19 and 
their synthesis represents the most concise enantioselective approach to hirsutine to date. 
Additionally, the Tietze synthesis also constitutes a biomimetic approach involving a 
highly regio- and diastereoselective tandem reaction as a key step to rapidly construct the 
fully functionalized D-ring. As depicted in Scheme 1.9, sonication of a solution of 
aldehyde 1.66, Meldrum’s acid 1.65, enolether 1.68, and a catalytic amount of 
ethylenediamine diacetate (EDDA) in benzene for 12 hours effected an intermolecular 
Knoevenagel condensation to afford the 1-oxa-1,3-butadiene 1.69. This highly reactive 
intermediate immediately underwent a hetero Diels-Alder reaction with enol ether 1.68 
present in the reaction mixture to furnish cycloadduct 1.70, which in turn suffered in situ 
thermolysis involving the loss of acetone and carbon dioxide to provide cycloadduct 1.71 
in 84% yield and in a 20:1 diastereomeric ratio. Solvolysis of the crude 1.71 afforded 
aldehyde 1.72, which upon hydrogenolysis of the Cbz group underwent cyclization to 
form the tetracyclic indoloquinolizidine intermediate 1.73. From this point, only three 
transformations remained to complete the synthesis of 1.5; deprotection of the Boc-
























1.63 R = CO2Et
1.64 R = CH2OH




































































































While the elegant domino-sequence was an efficient way to construct the 
indoloquinolizidine ring system, the approach required a total of fifteen steps to complete 
the synthesis of 1.5. An obvious shortcoming was the fairly lengthy sequence that was 
required to prepare the enantiopure aldehyde 1.66, which involved chromatographic 
separation of a mixture (1:1) of diastereomeric amides 1.63 derived from camphanic acid.  
This issue was addressed in a later publication, in which an enantioselective approach to 
tetrahydro-β-carbolines and tetrahydroisoquinolines was developd.20 As outlined in 
Scheme 1.10, racemic 1,2,3,4-tetrahydro-β-carbolines such as 1.75 were obtained via a 
Pictet-Spengler reaction of tryptamine (1.59) with keto acid 1.74. This intermediate could 
then be oxidized with solid KMnO4 to provide imine 1.76. An asymmetric ruthenium 
catalyzed transfer hydrogenation using 1.77 then provided the requisite carboline 
derivative 1.78 in excellent yield (96%) and enantiomeric excess (>98%). Further 
functional group transformation finally yielded the requisite aldehyde 1.66 en route to 
hirsutine. The improved route to 1.66 reduced the length of the synthesis of hirsutine with 
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1.3 RHYNCHOPHYLLINE AND ISO-RHYNCHOPHYLLINE 
1.3.1 Background 
Rhynchophylline (1.7) and its C(7) epimer iso-rhynchophylline (1.8) were first 
isolated by Kondo and co-workers in the early 1900’s from the aerial parts of Uncaria 
Rhynchophylla (Rubiaceae).21 There are approximately fifty species of this vine-like 
plant distributed throughout the tropical regions around the world, and many have found 
use in traditional medicine. For example, various species of Uncaria have been employed 
in Malaysian traditional medicine for the treatment of cardiovascular disorders such as 
hypertension, and 1.7 and its 1.8 are believed to be the active principles. The 
investigation into the biological activity of 1.7 and 1.8 has continued until present time, 
and these alkaloids were recently found to protect against glutamate-induced neuronal 
death in cultured cerebellar granule cells.22 
An interesting synthetic challenge associated with these alkaloids is the C(7) 
spirocenter, which is known to be configurationally labile. In fact, rhynchophylline (1.7) 
and iso-rhynchophylline (1.8) are known to equilibrate upon standing via a retro-
Mannich/Mannich pathway. This is an important consideration when designing a 
synthesis of 1.7 and 1.8 since the early introduction of the oxindole function likely will 
result in epimerization of the C(7) spirocenter. 
1.3.2 Finch and Taylor’s Partial Syntheses of Rhynchophylline and Iso-
rhynchophylline (1962) 
Aside from a one-step conversion of corynoxeine to rhynchophylline in 1952,23 
the first partial synthesis of rhynchophylline was reported by Finch and Taylor in 1962.7 
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These workers examined the application of a biomimetic oxidative rearrangement to 
convert indole alkaloids to their corresponding oxindole counterparts. As depicted in 
Scheme 1.11, dihydrocorynantheine (1.79) was treated with t-butyl hypochlorite to 
chlorinate the C-3 position of the indole. The resultant chloroindole species 1.80 was 
refluxed in methanol to effect the conversion of 1.80 to imido ether 1.81. Finally, 1.81 
was refluxed in 10% acetic acid, which hydrolyzed the imido ether to the target oxindole 
1.7 which could be isolated in 32% yield over the three steps.  
Oxindole alkaloids are not configurationally stable at C(7) but undergo 
epimerization via a retro-Mannich/Mannich pathway as indicated in Scheme 1.11. The 
energy difference between the two epimers is very small as many oxindole natural 
products exist in nearly a one to one ratio. Interestingly, this equilibrium composition is 
slightly different in acidic and basic media with rhynchophylline being the predominant 
isomer in acidic solutions where as isorhynchophylline predominates under basic 
conditions. Finch and Taylor took advantage of this phenomenon by refluxing synthetic 
rhynchophylline (1.7) in pyridine overnight to convert it to isorhynchophylline (1.8), 























































The studies on the oxidative rearrangements of indoles to oxindoles by Finch and 
Taylor, Seaton and Nair,24 Acklin25 as well as Martin,26 have been of great importance in 
the area of oxindole alkaloid synthesis. To this day they continue to inspire the 
development of new, innovative methods for the construction of oxindoles as will be 
discussed in detail in chapters 3 and 4. 
1.3.3 Ban’s Racemic Total Syntheses of Rhynchophylline (1974) 
The synthesis of 1.8 by Ban and co-workers27 commenced with the condensation 
of 2-hydroxytryptamine hydrochloride (1.83) with ethyl sodium formyl acetate (1.84) to 
furnish 1.86 via the intermediacy of 1.85. These reaction conditions were carefully 
optimized to avoid hydrolysis/decarboxylation of the ethyl ester. The resultant secondary 
amine 1.86 was then condensed with ethyl α-formyl butyrate (1.87) to give 1.88, which in 
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turn was hydrogenated to furnish a mixture of diastereomers 1.89a and 1.89b. The lack of 
diastereoselectivity could be explained by epimerization of the spirocycle via a retro-
Mannich/Mannich pathway during the acidic reaction conditions. After chromatographic 
separation of diastereomers, a diastereomerically pure sample 1.89b was subjected to 
Diekmann condensation followed by acid catalyzed hydrolysis/decarboxylation to afford 
a mixture of the C(7) epimers 1.90a and 1.90b. The reaction could also be carried out 
starting with the other isomer 1.89a. Following chromatographic separation of the 
diastereomers, 1.90b was subjected to a Horner-Wadsworth-Emmons reaction with 
phosphonate 1.91 to give 1.92 as an unidentified mixture of olefin regio- and geometrical 
isomers. The mixture was hydrogenated using Adams’ catalyst in acetic acid to afford the 
three saturated esters 1.93a, 1.93b, 1.93c in 38%, 28%, 22% yield respectively. This 
represented an improvement over earlier reaction conditions using palladium on carbon 
in ethanol which gave the three isomers in 6%, 26% and 37% yield. The stereochemistry 
of 1.93c was not fully elucidated but the isomer was presumed to have the C(15)-C(20) 
cis-configuration. With the complete tetracyclic framework in hand, only three steps 
remained to complete the synthesis. Even though one could envision either isomer 1.93a 
or 1.93b as being carried forward, only 1.93b was elaborated to the final targets. Thus, 
condensation with ethyl formate followed by methylation with diazomethane furnished 
iso-rynchophylline (1.8). The natural product was then be epimerized under acidic 
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The archetypal corynanthe alkaloid dihydrocorynantheol (1.6) was first isolated in 
1962 by Djerassi and co-workers.28 It was obtained from the bark of Aspidosperma 
marcgravianum Woodson (Apocynaceae), and it has been shown to possess antimicrobial 
activity against Gram-positive bacteria.29 While closely related to hirsutine (1.5), 
dihydrocorynantheol (1.6) possesses the more thermodynamically stable “normal” 
configuration (C(3)-H α,  C(15)-H α, C(20)-H β).  
Dihydrocorynantheol has been a popular target for showcasing new 
methodologies and synthetic strategies, and a substantial amount of work has been 
recorded in the literature. Several of the early accounts were semi-syntheses using other 
alkaloids as starting material. Thus, dihydrocorynantheol has been prepared from 
dihydrocorynantheine,30 geissoschizol,31 quinine,32 ajmalicine33 and guettardine.34  The 
first total syntheses of 1.6, appeared as early as 1969 and was published by Ziegler and 
Sweeny (vide infra).18 
1.4.2 Zieglers’s Synthesis of Dihydrocorynantheol and 3-epi-Dihydrocorynantheol 
(1969) 
The key step in the synthesis by Ziegler and Sweeny18 was a reaction developed 
by Eschenmoser,35 in which allylic alcohol 1.97 was condensed with dimethylacetamide 
dimethylacetal (1.98) resulting in an intermediate 1.99 that was poised to undergo a 
Claisen rearrangement (Scheme 1.13). The synthesis commenced with the elaboration of 
6-chloronicotinic acid (1.94) to furnished secondary alcohol 1.95, which was alkylated 
with tryptophyl bromide to afford 1.96 in modest yield (27%). Reduction of 1.96 with 
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sodium borohydride then delivered the key intermediate 1.97 as mixture (1:1) of 
diastereomers. Upon refluxing this mixture in dioxane in the presence of 
dimethylacetamide dimethylacetal (1.98), amides 1.100a and 1.100b were formed in 
73% yield as a mixture of 4 different isomers due to the formation of diastereomers and 
olefin E/Z isomers. Amides 1.100a and 1.100b could be separated by prep-TLC, although 
both were isolated as a mixture of E/Z isomers. Amide 1.100b was then subjected to 
hydrolysis, Fisher esterification, and LiAlH4 reduction to deliver 1.102, again as mixture 
of E/Z isomers. Finally, hydrogenation of the olefin afforded 1.103 the major product and 
dihydrocorynantheol (1.6) as the minor constituent.36 Interestingly, 1.102 resulted from 












































1.100b R = N(CH3)2, C3-H β









73%, dr = 1:1
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1.100a R = N(CH3)2, C3-H α
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1.103 R = C3-H β, C20-H β
1.6     R = C3-H α, C20-H β
1.99
1.102
1.105 R = C3-H β, C20-H α
1.104 R = C3-H α, C20-H α
1.98
 
This eleven step synthesis represents an excellent example of the challenges 
involved in designing an efficient approach to the corynanthe alkaloids, namely 
controlling the stereochemistry of the C(3), C(15), and C(20) stereocenters around the D-
ring. While it incorporates an interesting tactic for the introduction of the C(15) 
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substituent, Ziegler’s approach fell short with regard to controlling stereochemistry, and 
this challenge has continued to inspire chemist up to present time. 
1.4.3 Kametani’s Total Synthesis of Dihydrocorynantheol (1980) 
In contrast to Zieglers’s approach, Kametani offered an elegant solution to the 
challenge of controlling the D-ring stereochemistry.37 Kametani’s synthesis utilized an 
enamine annelation of 3,4-dihydro-1-methyl-8-carboline (1.106), which is available in 
two steps from tryptamine, with 3-methoxy-allylidinemalonate (1.107) to afford 1.108 in 
77% yield as a single stereoisomer. Following introduction of the ethyl substituent via 
alkylation, the olefin of 1.109 was reduced by hydrogenation using Adams’s catalyst to 
afford 1.110 in 96% yield as a single stereoisomer. The hydrogenation was presumed to 
occur from the sterically more accessible face to give 1.110 exclusively. Interestingly, 
two stereoisomers were formed in this reaction if palladium on carbon was used as the 
catalyst rather than Adam’s catalyst (PtO2).  
Following saponification of the methyl ester, the β-keto acid 1.111 underwent 
decarboxylation upon heating to 160 °C in DMSO. The acetal was partially hydrolyzed to 
the aldehyde during the decarboxylation reaction, and exposure of the resultant mixture 
to pTsOH cleanly afforded 1.112 in 92% yield from 1.111. Finally, the aldehyde and the 




































































1.6 OH  
The level of stereocontrol in this synthesis is remarkable. While the 
stereochemistry of 1.108, 1.109 and 1.110 was not fully elucidated, each was formed as a 
single stereoisomer. The synthesis consists of nine steps from tryptamine in its longest 
linear sequence. However, while it is a simple and elegant synthesis, Kametani’s 
synthesis, unlike other approaches to this molecule, does not readily lend itself to the 
enantioselective preparation of 1.6.  
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1.4.4 Danieli and Palmisano’s Total Synthesis of Dihydrocorynantheol (1981) 
The synthesis of 1.6 by Danieli and Palmisano was very similar to that of 
Kametani in that it utilized the 1,4-addition of 1.106 to an enoate.38 In this case lactone 
1.113 was used, which was available in three steps from 1,3-propanediol. Following the 
successful 1,4-addition, a lactone-lactam rearrangement spontaneously ensued to deliver 
1.114 in 71% yield and 19:1 diastereoselectivity. Danieli then devised an interesting 
solution to the problem of diastereoselectively and reduced the enamine of 1.114 to 
control the C(3) stereochemistry. Following reduction of the lactam with LiAlH4, a 
solution of NaBH4 in 2-propanol was added. This resulted in the protonation of the 
enamine function to give an iminium ion, which was reduced to furnish 1.115 with 
complete stereoselectivity. Deprotection of the THP group followed by reductive removal 









































The synthesis described above was fairly concise affording 1.6 in eight steps in its 
longest linear sequence (ten steps total) and with a high degree of stereoselectivity. 
  34
However, like Kametani’s approach, there was no apparent way to render the strategy 
enantioselective.  
1.4.5 Takano’s Total Synthesis of Dihydrocorynantheol (1981) 
Takano and co-workers developed an approach that allowed access to alkaloids of 
all four possible stereochemical configurations; normal, allo, pseudo, and epi-allo, 
through epimerizations and separation of diastereomers at various stages of the 
synthesis.39 Two routes to dihydrocorynantheol were actually developed; however, the 
one presented in Scheme 1.16 was the most efficient requiring only one separation of 
diastereomers.  
Carboxylic acid 1.119, which was prepared in seven steps from (±)-norcamphor 
(1.116), was coupled with tryptamine via a mixed anhydride to afford 1.120 in 72% yield. 
Bishler-Napieralski reaction of 1.120 followed by NaBH4 reduction of the resultant 
iminium hydrochloride salt proceeded with spontaneous lactam formation to give 1.121 
and 1.122 in 51 % yield as an equimolar mixture of diastereomers. This mixture could be 
separated following conversion of 1.121 and 1.122 to the corresponding selenides 1.123 
and 1.124. Elaboration of 1.124 to dihydrocorynantheol (1.6) was then accomplished in 
ten relatively straightforward steps, with the last four transformation being devoted to the 
epimerization of the C(3)-proton. By choosing norcamphor (1.116) as the starting 
material, Takano ensured that the synthesis would readily lend itself to the 
enantioselective preparation of 1.6. However, the synthesis was relatively lengthy 
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1.4.6 Suzuki and Kametani’s Enantioselective Synthesis of (-)-Dihydrocorynantheol 
(1985)   
The first enantioselective synthesis of 1.6 was reported by Suzuki and Kametani 
in 1985.40 The chirality was derived from (R)-1,2-isopropylidineglyceraldehyde (1.127), 
which was elaborated to cyclopentenone 1.128 via a seven-step sequence involving 
chirality transfer using an orthoester Claisen rearrangement.  The chiral synthon 1.128 
was further elaborated in nine steps using a 2,3-sigmatropic rearrangement and a 
stereoselective hydrogenation as key steps to provide thioketal carboxylic acid 1.134, 
bearing the two adjacent stereocenters that would eventually become the C(15) and C(20) 
carbons of the D-ring. Following conversion of the carboxylic acid function to acetate 
1.135, the dithiane was deprotected to reveal an aldehyde that underwent a Pictet-
Spengler reaction with tryptamine. After removal of the silyl protecting group, 1.136 
could be obtained in almost quantitative yield over the three steps. Unfortunately, there 
did not seem to be any significant stereocontrol in the Picted-Spengler reaction. While the 
two diastereomers were inseparable at this stage, following ring-closure via mesylation 
and intramolecular alkylation, the two indoloquinolizidines 1.137 and 1.138 were isolated 
in 30% and 26% respectively. One should note that it was possible to convert 1.138 to 
1.137 via a two step sequence by the dehydrogenation with Hg(OAc)2 to give an iminium 
ion which was then reduced with NaBH4. Finally, hydrolysis of the acetate of 1.137 
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While these efforts did result in the first enantioselective synthesis of 
dihydrocorynantheol, the synthesis was exceedingly lengthy, requiring a total of 23 steps 
from (R)-1,2-isopropylidineglyceraldehyde (1.127). Furthermore, there was virtually no 
stereocontrol in the Pictet-Spengler reaction resulting in a roughly mixture (1:1) of C(3) 
epimers, which had to be separated by chromatography.  
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1.4.7 Fukumoto’s Total Synthesis of Dihydrocorynantheol (1987) 
In his synthesis of dihydrocorynantheol, Fukumoto employed a radical cyclization 
as a key step to construct the D-ring and to control the relative stereochemistry of the 
C(15) and C(20) stereocenters.41 When enoate 1.141, which was prepared in five steps 
from 2-ethylpropane-1,3-diol,42 was treated with tributyltinhydride in the presence of 
AIBN, the corresponding tetrahydropyran derivatives 1.142 and 1.143 were formed in 
94% yield as a mixture of all four possible diastereomers (Scheme 1.18). This reaction 
could also be carried out using the corresponding α-bromo ester of 1.141 to give a single 
diastereomer, albeit in only 35% yield. The mixture of 1.142 and 1.143, which could not 
be separated at this stage, was further elaborated through four steps to give 1.144 and 
1.145 in a 4:1 ratio, which could be separated by HPLC. The major isomer 1.144 was 
then condensed with tryptamine, which following mesylation of the resultant alcohol and 
exposure to KOtBu, afforded the indole derivative 1.146 in 70% yield. Finally, Bischler-
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Fukumoto’s approach, which was sixteen steps from 1.139, featured an interesting 
strategy for controlling the stereochemistry around the D-ring. However, the need for 
carrying a mixture of four diastereomers through a four-step sequence coupled with the 
low level of diastereoselectivity in the radical cyclization (4:1) leaves room for further 
improvement.  
1.4.8 Fuji’s Enantioselective Synthesis of (-)-Dihydrocorynantheol (1991) 
Fuji and co-workers developed a gram-scale enantioselective synthesis of 1.6. The 
synthesis started from piperidine 1.147, which was available through degradation of (+)-
cinchonine or through completely synthetic means. A major challenge in the synthesis 
was the equilibration of the 3,4-cis piperidine 1.150 to the 3,4-trans derivative 1.151, 
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which gave a mixture (66:34) of unseparable diastereomers. Fuji found that the 
diastereomeric p-methoxybenzoate derivatives 1.152a and 1.152b could be readily 
separated by crystallization. Following removal of the protecting group of the unwanted 
diastereomer 1.152b, this material was then resubmitted to the equilibration protocol 
resulting in a 73% combined yield of 1.152a from 1.150 after two recycles. The synthesis 
could then be completed in nine steps in a relatively straightforward manner. The strength 
of Fuji’s approach, which required 14 steps from 1.147, was that it allowed for the 
preparation of 1.6 on gram scale. This was a significant improvement over the previous 
enantioselective synthesis, which only afforded 1.6 in milligram quantities.40 On the other 
hand, the synthesis was quite lengthy when considering the number of steps required to 
prepare the starting material 1.147. Additionally, only modest levels of stereoselectivity 
were obtained in the equilibration protocol resulting in the need to recycle the unwanted 

























































1.148 1.149 R = Et 1.151









































1.4.9 Lounasmaa’s Synthesis of (-)-Dihydrocorynantheol (1991) 
 Louansmaa and co-workers decided to re-examine the approach described by 
Ziegler and Sweeny, in which a diastereomeric mixture of allylic alcohols served as 
precursors for a key Claisen rearrangement.18 Lounasmaa reasoned that if 
diastereomerically pure allylic alcohol 1.97 was used in the Claisen rearrangement, one 
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would likely be able to attain high levels of diastereoselectivity. Using an improved route 
to the pure diastereomer 1.97 that involved separating diastereomers through successive 
fractional crystallization (vide supra),15 they then attempted the direct conversion of 1.97 
to 1.159 using trimethyl orthoacetate. While a diastereomeric ratio was not given, the 
reaction clearly exhibited some diastereoselectivity since the desired diastereomer was 
isolated cleanly in 77% yield. Following reduction of the ester to a primary alcohol 
1.160, only the hydrogenation of the exocyclic olefin remained to complete the synthesis. 
However, as was observed by Ziegler and Sweeny, this reaction proceeded with virtually 
no diastereoselectivity to deliver 1.6 in 50% yield following chromatographic separations 
of the two diastereomers. Lounasmaa’s synthesis of hirsutine only required seven steps 
from tryptophyl bromide, and it is therefore the shortest synthesis of 1.6. However, it was 
not diastereoselective and required two separations of virtually equimolar mixtures of 
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1.4.10 Meyers’ Enantioselective Synthesis of (-)-Dihydrocorynantheol (1991) 
Meyers’ synthesis represents an elegant solution to the challenge of controlling 
both the relative and absolute stereochemistry.43 His strategy involved directed lithiation 
of carboline derivative 1.165 bearing a chiral formamidine directing group. Using this 
tactic, cyanomethyl substituted carboline 1.166 was obtained in up to 65% yield and 85% 
ee (Scheme 1.21). Acylation of the resultant secondary amine 1.166 with 2-
bromobutanoyl chloride (1.167) then set the stage for a rarely used Blaise reaction using 
zinc-silver couple and sonication to construct the D-ring and provide 1.169 in 84% yield. 
Interestingly, following additional functional group transformation to give 1.171, it was 
discovered that the C(15) ethyl group cleanly underwent epimerization under the acidic 
MOM deprotection conditions to provide 1.172 in 84% yield and 10:1 
diastereoselectivity. Ketone 1.172 was then subjected to a Horner-Wadsworth-Emmons 
olefination followed by diastereoselective hydrogenolysis and reduction of the ethyl ester 
to complete the total synthesis of 1.6. 
The control of relative stereochemistry was generally good through out the 
synthesis, but the approach required a total of 13 steps from commercially available 
carboline 1.62. While this is somewhat lengthy, it is a considerable improvement over 
previous enantioselective syntheses of 1.6. It is noteworthy that Meyers asymmetric 
approach to dihydrocorynantheol also could be used to prepare the closely related natural 
product corynantheidol, which differs from dihydrocorynantheol only in the 
stereochemistry of the C(20) ethyl substituent. Simply by delaying the deprotection of the 
MOM group until the last step of the synthesis, the epimerization of the C(20) ethyl 
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62%, 2 steps
1.171 R = CH2OMe, C15-H α
















1.4.11 Rubiralta’s Synthesis of Dihydrocorynantheol (1993) 
Rubiralta and co-worker used a rather different approach to dihydrocorynantheol 
as compared with previous synthesis.44 Rather than the classical ABD→ABCD approach, 
their strategy involved the formation of spiroindolenine 1.182 upon exposure of 1.181 to 
KOtBu.  Lewis acid activation of the imine nitrogen of 1.182 resulted in the formation of 
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two new products.  As shown in Scheme 1.22, path b involved the attack of the ester 
enolate onto the C(2) position of the indole delivering tetrahydroakummicine 1.184 with 
the characteristic carbon skeleton of the Strychnos alkaloids.  Path a, on the other hand, 
involved a C(3)-C(2) bond migration to furnish 1.183. The two products 1.183 and 1.184 
were obtained in a combined yield of 28% in a 1:2 ratio, and with 1.183 in hand, the 
synthesis of dihydrocorynantheol (1.6) could be completed by the reduction of the ester 
to the primary alcohol (Scheme 1.22).  
The synthesis of dihydrocorynantheol (1.60) was completed in nine steps from 
1.175 and 1.176, but the brevity of the sequence was offset by the low yield and poor 
selectivity of the key step. Moreover, the synthesis leading up to the substrates 1.181 was 
complicated by a lack of stereocontrol. For example, when the acetal function in 
piperidine 1.177 was hydrolyzed under acidic conditions, the C(5) stereocenter bearing 
the ethyl group was epimerized to a 2.5:1 ratio of cis to trans isomers. Likewise, the 
hydrogenation of the enoates resulting from the HWE olefination of 1.178 and 1.179 
resulted in a complicated mixture of diastereomers that had to be separated prior to 
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then  BF3 Et2O
28% from 1.181
1.179 R = C5-H β
1.178 R = C5-Et α
1.181 R1 = CH2CO2Me; R2 = H























1.4.12 Itoh’s Enantioselective Total Synthesis of ent-Dihydrocorynantheol (2006) 
Itoh and co-workers recently reported an attractive enantioselective synthesis of 
ent-dihydrocorynantheol, which was published after we had completed our work in this 
area. Their approach relied on organo-catalysis to construct C(3)-substituted 1,2,3,4-
tetrahydro-β-carboline derivatives in an enantioselective manner.45 Tosyl protected 
carboline 1.185, which was the substrate for the key step, was available in three steps 
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from tryptamine (Scheme 1.23). This material was exposed to the enamine derived from 
(S)-proline and 3-ethyl-2-butene-2-one to (1.186) give 1.185 in 85% yield and 90% ee 
with complete diastereoselectivity. It was not possible to draw any conclusions about the 
mechanism of the reaction since no intermediates could be isolated, but it was postulated 
that the reaction could proceed either via a hetero Diels-Alder mechanism or a Mannich-
Michael-type pathway. However, the authors made the observation that the reaction 
works equally well using enamines derived from various methyl ketones, which undergo 
a Mannich reaction with 1.185 but cannot undergo the cyclization due to the lack of the 
enone functionality. This result suggests that the reaction of 1.185 with the enamine 













































With advanced intermediate 1.187 in hand, the synthesis was completed by 
performing a Horner-Wadsworth-Emmons reaction to furnish 1.188, which upon 
exposure to Red-Al underwent reduction of the ester function to give the corresponding 
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alcohol 1.189 with concomitant deprotection of the tosyl group. Finally, the C(15) 
stereocenter was set through a diastereoselective hydrogenation to give ent-
dihydrocorynantheol (ent-1.6). By simply using (L)-proline instead of (S)-proline one 
should be able to obtain the correct absolute stereochemistry of the natural product. A 
potential drawback to Itoh’s approach is that a large excess (30 equivalents) of enone 
1.186 was needed in the key step, which would make the synthesis impractical on larger 
scale. Furthermore, even though an excess was used, this reaction required seven days at 
room temperature to go to completion. Nevertheless, Itoh’s strategy resulted in the most 
concise enantioselective synthesis of ent-1.6 requiring only seven steps from tryptamine. 
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1. 5 PRIOR ART IN THE MARTIN GROUP 
We have had a long-standing interest in the development of general and efficient 
strategies for the synthesis of a wide variety of complex indole alkaloids. In particular, 
we have demonstrated the utility of ring-closing metathesis (RCM) as an extremely 
powerful construct in alkaloid synthesis, and we have expanded the scope of this useful 
transformation to allow access to a number of structurally diverse alkaloids.46 After the 
initial disclosure by Grubbs and Fu in 1992 that RCM can be exploited to construct 
nitrogen-containing heterocycles from α,ω-dienes,47,48 we rapidly capitalized on the 
tremendous utility of RCM. In fact, our application of RCM to the construction of the 
ABCE ring system of manzamine represents on of the first examples of RCM in complex 
alkaloid synthesis.46a 
1.5.1 Diastereoselective Total Synthesis of Dihydrocorynantheol 
In the context of our on-going efforts to apply and expand the scope of ring-
closing metathesis towards alkaloid synthesis, we envisioned the potential of this 
transformation for the rapid construction of the D-ring of various corynanthe and 
oxindole alkaloids. In particular, an extremely concise route to dihydrocorynantheol (1.6) 
was developed using RCM as a key step.49 Unlike our previous applications of RCM to 
alkaloid synthesis, this approach utilized RCM to fabricate α,β-unsaturated lactam that, in 
turn, could serve as a substrate for 1,4-additions of various nucleophiles, thus rapidly 
building up complexity while maintaining good control of relative stereochemistry. 
As depicted in Scheme 1.24, the synthesis of 1.6 commenced with the EDCI-
mediated coupling of indole-3-acetic acid (1.190) and diallylamine to give 1.191 in 88% 
yield. This material was then subjected to a one-pot RCM/zirconium catalyzed 
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carbomagnezation to afford 1.194 in 71% yield. The applications of carbomagnezations 
in natural product synthesis are rare,50 and since this transformation can be carried out in 
an enantioselective fashion using chiral ligands,51 the present strategy may readily 
adapted to provide dihydrocorynantheol enantioselectively. Reduction of the lactam 
function of 1.194 with LiAlH4 and acylation of the resultant secondary amine with 
acryloyl chloride delivered 1.196, thus setting the stage for a second RCM. In the event, 
exposure of 1.196 to Grubbs first generation catalyst 1.192 afforded the key α,β-
unsaturated lactam 1.197 in 91% yield. This pivotal intermediate then served as a 
substrate for the critical 1,4-addition, and through the judicial selection of nucleophiles, 














































1.194: X  = O

































For the purpose of preparing dihydrocorynantheol, the 1,4-addition of a vinyl 
equivalent was studied in depth. It was eventually discovered that the cuprate derived 
from vinylmagnesium bromide and copper cyanide in the presence of TMSCl was an 
excellent nucleophile, which afforded the adduct 1.198 in 91% yield and 92:8 
diastereomeric ratio. Having succeeded in the key 1,4-addition, the complete ABCD ring-
system of 1.6 could be constructed through a Bishler-Napieralski reaction followed by a 
diastereoselective reduction of the resultant imine to give 1.198 in 87% yield as a single 
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diastereomer. Finally, the terminal olefin was subjected to a hydroboration with 9-BBN 
to deliver dihydrocorynantheol (1.6) in 67% yield. Thus, the natural product was 
prepared in 19% overall yield in only eight distinct chemical operations, which at the 
time of the publication of the preliminary communication represented the most concise 
and efficient approach to 1.6.52 It is also noteworthy that unlike many of the previous 
syntheses, excellent control of relative stereochemistry was achieved, and furthermore, 
no protecting groups were necessary through out the synthesis. 
1.5.2 Formal Synthesis of Rhynchophylline and Iso-rhynchophylline 
 Encouraged by our successful 1,4-additions to the key intermediate 1.197 using 
cuprates, we next investigated the possibility of employing metal enolates as 
nucleophiles. It was envisioned that the introduction of a carbonyl function in the C(15) 
position could potentially allow for an efficient synthesis of the oxindole alkaloid 
rhynchophylline (1.7). A number of enolates including the lithium and sodium enolates of 
dimethyl malonate were explored. While the diastereoselectivity in these reactions were 
excellent, we were unable to obtain yields above 30%. We eventually discovered that 1,4-
addition the lithium enolate of ethyl-1,3-dithilane-2-carboxylate (1.200) afforded 1.201 in 
good yield (71%) as a single diastereomer (Scheme 1.25).  On the other hand, the 1,4-
addition of the analogous methyl ester enolate, which would have represented a more 
direct route to rhynchophylline since the corresponding adduct 1.202 posseses a methyl 
ester, resulted in cross-Claisen reaction to generate preferentially β-ketoester 1.203. 
 With intermediate 1.201 in hand, the C-ring was constructed via Bischler-
Napieralski cyclization followed by highly diastereoselective imine reduction to deliver 
1.204 in 92% yield and >95:5 diastereoselectivity. Following excision of the dithiolane in 
95% yield using Raney-Ni, 1.205 was subjected to a three-step oxidative rearrangement 
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to deliver 1.207 and 1.208 in 75% yield, thus completing a formal synthesis of 
















1.201: R = OEt
1.202: R = OMe
1.203: R =































































1.6 EXTENDING THE SCOPE OF THE RCM/1,4-ADDITION STRATEGY TO 
INDOLOQUINOLIZIDINES: A POTENTIAL APPROACH TO HIRSUTINE AND 
RHYNCHOPHYLLINE 
Over the past century, conjugate additions to various α,β-unsaturated carbonyl 
compounds has become one of the most important C-C bond forming reactions.53 On the 
contrary, 1,4-additions to α,β-unsaturated amides and lactams are not as frequently 
utilized due to their lower reactivity relative to enones and enoates.54 A number of 
examples of 1,4-additions to α,β-unsaturated piperidones have appeared in the 
literature.55 However, the majority of these examples involve activation of the lactam by 
the incorporation of electron withdrawing groups either on the α-carbon or on the amide 
nitrogen as exemplified by the elegant synthesis of geissoschizine (1.212) by Overman 
and Robichaud (Scheme 1.26).55d Although this strategy renders the lactam more 
susceptible to 1,4-addition, the process typically adds steps to any given synthesis 
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As demonstrated in our approach to dihydrocorynantheol (1.6) and 
rhynchophylline (1.7) (vide supra), and as summarized in Table 1.1, we have shown that 
unactivated lactams such as 1.197 undergo stereoselective conjugate additions with the 
lithium enolate of ethyl-1,3-dithiolane carboxylate (1.200). Additionally, cuprates derived 
from Grignard reagents and copper(I) salts in the presence of TMS-chloride were found 


































Given these results, we became intrigued by the possibility of extending the scope 
of the RCM/1,4-addition strategy to indoloquinolizidine-derived Michael acceptors such 
as 1.216 and 1.217 (Scheme 1.27). 1,4-additions to 1.197 and a subsequent Bischler-
Napieralski cyclization resulted in a cis relationship between the hydrogens on the C(3) 
and C(15) positions. On the contrary, 1,4-addition to 1.216 should result in a C(3)-H / 
C(15)-H trans relationship based on the stereoelectronic preference for axial attack 
coupled with our prediction that the nucleophile should approach the Michael acceptor 
from the sterically less hindered face. As a consequence, 1,4-adducts such as 1.214 or 
1.215 should be readily accessible, thus nicely mapping onto pseudo-corynanthe 
alkaloids such as hirsutine (1.6). Furthermore, a biogenetically inspired oxidative 
rearrangement of the indole to the corresponding oxindole would provide access to 
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spirooxindole alkaloids and could potentially allow us to develop a complimentary 
































1.216 R = H






1.214 R = H




There were a number of challenges that could be foreseen in this strategy. The 
most direct approach would be to utilize a Michael acceptor such as 1.217 in which the 
ethyl group had already been incorporated. In such an approach, however, one would 
have to overcome the additional steric hindrance imparted by the ethyl substituent in the 
1,4-addition. On the contrary, if the introduction of the ethyl group were delayed until 
after the 1,4-addition, one would have to face the challenge of performing a 
diastereoselective alkylation of an exceedingly hindered amide enolate, and the literature 
precedence for such transformations was very limited.  
1.7 CONCLUSION 
For almost half a century, the structural challenges and significant biological 
activities of the corynanthe and oxindole alkaloids have inspired synthetic chemists to 
devise novel methodologies and clever tactics for their efficient syntheses. The ability to 
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control stereochemistry around the D-ring represents an interesting problem that has been 
addressed with varying degrees of success. While a significant amount of work has 
already been described in this area, these alkaloids still remain an important testing 
ground for new methods and strategies. Many of the approaches described above were 
either lengthy, non-selective, or did not readily lend themselves to the enantioselective 
preparation of these materials. However; a few stand out as quite impressive such as  
Meyers’ enantioselective, 13-step synthesis of dihydrocorynantheol (1.6) using a chiral 
formamidine lithiation strategy to control the stereochemistry at the C(3) position. 
Another example is Deiters and Martin’s eight step synthesis of racemic 1.6 using a 
highly efficient tandem RCM/carbomagnesation protocol as well as a RCM/1,4-addition 
strategy, which is readily adapted to allow for an enantioselective synthesis of 1.6. 
Finally, Itoh’s seven step enantioselective synthesis of ent-1.6 using an elegant 
organocatalytic enamine addition to a tetrahydro-β-carboline derivative showcases the 
current state-of-the art in efficiency and selectivity in organic synthesis.  
Form the discussion in this chapter it should be apparent that the synthetic 
approaches to hirsutine (1.5) and rhynchophylline (1.7) are significantly less refined as 
compared to those of dihydrocorynantheol (1.6). The major problem with all of these 
approaches is the low overall yield, which is due either to non-selective steps, requiring 
the separation of near equimolar mixtures of diastereomers, or several inefficient 
transformations (<45% yield). Furthermore, only Brown and Tietze controlled absolute 
stereochemistry; however, Brown’s approach was lengthy requiring 17 steps, and 
Tietze’s synthesis (15 steps) relied on the separation of a mixture (1:1) of diastereomers. 
Tietze eventually addressed this issued with the development of a catalytic asymmetric 
reduction of imine 1.76, but the transformations required to elaborate this material to the 
requisite key intermediate 1.66 were not reported.  
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Given the important biological activity of hirsutine and rhynchophylline, we felt 
the need to address the significant shortcomings of the previous synthetic approaches. In 
particular, we wanted to develop a synthesis that efficiently controlled stereochemistry 
around the D-ring, in addition to being readily adapted for the enantioselective syntheses 
of these alkaloids. Furthermore, these efforts would allow us to examine in depth the 
scope and limitations of our RCM/1,4-addition strategy that was used so successfully in 
the synthesis of dihydrocorynantheol. As discussed above, 1,4-additions to α,β-
unsaturated carbonyl derivative represent an extremely useful tool in organic synthesis, 
but the analogous transformations with α,β-unsaturated lactams have primarily been 
limited to those bearing electron withdrawing groups on the amide nitrogen or the α-
carbon. Hence, the development of conditions that would allow for 1,4-additions to 
unactivated lactams such as indoloquinolizidine derivatives 1.216 and 1.217 would be an 
important contribution. In particular, 1,4-additions to α,β-unsaturated lactams such as 
1.217 bearing an inactivating alkyl substituent in the α-position have to the best of our 
knowledge not been demonstrated. In the event that this transformation cannot be 
achieved, we will need to introduce the C(20) ethyl substituent at a later stage of the 
synthesis. However; this would represent a significant challenge given the scarcity of 
literature precedence for the diastereoselective alkylation of lactams of such complexity. 
Our efforts toward solving these problems will be detailed in the following chapter.  
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Chapter 2: Formal Syntheses of Rhynchophylline and Hirsutine 
2.1 INTRODUCTION 
The oxindole alkaloid rhynchophylline (2.1) and the pseudo-corynanthe alkaloid 
hirsutine (2.2) both possess valuable biological activity. In particular, 2.2 has been shown 
to be 11-20 times more potent against the influenza A virus (subtype H3N2) than the 
clinically used ribavarin.5 As described in chapter 1, the previous synthetic approaches to 
2.1 and 2.2 were relatively inefficient because of one or more low yielding 
transformations or the need to separate nearly equimolar mixtures of diastereomers. 
While addressing these issues, our goal was to expand the scope of the RCM/1,4-addition 
strategy, which had previously been developed in our group for the concise synthesis of 
dihydrocorynantheol (1.6), to include indoloquinolizidine derived Michael acceptors. Of 
particular interest was the 1,4-addition to α,β-unsaturated lactam 2.6 bearing an ethyl 
substituent in the α-position, since such transformations had not previously been 
described in the literature. The alternative strategy would involve the introduction of this 
substituent at a later stage of the synthesis; however, this would require the development 
of a diastereoselective alkylation of an exceedingly hindered lactam enolate 
Thus, our initial retrosynthetic analysis of rhynchophylline and hirsutine is 
outlined in Scheme 2.1. We envisioned the target structure 2.3, which has previously 
been converted to rhynchophylline (2.1),27 as coming from indoloquinolizidine 2.4 via an 
oxidative rearrangement of the indole to the oxindole.25 Preparation of the late stage 
intermediate 2.4 would also represent a formal synthesis of hirsutine (2.2), since 2.4 has 
previously been converted to 2.2 by Tietze and co-workers.19 Indoloquinolizidine 2.4, 
may be available in two steps from 2.5, which in turn would result from the pivotal 1,4-
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addition of the lithium enolate of ethyl 1,3-dithiolane carboxylate to α,β-unsaturated 
amide 2.6. Finally, Michael acceptor 2.6 may be derived in five steps from tryptamine via 























































2.2 SYNTHESIS OF THE ETHYL-SUBSTITUTED MICHAEL ACCEPTOR 2.6 
The synthesis of hirsutine (2.2) and rhynchophylline (2.1) commenced with the 
preparation of Michael acceptor 2.6. Starting with tetrahydro-β-carboline 2.8, which is 
available in two steps from tryptamine,56 precomplexation of 2.8 with BF3·OEt2 in THF 
at –30 °C for 10 min followed by the addition of allylmagnesium bromide (1 M solution 
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in Et2O) provided the desired product 2.9 in 44% yield (Scheme 2.2).  The first time the 
reaction was performed, it was allowed to warm to 10 °C, a tactic that resulted in the 
formation of a significant amount of an unidentified side product. However, if the 
reaction temperature was maintained at –30 °C for 2 h, followed by the addition of a 
saturated aqueous solution of NaHCO3, the formation of the side product was suppressed 
and the desired product 2.9 could be isolated in 81% yield. This procedure was also 
convenient for scale up, and when performing the reaction on three-gram scale, the 
allylcarboline 2.9 could be readily isolated in 80% yield. 
The resultant secondary amine function of 2.9 was then subjected to an EDCI-
mediated amide bond coupling with the known 2-ethylacrylic acid (2.10)57 to furnish 
RCM precursor 2.7 in 85% yield. With diene 2.7 in hand, we then began exploring the 
key RCM reaction using Grubbs 2nd generation catalyst (2.11).  The reaction was found 
to be sluggish at room temperature, which is not surprising given that the RCM precursor 
2.7 is not only electron deficient, but it is also 1,1-disubstituted. Nevertheless, after some 
experimentation we found that when running the reaction at 0.02 M concentration using 
15 mol% 2.11 at 45 °C overnight, the desired product 2.6 could be isolated in 87% yield 








































While 2.6 is a known compound,58 the present synthesis, which provides 2.6 in 
only three steps and 60% overall yield from 2.8, represents a significant improvement 
over previously published routes. It is also noteworthy that our approach readily lends 
itself to the enantioselective synthesis of 2.6. In 1996, Nakamura and co-workers showed 
that one can perform asymmetric allylzincations to carboline 2.8 using bis-oxazoline 
ligands to afford 2.9 in 54% yield and 90% ee.59 More recently, Chong and co-workers 
demonstrated an asymmetric allylboration to carboline 2.8, which proceeded in 80% 
yield and 94% ee as depicted in Scheme 2.3.60 Thus, while the racemic syntheses of 
hirsutine and rhynchophylline were initially targeted, the opportunity exists to achieve an 





















2.3 ATTEMPTED CONJUGATE ADDITIONS TO THE ETHYL-SUBSTITUTED MICHAEL 
ACCEPTOR 2.8  
With the ethyl-substituted Michael acceptor 2.6 in hand, we then began to explore 
the key 1,4-addition.  In spite of several attempts, including changing the counter ion, 
adding a Lewis acid, and heating the reaction, only starting material was recovered 
(Table 2.1). Conjugate additions of enolates such as the one derived from ethyl-1,3-
dithiolane carboxylate are known to be reversible.53a It is therefore possible that the 
addition took place but that the steric bulk associated with the C(20) ethyl group 




























THF TMSCl 69% rsmCuI
Et2O TMSCl 64% rsmCuI
THF TMSCl 81% rsmCuI
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At this point, we turned our attention to the use of organocuprates (Table 2.1). 
There were no examples in the literature of 1,4-additions of cuprates to α,β-unsaturated 
lactams bearing an inactivating alkyl substituent in the α-position, although 1,4-additions 
of cuprates to lactams with an activating acyl substituent in the α-position are known.55d 
The use of trimethylsilylchloride to accelerate the reaction, which successfully effected 
1,4-addition of cuprates to unsubstituted lactam 1.197,52 was attempted but without 
success. Addition of BF3·OEt2, which is known to create a more reactive cuprate,
61 was 
also explored, but only starting material was isolated. A possible problem in these cuprate 
additions is that the added steric bulk exerted by the C(20) ethyl group as well as the 
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alkyl substituent on the amide nitrogen prevent simultaneous coordination of the cuprate 
reagent to both the carbonyl and the olefin.  
2.4 SYNTHESIS OF, AND 1,4-ADDITION TO AN α,β-UNSATURATED THIOLACTAM  
In an effort to render lactam 2.6 more susceptible toward conjugate addition, the 
corresponding thiolactam13 was prepared since it has been reported that α,β-unsaturated 
thiolactams are better Michael acceptors than lactams.11 The direct conversion of lactam 
2.6 to thiolactam 2.14 was not attempted because α,β-unsaturated lactams are known to 
readily undergo deconjugation when treated with Lawesson’s reagent.62  Instead, 2.7 was 
converted to the corresponding thiolactam63 2.13 in 86% yield, and then subjected to 2.11 
to affect the RCM (Scheme 2.4). Examples in the literature of α,β-unsaturated 
thiolactams undergoing RCM are rare. A likely problem in this transformation is that 
sulfur is known to poison the ruthenium catalyst 2.11;64 however, molecules containing 
sulfonamides65 and dithianes66 have successfully undergone RCM. The effects of catalyst 
loading, solvent, time, and temperature were studied, and it was eventually discovered 
that stirring a 0.2 M solution of 2.13 in 1,2-dichloroethane at 65 °C for 3 h in the 
presence of 15 mol % 2.11  provided the desired product in 45% yield (56% brsm).  
With thiolactam 2.14 in hand, we turned our attention to the 1,4-addition using the 
lithium enolate of ethyl-1,3-dithiolane-2-carboxylate.  Unfortunately, this reaction also 
failed to provide the desired product, and only starting material was isolated in each 
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2.5 CONJUGATE ADDITION/ALKYLATION APPROACH  
At this point in the project it became clear that the initial approach, in which we 
proposed a 1,4-addition to Michael acceptor 2.6 bearing the C(20) ethyl group, was not 
going to be successful. As discussed in Chapter 1, the alternative was to delay the 
introduction of the C(20) ethyl group until after the conjugate addition. As shown in the 
revised synthetic plan outlined in Scheme 2.5, this would involve a 1,4-additon to the less 
sterically encumbered Michael acceptor 2.17, which in turn would be available from 





































The synthesis of 2.17, which was initially described by Deiters,49b commenced 
with carboline 2.8 applying acyl iminium ion chemistry that has been frequently utilized 
in the Martin group (Scheme 2.6).67 In the event, 2.8 was treated with acryloyl chloride 
giving rise to a transient acyl iminium ion 2.19, which was readily engaged by the 
allyltributyltin that was already present in the reaction mixture. RCM precursor 2.18 was 
thus obtained in 75% yield in a one-pot operation. The ensuing RCM proceeded smoothly 
with Grubbs 1st generation catalyst 2.20 to furnish the requisite tetracyclic Michael 
acceptor 2.17 in only two steps from 2.8.68 Given the poor solubility of 2.17, it was 
particularly convenient to avoid purification by chromatography. Instead, following 
removal of most of the solvent, the product crystallized directly from the reaction mixture 
upon cooling.  Further trituration and recrystallization from CH2Cl2 / CHCl3 furnished 
Michael acceptor 2.17 as a white powder in high purity. While lactam 2.17 is a known 
compound, previous syntheses were relatively long (six or seven steps) and proceeded in 
fairly low overall yield.69 Our approach to 2.17, which proceedes in two steps and 65% 
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Having developed a short and efficient route to tetracyclic Michael acceptor 2.17, 
we began exploring its reactivity in the key 1,4-additions. The conjugate addition of the 
sodium enolate of dimethyl malonate to 2.17 required 48 h to reach completion but 
afforded the corresponding adduct in 74% yield (Scheme 2.7); however, the 
diastereoselectivity was low (dr = 60:40). On the contrary, 1,4-addition of the lithium 
enolate derived from ethyl-1,3-dithiolane-2-carboxylate to 2.17 proceeded in excellent 
diastereoselectivity (dr = 91:1) to furnish the expected adduct 2.16, which could be 
readily isolated in 55-60% yield after facile removal of the minor diastereomer by 
chromatography. In order to obtain reproducible results in this reaction, it was necessary 
to deoxygenate the solvent through several freeze-pump-thaw cycles; however, even 
when this was done there was an erosion in the diastereomeric ratio upon scaleup. The 
stereochemical configuration of the major diastereomer 2.16 was tentatively assigned as 
trans between C(3)-H and C(15)-H protons. This assignment was based on the 
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stereoelectronic preference for axial attack during 1,4-additions as well as to the 
expectation that the dithiolane enolate should approach the α,β-unsaturated lactam from 
the convex face. This analysis was eventually corroborated at a later stage in the 
synthesis by obtaining an X-ray structure of 2.33 (vide infra).   






















































THF, −78 °C → rt, 2 h
 
2.6 INTRODUCTION OF C(20) ETHYL GROUP VIA ALKYLATION 
After finally achieving success in the difficult introduction of the C(15) 
substituent via 1,4-addition, the next challenge involved a diastereoselective alkylation to 
introduce an ethyl group at the C(20) position. It was anticipated that this would not be a 
trivial transformation due to the significant steric hindrance of the enolate derived from 
2.16. In preliminary experiments, all attempts to generate a dianion and selectively 
alkylate the more reactive α-carbon resulted in concomitant and unavoidable alkylation of 
the indole nitrogen. A possible solution to this problem involved protection of the indole 
nitrogen. We reasoned that by introducing a protecting group prior to the 1,4-addition it 
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may be possible to perform the addition and the alkylation in the same pot. Toward this, 
end the indole nitrogen of 2.17 was protected with a MOM group, which is a common 
indole protecting group, to furnish 2.24 in 55% unoptimized yield (Scheme 2.8). 
However, the ensuing 1,4-addition not only furnished the expected adduct 2.25 in low 




















40%, dr = 60:40 

















THF, −78 °C → rt
0 °C → rt
 
Based on the aforementioned results, a step-wise approach involving 1,4-addition 
to the unprotected Michael acceptor 2.27, followed by protection and alkylation appeared 
to be the best path forward to ensure optimal yield and diastereoselectivity. Protection of 
the Michael adduct 2.16 with MOMCl/NaH was examined, but this reaction proceeded in 
low yield (32%, Scheme 2.9). Nevertheless, sufficient quantities of 2.25 were obtained to 
explore the key alkylation step. In the event, 2.25 was deprotonated with LDA, and the 
resultant enolate was treated with excess ethyl iodide at –78 °C. Because no alkylation 
product 2.27 was observed, the reaction was allowed to warm to room temperature. This 
tactic, however, induced a retro-Michael reaction to afford 2.24 in 19% yield in addition 
to 66% recovered starting material (Scheme 2.9). This experiment suggests that the 
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lithium enolate derived from 2.16 is not sufficiently reactive to undergo allylation with 









































 −78 °C → rt
   
2.7 ACYLATION APPROACH 
Because of the significant problems that were encountered during the initial 
attempts to introduce the C(20) ethyl substituent via alkylation, we opted to explore an 
alternative route. As shown in Scheme 2.10, the late stage intermediate 2.28 was 
envisioned as coming from bis-dithiolane 2.29 via reduction with Raney-nickel. 
Dithiolane 2.29 would be available from the β-keto amide 2.30, which in turn may be 








































Before efforts toward the introduction of the C(20) acyl-group could commence, a 
suitable protecting group for the indole nitrogen had to be identified. While MOM is a 
fairly common indole protecting group, it could only be introduced in low yield (vide 
supra). Although protection with a silyl group was attempted, treating 2.16 in CH2Cl2 
with TBSCl and NaH at 0 °C did not afford even a trace of the desired product.  Only 
starting material was observed (51% isolated) along with substantial amounts of baseline 
material (TLC solvent: 3:1 EtOAc/hexanes) that was not isolated.  Presumably the TBS 
group is too bulky to be introduced onto the hindered indole nitrogen of 2.16, or 
alternatively, the resultant TBS protected indole may be too labile. On the contrary, a Boc 
group could be introduced in excellent yield (85%) simply by stirring 2.16 in THF in the 
























Because of the ease by which the Boc protecting-group could be installed on the 
indole nitrogen, the opportunity arose to develop a one-pot conjugate addition/indole 
protection protocol. Such a procedure would have the benefit of avoiding the isolation 
and purification of Michael adduct 2.16, which was somewhat inconvenient due to its 
poor solubility in most common organic solvents such as EtOAc and CH2Cl2.  In the 
event, the 1,4-addition was carried out as described earlier (vide supra), and after the 
starting material had been consumed, the reaction mixture was cooled to 0 ˚C, and 1.1 
equivalent of t-BuOH was added to ensure that the indole was fully protonated. Boc2O 
and DMAP were then added directly to the reaction mixture, resulting in the formation of 
2.31 and 2.32, which could be isolated in 60-65% yield (Scheme 2.12). Unfortunately, 
the two diastereomers have identical Rf and could not be separated by chromatography. 
As a result, it was more convenient to carry out the two reactions in a stepwise fashion, 































60-65%, dr = 91:9 
              2.31/2.32
THF, −78 °C → rt, 2 h
0 °C → rt, 2 h
Boc Boc
 
With an ample supply of Boc-protected Michael adduct 2.31 in hand, our efforts 
were directed toward introducing the C(20) substituent via acylation. Deprotonation of 
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2.31 with LDA followed by acylation of the enolate with dimethylcarbonate according to 
the procedure of Beak70 afforded the desired product 2.30 in a modest yield of 25%, 
although 2.30 could not be isolated cleanly.  A more promising procedure involved the 
deprotonation of 2.31 with KHMDS in the presence MgBr2-OEt2, followed by addition 
of acetyl chloride according to a protocol exploited by Gammill71 to provide 2.30 in 39% 
yield along with 8% recovered starting material.  By increasing the amount of base and 
acylating agent from 1.5 equiv. to 3 equiv., the yield of 2.30 could be increased to 60% 
(Table 2.2).  The product was obtained as a single diastereomer, and an nOe contact 
between H(3) and H(20) suggested that these hydrogen atoms were on the same side of 
the ring. Thus, β-ketoamide 2.30 most likely posses the requisite stereochemical 










Entry        Base                  Lewis acid                Acylating agent       Yield (%)
1        LDA (1.5 eq.)                -                             MeOAc                     25   
2        KHMDS (1.5 eq.)   MgBr OEt (1.1 eq.)        AcCl (1.5 eq.)           28  















The next step in the sequence involved the removal of the carbonyl oxygen of the 
acetyl group of 2.30 through the conversion to the bis-dithiolane 2.29 followed by 
reduction with Raney-nickel to afford 2.28 (Scheme 2.13). However, all efforts to 
introduce the dithiolane moiety were unsuccessful. For example, treating 2.30 with 1,2-
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ethanedithiol/BF3⋅OEt2 in CH2Cl2
72 resulted only in the loss of the Boc group. Refluxing 
2.30 in TFA and 1,2-ethanedithiol73 resulted in a complicated mixture of products that 


































At this point in the project, preliminary success had been achieved in the 
alkylation of 2.31, which was being pursued concurrently with the acylation studies.  
Since the introduction of the ethyl substituent via alkylation would result in a synthesis 
that is one step shorter, the acylation approach was abandoned, and no further attempts 
were made to convert 2.30 to 2.29. 
2.8 RETURNING TO THE ALKYLATION APPROACH 
Having established an efficient approach to the protected Michael adduct 2.31, we 
decided to reinvestigate the possibility of introducing the ethyl substituent via alkylation. 
Preliminary experiments using LDA and an excess of EtOTf resulted of the destruction of 
the dithiolane moiety as well as loss of the Boc group. Therefore, we turned to the milder 
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alkylating agent EtBr as shown in Table 2.3. Interestingly, while none of the desired 
product 2.33 could be isolated, compound 2.34, in which a hydroxyl group had been 
incorporated in the C(20) position, was obtained in 26% yield as a single diastereomer 
along with 46% recovered starting material (entry 1). It was hypothesized that dissolved 
oxygen in the solvent was responsible for the α-oxidation of the enolate.  The solvents 
were therefore degassed using the freeze-pump-thaw method immediately prior to use for 


















entry     base                         RX           solvent/additives             results
conditions
























67% 2.35  
16% rsm







Boc48% 2.33  
22% rsm
4      NaHMDS (2 eq.)       EtI (4 eq.)       THF/toluene










After discovering and eliminating the problem of α-oxidation, the next challenge 
was to find conditions that would effect the alkylation without destroying the dithiolane 
moiety. Toward this end, the reactivity of the enolate was increased by deprotonation 
with KHMDS to generate the potassium enolate followed by the addition of HMPA. The 
enolate was then subjected to the more reactive electrophile EtI, but none of the desired 
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product 2.33 was obtained. Instead, product 2.35 was isolated in 67% yield as a mixture 
of diastereomers along with 16% recovered starting material. The dithiothioether 2.35 
can be thought of as arising from cleavage of the dithiolane ring via E2 elimination under 
the strongly basic conditions,74 followed by alkylation with ethyl iodide.  Gratifyingly, 
after considerable experimentation it was eventually discovered that the desired product 
could be obtained by increasing the amount of KHMDS and EtI, and running the reaction 
in the absence HMPA. These conditions afforded the requisite product 2.33 in 36% yield 
along with 17% unreacted starting material (entry 3). The low yield and mass balance can 
be attributed to the formation of a number of side products including 2.35. 
An X-ray structure of alkylation product 2.33 was obtained in order to establish 
the stereochemistry of the alkylation as well as of that of the 1,4-addition (Figure 2.1).  
Gratifyingly, the crystal structure indicated that the 1,4-addition step had indeed resulted 
in a trans relationship of C(3)-H/C(15)-H, which is the product resulting from axial 
attack. Furthermore, the alkylation had occurred from the opposite face of the C(15)-
substituent, resulting in the requisite stereochemistry for pseudo-corynanthe alkaloids 
such as hirsutine (2.2).  The X-ray analysis also offered insight into the difficulties 
associated with the alkylation of 2.31. Lactam 2.33 shown in Figure 2.1 is extremely 
sterically congested.  The X-ray structure reveals that there is a severe steric interaction 
between the Boc-protecting protecting group and the C(15) dithiolane substituent.  This 
steric interaction may account for why 2.31 shows such a high propensity for undergoing 
a retro-Michael reaction.   
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Figure 2.1 ORTEP plot of 2.33. Displacement ellipsoids are scaled to the 50% probability level. 
 
The choice of enolate counter ion was found to be critical. The lithium enolate 
was not sufficiently reactive to undergo alkylation with EtI at −78 ˚C (see Scheme 2.9), 
whereas the more reactive potassium enolate gave a number of side products along with 
the desired alkylation product 2.33. The use of the sodium enolate of 2.31, however, 
resulted in a much cleaner reaction, and a significantly improved yield (entry 4). Thus, 
deprotonation of 2.31 with 2 eq. NaHMDS followed by the addition of 4 eq. EtI gave 
2.33 in 48% yield as a single diastereomer along with 22% recovered starting material.  
All efforts to drive the reaction to completion through warming, using a larger excess of 
EtI, or prolonging the reaction time, resulted in a reduction in the yield as well as a 
reduction in the amount of recovered starting material. Furthermore, although the 
reaction was significantly cleaner than when using KHMDS as the base, several side 
products were still being formed. For instance, the 1H NMR spectrum of the crude 
reaction mixture indicated the presence of dithioether 2.35 as well as 2.36 resulting from 
a retro-Michael reaction.  
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We reasoned that it may be possible to suppress the formation of these and other 
side reactions by lowering the temperature of the reaction to –100 ˚C.  Since the 
alkylation with ethyl iodide was sluggish at –78 ˚C, we felt that a more reactive 
electrophile would be needed at –100 ˚C, and we therefore used EtOTf for all subsequent 
experiments. In the event, 2.31 was deprotonated with NaHMDS at –78 ˚C, and after 
stirring the mixture for 1 h at this temperature, the reaction was cooled to –100 ˚C, and 
EtOTf was added.  The reaction was quenched after 30 min, and the desired product was 
isolated along with unreacted starting material in 29% and 59% yield respectively.  The 
reaction was extremely clean as indicated by the 1H NMR spectrum of the crude reaction 
mixture, which only displayed resonances corresponding to product and unreacted 
starting material. The Rf value of the product and the starting material were almost 
identical, and 2.31 and 2.33 were therefore not separated in these experiments but rather 
isolated as a mixture. By weighing the mixture, the yields of 2.31 and 2.33 were then 





















Entry       Conc. (M)        Eq. EtOTf          Additive         Time / temp (°C)       Yield (%)       RSM (%)
1              0.075 M              4                       -                30 min, −100 °C          29%              59%
2              0.15 M                4                       -                2.5 h, −100 °C             57%              33%
3              0.15 M                4             DMPU, 1.5 eq.    2.5 h, −100 °C             70%              20%
4              0.15 M                4             DMPU, 4.0eq.     2.5 h, −100 °C             66%              19%
5              0.15 M                8             DMPU, 1.5 eq.    2.5 h, −100 °C             67%              15%
6              0.15 M                4             DMPU, 1.5 eq.    15 min, −100 °C;         70%               9%
2.5 h, −78 °C
Boc
 
In order to optimize the yield in this alkylation, the concentration of the reaction 
was doubled, and the reaction time was extended to 2.5 h (entry 2).  These changes 
increased the yield of 2.33 to 57% and reduced the amount of recovered starting material 
to 33%.  In order to increase the reactivity of the enolate, DMPU (1.5 eq.) was added 
resulting in an increase in the yield of 2.33 to 70% (20% rsm), which was the best result 
obtained (entry 3).  Repeated attempts to drive the reaction to completion, however, were 
fruitless.  Increasing the amount of DMPU from 1.5 to 4 eq. (entry 4) or increasing the 
amount of EtOTf (entry 5) did not lead to any significant change in the yields of product 
and recovered starting material. Additionally, increasing the reaction temperature from –
100 ˚C to –78 ˚C 15 min after the addition of electrophile did not increase the yield of 
2.33 (entry 6), but the amount of recovered starting material was reduced to 9% due to 
the formation of side products that were not isolated.  
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With the hope of being able to drive the reaction to completion, the effect of 
varying the base was reinvestigated, and the results are summarized in Table 2.5; entry 1 
shows the optimal conditions from Table 2.4 for the sake of comparison. An increase in 
the amount of base, however, led to slightly reduced yields of 2.33 (entries 2 and 3). It 
was also confirmed that sodium is indeed the optimal counter ion, as deprotonation with 
KHMDS (entry 4) led to a sharp decline in the yield of 2.33 (36%). Finally, the use of 
HMPA instead of DMPU was explored, but there was no noticeable difference between 
entry 5 and entry 2. After extensive experimentation, it was not possible to drive the 
reaction to completion even after rigorous exclusion of water. A possible explanation 
may be that the enolate of 2.31, which is rather hindered, abstracts a proton from EtOTf 
via an E2 elimination pathway. Another explanation could be that the alkylation product 



















Entry                 base          Eq. EtOTf      Additive       Yield (%)      RSM (%)
2             NaHMDS (3 eq.)       6              DMPU          68%             17%
4             KHMDS   (2 eq.)       4              DMPU          36%             36%
3             NaHMDS (4 eq.)       8              DMPU          62%             22%
5             NaHMDS (4 eq.)       8              HMPA          62%             23%
1             NaHMDS (2 eq.)       4              DMPU          70%             20%
2) EtOTf, additive 1.5 eq.   




The best conditions identified thus far (i.e. 2 eq. NaHMDS, 4 eq. EtOTf, 1.5 eq. 
DMPU, 2.5 h, −100 ˚C) were then applied to a larger scale reaction, and the product and 
the starting material were separated to determine the isolated yield of the reaction.  As 
shown in Table 2.5, the reaction works well on larger scale, and the yields after 
chromatographic separation of product and starting material were virtually identical for 
the two experiments. One final and important note regarding the alkylation is the 
exceedingly high diastereoselectivity; only one diastereomer was observed in the 1H 
NMR spectrum of the crude reaction mixture. 
Table 2.6 
Entry       Scale (mg 2.31)     Yield (%)     RSM (%)
2                  240 mg                68%           22%
1                  200 mg                67%           20%
 
2.11 FORMAL SYNTHESIS OF HIRSUTINE  
With alkylation product 2.33 in hand, the formal synthesis of hirsutine (2.2) could 
be completed in a relatively straightforward manner. The next step in the synthesis 
involved the removal of the dithiolane moiety. As depicted in Scheme 2.14, this was 
accomplished by stirring 2.33 in ethanol the presence of Raney-Nickel to afford 2.36 in 






















At this point in the synthesis we elected to remove the indole protecting group 
(Scheme 2.15). In an initial experiment to deprotect the indole with TFA, no change in Rf 
was observed by TLC after stirring for 3 h. Additional TFA was added and the reaction 
was stirred at room temperature overnight. Analysis of the mixture indicated two new 
spots on the TLC plate in addition to a spot with the same Rf as the starting material.  
Following chromatographic separation of the three spots it was determined that all the 
starting material had indeed been consumed.  In addition to the desired product 2.28 
(which co-eluted with the starting material using 1:1 EtOAc/hexanes), a lower Rf product 
2.37 was isolated and was assigned as the C-3 epimer based on its 1H NMR, 13C NMR, 
COSY, HMQC, LR-MS data. This result is not surprising given that indoloquinolizidine 
skeletons are known to be susceptible to C(3)-H epimerization under acidic conditions.10 
Additionally, a higher-Rf product 2.38 was isolated that was assigned as the product of 






























This experiment demonstrates that 2.36 or the corresponding deprotected indole 
2.28 are not stable. Although the formation of side products might be avoided by 
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reducing the reaction time, a different and more efficient approach was pursued. Thus, 
Boc-protected indole 2.36 was treated with NaOMe/MeOH in THF with the hope of 
cleanly removing the protecting group and effecting the transesterification to the requisite 
methyl ester (Scheme 2.16).  Boc-deprotection of indoles with NaOMe has been reported 
to give low and inconsistent yields of product due to the fact that the deprotected indole is 
susceptible to oxidation in the 3-position during the basic reaction conditions.75 However, 
when performing the reaction in degassed THF using a freshly prepared solution of 
NaOMe prepared from degassed MeOH, the reaction worked nicely. As expected, the 
reaction proceeded with concomitant transesterification to afford methyl ester 2.39 in 





















Following deprotection/transesterification, the final step in the formal synthesis of 
hirsutine (2.2) involved the reduction of lactam 2.39 to the indoloquinolizidine 2.476 
(Scheme 8). In the event, exposing 2.39 trimethyloxonium tetrafluoroborate and 2,6-di-t-
butylpyridine followed by reduction of the resultant iminium ion with NaBH4 according 
to a published procedure77 furnished the target indoloquinolizidine 2.4 in 81% yield the 



























In order to obtain a good yield in the reduction, it was important to ensure high 
purity of lactam 2.39. Furthermore, the indoloquinolizidine 2.4 was found to be unstable 
to air, and the crude material readily decomposed when exposed to the atmosphere for a 
few hours. This problem could be avoided by simply purifying the crude reaction mixture 
immediately following the workup. Thus, the synthesis of 2.4, which is shown in its 
entirety in Scheme 2.18, completes the formal synthesis of hirsutine 2.2, since 2.4 has 




−78 °C, 1h; then





























62% dr = 91:1
2.16 R = H
S
S Li
THF, −78 °C → rt, 2 h























2.36: R = Boc, R' = Et
















2.12 FORMAL SYNTHESIS OF RHYNCHOPHYLLINE 
A formal synthesis of the oxindole alkaloid rhynchophylline (2.1) was achieved 
via the oxidative rearrangement of 2.4 to give oxindoles 2.3 and epi-2.3.  This 
transformation was first attempted using a two-step procedure79 in which 2.4 was first 
chlorinated with t-BuOCl to give.  Following removal of the solvent, 2.40 was dissolved 
in a mixture of MeOH and aqueous acetic acid and heated to 70 ˚C to effect the 
rearrangement to a spirocyclic imidoether followed by hydrolysis to provide 2.3 and epi-
2.3 (Scheme 2.19).  After aqueous workup and chromatographic separation, oxindoles 2.3 
and epi-2.3 were isolated in 10% and 18% respectively. The low yield of the one pot 
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procedure can be attributed to the formation of several side products that were difficult to 























epi-2.3 18% 2.3 10%







70 °C, 1.5 h
2.40
 
In order to improve the yield of the oxidative rearrangement, an alternative 
procedure was investigated in which the 1,2-rearrangement and the hydrolysis were 
conducted in separate steps.  The conversion of corynanthe alkaloids to their 
corresponding oxindoles using this tactic has been extensively investigated by Acklin and 
co-workers,24 and has also been employed by Martin and co-workers.26,49b Thus, 2.4 was 
exposed to t-BuOCl to effect the chlorination of the C(3) position.  Following removal of 
the solvent, the residue was treated with NaOMe/MeOH to effect the pinacol-type 
rearrangement to give spirocyclic imidoether 2.40 (Scheme 2.20).  This intermediate was 
then hydrolyzed under acidic condition in a separate step to afford the desired oxindoles.  
Using this procedure, the desired oxindoles 2.3 and epi-2.3, which are epimeric at C(7), 
could be isolated in good yield (39% and 37% respectively over the three steps). The 1H 
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NMR data of 2.3 and epi-2.3, and the melting point of 2.3, were in good agreement with 


















































Ban and co-workers assigned the stereochemistry of the lower Rf C(7) epimer as 
oxindole 2.3, and we were able to verify this structural assignment, through single crystal 
X-ray analysis (Figure 2.3). This reveals a mistake in a structural assignment in an earlier 
paper, which claims the synthesis of 2.3.80  
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Figure 2.2 ORTEP plot of 2.3. Displacement ellipsoids are scaled to the 50% probability level. 
 
The C(7)-epimers 2.3 and epi-2.3 are readily separated by chromatography; however, 
they are not configurationally stable. In fact, they readily interconvert under acidic or 
basic conditions via a retro-Mannich/Mannich pathway that is frequently observed with 
spiro-(pyrrolo-3,3’-oxindoles) (Scheme 2.21).27 Although one could envision the 
possibility of advancing either 2.3 and epi-2.3 to their corresponding natural products, 
Ban and co-workers elaborated epi-2.3 into both epi-2.1 and 2.1 and in two and three 
steps, respectively.27 Our approach to epi-2.3 therefore represents a formal synthesis of 
2.1 and epi-2.1.  





















2.13 UNEXPECTED REVERSAL OF DIASTEREOSELECTIVITY IN THE 1,4-ADDITION  
During the optimization and streamlining phase of the project we decided to 
reinvestigate the idea of introducing an indole protecting group prior to the 1,4-addition 
in order to attempt the conjugate addition and the subsequent alkylation in the same pot.  
Toward this end Michael acceptor 2.12 was treated with Boc2O and catalytic DMAP in 
THF to afford 2.36 in 99% yield. With an ample supply of Boc-protected Michael 
acceptor 2.36 in hand, we turned our attention to the key 1,4-addition. However; 
exposure of 2.36 to the lithium enolate of ethyl-1,3-dithiolane-2-carboxylate did not 
result in the formation of the expected Michael adduct 2.31.  Rather, its C(15) epimer 












THF, −78 °C  


























In order to gain insight into the origin of this unexpected reversal in 
diastereoselectivity, a single crystal X-ray analysis was performed on Michael acceptor 
2.36. As shown in Figure 2.3, the α,β-unsaturated lactam moiety is twisted out of the 
plane defined by the indole and the Boc group. Operating under the assumption that the 
structure in solution bears a resemblance to that in the solid state, one can see that the top 
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face of the α,β-unsaturated lactam is no longer the more sterically accessible face because 
it is blocked by of the presence of the bulky Boc group. The incoming nucleophile is 
therefore redirected to the bottom face of the α,β-unsaturated lactam through steric 
approach control, which appears supersede the typical preference of axial attack. An 
alternative explanation may be that 1,4-addition occurs via axial attack on the opposite 
half-chair conformer of the α,β-lactam 2.36, although the nucleophile would experience a 
1,3-diaxial interaction in such a transition state. 
Figure 2.3 ORTEP plot of 2.36. Displacement ellipsoids are scaled to the 50% probability level. 
 
The interesting and unexpected reversal of diastereoselectivity in the 1,4-addition 
was corroborated during one of the numerous experiments aimed at optimizing the 
alkylation of lactam 2.31. Because of the significant amounts of side products that were 
formed during the early alkylation studies, we decided to examine the stability of the 
enolate of 2.31. In the event, 2.31 was deprotonated with NaHMDS at −78 ˚C and then 
incubated at −20 ˚C for 1.5 h, whereupon the reaction was cooled again to −78 ˚C and 
quenched (Scheme 2.23).  Interestingly, the NMR spectrum of the crude reaction mixture 
did not show any of the notorious retro-Michael product 2.36 that was frequently 
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observed in the early alkylation experiments. Instead, the spectrum indicated the presence 
of the C(3)-H/C(15)-H cis diastereomer 2.32, which was isolated in 55% yield after 
purification by chromatography. The formation of this diastereomer can be rationalized 
as resulting from retro-Michael reaction followed by 1,4-addition from the less sterically 
encumbered face of 2.36, which is in accordance with the results shown in scheme 2.22.81  






























2.14 SYNTHESIS OF THE CARBON SKELETON OF DIHYDROCORYNANTHEOL  
The fact that the stereochemistry of the 1,4-addition can be efficiently controlled 
through steric approach control greatly expands the scope of the RCM/1,4-addition 
approach to corynanthe alkaloids. Simply though re-sequencing two of the steps in the 
synthesis, we now have the opportunity to access structures with either a C(3)-H/C(15)-H 
trans or a C(3)-H/C(15)-H cis stereochemical relationship, the latter of which is the 
configuration of the “normal” corynanthe alkaloids such as dihydrocorynantheol (2.44) 
and geissoschizine (2.45). To explore the scope of this approach, the total synthesis of 









































75%, dr > 95:5
H
THF, −78 °C  





























It was possible to streamline the synthesis of the Boc protected Michael acceptor 
2.36 by combining the ring-closing metathesis of acrylamide 2.18 with the subsequent 
protection step. By simply adding Boc2O and catalytic DMAP upon completion of RCM 
reaction, the protected Michael acceptor 2.18 could be isolated in 93%, which is a slight 
improvement over the stepwise procedure (86% overall yield). Following 1,4-addition of 
the lithium enolate of ethyl-1,3-dithiolane-2-carboxylate to 2.18, attempts to install the 
C(20) ethyl group in order to complete the construction of 2.44 were undertaken.  
Surprisingly, alkylation of the sodium enolate of 2.32 with ethyl triflate using the 
  96
optimized conditions for the alkylation of 2.31 resulted in an intractable reaction mixture. 
On the other hand, running the alkylation at −78 °C using the less reactive electrophile 
ethyl iodide, afforded the desired product 2.42 in 20% yield (unoptimized) along with 
35% recovered starting material.  The purification of 2.42 was complicated by the 
presence of side products that could not be completely removed by chromatography, and 
efforts to recrystallize 2.42 failed. Nevertheless, 2.42 was reduced with Raney Ni to 
afford 2.43, which could be obtained cleanly in 18% yield over the two steps, thus 
completing the carbon skeleton of dihydrocorynantheol (2.44). It is not inherently clear 
why 2.32 should be more difficult to alkylate than its diastereomer 2.31, and more 
experimentation would be needed to make this a viable route to dihydrocorynantheol. 
After optimization of the alkylation, one can envision the completion of the synthesis of 
2.44 by simply refluxing 2.43 in the presence of LiAlH4 to effect the necessary 
reductions to afford the natural product. 
2.15 CONCLUSION  
A unified approach to the synthesis of corynanthe and oxindole alkaloids that 
employs an RCM/1,4-addition strategy has been developed. This culminated in the 
formal syntheses of hirsutine, rhynchophylline, and the carbon skeleton of 
dihydrocorynantheol. The advantage of this strategy over the majority of previous 
approaches is that it allows access to both the normal and pseudo corynanthe alkaloids, 
which have a C(3)-H/C(15)-H cis, and C(3)-H/C(15)-H trans stereochemical relationship 
respectively. The syntheses diverge in a highly stereoselective manner from a common 
intermediate upon the efficient control of the stereochemistry in the 1,4-addition. This 
may facilitate the preparation of analogs of these biologically valuable alkaloids. The 
development and application of 1,4-additions to unactivated α,β-unsaturated lactams was 
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significant in that the majority of literature examples involve prior activation of the 
lactam by the incorporation of electron withdrawing groups. In another key step, 
conditions were developed to allow for a highly diastereoselective alkylation of an 
exceedingly hindered lactam, a transformation with little precedence in the literature. 
The synthesis of 2.4, the formal target of hirsutine (2.2), proceeded in eight steps 
and 14.4% overall yield from 2.8 (10 steps from tryptamine). This compares favorably to 
Tietze’s 11-step enantioselective synthesis of this intermediate. Among the 
diastereoselective racemic total syntheses of 2.2, the syntheses of Wenkert, Brown, and 
Lounasmaa were shorter than our approach, but the overall yields were lower (less than 
7.8%, 3.8%, and 1.1% respectively). Additionally, unlike our synthesis, none of these 
approaches are readily adapted to the enantioselective synthesis of 2.2. The formal 
synthesis of rhynchophylline (2.1) proceeded in 11 steps and 5.4% overall yield to epi-2.3 
(13 steps from tryptamine). Although Ban’s synthesis of 2.1 required only nine steps, it 
involved four separations of diastereomers formed in almost equimolar ratios due to early 
formation of the configurationally labile oxindole skeleton and a non-selective 
introduction of the C(20) ethyl group.   
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Chapter 3: Citrinadin A and B: Syntheses of Spirooxindoles 
3.1 INTRODUCTION 
Marine-derived fungi represent an important source of structurally diverse 
secondary metabolites that often possess significant biological activity.82  In the fall of 
2004, Kobayashi and co-workers reported the isolation and structure elucidation of 
citrinadin A (3.1), a novel pentacyclic spiroindolinone alkaloid.83  This marine natural 
product was obtained from the fermentation broth of the fungus Penicillium citrinum 
(strain N-059), derived from the red alga Actinotrichia fragailis, which was collected at 
Hedo Cape, Okinawa Island. Citrinadin A (3.1) features a densely functionalized carbon 
skeleton including nine stereogenic centers, an α,β-epoxy carbonyl moiety, and a rare 
N,N-dimethylaminovaline residue. The latter functional group has only been observed in 
two other natural products: 14-(N,N-dimethyl-L-valyloxy)paspaline, obtained from a 
fungus,84  and the dolastatins, which were isolated from sea hares.85 In 2005, Kobayashi 
also reported the isolation of the closely related analogue citrinadin B (3.2), which differs 













citrinadin A (3.1) R =
citrinadin B (3.2) R = H  
 
Over the years a number of spiroindolinone alkaloids have been isolated from 
fungi of the Penicillium or Aspergillus genera including the brevianamides,87 
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paraherquamides,88 marcfortines,89 and sclerotamide.90 Although these alkaloids contain 
structural similarities to 3.1 and 3.2, the molecular architecture and substitution pattern 
displayed by citrinadin A and B are unique. Furthermore, preliminary biological assays 
demonstrated that 3.1 exhibits cytotoxicity against murine leukemia L1210 (IC50 = 6.2 
μg/mL) as well as human epidermoid carcinoma KB cells (IC50 = 10 μg/mL)83 making it 
an attractive target for total synthesis. To date, no total synthesis or synthetic studies have 
been reported of citrinadin A or B. We anticipated that the pursuit of the enantioselective 
total synthesis of 3.1 would likely inspire the development of potentially useful and 
general solutions to a variety of synthetic problems (vide infra). 
3.2 RETROSYNTHETIC ANALYSIS/SYNTHETIC CHALLENGES  
It was envisioned that the natural product 3.1 could be derived from the late-stage 
intermediate 3.3 via a directed ortho-metallation of the indole and trapping as a stannane, 
which in turn could undergo palladium mediated cross-coupling with an appropriately 
functionalized acid chloride to install the α,β-epoxy carbonyl moiety (Scheme 3.1). While 
ortho-metallation of indoles have been demonstrated,91a there is no precedent for the 
corresponding reaction of oxindoles. If such a process cannot be realized it may be 
necessary to incorporate a halogen in the indole 7-position from the start of the synthesis. 
In that case, several options exist for the introduction of the α,β-epoxy carbonyl moiety. 
The most direct approach would involve using a mild protocol developed by Gosmini, in 
which the aryl bromide is converted to an aryl zinc species that readily undergoes cross-
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The N,N-dimethylaminovaline residue will be installed on the quinolizidine 
section of the molecule via EDCI-mediated esterification of a secondary alcohol. Late 
stage intermediate 3.3 may be obtained from 3.4 through the addition of a methylamine-
derived nucleophile via trans-diaxial opening of an epoxide at the less hindered carbon. 
Although we recognized that this may be a significant synthetic challenge, this 
transformation has been demonstrated in hindered systems using amino-magnesium 
species as nucleophiles.93 Pentacyclic intermediate 3.4, in turn, would be obtained from 
tetracycle 3.5 via Sharpless asymmetric epoxidation according to close literature 
precedent,94 followed by D-ring formation via intramolecular alkylation. 
The tetracycle 3.5 was projected to arise from addition/elimination of the Knochel 
cuprate of alkyl zinc species 3.7 to the alkenyl triflate 3.6 following chemistry described 
by Lipshutz.95 In this method, Lipshutz converted alkyl halides such as 3.8 to the 
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corresponding alkyl zinc halides 3.9 by direct insertion of zinc that had been activated 
with TMSCl and dibromoethane (Scheme 3.2).96 Since alkyl zinc halides are fairly 
unreactive, methyllithium was added to generate the more reactive dialkyl zinc species 
3.10, in which the methyl group serves as a nontransferable ligand. This species 
underwent facile addition/elimination to a variety of substrates in the presence of 3 mol 
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3.15 3.16  
The application of this tactic to the fragment coupling of 3.6 and 3.7 would result 
in a highly convergent synthesis, but would also entail significant challenges because of 
the steric hindrance of triflate 3.6. Not only is the triflate neopentyl but it is also flanked 
on both sides by the spirooxindole unit. Furthermore, all examples by Lipchutz and co-
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workers utilized linear nucleophiles whereas the proposed fragment coupling would 
entail the use of the β-branched alkyl zinc species 3.7.   As such, this provided an 
opportunity to examine and potentially expand the scope of this useful coupling 
methodology. 
In preparation for the fragment coupling, an efficient enantioselective synthesis of 
the trisubstituted piperidine 3.7 will be required. Although numerous methods have been 
described for the synthesis of piperidines with various substitution patterns, there are not 
as many general methods available for the synthesis of trans-2,6-dialkyl piperidines as 
there are for cis-2,6-disubstituted piperidines.97 Singh and Han have recently described a 
facile entry into these systems, which utilizes a tandem Overman rearrangement/mercury 
cyclization (Scheme 3.3).98 The high trans selectivity in the mercury cyclization was 
attributed to steric repulsion between the N-trichloroacetyl group and the mercury 
complexed terminal olefin in 3.18. Since organomercurials can be directly converted to 
alkyl iodides,99 the application of this mercury cyclization could potentially allow for a 
rapid synthesis of the iodide precursor to 3.7. However, it would require the 
enantioselective synthesis of a suitable substrate related to 3.18 incorporating an oxygen 
substituent in the 4-position, which in turn may influence the stereoselectivity of the 
mercury cylization. Another possibility would be to carry out the cyclization using iodine 
















 A more straightforward, albeit somewhat longer, approach may involve the 
application of methodology developed by Comins101 coupled with a trans-selective Beak 
lithiation.102 Comins and co-workers have demonstrated that acyl pyridinium salts such as 
3.20, derived from 4-methoxy-3-(triisopropyl)pyridine and the chloroformate of (-)-trans-
2-(α-cumyl)cyclohexanol ((-)-TCC), undergo addition of Grignard reagents in good yield 
and high diastereoselectivity. The presence of the TIPS group was necessary to ensure 
high diastereoselectivity. This methodology has been applied to the enantioselective 









































































A convenient one-pot procedure involving the exposure of 3.21 to NaOMe/MeOH 
followed by 10% HCl delivered 3.22 where both the TIPS group and the TCC auxiliary 
had been removed. The auxiliary could be recovered in 95% yield at this point. Following 
elaboration of 3.22 to 3.25, the stage was set for the ortho-directed lithiation to introduce 
the requisite methyl group and establish the 2,6-trans stereochemical relationship. This 
reaction, which was developed by Beak and co-workers, relies on the directing effect of 
the Boc protecting group.102 The substituent in the 2-position is axially disposed in order 
to minimize A1,3 strain resulting from the partial double bond character of the amide 
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bond. With the equilibrium favoring this chair conformation, the carbonyl oxygen of the 
Boc group directs deprotonation of an equatorial proton. The resultant lithiated species 
3.26 undergoes alkylation with retention of configuration to deliver the trans-2,6-dialkyl 
species 3.27 in excellent yield and diastereoselectivity. 
3.3 SYNTHESES OF SPIROOXINDOLES 
One of the major challenges in the proposed synthesis of citrinadin A will be the 
enantioselective synthesis of the ABC-tricyclic fragment 3.6. Its densely functionalized 
carbon skeleton contains a  five membered ring bearing two adjacent quaternary centers, 
one of which is a stereogenic center in addition to being spirocyclic. There are a plethora 
of methods available in the literature for the synthesis of spiro[pyrrolidine-3,3'-
oxindoles], that contain a nitrogen in the five membered ring as exemplified by 
spirotryprostatin (3.30) (Figure 3.2).104 On the contrary, not as many general methods 
have been devised for the enantio- or stereoselective construction of spirooxindoles 
composed of an all-carbon frame work as in citrinadin A. Gelsemine (3.31) represents 
another structurally intriguing alkaloid that has generated considerable interest in the 
synthetic community, and its challenging spirooxindole motif has inspired the 
development of several new methods for its efficient construction. The remainder of this 
chapter will focus on the various approaches the spirooxindole of gelsemine and other 


















spirotryprostatin (3.30)  
3.3.1 Spiroannelation via Photoinduced Formation of a Diradical Species 
Gelsemine (3.31) has served as a testing ground for new methodology for the 
synthesis of spirooxindoles. In Johnson’s 1994 approach to this challenging alkaloid, a 
method for the conversion of ketone 3.32 to a spirooxindole was required.105 It was 
quickly determined, however, that the steric congestion of this ketone precluded the use 
of many of the conventional methods for constructing quaternary centers.106 A solution to 
this problem was eventually devised that involved a photochemical reaction to generate a 
diradical that could undergo ring closure. As depicted in Scheme 3.5, the benzotriazole 
derivative 3.33 was lithiated and then condensed with ketone 3.32 via a Peterson-type 
olefination. The product 3.34 was obtained as a mixture of E/Z isomers, which were 
separated and subjected independently to the ensuing photochemical transformation. In 
the event, irradiation of 3.34 resulted in the fragmentation of the benzotriazole to expel 
nitrogen and generate a diradical 3.35, which could recombine to give the diastereomeric 
spiro-derivatives 3.36 and 3.37 in a 1:2 ratio. The requisite spirooxindoles could then be 
formed through acid hydrolysis. 
In spite of the low yield and the poor diastereoselectivity favoring the unwanted 
diastereomer, Johnson’s success in converting the sterically encumbered ketone 3.32 to 
the requisite spirooxindole was a notable achievement. Flemming had previously 
attempted to convert a ketone similar to 3.5 and developed three spirooxindole syntheses, 
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none of which actually worked in the real system.107 Nevertheless, Johnson’s work 
illustrates the challenge of constructing this type of spirooxindole in good yield and 
diastereoselectivity. As a consequence, this problem became the focus of a number of 
synthetic groups during the ensuing decade. Since the proposed route to citrinadin A 
(Scheme 3.1) requires the enantioselective preparation of the spirocyclic fragment 3.6, 














































3.3.2 Spirooxindoles via Radical Cyclization 
Radical cyclization represents a fairly general method for the construction of 
spirooxindoles, and this tactic was employed by Hart and co-workers in their total 
synthesis of gelsemine (Scheme 3.6).108 These workers discovered that excellent 
regiochemistry could be attained during the enolization of ketone 3.38. As a result, the o-
bromoanilide moiety could be efficiently incorporated through acylation using o-
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bromophenyl isocyante as the acylating agent. Following conversion to 3.39, the stage 
was set for the key radical cyclization. In the event, irradiating a solution of 3.39 and n-
Bu3SnH in refluxing toluene afforded the desired spirooxindole 3.40 in 42% yield, along 
with the two unwanted diastereomers 3.41 and 3.42 in 9% and 7%yields respectively. 
One should note that considerable effort was required to identify 3.39 as the optimal 
substrate for this key transformation, as the cyclization using substrates with different 
protecting groups suffered from poor yields and/or low diastereoselectivity. 
Radical cyclization represents a potentially useful method for the construction of 
such challenging spirocyclic motifs as the one present in gelsemine. Furthermore, 
Jones109 and Murphy110 have recently demonstrated the utility of radical cyclizations in 
the synthesis of spiro[pyrrolidine-3,3'-oxindoles]. However, as in the case of Johnson’s 
photo induced transformation (vide supra), this method does not address the absolute 
stereochemistry. Additionally, the low yield and diastereoselectivity would limit its utility 






































3.41 R1 = H; R2 = OAc, 9%
R1
3.42 R1 = H; R2 = OAc, 7%
+
 
3.3.3 Spirooxindoles via Intramolecular Heck Reaction 
In 1987 Overman and co-workers demonstrated the application of an 
intramolecular Heck reaction to the construction of spirooxindoles.111 The utility of this 
transformation did not go unnoticed by the synthetic community, and in 1994 Hiemstra 
and Speckamp applied an intramolecular Heck reaction in their total synthesis of 
gelsemine.112 The synthesis of the spirooxindole unit starting from triflate 3.43, which 
was subjected to a carbonylation reaction to deliver anilide 3.44, following protection of 
the amide nitrogen with a SEM group (Scheme 3.7). This material then served as the 
substrate for the key spiroannulation reaction. In the event, exposure of 3.44 to Pd2(dba)3 
and Et3N in toluene at room temperature for 4 h delivered spirooxindoles 3.45 and 3.46 
in 90% yield and a 2:1 diastereomeric ratio in favor of the desired spirooxindole 3.45. 
This successful application of an intramolecular Heck reaction to the synthesis of the 
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exceedingly hindered spirooxindole of gelsemine serves as a powerful testimony to the 
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A few years following Speckamp’s synthesis of gelsemine, Overman and co-
workers reported their approach.113 The intramolecular Heck reaction was again featured 
as the key step in constructing the spirooxindole unit, but their system was slightly 
different than the one employed by the Speckamp group. Because in Overman’s 
synthesis, a vinylogous carbamate 3.47 was used, a migratory insertion of an aryl 
palladium species into a tetrasubstituted olefin would be required (Scheme 3.8). 
Nevertheless, the reaction proceeded in 61-78% yield to deliver spirooxindole 3.48 in a 
diastereomeric ratio of 11:1. Unfortunately, the major isomer was in fact the undesired 
diastereomer, and it was therefore necessary to epimerize the spiro-center. Following 
elaboration of 3.48 to 3.49, this goal was achieved by refluxing 3.49 in toluene in the 
presence of DBU to effect a major skeletal reorganization. This transformation was 
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presumed to occur via initial retro-aldol reaction to give 3.50a. In order to minimize 
steric repulsion between the oxindole aryl ring and the vinyl group this material 
undergoes C-C bond rotation to give 3.50b, whereupon ring-closure can occur via an 
aldol reaction. The latter transformation was followed by addition of the resultant axial 
hydroxyl group in 3.51 to the nitrile to form the final ring and deliver 2.52 in 80% yield. 
Again, the intramolecular Heck reaction has proved to be useful in constructing sterically 
hindered spirooxindole units. One remaining limitation, however, is the problem of 
























































3.3.4 Spirooxindoles via the Asymmetric Intramolecular Heck Reaction  
The asymmetric version of the intramolecular Heck reaction was discovered and 
reported independently by Shibasaki and Overman in 1989.114 Overman and co-workers 
applied this transformation to the asymmetric synthesis of spirooxindoles, and they were 
able to obtain moderate levels of enantioselectivity as shown in Scheme 3.0.115 
Surprisingly, either enantiomer of the spirooxindole 3.54 could be obtained using the 
same enantiomer of the chiral diphosphine ligand depending on whether Ag3PO4 or PMP 
was used as the HI scavenger. While the asymmetric Heck reaction has proven extremely 
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powerful in the synthesis of a number of indole and oxindole alkaloids, it is unclear, 
whether or not this transformation could be applied to the synthesis of citrinadin A. A 
potential problem would be the presence of the gem-dimethyl substituents, which would 
incur unfavorable steric interactions with the aryl palladium species in the transition state. 































3.3.5 Spirooxindoles via Divinylcyclopropane Rearrangement 
A major drawback with all the previous approaches to the gelsemine 
spirooxindole unit was the lack of control over stereochemistry. To address this problem 
Fukuyama and co-workers developed an efficient strategy using a divinylcyclopropane 
rearrangement as a key step that allowed for the incorporation of the spirooxindole with 
complete diastereoselectivity.116 The substrate for the key step was prepared through a 
Knovenagel condensation of aldehyde 3.55 with 4-iodooxindole to give 3.56 in excellent 
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yield as a single olefin regioisomer (Scheme 3.10). During the development of the 
racemic synthesis of gelsemine using a system closely related to 3.55, it was discovered 
that the use of a substituted oxindole bearing a bulky iodide in the 4-position was crucial 
in order to obtain good E/Z-selectivity in the Knovenagel condensation. In fact, 
performing this condensation using oxindole itself resulted in a mixture (4:1) of E- and Z-
isomers. Following deprotection of the silyl group, the resultant secondary alcohol 3.57 
underwent Jones’ oxidation to give a mixture of cyclopropane cis and trans isomers 3.58 
and 3.59. This was of no concern since both isomers underwent the key rearrangement 
equally well. Thus, heating the mixture to 80 °C in toluene/acetonitrile induced the key 
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3.59 cis isomer  
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Fukuyama’s approach to the spirooxindole of gelsemine represented an elegant 
solution to the challenging problem of controlling diastereoselectivity. On the other hand, 
the strategy is highly specific to the gelsemine ring-system, and could not be readily 
applied to the synthesis of the spirooxindole of citrinadin A.  
3.3.6 Spirooxindoles via Eschenmoser Claisen Rearrangement 
Danishefsky and co-workers envisioned the formation of spirooxindole 3.62 from 
allylic alcohol 3.61 via the incorporation of a one carbon unit (Scheme 3.11).117 
Unfortunately, all attempts to realize this goal using a [2.3] Still-Wittig or a Büchi 
rearrangement of allylic alcohol 2.61 were unsuccessful. The researchers were therefore 
forced to consider [3,3]-sigmatropic rearrangements as an alternative, although such a 
process would have the obvious disadvantage that it would generate a six membered ring 















After much experimentation, the strategy involving a [3,3]-process was reduced to 
practice by a successful Eschenmoser amideacetal, Claisen rearrangement of 3.63 to 
afford 3.65 in 44% yield after exposure of intermediate 3.64 to silica gel (Scheme 3.12). 
Contraction of the six-membered spiro lactam commenced with the reduction of the 
lactam carbonyl followed by dehydration to give enamide 3.66. Osmylation of the more 
electron rich olefin followed by periodate cleavage and silyl protection of the primary 
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hydroxyl group delivered 3.67 in moderate yield. Bis-aldehyde 3.67 was then subjected 
to K2CO3 in methanol resulting in the cleavage of the N-formyl group and spontaneous 
cyclization of the carbamate nitrogen with axial aldehyde to afford an aminal, oxidation 
of which furnished the requisite spirooxindole 3.68. While the approach was eventually 
successful, the low yield of the rearrangement of 3.63 to 3.65 coupled with the need for a 
seven-step ring contraction would not allow for an efficient synthesis of the spirooxindole 
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3.3.7 Spirooxindoles via Hetero Claisen Rearrangement  
Another example of [3,3]-sigmatropic rearrangements in the synthesis of 
spirooxindoles was reported by Baldwin and co-workers.118 These researchers developed 
a three-step protocol, which is conceptually related to the Brunner oxindole synthesis,119  
and starts from a carboxylic acid using an Eschenmoser-Claisen reaction to construct the 
quaternary center. As depicted in Scheme 3.13, hydroxamic acid 3.69 underwent a DCC-
mediated coupling with cyclohexane carboxylic acid (3.70). The corresponding product 
was treated with KHMDS at −78 °C to generate enolate 3.72, which upon warming to 
room temperature underwent a [3,3]-sigmatropic rearrangement to give spiro-derivative 
3.73. Exposure of 3.73 to NaOAc and Ac2O then effected the ring closure to furnish 
spirooxindole 3.74 in 75% yield over the three steps. It is notable that all the reactions 


























Baldwin and co-workers then sought to examine the stereochemical implications 
of their spiroannelation protocol (Scheme 3.14). A significant finding was that the 
procedure works well even in exceedingly hindered systems such as camphor carboxylic 
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acid (3.78), which underwent the three step sequence to give 3.79 and 3.80 in 52% 
overall yield. The diastereomeric ratio, however, was quite low affording the 
spirooxindoles 3.79 and 3.80 in a 2.3:1 dr. Because the diastereomeric ratios ranged from 
1.6:1 to 2.8:1 this methodology is clearly limited. Nevertheless, Baldwin’s oxindole 
synthesis represents a potentially useful approach that warrants further examination in the 



























3.3.8 Spirooxindoles via Pummerer Reaction 
Feldman recently reported an interesting asymmetric spirooxindole synthesis 
involving a Pummerer reaction of chiral indole-2-sulfoxides bearing a nucleophile 
tethered to the 3-position of the indole (Sheme 3.15).120 The reaction is of considerable 
mechanistic interest since it can be thought of as proceeding through two different 
pathways; additive or vinylogous (Scheme 3.16). Upon addition of triflic anhydride the 
resultant intermediate 3.87 can undergo direct cyclization of the tethered nucleophile onto 
the indole 3-position via a SN2’ mechanism (additive pathway). Alternatively, 3.87 can 
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ionize through the participation of the indole nitrogen lone pair (vinylogous pathway) to 
generate a tight ion pair 3.90, that can either cyclize to afford the enantioenriched 
spirooxindole 3.89 or dissociate to furnish an achiral thionium species 3.91.  
Scheme 3.15 













3.82 R = OCH3
3.83 R = H; 58% yield, 86% ee
3.84 R = OCH3; 33% yield, 74% ee
1) Tf2O,2,6-lutidine 
    Et2O, −100 °C
2) HgCl2, H2O  
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3.91 achiral thionium ion
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In order to achieve good chirality transfer, it was necessary to find conditions that 
would suppress the formation of the achiral thionium ion 3.91. Scheme 3.15 shows the 
three examples that gave the highest ee’s of the final oxindoles. The reactivity of the 
nucleophile was found to be important. Reactions with substrates bearing a silylenol ether 
such as 3.81 and 3.82 generally proceeded in higher ee than the less reactive vinylsilane 
3.85 under identical conditions. Given the requirement that the cyclization event be fast 
in order to attain good yield and ee, this process may not be applicable to the synthesis of 
challenging spirooxindoles such as the one found in citrinadin A because of the presence 
of the gem-dimethyl substituent, which would require an SN2’-like attack onto a 
neopentyl carbon. 
3.3.9 Spirooxindoles via Nucleophilic Addition to an Aryl isocyanate 
In the pursuit of the synthesis of (±)-welwitindolinone A (3.95), Wood and co-
workers required a mild method for the diastereoselective formation of a spirooxindole in 
the presence of a sensitive cyclobutene ring.121 Toward this end, Wood developed an 
attractive samarium diiodide mediated cyclization of an enone with an aryl isocyanate 
(Scheme 3.17). Isocyanate 3.93 was generated through the β-elimination of ketone 3.92 
with DBU followed by loss of CO2. The resultant aniline was then exposed to phosgene 
to generate the unstable isocyanate 3.93, which following filtration to remove the HCl 
salts, underwent a reductive cyclization upon exposure to a solution of SmI2/LiCl. The 
requisite spirooxindole 3.94 could be isolated in a 75% yield a single diastereomer. 
Unfortunately, the ketone of 3.94 was too sterically encumbered to be converted to the 
















































Given the unreactive nature of 3.94, it was decided to functionalize the ketone 
prior to the construction of the oxindole. Toward this end 3.92 was converted to oxime 
3.96; however, this material was not sufficiently reactive toward the SmI2 mediated 
reductive cyclization conditions (Scheme 3.18). Because of this problem, Wood and co-
workers developed a complementary spirooxindole synthesis, which was closely related 
to the original strategy.122 Intermediate 3.96 was converted in four steps to 3.97, which 
was treated with phosgene. This resulted in the formation of 3.98 bearing the requisite 
isonitrile group as well an aryl isocyanate thus setting the stage for the pivotal 
spirooxindole formation. In the event, the isonitrile α-proton in  3.98 was readily 
deprotonated with LiHMDS at −78 °C to induce a cyclization of the olefin with the aryl 
isocyanate to afford the desired spirooxindole as a single diastereomer in 48% yield. 
Woods synthesis of this (±)-welwitindolinone A represents an excellent example of how 
the synthesis of complex natural products continue to inspire the development of new 
synthetic strategies. As in the case of Fukuyama’s approach to Gelsemine, the 
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spirooxindole syntheses developed by Wood proceed in good diastereoselectivity but are 
highly specific to structures related to 3.94 and may not be readily applied to the 
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3.3.10 Spirooxindoles via Oxidative Rearrangement of Indoles 
One of the most common methods for constructing spiro[pyrrolidine-3,3'-
oxindoles], such as the one present in spirotryprostatin (3.30), is the oxidative 
rearrangement of an indoloquinolizidine.26 Scheme 3.19 shows the last three steps in the 
total synthesis of (+)-paraherquamide B (3.101), by Williams and co-workers, in which 
an oxidative rearrangement was used to introduce the spirooxindole motif in excellent 
diastereoselectivity. Unlike in the synthesis of spiro[pyrrolidine-3,3'-oxindoles], there are 
not as many literature examples of the application of this transformation to substrates 
such as 3.98, which do not have a nitrogen atom present in the ring appended to the 
  123
indole unit. While the chlorination step proceeded smoothly to give a single 
chloroindolinine 3.99, the ensuing pinacol-type rearrangement was problematic. 
Commonly used procedures such as refluxing 3.99 in MeOH/H2O/AcOH for 1 h,
123 or 
treating 3.99 with AgClO4 and HClO4
124
 resulted in the formation of intractable reaction 
mixtures. After considerable experimentation, it was eventually discovered that 3.99 
could undergo the desired  hydration/rearrangement sequence by refluxing in the 
presence of TSOH in a 9:1 THF/ H2O solvent mixture to give spirooxindole 3.100 in 
80% yield (dr = 19:1). A disadvantage to the use of oxidative rearrangement is the 
incompatibility with olefins. As seen in Scheme 3.19 it was necessary to mask the olefin 
in the hydrated form and perform a dehydration at the last step of the synthesis. While 
this approach could potentially be applied to the synthesis of citrinadin A, it would 
require that facial selectivity can be achieved in the chlorination step based on the 
stereochemical elements that are already present in the molecule. This may not be as 
readily achieved in the case of citrinadin A as in 3.98, which has a lactam ring partially 













































Foote and co-workers demonstrated in 1993 that dimethyldioxirane (DMDO) was 
an effective epoxidizing agent for the C(2)-C(3) double of indoles bearing and acyl, 
siliyl, or methyl group on the nitrogen (Scheme 3.20).125 They further demonstrated that 
while the resultant epoxides such as 3.103 are stable at low temperature, they rearrange to 
the oxindole upon warming to room temperature or upon exposure to silica gel 
chromatography. Foote was able to obtain X-ray structures of an indole epoxide, which 
indicated elongation of the bond between the C(3) carbon  and the epoxide oxygen. This 
elongation presumably stems from benzylic stabilization and of the C(3) position, which 











3.102 3.104  
While the rearrangement works exceedingly well for simple substrates such as 3.102, the 
scope of this transformation was not investigated beyond simple 2,3-alkyl substituted 
indoles. Furthermore, to the best of our knowledge this rearrangement has never been 
applied to the synthesis of natural products. As will be discussed in detail in the following 
chapter, this transformation caught our attention, and it came to serve as the foundation 
on which we built our approach to the challenging spirooxindole motif of citrinadin A.  
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3.3.11 Spirooxindoles via Palladium Catalyzed Carboxylative TMM-Cycloaddition 
The most recent contribution to the area of spirooxindole synthesis, and the one 
that perhaps holds the most promise for the synthesis of alkaloids such as citrinadin, was 
reported in 2007 by Trost and co-workers.126 Their approach involved the application of a 
carboxylative palladium catalyzed trimethylenemethane (TMM) cycloaddition,127 and 
was successfully applied to the first total synthesis of (±)-marcfortin B (3.108).126 As 
depicted in Scheme 3.21, refluxing α,β-unsaturated indole 3.105 and TMM-donor 3.106 
in the presence of Pd(OAc)2 gave the spirooxindole 3.107 in 94% yield as a mixture (1:1) 
of diastereomers following methylation of the carboxylic acid.  The formation of a 
diastereomeric mixture was of no consequence as this stereocenter was destroyed in the 
subsequent step.  
Scheme 3.21 
1) Pd(OAc)2, P(Oi-Pr)3















Boc Boc2) Me2SO4, K2CO3













The mechanism of this carboxylative variant of the TMM-cycloaddition is rather 
interesting and merits some comment. Exposure of TMM-donor 3.106 to Pd(OAc)2 
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generates a π-allyl palladium complex that loses a TMS group through the nucleophilic 
attack by the carbonate anion to give 3.109 (Scheme 3.22). As shown in the box, the 
resultant methyl trimethylsilyl carbonate 3.112 presumably exists in equilibrium with 
methyl trimethylsilyl ether and CO2, the latter of which can react with TMM intermediate 
3.109 to give 3.110. This intermediate can again undergo loss of a TMS group by the 
nucleophilic attack of a carboxylate anion to give the final reagent 3.111, which 
subsequently undergoes the cycloaddition with 3.105. Following cycloaddition, acid 




























Trost’s carboxylative TMM cycloaddition is an extremely powerful strategy to 
construct highly functionalized spirooxindoles. In particular the reaction proceeded in 
excellent yield in spite of the fact that the oxindole TMM acceptor was disubstituted in 
the β-position, which allowed for the incorporation of the gem-dimethyl group. A 
remaining limitation in this methodology is that the enantioselective version of this 
transformation has not yet been reported, although moderate success (63-84% ee) was 
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recently achieved in the non-carboxylative TMM cycloaddition.128 As such, it would not 
be applicable to the asymmetric synthesis of 3.6 toward the synthesis of citrinadin A. 
3.3 CONCLUSION 
The discovery and isolation of biologically active and structurally complex 
oxindole alkaloids have spurred the development of novel methodologies for their 
efficient construction. Similar to alkaloids such gelsemine, welwitindolinone A, and 
marcfortin B, the recently isolated spiroindolinone alkaloid citrinadin A promises to gain 
the attention of the synthetic community due to its highly complex molecular architecture 
coupled with its useful biological activity.  
One of the major synthetic challenges lies in the construction of the central five-
membered ring in which all but one of the carbon atoms are fully functionalized and two 
adjacent quaternary centers are present. In contrast to spiro[pyrrolidine-3,3’-oxindoles] 
that contain a nitrogen in the five membered ring, the synthesis of spirooxindoles bearing 
an all-carbon framework has not been as extensively studied. The most general methods 
are radical cyclization, the asymmetric intramolecular Heck reaction, and most recently, 
the palladium catalyzed TMM cycloaddition. However, none of these methods can be 
readily applied to the enantioselective synthesis of 3.6. The approach outlined herein also 
requires an efficient enantioselective synthesis of the trisubstituted piperidine fragment 
3.7. Notably, there are only a limited number of synthetic methods available for the 
preparation of 2,6-trans disubstituted piperidines. Finally, the proposed coupling of the 
spirocyclic ABC fragment 3.6 with the trisubstituted piperidine 3.7 will expand the limits 
of organozinc coupling chemistry.  
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The efficient enantioselective synthesis of spirooxindole fragment 3.6 and a 
trisubstituted piperidine fragment, as well as efforts toward the fragment coupling will be 
discussed in the following chapter. 
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Chapter 4: Studies Toward the Enantioselective Total Synthesis of 
Citrinadin A  
4.2 INTRODUCTION 
In the fall of 2002, when Kobayashi and co-workers reported the isolation and 
structure elucidation of the marine spiroindolinone citrinadin A (4.1), we were 
immediately attracted to this alkaloid because of its promising biological activity and its 
unique and highly complex molecular framework. We felt that the development of an 
efficient synthetic approach to this natural product would be of value for two reasons; (1) 
it would provide sufficient quantities amenable to extensive biological evaluation, and (2) 
it would offer significant synthetic challenges, which would inspire the development of 
useful and general solutions.  
As discussed in Chapter 3, examination of the structural features of citrinadin A 
(4.1) revealed several synthetic challenges that needed to be addressed (Scheme 4.1). A 
major issue was the formation of the sterically hindered five-membered ring bearing the 
amino alcohol motif, which we envision coming from epoxide 4.3 via a trans-diaxial 
opening with an amine nucleophile. Another key step involved the coupling of alkylzinc 
species 4.6 with β-ketoester derived enol triflate 4.5 via a cupper catalyzed 
addition/elimination process. Jackson129 and Knochel96 have demonstrated the formation 
and subsequent cross coupling of aminoacid derived alkylzinc species, and Lipshutz have 
developed a coupling process in which alkylzinc reagents undergo 1,4-addition to α,β-
unsaturated enoates bearing triflates in the β-position.95 The 1,4-addition is then followed 
by β-elimination of the triflate to regenerate the double bond. This strategy, however, has 
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not been applied to systems as complex as in citrinadin, and its pursuit is likely to push 
the envelope of the current stage-of-the art.  
The synthesis of the right hand fragment, the 2,4,6-trisubstituted piperidine 4.6, 
may superficially appear simple; however, there are only a limited number of methods 
available for the efficient construction trans-2,6-piperidindes in an enantio- and 
diastereoselective manner.97 Finally, the enantioselective synthesis of the tricyclic 
spirooxindole fragment 4.5 was thought of as a major challenge given the presence of the 
gem-dimethyl groups that would preclude the use of most existing methods as discussed 
in detail in Chapter 3. Additionally, the remaining available methods such as the 
carboxylative TMM-cycloaddition and radical cyclizations have not been performed in an 
enantioselective fashion. Hence, we decided to focus our initial efforts on the 
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4.2 SPIROOXINDOLE SYNTHESIS VIA SEMI-PINACOL REARRANGEMENT 
Tu and co-workers recently reported a novel NBS induced semi-pinacol 
rearrangement to generate quaternary centers in excellent diastereomeric ratio (Scheme 
4.2).130 It was envisioned that this methodology could be extended to the synthesis of 
spirooxindoles by designing an appropriate substrate such as 4.9 (Scheme 4.3).  Exposure 
of 4.9 to NBS should lead to attack of “Br+” on the less hindered face of the olefin 
leading to the stereospecific generation of spiro-derivative 4.11 via the intermediacy of 
4.10.  Danishefsky showed in his synthesis of gelsemine that aryl carbamates such as 
4.11 spontaneously react intramolecularly with aldehydes to form five-membered aminals 
such as 4.12.117  It might therefore be possible to go directly from 4.9 to 4.12 in a single 
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operation.  Furthermore, Danishefsky demonstrated that aminals such as 4.12 are 






















































Preparation of the substrate 4.9 began with commercially available 1,2-bis-
trimethylsilyloxybutene (4.15), which can be conveniently prepared on large scale via an 
intramolecular acyloin condensation of diethyl succinate.131  Following published 
  133
procedures, 4.15 was converted to 4.16 in 89% yield using a one-pot Mukaiyama 
aldol/ring expansion sequence (Scheme 4.4).132 Next, asymmetry was introduced via a 
baker’s yeast reduction to give ketol 4.17 in 44-65% yield.133  This transformation has 
been reported to proceed with greater than 99% ee, although this was not verified by 
chiral HPLC. Following protection of the hydroxyl group gave the TBS ether 4.18 in 
89% yield, the ketone moiety was deprotonated with NaHMDS and trapped with Tf2NPh 
























The aldehyde coupling partner 4.22 was prepared from the Boc-protected aniline 
4.20 via ortho-directed metalation followed by formylation with DMF (Scheme 4.5).134 
Aldehyde 4.22 could only be obtained in 36% yield (55% was reported in the literature 
for this transformation; however, enough material could be secured to test the ensuing 
Nozaki-Hiyama-Kishi coupling.  Unfortunately, exposure of triflate 4.19 and aldehyde 
4.22 to stoichiometric Cr2Cl2 and catalytic NiCl2 in DMF did not afford any of the 
desired product 4.9. Rather, the reduced species 4.23 was isolated in 41% yield along 
with 45% recovered triflate starting material.  The presence of 4.23 suggests that the 
alkenyl chromium reagent was indeed formed, but it did not react with aldehyde 4.22 and 

























Since the alkenyl chromium reagent derived from 4.19 was not reactive enough to 
add to aldehyde 4.22, we envisioned using the corresponding alkenyllithium species, 
which could be obtained from 4.18 via the Shapiro reaction (Scheme 4.6). After some 
optimization, ketone 4.18 could be smoothly converted to the trisylhydrazone 4.25 in 
94% yield. Because of the acidic carbamate NH in 4.22, the direct coupling of 4.25 with 
4.22 was not pursued. Instead, a stepwise approach was taken in which 4.25 was first 
converted to enal 4.26 in 67% yield (Scheme 4.6). While this reaction worked well 
initially, subsequent attempts revealed that the reaction was not reproducible, and 4.26 
could only be formed in low and inconsistent yields. In spite of this problem, sufficient 
quantities of 4.26 could be secured to attempt the coupling reaction with 4.21. In the 
event, 4.21 was lithiated with t-BuLi and added to 4.26; however, only a trace of the 
requisite substrate 4.9 was observed in the 1H NMR spectrum of the crude reaction 
mixture. Given these problems, a third and final approach to the rearrangement substrate 








































After some experimentation, it was eventually discovered that 4.9 could be 
accessed via the Shapiro reaction of 4.25 with o-azidobenzaldehyde (4.27) to afford 4.28 
in 77% yield as a mixture (1:1) of diastereomers (Scheme 4.7). The stereochemistry of 
the secondary alcohol is inconsequential to the semi-pinacol rearrangement as the facial 
selectivity of the bromination of the olefin is presumably dictated by the stereochemistry 
of the silylether.130 The order of addition of the reagents was found to be critical for the 
Shapiro reaction as the azide was unstable to strongly nucleophilic conditions. When o-
azidobenzaldehyde was added as to the alkenyllithium intermediate generated from 
hydrazone 4.25, the product could only be isolated in at most 22% yield. When the order 
of addition was reversed, however, the yield increased to 77%. With a scalable route to 
4.28 in hand, the rearrangement precursor 4.9 could be accessed in just two additional 
steps: The azide was reduced via the Staudinger reaction to afford aniline 4.19, which 
was treated with Boc2O/DMAP to provide the requisite substrate 4.9 in 42% yield over 





























Having gained access to sufficient quantities of 4.9, the stage was now set to explore the 
key semi-pinacol rearrangement. In the event, 4.9 was exposed to NBS in i-PrOH 
according to the conditions reported by Tu,130 but only starting material was obtained 
after 1.5 h at room temperature (Table 1). The use of Hg(COCF3)2 was also explored, but 
again, only  recovered starting material was obtained after 1.5 h at room temperature. 
Finally, the reaction was heated in a microwave reactor, but this resulted in loss of the 
Boc-group and extensive decomposition. It was postulated that the substrate might be too 
sterically hindered for the reaction to occur because of the presence of the gem-dimethyl 
groups.  In light of these findings, the semi-pinacol approach was abandoned in favor of a 
different approach to the spirooxindole that was being pursued in parallel with the semi-
















4.12 X = Br
4.30 X = Hg
Entry         reagent           Solvent       Temp (°C)       Time         Result
1                NBS              i-PrOH             rt                1.5 h        only rsm
2             Hg(OTf)2            THF               rt                1.5 h        only rsm
4             Hg(OTf)2            THF            150 °C*         5 min       decomp
3             Hg(OTf)2            THF             80 °C*          5 min       only rsm
*Heating was preformed in a microwave reactor
 
4.3 SPIROOXINDOLE SYNTHESIS VIA ASYMMETRIC OXIDATIVE REARRANGEMENT 
An interesting possibility for the enantioselective construction of spirooxindoles 
would be to use a variant of the oxidative rearrangement of indoles. It was envisioned 
that this process could be rendered asymmetric by employing a chiral halogen source 
such as hypochlorite derived from menthol, or a C2-symmetric NBS derivative (Scheme 
4.8). If facial selectivity can be achieved in the initial bromination or chlorination of the 
indole C(2),C(3)-double bond, enantioenriched spiro-oxindols may be obtained since the 
































4.3.1 Oxidative Rearrangement: Chiral NBS Approach 
The preparation of a C2-symmetric chiral NBS-derivative was relatively 
straightforward (Scheme 4.9).  A mixture of L-tartaric acid, p-methoxybenzyl alcohol and 
catalytic p-toluenesulfonic acid were refluxed in xylenes to afford 4.37, which without 
purification was converted to the bis-pivalate derivative 4.38 in 57% yield over two steps.  
The PMB group was then oxidatively cleaved with ceric ammonium nitrate in 49% yield 
to give 4.39. With pivalate 4.39 in hand, all that remained was the bromination of the 
imide function, which is typically carried out under strongly basic conditions. Since the 
application of such conditions would likely result in the hydrolysis of the pivalate esters, 
we turned to an alternative method reported by Fujisaki.135 This protocol employs sodium 
bromate under mildly acidic conditions, and gratifyingly, when using this procedure, 
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Next, an attempt was made to synthesize indole 4.47 in preparation for the 
oxidative rearrangement. Following literature procedures, 4.45 was prepared in three 
steps from commercially available phenylhydrazine (4.41) and 1,4-cyclohexadione 
monoketal (4.42), (Scheme 4.10).136  After protecting the indole as the t-butyl carbamate, 
4.46 was exposed to MeI and NaH in DMSO in an attempt to install the two geminal 
methyl groups.  This transformation was unsuccessful as a complex reaction mixture was 










































Since it was anticipated that the synthesis of 4.47 might be rather challenging, it 
was decided to first attempt the rearrangement on a simpler substrate such as 4.45.  
Unfortunately, all attempts to effect the oxidative rearrangement using 4.40 resulted in 
intractable reaction mixtures (Scheme 4.11).  This is perhaps not too surprising since we 
were unable to identify literature examples of an all-carbon framework undergoing this 






















Although, the proposed oxidative rearrangement in its current form would not be 
applicable to the synthesis of citrinadin A, it was still worth exploring whether or not 
asymmetric induction could be achieved using the chiral NBS derivative 4.40.  Toward 
this end, a carboline derivative of the type that is known to undergo oxidative 
rearrangements with NBS was prepared according to published procedures as delineated 
in Scheme 4.12.137 With 4.51 in hand, the oxidative rearrangement was attempted using 
the C2-symmetric NBS derivative 4.40, and gratifyingly, the rearrangement delivered 
oxindole 4.52 in 94% yield. However, analysis of 4.52 by chiral HPLC and comparing 
the chromatogram to that of racemic 4.52 generated by the rearrangement of 4.51 with 
NBS, revealed that there was no detectable asymmetric induction. There are several 
conceivable explanations for this result. One possibility is that the chirality of 4.40 is too 
far removed from the indole C(2),C(3)-double bond in the transition state. Another 
explanation would be the possibility that the NBS derivative generates small amounts of 

































NBS                           84%
4.40 (chiral NBS)       94%
Br-source                 yield
 
4.3.2 Oxidative Rearrangement: Shi Asymmetric Epoxidation Approach 
At this point, two problems had to be addressed in order to make the strategy 
successful.  First, a reagent had to be identified that is capable of effecting the 
rearrangement of a substrate such as 4.31, which unlike 4.51 does not have a nitrogen in 
the ring appended to the indole. Second, the source of chirality had to be brought in 
closer proximity to the indole C(2),C(3) double bond in the transition state in order to 
achieve asymmetric induction. During a literature search, publications by Foote125 and 
Adam138 were identified, that inspired the solution two both of these problems. In 1993 
and 1994, these workers demonstrated that dimethyldioxirane (DMDO) epoxidizes the 
indole C2-C3 double bond of N-acyl indoles such as 4.53 (Scheme 4.13). They further 
showed that while the resultant epoxide 4.54 was stable at low temperature, it rearranged 
to the oxindole 4.55 upon warming to room temperature or upon silica gel 
chromatography. Based on this precedent one can envision that if a chiral dioxirane such 
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as the one used in the Shi asymmetric epoxidation is employed, one might be able to 











4.53 4.55  
To examine the feasibility of this proposal, compound 4.44 was acylated to 
provide 4.56 as a model substrate.  Subjecting 4.56 to the conditions reported by Foote 
afforded the spirocyclic indolinone 4.57 in 69% yield (Scheme 4.14).  The successful 
oxidative rearrangement of a substrate containing an acetal was encouraging since Foote 
and co-workers did not provide any examples substrates bearing functionalization other 




















4.44 4.56 4.57  
Next, 4.56 was subjected to the standard conditions used in the Shi asymmetric 
epoxidation reaction.139 To our delight, the spirooxindole 4.57 could be isolated, albeit in 
only 7% yield, with the majority of the remaining mass balance being recovered starting 
material (Scheme 4.15). The product was then subjected to chiral HPLC analysis, and 





















aq. EDTA (10-4 M)
O 4.58
 
Having achieved proof of concept for the asymmetric oxidative rearrangement of 
a prochiral indole to an oxindole we decided to switch to the real system that would lead 
to the carbon skeleton of citrinadin rather than optimize a model system. Previous efforts 
had targeted 4.59 (Scheme 4.16), but the introduction of the gem-dimethyl groups 
through alkylation of ketone 4.46 was met with failure.  It then became apparent that 
substrate 4.60, which would be much easier to prepare, would give the same product in 
the oxidative rearrangement. The only difference would be that the opposite enantiomer 












4.59 4.60 4.61  
Starting from 2-methyl-1,3-cyclohexanedione (4.62), methylation140 followed by 
monoacetal formation141 afforded ketone 4.64, which was subjected to a Fisher indole 
synthesis (Scheme 4.17). In the event, refluxing a solution of the hydrazone derived from 
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4.64 and freshly fused zinc chloride in benzene according to the procedure reported by 
Britten,136 gave indole 4.65 in 14% yield over the two steps. However, changing the 
solvent from benzene to the higher boiling solvent toluene, and increasing the amount of 
zinc chloride from one to two equivalents, improved the yield significantly, although 
some variability still remained (47%-69%). Following acylation of 4.65 with acetyl 
chloride as well as methyl chloroformate, we then turned our attention to the key 




































With the requisite substrates in hand, 4.66 was exposed to the same conditions as 
4.56 (vide supra), although this reaction was run at room temperature to increase the rate 
of the reaction (Table 4.2). The desired product 4.68 was isolated in 15% yield together 
with 61% recovered starting material (entry 1). The product and starting material co-elute 
and could not be separated by chromatography. The yields were therefore determined by 
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integration of the 1H NMR spectrum of the isolated mixture. Shi has reported that the 
reaction rate can be increased further by running the reaction at higher pH, which also 
prevents decomposition of the chiral ketone through Bayer-Villager reaction.142 Buffering 
the reaction with K2CO3/sodium tetraborate (entry 2) gave oxindole 4.68 in 20% yield 
together with 40% recovered starting material. While this was the best result so far, the 
overall mass balance was lower than when the reaction was conducted at near neutral pH. 
This could presumably be due to the hydrolytic instability of the product imide, or even 









aq. EDTA (10-4 M)





Base product / s.m. yield (%) rsm (%)
NaHCO3 1:4 15% 61%






























K2CO3* 1:3.6 n/a n/a
NaHCO3 1:2 7% 38%














4.67: R = OCH3
4.68: R = CH3
4.69R = OCH3
 The effect of changing the indole protecting group from N-acetyl to N-
methylcarbamate was then explored (entry 3). The 1H NMR spectrum of the crude 
reaction mixture revealed a significant reduction in the amount of product formed as 
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compared to entry 2, so the product was not isolated. The 1H NMR spectrum of 4.67 
revealed that the indole aromatic protons were shifted further downfield as compared to 
4.66, suggesting that the methyl carbamate renders the indole ring more electron deficient 
than the acetate group. This in turn would cause the indole C(2),C(3)-olefin to be less 
reactive toward the dioxirane. Shi has reported that the more electron deficient chiral 
ketone 4.58b is a better catalyst for epoxidations of electron deficient olefins such as 
enoates.143 However, the oxidative rearrangement using this catalyst, which was prepared 
in two steps from 4.58,143 afforded the desired product 4.68 in only 7% yield (entry 4). 
Finally, an attempt was made to carry out the oxidative rearrangement using Jacobsen’s 
catalyst 4.70.144 While this reaction typically works well with electron deficient olefins 
such as enones and enoates,145 only starting material could be isolated from this reaction 
(entry 5.   
After exploring a variety of reaction conditions the desired spirooxindole 4.68 
could only been obtained in a maximum of 20% yield (Table 4.2, entry 2). Presumably, 
the indole C(2),C(3) double bond is simply too hindered to react efficiently with the 
bulky dioxirane derived from 4.58. As a result we decided to pursue a different avenue to 
achieve asymmetric induction. Nevertheless, this catalytic enantioselective approach to 
spirooxindoles may hold promise for less sterically hindered substrates, although this has 
not yet been explored.  
4.3.3 Oxidative Rearrangement: Chiral Auxiliary Approach 
It was envisioned that rather than using reagent control, one might be able to 
achieve facial selectivity in the epoxidation by using substrate control if a chiral auxiliary 
was placed on the indole nitrogen atom. Unlike the N-acetyl derivative 4.66, the 
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carbamates 4.71 and 4.72 derived from menthol and 8-phenylmenthol could both be 













4.72 = Ph: (65%)





With an ample supply of indole carbamates 4.71 and 4.72 in hand, we then turned 
our attention to the pivotal oxidative rearrangement. In the initial procedure, the reaction 
of 4.72 was typically run in CH2Cl2 or acetone for 2 h at 0 ˚C, at which point TLC 
analysis indicated that the all starting material had been consumed. The volatiles were 
then removed under reduced pressure, and the residue was purified by chromatography 
on silica gel to afford spirooxindole 4.76. In these initial attempts to carry out the 
oxidative rearrangement, 4.76 was obtained in a 53% yield; however this yield was 
difficult to reproduce. Typically, the yields for this reaction ranged from 35-45%, and 
efforts were therefore directed toward optimizing this transformation. A clue to 
improving the yield was an observation in the 1H NMR spectrum of the crude reaction 
mixture following the oxidation step. While TLC analysis of this material indicated a new 
product that co-spotted with the desired oxindole, 1H NMR analysis revealed that none of 
the desired oxindole 4.76 was present in the reaction flask at that time. This observation 
suggested that the crude material was not the oxindole, but rather the indole epoxide 4.74, 
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which underwent rearrangement to the oxindole 4.76 upon exposure to silica gel during 
TLC analysis or column chromatography (Table 4.3).  
In order to test the hypothesis that the material isolated from the oxidation of 4.72 
was the indole epoxide 4.74, this material was dissolved in a mixture (4:1) of hexanes 
and EtOAc and stirred in the presence of silica gel at room temperature for 1 h. After 
removing the silica gel by filtration, 1H NMR analysis indicated approximately 60% 
conversion of the intermediate to the requisite oxindole 4.74, thus supporting the 
hypothesis that the unknown intermediate was indeed the indole epoxide 4.76. Because 
the crude epoxide was exceedingly clean, it was assumed that it was the rearrangement of 
the epoxide that was the problematic step. A brief study of the effect of the solvent on the 



















Xc = 8-phenylmenthol; 4.72
0 °C, 1 h rt, 3.5 h
solvent                unknonwn          8-phenyl-    epoxide 4.74 oxindole 4.76 
                           side product       menthol
THF                   trace                    trace              >95%                0%
EtOAc                 0%                     trace              >95%               trace
Toluene             14%                     11%                 0%                 75%
Hexanes            14%                     14%                 0%                 72%
CH2Cl2              11%                     11%                  0%                 78%
solvent effect on epoxide rearrangment of 4.74    
mol% determined by 1H NMR of the crude product mixture
4.75  78%; dr = 2:1







Epoxide 4.74 was stirred at room temperature in the presence of silica gel for 3.5 
h in various polar and non-polar solvents. Upon filtration and removal of the volatiles, the 
crude reaction mixtures were analyzed by 1H NMR, and the product distribution was 
reported as mol % (Table 4.3). Interestingly, these experiments revealed that the choice 
of solvent had a dramatic impact on the reaction. The use of polar solvents such as THF 
and EtOAc resulted mostly in recovered epoxide 4.74 and small amounts of side 
products, while non-polar solvents such as hexanes, toluene, and CH2Cl2 showed good 
conversion of 4.74 to 4.76. CH2Cl2 appeared to be the best solvent resulting in 78% 4.76 
along with 11% 8-phenylmenthol and 11% of an unknown side product. A potential 
explanation for the dramatic solvent effect in the 1,2-epoxide rearrangement of 4.74 to 
4.76 is that silica is serving as an acid catalyst. Hence, a polar solvent more strongly 
coordinates to the acidic silica and disrupts the interaction between the epoxide with the 
silica, while non-polar solvents allows the epoxide to coordinate more strongly to the 
silica gel. 
It is interesting to note that no 8-phenylmenthol was observed in the 1H NMR 
spectrum of the crude epoxide 4.74. This indicates that the 8-phenylmenthol-derived 
carbamate auxiliary is stable to DMDO, and that the partial fragmentation of the chiral 
auxiliary actually occurs during the rearrangement of step. Hence, a slight excess of 
DMDO can safely be used in the epoxidation step to drive the reaction to completion 
without any deleterious effects.  
Using the optimized conditions the reaction was then performed on 50 mg scale 
with both the menthol- and 8-phenylmenthol-derived carbamates 4.71 and 4.72. 
Gratifyingly, both reactions afforded the corresponding spirooxindoles 4.75 and 4.76 
reproducibly in 78% yield. While the substrate bearing menthol-derived auxiliary 
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afforded the corresponding oxindole in a 2:1 diastereomeric ratio, switching to the 8-
phenylmenthol derived auxiliary resulted in a significant increase in the diastereomeric 
ratio to 12:1.  
Since the crude spirooxindole 4.76 was very clean, and since the small amount of 
8-phenylmenthol impurity was difficult to remove by chromatography, an attempt was 
made to use the crude oxindole 4.76 directly in the ensuing deprotection step (Scheme 
4.19). This three-step sequence was found to work very well and has been carried out 
multiple times on 0.5 g to 1.0 g scale. The yield is invariably above 70% for the three-




























4.4 COMPLETION OF THE ABC FRAGMENT, AND A MODEL STUDY OF THE 
FRAGMENT COUPLING  
With an efficient and scalable route to 4.77 in hand, the next challenge was to 
determine the stereochemical configuration at the spirocenter. Compound 4.77 was 
obtained as a foam, and all efforts to crystallize this material were unsuccessful. A 
number of attempts were made to prepare a crystalline derivative; however, exposing 
4.77 to reagents such as phenylhydrazine, p-nitrophenylhydrazine, and trisylhydrazide 
predominantly resulted in recovered starting material. On the other hand, subjecting 4.77 
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Interestingly, it was not the ketone that had been reduced but rather the carbonyl group of 
the oxindole. This is perhaps not too surprising since this carbonyl is part of an imide 
function. Nevertheless, aminal 4.78 was a crystalline solid and was submitted for single 
crystal X-ray analysis. To our delight X-ray structure of 4.78 revealed that the 
configuration at the spirocenter was indeed that of the natural product (Figure 4.1). 
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Figure 4.1 X-ray structure of spirooxindole 4.78. Left: ORTEP plot, displacements ellipsoids are scaled 
to the 50% probability level; Right: X-ray plot generated by Mercury 2.1 
   
Having developed an efficient approach to the spirooxindole 4.77 we were now in 
a position to complete the synthesis of the fully functionalized ABC coupling partner 
4.80. The next step involved the formation of the β-ketoester 4.79. Acylation of the 
sodium enolate of 4.77 with methyl chloroformate gave exclusively the O-acylated 
product in 87% yield. On the contrary, the corresponding lithium enolate generated from 
deprotonation of 4.77 with LDA could be successfully acylated with Mander’s reagent to 
afford 9 in 80% yield with only trace amounts of O-acylated material, which was readily 
removed by chromatography (Scheme 4.21). The β-ketoester 4.79 exists exclusively in 
the keto form as evident by 13C NMR and was formed as a single stereoisomer, although 
the stereochemistry of the newly formed stereocenter was not determined. The formation 
of a single stereoisomer in this reaction suggests that the spirocyclic oxindole imparts a 























  THF, −78 °C









The final step in the synthesis of ABC-fragment involved the conversion of β-
ketoester 4.79 to the corresponding triflate 4.80. This transformation was first attempted 
by deprotonation of 4.79 with KHMDS followed by trapping the enolate with Comins’ 
reagent. While this reaction resulted in a complicated mixture of products, deprotonation 
of 4.79 with NaH in CH2Cl2 followed by the addition of Tf2O gave the desired triflate 
4.80, albeit in low to moderate yields. Unfortunately, the reaction was found to be 
irreproducible, and the yields varied from 10% to 53% depending on the batch of NaH 
that was used. The solution to this problem entailed using KHMDS in toluene as the base, 
and employing the more reactive electrophile Tf2O. Using this reagent combination, 
requisite triflate 4.80 could be isolated in 76% yield in a reproducible manner (Scheme 
4.21). The formation of triflate 4.80 thus completed the synthesis of the ABC tricyclic 
fragment of citrinadin, which proceeded in only ten steps and 14.6% overall yield from 
commercially available starting materials. 
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At this point it was desirable to explore the cross-coupling of triflate 4.80 via the 
proposed addition/elimination of a Knochel cuprate. This chemistry has been developed 
by Lipshutz using catalytic quantities of CuCN·2LiCl; however, none of the substrates in 
the study had branching in the γ-position.95 Furthermore, prolonged reaction times were 
reported for substrates with only moderate steric hindrance. Since the rate of the reaction 
was found to be dependant on the loading of copper catalyst, we reasoned that by using 
stoichiometric amount of copper, the proposed coupling maight be possible in spite of the 
severe steric hindrance of 4.80. Following the procedure of Knochel,96 4-chloro-1-
iodobutane which is one of the iodides used by Lipchutz,95 underwent direct insertion of 
zinc to give 4.82, which in turn was converted to the more reactive dialkyl halide via 
addition of methyllithium at –78 ˚C (Scheme 4.22). Addition of a solution of 
CuCN·2LiCl then afforded the requisite species 4.83, to which a solution of triflate 4.80 
was added. The reaction was found to be quite rapid with complete consumption of 4.80 
in less than an hour. Gratifyingly, 4.84 was isolated in 78% yield, demonstrating the 
























TMSCl, THF     
35 oC, 16 h
MeLi, Et2O; then 








THF, −78 °C → rt, 1 h
75%
Xc = 8-phenylmeththol  
4.5 SYNTHESIS OF THE E-RING FRAGMENT 
4.5.1 Electrophilic Cyclization Approach 
Having succeeded in synthesizing of the ABC-tricyclic fragment 4.80 and 
demonstrating the viability of the fragment coupling in a model system, the next 
challenge involved the preparation of the E-ring coupling partner. Unlike in the case of 
2,6-cis-piperidines, there are not nearly as many methods available in the literature for 
the enantioselective construction of 2,6-trans piperidines. As a result, the synthesis of the 
E-ring fragment 4.6 was actually considerable more challenging than initially anticipated. 
In one of the early approaches to the synthesis of 4.6, we envisioned that the requisite 
iodide 4.85 could be accessed directly from olefin 4.87 via an iodo-cyclization.100 
Alternatively, a trans-selective mercury cyclization98 might be employed to generate 











4.85  X = I
4.86  X = HgBr
4.87
 
The synthesis of the cyclization precursor 4.92 commenced with a Parikh-Doering 
oxidation of Cbz-alaninol (4.88),146 followed by a two-step homologation to afford the 
known 4.90147 in 44% yield over the three steps (Scheme 4.24). Aldehyde 4.90 was then 
subjected to a Brown allylation to provide homoallylic alcohol 4.91 in 66% yield. This is 
the wrong stereochemistry of the hydroxyl group because the incorrect enantiomer of 
DIP-chloride was used. The mistake was not apparent until later in the synthesis via 
single crystal X-ray analysis of 4.95. Nevertheless, following protection of the alcohol 
4.91 as the TIPS-silyl ether to give 4.92, we turned our attention to the key electrophilic 
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Piperidine formation via iodocyclization of 4.92 was attempted first since it would 
generate the iodide 4.93 directly, resulting in an exceedingly concise synthesis of this 
fragment (Scheme 4.25). In order to force the reaction to go to completion it was 
necessary to use non-reversible, conditions, which can be achieved by the addition of 
K2CO3 to the reaction mixture. However, none of the iodide 4.93 could be isolated, and 











4.92 4.93  
We next turned our attention to cyclization via amidomercuration since 
organomercurials can be directly converted to alkyl iodides.99 Whereas the use of 
reversible conditions (Hg(CF3CO2)2 in CH3NO2)
98 only resulted the recovery of starting 
material non-reversible conditions involving the use of Hg(OAc)2 in THF
148 afforded 
piperidine 4.94 in 70% yield (dr > 10:1), (Scheme 4.26). With the organomercurial 4.94 
in hand, its conversion to the iodide 4.93 was attempted. In the event, 4.94 was subjected 
to KI in refluxing CH2Cl2; however, none of the iodide 4.93 was observed. Instead, a 
different compound was isolated that had suffered loss of the Cbz protecting group. This 
material was crystalline a solid, and it was therefore submitted for single crystal X-ray 






























Figure 4.2 ORTEP plot of 4.95. Displacement ellipsoids are scaled to the 50% probability level. 
 
The formation of 4.95 was initially somewhat puzzling; however, we eventually 
developed a hypothesis as to how this reaction may be occurring. Presumably, the iodide 
4.93 was is indeed formed, but it was not stable to the reaction conditions (Scheme 4.27). 
It is conceivable that 4.93 could undergo intramolecular cyclization by attack of the 
carbamate carbonyl oxygen onto the iodide to generate 4.96. This intermediate could then 
further decompose to the give oxazolidinone 4.95. If this mechanistic hypothesis is 
correct, one would also generate an equimolar amount of benzyl iodide, and indeed, 
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examination of the 1H NMR spectrum of the crude reaction mixture of 4.95 revealsed 



























As discussed above, the incorrect stereochemistry of the hydroxyl substituent was 
obtained during the Brown allylation. This in turn resulted in the exclusive formation of 
the 2,6-cis stereochemistry during the cyclization. It was therefore necessary to prepare 
substrate 4.97 with the correct relative stereochemical configuration since the 
stereochemistry may be an important factor for oxazolidinone formation. Substrate 4.97 
was synthesized in an analogous manner to 4.92 and was submitted to the 
amidomercuration conditions (Scheme 4.28). The resultant crude organomercurial was 
treated with I2 in refluxing CH2Cl2, but unfortunately, as was observed with 4.92, the 1H 
NMR spectrum of the crude reaction mixture indicated formation of the corresponding 
oxazolidinone. Furthermore, unlike in the case of 4.92, 4.97 underwent the cyclization in 
a surprisingly low diastereomeric ratio (1:1.2). After observing oxazolidinone from both 
substrates 4.92 and 4.97, we were mindful of the fact that it may be difficult to generate 
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the requisite precursor for the organozinc fragment 4.6. Nevertheless, we felt that the 
oxazolidinone formation might be avoided if the iodide was formed under milder 
conditions that did not require heating of the reaction mixture. As such, we opted to 





2) I2, DCM 
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4.5.2 RCM/Hydroboration Approach 
Because of the difficulties that were encountered in the mercury cyclization, a 
different strategy was investigated. Beak has demonstrated that 2,6-trans-piperidines can 
be prepared in excellent diastereoselectivity via ortho-directed lithiation of Boc protected 
piperidines followed by alkylation,102 and it was envisioned that this technology could be 
utilized to install the methyl group of piperidine 4.100 (Scheme 4.29). The C(4) hydroxyl 
group would be introduced via hydroboration of the olefin 4.101, where the use of the 
sterically demanding 9-BBN was expected to ensure the correct regiochemistry.149 The 
4,6-trans stereochemistry should result form approach of 9-BBN from the less sterically 
encumbered face through a transition state in which the boron approaches the olefin in an 















4.100 4.101 4.102  
These studies were initially carried starting from L-serine methyl ester since the 
requisite D-enantiomer was more expensive. The plan was then to use the correct 
enantiomer once a successful synthesis of 4.100 had been achieved. Thus, synthesis of 
RCM precursor 4.102 commenced with the protection of the hydroxyl group of L-serine 
methyl ester as its TBS-ether followed by conversion of the primary amine to the nosyl 
amide to afford 4.104 in 96% overall yield (Scheme 4.30). This material was then 
subjected to a Fukuyama-Mitsunobu reaction151 to install the homoallylic side chain in 
82% yield. The nosyl group was readily removed by the action of phenyl thiolate, and the 















    K2CO3, DMF
52%, 2 steps
2) Boc2O, DMAP





























At this point, the ester was to be converted to the aldehyde in preparation for the 
ensuing Wittig olefination. However, subjecting 4.106 to DIBAL in toluene at –78 ˚C did 
not provide aldehyde 4.107. The 1HNMR spectrum of the crude reaction mixture only 
indicated a trace of aldehyde, and the majority of the material had suffered loss of the 
Boc group. It was postulated that over-reduction afforded an aluminum alkoxide, which 
may have cyclized onto the carbamate to afford 4.108. It was therefore thought that it 
would be desirable to introduce the olefin at an earlier stage of the synthesis, and to that 
end, vinyl serine derivative 4.113 emerged as a suitable starting material. This compound 
is commercially available, which should ensure a relatively concise synthesis of 
piperidine 4.100 but it could also be prepared on large scale from the parent amino acid 
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With vinyl serine derivate 4.113 in hand, the synthesis of 4.100 commenced with 
the protection of the primary alcohol as its TBS ether to give 4.114 in 95% yield (Scheme 
4.32). The homoallylic side chain was then installed via monoalkylation of the primary 
amine with 4-bromo-1-butene, followed by Boc protection to afford 4.102 in 51% overall 
yield. It is interesting to note the alkylation of the corresponding Boc-protected derivative 
of 4.114 only resulted in recovered starting material, which is in accordance with the 














    K2CO3, CH3CN
    90 °C, 12 h
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4.117: R = H










Having established an efficient route to RCM precursor 4.102, this material was 
then subjected to 5 mol % Grubbs I catalyst (4.115) to furnish 4.101 in 75% yield. The 
next challenge involved the introduction of the hydroxyl group in the 4-position via 
hydroboration. In the event, a solution of 4.101 and excess 9-BBN in THF was heated 
under reflux overnight to afford a mixture of compounds, the major of which was isolated 
in 64% yield. This material was initially believed to have the desired regiochemistry 
based on its COSY spectrum. However, we were surprised to discover at a later stage in 
the synthesis that this structural assignment was incorrect by obtaining the X-ray 
structure of 4.121 (vide infra).  
Unaware that the hydroboration of 4.101 had resulted in the undesired 
regiochemistry, the synthesis of 4.100 was continued. After protecting the newly 
introduced hydroxyl group as its TBDPS ether to give 4.118, attention was focused on the 
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pivotal alkylation to introduce the C(2) methyl group. Following the protocol by Beak,102 
4.118 was lithiated with sec-BuLi and alkylated with iodomethane to afford 4.119, which 
was isolated as a single stereoisomer in 54% yield (Scheme 4.32). The yield could likely 
be improved further by using dimethyl sulfate instead of iodomethane, since dimethyl 
sulfate has shown to be a superior alkylating reagent in many cases for this reaction.102  
With all the stereocenters now installed, it only remained to elaborate the TBS 
ether to the requisite iodide. But before going any further, it was necessary to establish 
the stereochemistry of the two newly formed stereocenters as well as the position of the 
hydroxyl group. With this goal in mind, 4.119 was treated with TBAF to afford diol 
4.120 in 75% yield (Scheme 4.33). The plan was to acylate both hydroxyl groups to 
afford the bis-p-nitrobenzoate. Unexpectedly, when exposing 4.120 to p-nitrobenzoyl 
chloride and DMAP in CH2Cl2, a different compound was isolated in 45% yield, the 1H 
NMR spectrum of which was consistent with oxazolidinone 4.121. Nevertheless, this 
compound was a crystalline solid and was submitted for X-ray analysis. However, the X-
ray structure revealed that the undesired regiochemistry had been produced as the major 

































Figure 4.3 ORTEP plot of 4.121. Displacement ellipsoids are scaled to the 50% probability level. 
 
The unexpected regiochemical outcome of the hydroboration of 4.101 merits 
some discussion. It was hypothesized that hydroboration of 4.101 to afford 4.116 with the 
hydroxyl group in the 4-position would be preferred in order to minimize steric 
interactions between 9-BBN and the silyloxymethyl substituent in the transition state. 
This assumption was based on literature precedent in which 1-methylcyclohexene (4.122) 
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was hydroborated with various borane reagents (Scheme 4.34). In this study, the 
hydroboration of 4.122 using 9-BBN resulted a 80:20 ratio of regioisomers favoring 
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On the other hand, Evans demonstrated that electronic effects can play a major 
role in determining the regiochemical outcome of hydroborations of cyclohexene 
derivatives.155 Contrary to what would be expected based on steric arguments, 
hydroboration of 4.125b gave 4.127b as the major products in which the hydroxyl group 
has been introduced in the 2-position (Scheme 4.35). It therefore appears that the 
electronic effects resulting from the presence of the electron withdrawing oxygen 
substituent overrides the steric preference for introducing boron at the sterically less 
demanding C(3) carbon. 
Scheme 4.35 









4.125b R = Bn
 R = Bn
 R = TBS
0 : 68 : 19 : 13










A similar explanation may account for the regiochemistry in the hydroboration of 
piperidine 4.101. Introduction of boron at C(4) would place a partial positive charge at 
C(5) adjacent to C(6) in the transition state. Since C(6) is already electron deficient due to 
the presence of the carbamate this would be unfavorable. Furthermore, unlike in the case 
of 1-methyl cyclohexene in which the methyl group is planar, in the case of carbamate 
4.101, the silyloxymethyl group is likely forced into the axial orientation in order to 
minimize pseudo-A(1,3) strain with the carbamate (Scheme 4.36). As such, the 
silyloxymethyl group may be less a determining factor, allowing the regiochemistry to be 
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A known solution to this problem that could be applied to override the electronic 
preference for hydroboration in the 5-position would be to perform the hydroboration 
with pinacolborane in the presence of Wilkinson’s catalyst.155 This reaction was 
attempted on 4.101 several times, but in all cases only starting material was recovered. It 
was therefore decided that a new approach to the piperidine fragment would be needed.   
4.5.3 Acyl Pyridinium Ion Approach: Successful Racemic Synthesis of the E-ring 
A possible approach to the requisite 2,4,6-trisubstituted piperidine 4.100 would 
involve  an application of Comins’ technology103 coupled with ortholithiation chemistry 
developed by Beak.102 The use of Comins’ enantioselective piperidine synthesis in this 
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case, however, would render the sequence rather lengthy. Therefore, a synthesis of 
racemic material was initially pursued, hoping that an alternative to the Comins’ protocol 
eventually could be developed once a proof of concept for the fragment coupling of 4.6 
and 4.80 had been established.   
The synthesis of 4.137, which is outlined in Scheme 4.37, commenced with the 
addition of methylmagnesium chloride to the pyridinium salt generated by the reaction of 
4-methoxypyridine (4.130) with Cbz-Cl. Upon acidic workup, piperidone 4.131 was 
obtained in 81% yield and used directly in the next step without further purification. 
When, 4.131 was subjected to a 1,4-reduction with L-selectride, 4.132 was isolated in 
75% yield. At this point, the Cbz-group was replaced with a Boc-carbamate, which would 
be needed later in the synthesis in the ortho-lithiation step. In the event, hydrogenolysis 
of 4.132 in ethanol gave the corresponding secondary amine, which was not isolated but 
treated directly with Boc2O to give 4.133 in 77% yield in a one-pot operation. Following 
stereoselective reduction of the ketone (77% yield, dr = 17:1) and protection of the 
resultant alcohol as a TBDPS ether (97% yield), the stage was set for the key ortho-
























































−78 °C 1 h
  92%, dr = 20:1
 
 
While the introduction of a methyl group via ortholithiation of 4.118 worked 
poorly (max 55%), the formylation of 4.135 proceeded in high yield and excellent 
diastereoselectivity. After some experimentation, the requisite aldehyde 4.136 could be 
obtained in 92% yield and in a diastereomeric ratio of approximately 20:1. Furthermore, 
the scale of the reaction was increased to 1.4 g without any reduction in yield or 
diastereoselectivity. With ample quantities of 4.136 in hand, the aldehyde function was 
then reduced to the primary alcohol 4.137 in 91% yield upon exposure of 4.136 to 
NaBH4 (Scheme 4.37).  
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4.5.4 6-Exo-tet-cyclization/Beak Lithiation Approach: Successful Enantioselective 
Synthesis of the E-ring 
After having developed a reliable approach to racemic 4.137, it was necessary to 
adapt this route to afford enantiopure 4.137. It was envisioned that the synthesis of the 
racemic material described above could be intersected if an enantioselective synthesis of 
4.133 or 4.135 could be achieved. After some experimentation, success was eventually 
achieved using chemistry related to one of the early approaches to the piperidine E-ring. 
The synthesis started from aldehyde 4.138, using an asymmetric Brown-allylation 
followed by protection of the secondary alcohol as its TBDPS-ether (Scheme 4.38). So 
far, 4.139 has been isolated in only 31% yield over the two steps, which is somewhat 
surprising given that the Cbz-protected derivative 4.90 underwent Brown allylation to 
afford the corresponding product in roughly 67% yield. Nevertheless, assuming that the 
yield can be improved upon further optimization, the synthesis was carried forward. 
Ozonolysis of the olefin in 4.139 followed by reductive workup with NaBH4 delivered 
alcohol 4.140 in 88% yield. Following activation of the primary alcohol as the 
mesylation, the target piperidine 4.135 was obtained in excellent yield (98%) via 6-exo-
tet ring-closure upon exposure of 4.141 to KOtBu. From this point in the sequence, the 








    allylMgBr, THF
2) TBDPSCl, DMF 































   MeOH
1) sec-BuLi, Et2O
    TMEDA, −78 °C;  
    then DMF
84%%, 2 steps
 dr = 20:1
 
Piperidine 4.137 has thus been prepared in enantiomerically pure form in seven 
steps from commercially available 4.138. This compares favorably with Comins’ 
methodology, which would have required two additional steps. Furthermore, employing 
Comins’ strategy would also have required the four-step preparation of 8-phenylmenthyl 
chloroformate. 
4.5.5 Attempted Preparation of the Organozinc Reagent 
With trisubstituted piperidine 4.137 in hand, the next challenge involved the 
conversion of 4.137 to the corresponding iodide 4.100, which would serve as the 
precursor for generating the organozinc reagent 4.6. However, as observed in earlier 
approaches to this piperidine, upon attempted mesylation of the primary hydroxyl group 
of 4.137 in preparation for nucleophilic displacement of iodide, intramolecular ring-
closure occurred to afford oxazolidinone 4.143 in 91% yield (Scheme 4.39). This 
material was a crystalline solid and was submitted for X-ray analysis to verify the 
stereochemical assignments. As expected, piperidine 4.143 had the requisite S,S,R-
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configuration thus establishing the stereochemical outcome of the asymmetric Brown 




























Figure 4.4 ORTEP plot of 4.143. Displacement ellipsoids are scaled to the 50% probability level. 
 
A possible solution to the problem of oxazolidinone formation was to use a 
different protecting group on the piperidine nitrogen. Toward this, end the corresponding 
sulfonamide 4.147 was prepared starting from 4.137. TBS protection followed by 
tosylation of the piperidine nitrogen gave 4.145 in 72% yield over the two steps. The 
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TBS group was then removed in 96% yield setting the stage for the introduction of the 
requisite iodide. In the event, 4.146 was treated with PPh3 and I2 in the presence of 
imidazole to afford the iodide 4.147, which could be isolated 69% yield. Before actually 
attempting the fragment coupling it was necessary to determine if the organozinc species 
4.148 could indeed be generated from 4.147. Following the conditions developed by 
Knochel and co-workers,96 iodide 4.147 was treated with zinc dust that had been 
activated with Br(CH2)2Br and TMSCl, to generate alkylzinc species 4.148. In order to 
establish whether or not 4.148 had indeed been formed, the reaction was quenched with 
dilute acid. Unfortunately, none of the expected 2,6-dimethylpiperidine 4.149 was 
obtained. Instead, the acyclic material 4.150 resulting from β-elimination of the alkyl zinc 
species 4.148 was observed (Scheme 4.40). The reaction proceeded quickly at room 
temperature and had gone to completion in less than an hour as determined by 1H NMR 
analysis of the crude reaction mixture. While this approach has been unsuccessful thus 
far, it may be worth re-examining at lower temperature. By using Riekie zinck, it may be 













































4.137 R = Boc, R' = H
4.144 R= H, R' = TBS
1) TFA, CH2Cl2
2) TBSCl, CH2Cl2
    imidazole
71%, 3 steps
 
While protecting the piperidine nitrogen as a sulfonamide avoided the problem of 
oxazolidinone formation, this protecting group was too electron withdrawing and favored 
β-elimination during the formation of the organozinc species. To address this new 
problem it was envisioned that the nitrogen could be protected with a benzyl group. We 
reasoned that β-elimination would be less likely with the nitrogen protected as a tertiary 
amine since the leaving group would be a negatively charged secondary amine. To test 
this hypothesis, a model system was devised as depicted in Scheme 4.41. The requisite 
iodide 4.153 was readily prepared from 4.52, which was available in two steps from 
commercially available pipecolinic acid 4.151 as described in the literature.156 The iodide 
  177
was then subjected to the Knochel procedure for direct insertion of zinc.96 While THF is 
the most commonly used solvent for this transformation, DMF was used instead because 
it is known to coordinate more strongly to the organozinc species than does THF.157 In 
spite of these efforts, β-elimination was again observed, and the olefin 4.155 was found 
to be the exclusive product as determined by 1H NMR of the crude reaction mixture. It is 
perhaps not too surprising when considering that the alkyl zinc species could potentially 
coordinate with the tertiary nitrogen to render it a quaternary ammonium ion, which 
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4.154 4.155  
In a final attempt to realize the organozinc cross coupling approach, the Boc-
protecting group was revisited since both the sulfonamide and benzyl protecting groups 
resulted in β-elimination following direct insertion of zinc. Jackson has described 
numerous examples of zincates derived from alkyl iodides bearing a tert-butyl carbamate 
in the β-position with no mention of oxazolidinone formation.158 However, in all of these 
cases the substrates were acyclic. We therefore hypothesized that the high propensity for 
oxazolidinone formation that was observed in the piperidine substrates may be due to the 
presence of the 6-membered ring. As such, this problem could potentially be avoided if 
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an acyclic fragment was used instead. After successfully forming the organozinc species 
and effecting the cross coupling, the requisite piperidine may be formed by a cyclization 
event, perhaps by RCM. To examine the feasibility of this idea a model system was 
devised (Scheme 4.42).   
The synthesis commenced with TBS-protection of Boc alaninol (4.156), followed 
by alkylation with allylbromide to give 4.158. The silyl protecting group was removed to 
afford alcohol 4.159, and this material was then subjected to the same conditions to 
generate the iodide as reported by Jackson.158 However, contrary to expectations the 
oxazolidinone was again observed as the sole product of the reaction. This result stands 





































The major difference between 4.160 and the majority of iodides described by 
Jackson is the presence of two alkyl groups on the carbamate nitrogen atom of 4.160 as 
apposed to a free NH. Hence, we hypothesized that oxazolidinone formation might be 
avoided if a mono substituted carbamate was used instead. To test this hypothesis we 
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attempted the conversion of Boc-alaninol (4.156) to iodide 4.163 (Scheme 4.43). 
Interestingly, this reaction did indeed afford the iodide albeit in only 44% yield, however, 
the 1H NMR spectrum of the crude reaction mixture indicated a mixture (2:1) of iodide to 
oxazolidinone 4.164. Although, one can envision a path forward in which a simple 
acyclic fragment derived from alanine is used in the cross coupling followed by 
construction of the piperidine ring, we opted not to pursue this route in favor of 













4.6 FRAGMENT COUPLINGS  
4.6.1 Fragment Coupling via Mannich Reaction  
Given the difficulties in preparing a suitable iodide and the corresponding 
organozinc species, attention was shifted in favor of alternative coupling strategies. As 
outlined in Scheme 4.44, 4.165 could be envisioned as coming from 4.166 via 
epoxidation with DMDO from the less sterically hindered face of the olefin. The tertiary 
amine in 4.66 would be protected in situ if necessary as the HCl salt or as an amine-
borane complex.159 The pentacyclic intermediate 4.166 was projected to arise from an 
intramolecular ring-closure of an alkyl samarium species, which could undergo 
addition/elimination to the triflate.160 Triflate 4.167 would be obtained via standard 
functional group transformations from 4.168, which in turn would be the product of the 
key fragment coupling of silyl enol ether 4.169 with iminium ion precursor 4.170 using a 
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Mannich reaction. Enders has shown that trimethylsilyl enol ethers undergo Mannich 
reaction with N,O-acetals in the presence of BF3·OEt2 in high yields;
161 however, 
Mannich reactions of silyl enol ethers with preformed iminium ions is a relatively young 















































In preparation for the fragment coupling, piperidine 4.144 needed to be converted 
to a suitable iminium ion precursor. Several attempts were made to generate the N,O-
acetal 4.171, but to no avail. The use of an α-aminonitrile appeared to be a good 
alternative since α-aminonitriles are known to readily ionize to give the corresponding 
iminium ion upon exposure to AgOTf. Thus, piperidine, 4.144 was treated with 
iodoacetonitrile and Hünigs’ base to afford 4.172 in 93% yield (Scheme 4.45). These 
experiments were carried out using racemic 4.144 since the enantioselective route to 
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4.144 had not yet been developed at the time of these studies. With the key fragments in 



























Deprotonation of 4.77 with LDA followed by the addition of TMSCl delivered 
the trimethylsilylenol ether 4.173, which was submitted without further purification to the 
proposed fragment coupling (Scheme 4.46). Thus, silyl enol ether 4.173 and α-
aminonitrile 4.172 were stirred in the presence of silver triflate to afford the advance 
tetracyclic intermediate 4.174 in about 54% yield over two steps. However, a 
disadvantage to this strategy quickly became apparent as the Mannich base 4.174 was 
rather unstable even to mildly acid conditions. In fact, upon TLC analysis on silica, 
substantial degradation of 4.174 was observed to form exocyclic olefin 4.175 via a retro-



































The structure of 4.175 was corroborated by independently preparing 4.175 from 
ketone 4.77 (Scheme 4.47). Because of the instability of 4.174 to acid, it was necessary to 
deactivate the silica gel with triethylamine, but even when this was done, some 
fragmentation was observed and the 4.175 could not be isolated cleanly. Because of theis 
problem, the strategy involving fragment coupling via Mannich reaction was abandoned 


















4.6.2 Fragment Coupling via Lithiation/Alkylation 
In parallel with the Mannich approach, an alternative coupling strategy was 
pursued. Since the Beak lithiation worked remarkably well in the synthesis of the 
piperidine fragment 4.137, it was envisioned that one may be able to utilize this reaction 
to couple the two fragments of citrinadin A. As depicted in Scheme 4.48, we reasoned 
that tetracyclic intermediate 4.176 could be constructed by directed ortho-lithiation of 
piperidine 4.135 followed by alkylation with an allylhalide derivative of the spirocyclic 





















4.177 X = halide 
The synthesis of the allylhalide 4.177 commenced with a Stille-coupling of triflate 
4.80 with tributylvinyl tin. In spite of the fact that the triflate is exceedingly hindered, the 
coupling proceeded smoothly at room temperature when using Pd2(dba)3 and Ph3As as 
the catalyst system to afford 4.178 in good yield (Scheme 4.49). This was an important 
result in that it shows that 4.80 can undergo oxidative addition to palladium, and this may 
bode well for Pd-catalyzed couplings of more highly functionalized fragments in the 
future.  
Enoate 4.178, which was difficult to separate completely from the Ph3As ligand, 
was subjected to a chemoselective Johnson-Lemieux cleavage of the more electron rich 
terminal olefin to give aldehyde 4.179 in 64% yield over the two steps. The next 
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transformation involved the reduction of the aldehyde function of 4.179 to give allylic 
alcohol 4.180. It had been previously shown that the oxindole carbonyl group of 4.77, 
which is part of an imide function because of the presence of the chiral auxiliary, is 
readily reduced to the corresponding aminal 4.78 when exposed to NaBH4 at 0 °C 
(Scheme 4.49). To avoid this potential selectivity problem, the reduction was carried out 
at –78 °C in EtOH/CH2Cl2, conditions that are known to reduce aldehydes in the 
presence of a ketones.163 Gratifyingly, when employing these conditions the desired 
allylic alcohol 4.180 could be isolated in 81% yield. 
It now remained to convert the allylic alcohol 4.180 to a suitable halide. Toward 
this end the formation of the allyl iodide was attempted using I2, PPh3 and imidazole; 
however, while the reaction proceeded cleanly based on TLC analysis, the corresponding 
iodide was unstable to aqueous workup and silica gel chromatography and could only be 
isolated in diminished yields (<20%). On the other hand, the reaction of 4.180 with CBr4 
and PPh3 proceeded smoothly to afford allyl bromide 4.181, which in contrast to the 
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With allyl bromide 4.181 in hand, the key coupling reaction was explored. 
Piperidine 4.135 was lithiated using the same conditions that were successfully utilized in 
the synthesis of piperidine 4.137. Namely, exposure of 4.135 to sec-BuLi in the presence 
of TMEDA generated the corresponding lithiated species to which allylbromide 4.181 
was added. Because no reaction was observed at low temperature, the cold bath was 
removed, and reaction was allowed to warm to room temperature. Unfortunately, none of 
the desired coupling product was obtained. Instead, allyl bromide 4.182 lacking the chiral 
auxiliary was isolated in about 48% yield. It appears that the electrophilic imide 
functionality is more susceptible toward attack of the lithiated piperidine than the allyl 
bromide.  
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A possible solution to this problem was to use aldehyde 4.179 since aldehydes 
have been reported to be better electrophiles than allyl halides in reactions with lithiated 
piperidines.164 Preliminary experiments showed that this approach was indeed successful 
(Scheme 4.50). In the event, aldehyde 4.179 was added to the lithiated piperidine 4.135, 
and the reaction was allowed to warm to room temperature to form adduct 4.184 in 12% 
yield along with 24% recovered aldehyde. Interestingly, the expected adduct 4.183 was 
not isolated, rather compound 4.184 in which the secondary alcohol had undergone ring-
closure with the methyl ester to form a lactone was obtained. This product was isolated as 
a single diastereomer, although the configuration of the newly formed stereocenter was 
not determined. Lactone 4.184 was then subjected to K2CO3 in MeOH to effect the 
cleavage of the auxiliary and afford the advanced tetracyclic intermediate 4.185 in 70% 
yield. 
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Several attempts were made to try to optimize the coupling reaction but to no 
avail. Again, it was determined that the lithiated piperidine preferentially attacks the 
imide functionality rather than the aldehyde as deprotected starting material 4.179a was 
isolated in some of these reactions. A possible solution to this problem might involve 
removal of the auxiliary before performing the fragment coupling. An excess of lithiated 
piperidine or an exogenous base can then be used to deprotonated the oxindole NH prior 
to fragment coupling.  
With a route to the tetracyclic intermediate 4.185 in place, one can envision a 
relatively straightforward path to complete the pentacyclic framework of citrinadin A. 
Reduction of the lactone function of 4.185 followed by selective mesylation of the 
primary alcohol would give 4.186. Removal of the Boc group would result in 
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intermolecular alkylation to form the final D-ring, and oxidation of the secondary alcohol 
would furnish 4.187 (Scheme 4.51). The requisite amino and alcohol functionality on the 
five membered ring may then be installed via epoxidation from the least sterically 
hindered face of the enone with hydrogen peroxide followed by epoxide opening by an 
amine nucleophile. Following protection of the tertiary hydroxy in 4.188, the carbonyl 










































4.6.3 Attempted Fragment Coupling via Aldehyde/Vinylsilane Cyclization 
While the synthesis of the advanced tetracyclic intermediate 4.185 represented an 
exciting and important milestone in the project, the need for a deoxygenation of ketone 
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4.188 prompted us to investigate different strategy.  Rather than attempting to couple a 
fully functionalized piperidine unit, we envisioned a stepwise approach in which triflate 
4.80 would be coupled with a smaller fragment that could be elaborated into the requisite 
piperidine. Dobbs and co-workers have developed a convenient method for the synthesis 
of 2,6-trans-piperidines involving cyclization of a vinylsilane with an aldehyde using 


















This is an extension of work initially described by Overman and co-workers, who used 
protic acids to carry out the transformation and observed extensive racemization through 
an aza-Cope reaction.166 On the contrary, using the mild Lewis acid catalyzed conditions 
described by Dobbs, racemization could be completely avoided. We felt that this 
chemistry could potentially be applied to the construction of the piperidine unit of 






















The requisite enantiopure vinylsilane 4.190 was prepared according to the 
procedure by Overman (Scheme 4.54).166 The synthesis commenced with the reduction 
of D-alanine (4.194) followed by tosylation of both the nitrogen and the primary hydroxyl 
group. Exposure of 4.195 to KOH/MeOH then resulted in intramolecular displacement of 
the tosylate to afford aziridine 4.196 in 64% yield. The aziridine was then subjected to 
ring-opening by lithium trimethylsilylacetylide to furnish alkyne 4.197, which, in turn, 
was hydroborated with dicyclohexylborane, followed by protonolysis to afford 
vinylsilane 4.198 in 71% yield. At this point, all that remained was to replace the 
sulfonamide protecting group with a benzyl group. This was first attempted according to 
the procedure described by Overman in which the sulfonamide was treated with sodium 
naphthalenide.166 While this procedure did afford some of the desired product as 
observed by 1H NMR analysis of the crude reaction mixture, substantantial amounts of 
an unidentified side product were also formed. Additionally, the reaction was very slow. 
Mariano has described an improved method for the preparation of 4.190 in which 4.198 
was first benzylated to give 4.199 followed by removal of the tosyl group by reduction 
using Na/Hg.167 While the benzylation worked very well, the subsequent Na/Hg 
reduction only resulted in recovered starting material. Therefore, 4.199 was subjected to 
the original sodium naphthalenide procedure since it is known that tosyl groups can be 
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removed from benzylamines without affecting the benzyl group.168 As shown in Scheme 
4.54, the latter approach was successful and afforded sufficient quantities of vinylsilane 













































A perhaps bigger challenge was the preparation of the requisite aldehyde coupling 
partner. After some experimentation we discovered that a strategy similar to that used for 
the synthesis of aldehyde 4.179 could be employed. This would involve a cross coupling 
of triflate 4.80 with an allyl group rather than and vinyl group. The requisite aldehyde 
4.193 could then be accessed through a chemoselective oxidative cleavage of the terminal 
olefin (Scheme 4.55). A number of methods could be envisioned for the introduction of 
the allyl group. While Stille couplings of allylstannanes have been described in the 
literature, they are not very common.169 However, since the Stille coupling of 
vinyltributyltin with the exceedingly hindered triflate 4.80 worked quite well, it was 
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worth examining if the analogous reaction using allyltributyltin would afford the desired 
product 4.200. Gratifyingly, using identical conditions to those used for introducing the 
vinyl group resulted in the formation of 4.200 in 26% yield along with 20% recovered 
starting material. Perhaps the transmetalation step for the allylstannane is somewhat 
slower than that of the vinylstannane. Nevertheless, by heating the reaction to 50 °C 
overnight the reaction went to completion, and the allyl coupling product 4.200 could be 
isolated cleanly in 64% yield. Alternatively, one may be able to avoid the use of a 
stannane by performing a Negishi coupling using allyl zinc bromide. Finally, the requisite 
aldehyde 4.193 was obtained through cleavage of the terminal olefin via a Johnson-






















 With both the vinylsilane 4.190 and the aldehyde coupling partner 4.193 in hand, 
the stage was set for the pivotal cyclization (Scheme 4.56). The vinylsilane was added to 
a solution of aldehyde 4.193 and InCl3 in CH3CN and stirred at 80 °C for 3 h. However, 
none of the desired product was observed. Rather lactone 4.201 was isolated in 43% yield 


























80 °C, 1 h
6 4.190
  
While the failure of the cyclization approach was disappointing, the achievement 
of an efficient synthesis of aldehyde 4.193 represents an important milestone in the 
project, especially since carbon-carbon bond formation at the highly hindered C(6) 
position can be performed. With this key intermediate in hand, the synthesis of which is 
summarized in Scheme 4.57, one can now focus on the various possibilities for 
advancing this material to install the piperidine unit. As depicted in Scheme 4.57, an 
attractive path forward would involve the Lewis acid catalyzed asymmetric addition of 
allylsilane 4.202 to aldehyde 4.193, which unlike the cyclization can be carried out at –78 
°C. Wender and co-workers utilized this reaction in their synthesis of 11-
desmethyllaulimalide in which two complex fragments (both containing multiple 
stereocenters) were coupled in high yield and diastereoselectivity.170 The requisite allyl 
silane 4.202 would be available simply through Boc-protection of the corresponding free 
amine which is a known compound.171 Following successful fragment coupling, the 
resultant secondary alcohol in 4.204 would then be activated as the mesylate, which may 
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The presence of the highly functionalized spirooxindole motif in citrinadin A 
presents an opportunity to develop novel methods and synthetic strategy, since the 
existing methodologies for spirooxindole synthesis cannot be readily applied to the 
enantioselective synthesis of spirocyclic fragment 4.193. A novel enantioselective 
oxidative rearrangement of a prochiral indole proceeded in 55-60% ee in a model system, 
but the utility of this tactic was limited in that the yield could not be increased above 20% 
using the citrinadin substrate. This was presumed to be due to steric hindrance of the 
indole C(2),C(3) double bond. Nevertheless, this approach may be of utility in simpler 
systems and therefore warrants further investigation.  
An alternative approach was developed involving a DMDO-mediated oxidative 
rearrangement using an 8-phenylmenthol-derived chiral auxiliary on the indole nitrogen. 
This transformation proceeds in 78% yield and excellent diastereomeric ratio (dr = 12:1) 
on gram scale, and the presence of a gem-dimethyl group was found to enhance 
diastereoselectivity relative to indoles lacking this functionality. There are a number of 
natural products that have a substitution pattern similar to that of citrinadin A,87,88,89,90 
and this approach may be applicable to their synthesis.  
The utility of our spirooxindole synthesis was evidenced through a concise 
synthesis of the advanced intermediate 4.193 in only 12 steps and 6% overall yield.  After 
successful carbon-carbon bond formation at the highly hindered C(6) position via a rarely 
used Stille coupling to introduce an allyl group, a clear path forward can be envisioned. 
This will involve the asymmetric addition of allyl silane 4.202 to afford intermediate 
4.204, which has all the requisite functionality in place to complete the pentacyclic 
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framework of citrinadin. Thus, the application of our DMDO-mediated oxidative 
rearrangement promises to allow for a concise enantioselective synthesis of citrinadin A.  
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Chapter 5: Experimental Section 
General Methods. Solvents and reagents were reagent grade and used without 
purification unless otherwise specified. CH2Cl2, i-Pr2NH and Et3N were freshly distilled 
from CaH2. THF was passed through two columns of neutral alumina. DMF was passed 
through two columns of molecular sieves. Reactions involving air- of moisture-sensitive 
reagents or intermediates were performed under an inert atmosphere of argon or nitrogen 
in glassware that had been flame dried.  Melting points are uncorrected. Infrared (IR) 
spectra were recorded neat on sodium chloride plates and are reported in wave numbers 
(cm-1). 1H and 13C NMR spectra were obtained as solutions in CDCl3 unless otherwise 
noted, and chemical shifts are reported in parts per million (ppm) downfield from 
(CH3)4Si (TMS). Coupling constants are reported in hertz (Hz). Spectral splitting 

















1-Allyl-2,3,4,9-tetrahydro-1H-β-carboline (2.9) (mp1-095).  BF3-OEt2 (1.08 
mL, 8.56 mmol) was added to a solution of 4,9-dihydro-3H-β-carboline 2.8 in THF (44 
mL) cooled to –30 °C.  The solution was stirred for 10 min, whereupon a 1.0 M solution 
of allyl magnesiumbromide in ether (1.0 M, 25.6 mL, 25.6 mmol) was added via addition 
funnel over 45 min.   After the addition was complete, the stirring was continued at –30 
°C for 2 h, whereupon saturated aqueous NaHCO3 (10 mL) was added.  The resulting 
slurry was poured into a separatory funnel containing saturated aqueaous NaHCO3 (50 
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mL) and water (50 mL), and the mixture was extracted with EtOAc (3 x 50 mL).  The 
combined organic layers were dried (Na2SO4) and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with Et3N/MeOH/CH2Cl2 
(1:3:97) to give 1.52 g (81%) of 2.9 as a yellow solid. The 1H NMR spectrum was 
























101). A solution of 2.8 (100 mg, 0.42 mmol), 2-ethyl-acrylic acid (57 mg, 0.57 mmol), 
Et3N (0.12 mL, 0.83 mmol), HOBT (113 mg, 0.83 mmol) and EDCI⋅HCl (88 mg, 0.46 
mmol) in CH2Cl2 (4.2 mL) was stirred for 16 h at room temperature.  The reaction was 
poured into EtOAc (20 mL) and the organic mixture was washed with 0.5 M aqueous 
HCl (2 × 10 mL), saturated aqueous NaHCO3 (2 × 10 mL) and brine (10 mL).  The 
organic layer was dried (Na2SO4) and concentrated under reduced pressure.  The residue 
was purified by flash column-chromatography eluting with hexanes/EtOAc (1:3) to 
afford 105 mg (85%) of the title compound as white solid: mp 113-115 °C; 1NMR (500 
MHz) δ 8.33 (s, 1H), 7.45 (d, J = 7.8 Hz, 1 H), 7.31 (d, J = 8.0 Hz, 1 H), 7.18-7.12 (m, 1 
H), 7.11-7.08 (m, 1 H), 6.01-5.91 (m, 1 H), 5.79 (t, J = 6.6 Hz, 1 H), 5.19 (s, 1 H), 5.14-
5.10 (comp, 2 H), 5.07 (s, 1 H), 4.25-4.18 (m, 1 H), 3.51-3.41 (m, 1 H), 2.81-2.74 (comp, 
2 H), 2.39 (q, J = 7.3 Hz, 2 H), 1.11 (t, J = 7.3 Hz, 3 H); 13C NMR (500 MHz) δ 171.8, 
146.8, 136.1, 134.4, 133.6, 126.5, 121.9, 119.5, 118.4, 118.0, 112.6, 111.1, 107.7, 48.35, 
41.86, 39.1, 27.3, 22.3, 11.7; IR (neat) 3258, 2962, 2906, 1601, 1470, 1442, 1300, 1180, 
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913, 741 cm-1; mass spectrum (CI) m/z 295.1807 [C19H22N2O  (M+1) requires 
295.1810],  253, 295 (base), 323, 335, 377.  
 NMR Assignments. 1NMR (500 MHz) δ 8.33 (s, 1H, NH), 7.45 (d, J = 7.8 Hz, 1 
H, C5-H), 7.31 (d, J = 8.0 Hz, 1 H, C8-H), 7.18-7.12 (m, 1 H, C7-H), 7.11-7.08 (m, 1 H, 
C6-H), 6.01-5.91 (m, 1 H, C13-H), 5.79 (t, J = 6.6 Hz, 1 H, C11-H), 5.19 (s, 1 H, C17-
H), 5.14-5.10 (comp, 2 H, C14-H), 5.07 (s, 1 H, C17-H), 4.25-4.18 (m, 1 H, C2-H), 3.51-
3.41 (m, 1 H, C2-H), 2.81-2.74 (comp, 2 H, C1), 2.39 (q, J = 7.3 Hz, 2 H, C18-H), 1.11 
(t, J = 7.3 Hz, 3 H, C19-H); 13C NMR (500 MHz) δ 171.8 (C15), 146.8 (C16), 136.1 
(C9), 134.4 (C13), 133.6 (C4), 126.5 (C10), 121.9 (C7), 119.5 (C6), 118.4 (C14), 118.0 
(C5), 112.6 (C17), 111.1 (C8), 107.7 (C3), 48.35 (C11), 41.86 (C2), 39.1 (C14), 27.3 





















103). A solution of 2.7 (21 mg, 0.07 mmol) and Grubbs' second-generation catalyst (9.1 
mg, 0.01 mmol) in degassed CH2Cl2 (3.55 mL) was stirred at 45 °C under argon for 16 h. 
The mixture was cooled to room temperature, DMSO (40 μL, 0.564 mmol) was added, 
and the mixture was stirred for 16 h. The reaction was concentrated under reduced 
pressure, and the residue was purified by flash column-chromatography MeOH/CH2Cl2 
(0.5:99.5) to give 16 mg (87%) of 2.6 as a clear colorless glass. The 1H NMR spectrum 
























(mp1-120).  A solution of 2.7 (300 mg, 1.02 mmol) in THF (19.5 mL) was added via 
cannula to a refluxing solution of Lawesson’s reagent (491 mg, 1.22 mmol) in THF (24 
mL).  The reaction was heated under reflux for 3 h, whereupon additional Lawesson’s 
reagent (250 mg, 0.51 mmol) was added.  After refluxing for 2 h, the reaction was 
concentrated under reduced pressure.  The residue was dissolved in water (50 mL) and 
brine (10 mL), and the aqueous mixture was extracted with EtOAc (3 x 50 mL). The 
combined organic layers were dried (Na2SO4) and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with hexanes/EtOAc (1:1, then 
1:5) to give 338 mg (86%) of 2.13 as a pale yellow solid:  mp 133-135 °C; 1NMR (500 
MHz, DMSO-d6) δ 10.68 (s, 1H), 7.40 (d, J = 7.8 Hz, 1 H), 7.34 (d, J = 8.1 Hz, 1 H), 
7.09-7.05 (m, 1H), 7.01-6.94 (m, 1 H), 6.86-6.79 (m, 1 H), 6.01-5.90 (m, 1 H), 5.19-5.02 
(comp, 2 H), 4.97 (s, 1 H), 4.82 (s, 1 H), 4.50 (app dd, J = 13.0, 4.5 Hz, 1 H), 3.70 (app 
td, J = 13.0, 4.2 Hz, 1 H), 2.99-2.90 (m, 1 H), 2.88-2.71 (comp, 3 H), 2.40 (q, J = 7.2 Hz, 
2 H), 1.10 (t,  J = 7.2 Hz, 3 H); 13C NMR (500 MHz) δ 201.6, 151.9, 136.0, 133.4, 132.5, 
125.7, 120.7, 118.2, 117.2, 110.7, 108.5, 105.8, 53.7, 45.6, 37.5, 28.0, 21.6, 11.0; IR 
(neat)3393, 3266, 2971, 2907, 1468, 1431, 1252, 1231, 917, 745 cm-1; mass spectrum 
(CI) m/z 311.1582 [C19H22N2S (M+1) requires 311.1582], 277, 311 (base), 313, 339, 
351. 
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NMR Assignments. 1NMR (500 MHz, DMSO-d6) δ 10.68 (s, 1H, NH), 7.40 (d, J 
= 7.8 Hz, 1 H, C5-H), 7.34 (d, J = 8.1 Hz, 1 H, C8-H), 7.09-7.05 (m, 1H, C7-H), 7.01-
6.94 (m, 1 H, C6-H), 6.86-6.79 (m, 1 H, C13-H), 6.01-5.90 (m, 1 H, C11-H), 5.19-5.02 
(comp, 2 H, C14-H), 4.97 (s, 1 H, C17-H), 4.82 (s, 1 H, C17-H), 4.50 (app dd, J = 13.0, 
4.5 Hz, 1 H, C2-H), 3.70 (app td, J = 13.0, 4.2 Hz, 1 H, C2-H), 2.99-2.90 (m, 1 H, C1-H), 
2.88-2.71 (comp, 3 H, C1-H & C12-H), 2.40 (q, J = 7.2 Hz, 2 H, C18-H), 1.10 (t, J = 7.2 
Hz, 3 H, C19-H); 13C NMR (500 MHz) δ 201.6 (C15), 151.9 (C16), 136.0 (C9), 133.4 
(C13), 132.5 (C4), 125.7 (C10), 120.7 (C7), 118.2 (C6), 117.2 (C5 & C14), 110.7 (C8), 






















(mp1-126). A solution of 2.13 (22 mg, 0.07 mmol) and Grubbs' second-generation 
catalyst (9 mg, 0.01 mmol) in degassed dichloroethane (3.55 mL) was stirred at 65 °C 
under argon for 3 h. The mixture was cooled to room temperature, DMSO (30 μL, 0.42 
mmol) was added,  and the mixture was stirred at room temperature for 16 h. The 
reaction was concentrated under reduced pressure, and the residue was purified by flash 
chromatography hexanes/EtOAc (4:1) to give 4.5 mg (21%) of recovered starting 
material 27 and 9 mg (45%) of 28 as an orange solid:  mp 141-145 °C; 1NMR (500 MHz) 
δ 7.86 (s, 1 H), 7.54 (d, J = 7.8 Hz, 1 H), 7.33 (d, J = 8.0 Hz, 1 H), 7.20-7.17 (m, 1 H), 
7.15-7.12 (m, 1 H), 6.27-6.22 (m, 2 H), 4.70 (dd, J = 14.5, 4.4 Hz, 1 H), 3.22-3.19 (m, 1 
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H), 2.98-2.92 (m, 2 H), 2.73-2.67 (m, 3 H), 2.35 (app tq, J = 14.5, 2.4 Hz, 1 H), 1.11 (t, J 
= 7.4 Hz, 3 H); 13C NMR (500 MHz) δ 194.6, 142.1, 136.6, 132.2, 126.3, 124.5, 122.5, 
120.1, 118.6, 111.0, 109.9, 53.3, 47.6, 31.1, 28.4, 20.8, 13.1; IR (neat) 3278, 2923, 1606, 
1417, 1308, 1193, 1056, 746 cm-1; mass spectrum (CI) m/z 283.1262 [C17H18N2S (M+1) 
requires 283.1269],  249, 283 (base), 297, 311, 339.  
 NMR Assignments. 1NMR (500 MHz) δ 7.86 (s, 1 H, NH), 7.54 (d, J = 7.8 Hz, 1 
H, C5-H), 7.33 (d, J = 8.0 Hz, 1 H, C8-H), 7.20-7.17 (m, 1 H, C7-H), 7.15-7.12 (m, 1 H, 
C6-H), 6.27-6.22 (m, 2 H, C2-H & C13-H), 4.70 (dd, J = 14.5, 4.4 Hz, 1 H, C11-H), 
3.22-3.19 (m, 1 H, C2-H), 2.98-2.92 (m, 2 H, C1-H), 2.73-2.67 (m, 3 H, C12-H & C16-
H), 2.35 (app tq, J = 14.5, 2.4 Hz, 1 H, C12-H), 1.11 (t,  J = 7.4 Hz, 3 H, C17-H); 13C 
NMR (500 MHz) δ 194.6 (C15), 142.1 (C9), 136.6 (C4), 132.2 (C10), 126.3 (C13), 124.5 
(C14), 122.5 (C7), 120.1 (C6), 118.6 (C5), 111.0 (C8), 109.9 (C3), 53.3 (C11), 47.6 (C2), 





















1-(1-Allyl-1,3,4,9,tetrahydro-β-carbolin-2-yl)-propenone (2.18) (mp1-149).  
Acryloyl chloride (485 mg, 435 μL, 5.36 mmol) was added to a mixture of 2.8 (1.00 g, 
5.88 mmol) and allyltributyltin (1.62 g, 1.51 mL, 4.88 mmol) in CH2Cl2 (60 mL) at 0 °C. 
The reaction mixture was stirred for 2 h at 0 °C and 12 h at room temperature. The 
volatiles were evaporated under reduced pressure and the residue was purified by flash 
column-chromatography on silica gel, eluting with EtOAc/hexanes (1:2−2:3) to give 980 
  203
mg (75%) of 2.18 as a colorless oil. The 1H and 13C NMR spectra are consistent with 







6,7,12,12b-Tetrahydro-1H-indolo[2,3-a]quinolizin-4-one (2.17) (mp2-030). 
Grubbs' first-generation catalyst (462 mg, 0.561 mmol, 4 mol%) was added to a solution 
of 2.18 (3.73 g, 14.0 mmol) in CH2Cl2 (610 mL) at room temperature. The reaction 
mixture was stirred for 15 h, whereupon dimethylsulfoxide (2.00 mL, 2.20 g, 28.1 mmol) 
was added and the reaction was stirred at room temperature over night. The solvent was 
removed under reduced pressure, EtOAc (10 mL) was added, and the mixture was cooled 
to 4 ˚C over night.  The crude solid was triturated with EtOAc and recrystallized from 
CH2Cl2/CHCl3, and the mother liquors were purified by flash column-chromatography 
on silica gel, eluting with EtOAc to afford a total of 2.91 g (87%) of 2.17 as a pale grey 
solid. mp = 228-229 °C (CH2Cl2), Lit.
67 229-231 °C. The 1H and 13C NMR spectra are 













acid dimethyl ester (2.21) (mp2-166). Dimethyl malonate (0.29 mL, 2.51 mmol) was 
added to a suspension of NaH (60% suspension in mineral oil, 30 mg, 1.25 mmol) in 
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THF (15 mL) and stirred for 5 min. Solid 2.17 (60 mg, 0.25 mmol) was added and the 
solution was heated under reflux for 48 h. The reaction mixture was cooled to room 
temperature and a saturated aqueous solution of NaHCO3 (0.3 mL) and EtOAc (10 mL) 
was added. Stirring was continued for 15 min, the mixture was dried (MgSO4) and the 
volatiles were removed under reduced pressure. The crude product was purified by flash 
column-chromatography on silica gel, eluting with EtOAc to give 68 mg (74%, dr = 
60:40) of the title compound as a colorless oil.  1H NMR (300 MHz, CDCl3, mixture of 
diastereomers) δ 8.72 (br s, 0.6 H), 8.64 (br s, 0.4 H), 7.48 (d, J = 7.5 Hz, 0.6 H), 7.46 (d, 
J = 7.5 Hz, 0.4 H), 7.36 (d,  J = 7.5 Hz, 0.4 H), 7.29 (d, J = 7.8 Hz, 0.6 H), 7.19-7.06 
(comp, 2 H), 5.18-5.10 (m, 0.6 H), 5.04-4.99 (m, 0.4 H), 4.97-4.90 (m, 0.4 H), 4.81 (dd, J 
= 3.3, 10.8 Hz, 0.6 H), 3.77 (s, 1.2 H), 3.74 (s, 1.8 H), 3.73 (s, 1.8 H), 3.70 (s, 1.2 H), 
3.40 (d, J = 8.7 Hz, 0.4 H), 3.32 (d, J = 7.8 Hz, 0.6 H), 3.02-2.94 (m, 0.6 H), 2.92-2.60 
(comp, 4.4 H), 2.58-2.10 (comp, 2.4 H), 1.56 (q, J = 11.4 Hz, 0.6 H); 13C NMR (100 
MHz, CDCl3, mixture of diastereomers) δ 168.3, 168.2, 168.1, 168.0, 167.6, 136.3, 
136.2, 132.9, 132.6, 127.2, 126.5, 122.0, 119.7, 119.6, 118.3, 118.1, 111.2, 110.9, 110.3, 
109.0, 60.4, 55.5, 54.3, 53.6, 52.9, 52.7, 52.6, 42.0, 39.9, 36.5, 36.1, 32.8, 31.2, 29.9, 
29.8, 21.0, 20.9, 20.8, 14.1; IR (neat) 3256, 2954, 1731, 1621, 1435, 1305, 1234, 1157, 






























yl)-[1,3]dithiolane-2-carboxylic acid ethyl ester (2.16) (mp2-063). A solution of n-
BuLi (0.28 mL, 0.67 mmol) in hexanes (2.44 M) was added to a solution of i-Pr2NH (81 
mg, 112 μL, 0.80 mmol) in degassed THF (16 mL) at –78 °C.  After stirring at –78 °C for 
15 min, the flask was transferred to an ice/water bath and stirring was continued for 15 
min. The mixture was then recooled to –78 °C. Neat ethyl-1,3-dithiolane-2-carboxylate 
(120 mg, 96 μL, 0.67 mmol) was added, and the resulting solution was stirred at –78 °C 
for 30 min. A solution of 2.17 (80 mg, 0.34 mmol) in degassed THF (16 mL) at -78 °C 
was added via cannula. The dry ice/acetone bath was removed, and the reaction was 
stirred for 2 h at room temperature whereupon NH4Cl (2.0 mL) was added and 50% of 
the volatiles were removed under reduced pressure.  The mixture was poured into a 
separatory funnel containing 0.5 M HCl (20 mL) and extracted with EtOAc (3 × 30 mL). 
The combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure.  The crude mixture of diastereomers (dr = 91:9) was separated by flash column-
chromatography eluting with hexanes/EtOAc (1:3–100% EtOAc) to afford 84 mg, (60%) 
of the major diasteromer 2.16 as a pale yellow solid. mp 200-201 °C (CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 8.23 (br s, 1 H), 7.48 (d, J = 7.6 Hz, 1 H), 7.39 (d, J = 7.6 Hz, 1 H), 
7.20 (t, J = 7.6 Hz, 1 H), 7.13 (t, J = 7.6 Hz, 1 H), 5.03-4.94 (comp, 2 H), 4.32-4.20 
(comp, 2 H), 3.49-3.28 (comp, 4 H), 3.12-2.98 (comp, 2 H), 2.79-2.69 (comp, 2 H), 2.68-
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2.50 (comp, 3 H), 2.18-2.03 (m, 1 H), 1.29 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 171.8, 169.3, 136.0, 133.0, 127.4, 122.1, 119.8, 118.1, 111.2, 110.9, 72.9, 62.7, 
53.8, 42.6, 40.8, 40.2, 36.6, 35.9, 30.3, 20.9, 14.1; IR (CH2Cl2) 3265, 2928, 1714, 1621, 
1469, 1445, 1303, 1266, 1212, 1022, 908, 732 cm-1; mass spectrum (CI) m/z 417.1304 
[C21H25N2O3S2 (M+1) requires 417.1307]. 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 8.23 (br s, 1 H, NH), 7.48 (d, 
J = 7.6 Hz, 1 H, C9-H or C12-H), 7.39 (d, J = 7.6 Hz, 1 H, C9-H or C12-H), 7.20 (t, J = 
7.6 Hz, 1 H, C10-H or C11-H), 7.13 (t, J = 7.6 Hz, 1 H, C10-H or C11-H), 5.03-4.94 
(comp, 2 H, C3-H, C6-H), 4.32-4.20 (comp, 2 H, C21-H), 3.49-3.28 (comp, 4 H, C18-H, 
C19-H), 3.12-2.98 (comp, 2 H, C5-H, C6-H), 2.79-2.69 (comp, 2 H, C5-H, C16-H), 2.68-
2.50 (comp, 3 H, C14-H, C15-H, C16-H), 2.18-2.03 (m, 1 H, C14-H), 1.29 (t, J = 7.0 Hz, 
3 H, C20-H); 13C NMR (100 MHz, CDCl3) δ 171.8 (C17), 169.3 (C22), 136.0 (C13), 
133.0 (C2), 127.4 (C8), 122.1 (C10 or C11), 119.8 (C10 or C11), 118.1 (C9 or C12), 
111.2 (C9 or C12), 110.9 (C7), 72.9 (C23), 62.7 (C21), 53.8 (C3), 42.6 (C6), 40.8 (C18 





















(2.24). (mp1-73). NaH (60% dispersion in mineral oil, 13 mg, 0.321 mmol) was added to 
a solution of 6 (58.9 mg, 0.247 mmol) in DMF (2.8 mL) at 0 °C.  The reaction was stirred 
for 30 min, and chloromethoxy methane (74 μL, 0.998 mmol) was added.  The ice bath 
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was removed, and the reaction was stirred at room temperature for 2.5 h.  Saturated 
aqueous NaHCO3 (1 mL) and water (10 mL) were added, and the mixture was extracted 
with EtOAc (3 x 5 mL). The combined organic layers were dried (Na2SO4) and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with hexanes/EtOAc  (1:3) to give 38 mg (55%) of 2.24 as a white solid: mp 173-
175 °C; 1NMR (500 MHz) δ 7.53 (d, J = 7.8 Hz, 1 H), 7.42 (d, J = 8.4 Hz, 1 H), 7.25 
(app td, J = 7.2, 2.0 Hz, 1 H), 7.16 (app td, J = 7.2, 1.0 Hz, 1 H), 6.67 (ddd, J = 9.7, 6.5, 
2.1 Hz, 1 H), 6.09 (dd,  J = 9.7, 2.9 Hz, 1 H), 5.37 (q, J = 12.4 Hz, 2 H), 5.04-4.98 (m, 1 
H), 4.93 (dd,  J = 13.6, 4.2 Hz, 1 H),  3.31 (s, 1 H), 3.05 (ddd, J = 17.7, 6.5, 4.2 Hz, 1 H), 
2.90-2.76 (comp, 3 H), 2.32 (dddd, J = 17.7, 13.6, 2.9, 2.1 Hz, 1 H); 13C NMR (500 
MHz) δ 164.9, 138.7, 138.4, 133.7, 126.6, 125.6, 122.7, 120.5, 118.6, 112.1, 109.4, 74.4, 
56.0, 51.6, 38.4, 31.8, 21.3; IR (neat) 2920, 1661, 1610, 1416, 1307, 1062, 742 cm-1; 
mass spectrum (CI) m/z 283.1434 [C17H18N2O2 (M+1) requires 283.1447],  251, 283 
(base), 297, 323.  
 NMR Assignments. 1NMR (500 MHz) δ 7.53 (d, J = 7.8 Hz, 1 H, C5-H), 7.42 
(d, J = 8.4 Hz, 1 H, C8-H), 7.25 (app td, J = 7.2, 2.0 Hz, 1 H, C7-H), 7.16 (app td, J = 
7.2, 1.0 Hz, 1 H, C6-H), 6.67 (ddd, J = 9.7, 6.5, 2.1 Hz, 1 H, C13-H), 6.09 (dd, J = 9.7, 
2.9 Hz, 1 H, C14-H), 5.37 (q, J = 12.4 Hz, 2 H, C2-H), 5.04-4.98 (m, 1 H, C11-H), 4.93 
(dd, J = 13.6, 4.2 Hz, 1 H, C11-H), 3.31 (s, 1 H, C17-H), 3.05 (ddd, J = 17.7, 6.5, 4.2 Hz, 
1 H, C12-H), 2.90-2.76 (comp, 3 H, C2-H & C1-H), 2.32 (dddd, J = 17.7, 13.6, 2.9, 2.1 
Hz, 1 H, C12-H); 13C NMR (500 MHz) δ 164.9 (C15), 138.7 (C13), 138.4 (C9), 133.7 
(C4), 126.6 (C10), 125.6 (C14), 122.7 (C7), 120.5 (C6), 118.6 (C5), 112.1 (C3), 109.4 






























[2,3-a]quinolizin-2-yl)-[1,3]dithiolane-2-carboxylic acid ethyl ester (2.25).  (mp1-65). 
n-Butyllithium (2.47 M in hexanes, 67 μL, 0.166 mmol) was added to a solution of 
diisopropylamine (28μL 0.20 mmol) in THF (0.55 mL) at –78 °C.  The reaction was 
stirred at –78 °C for 15 min and then warmed to 0 °C for 15 min, whereupon it was added 
via cannula to a solution of 5 (63 mg, 0.15 mmol) in THF (4.5 mL) cooled to –78 °C.  
The reaction was stirred at -78 °C for 30 min, and chloromethoxy methane (28μL 0.38 
mmol) was added and the reaction was allowed to warm to room temperature.  After 
stirring for 40 min, the reaction was diluted with water (5 mL) and 0.5 M HCl (0.5 mL).  
The aqueous mixture was extracted with EtOAc (3 x 5 mL), and the combined organic 
layers were dried (Na2SO4) and concentrated under reduced pressure.  The residue was 
purified by flash chromatography eluting with hexanes/EtOAc  (1:2) to give 15 mg (24%) 
of recovered starting material 2.16 and 23 mg (32%) of 2.25 as a pale yellow solid: mp 
138-141 °C 1H NMR (400 MHz) δ 7.49 (d, J = 7.7 Hz, 1 H), 7.41 (d, J = 7.9 Hz, 1 H), 
7.26-7.19 (m, 1 H), 7.18-7.11 (m, 1 H), 5.43 (s, 2 H), 5.01(dd, J = 9.5, 3.7 Hz, 1 H), 4.94-
4.83 (m, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.51-3.33 (comp, 4H), 3.27 (s, 3H) 3.08-2.93 (m, 
1 H), 2.91-2.74 (comp, 4 H), 2.63 (dd, J = 15.4, 11.3 Hz, 1 H), 2.63 (ddd, J = 14.4, 4.4, 
3.7 Hz, 1 H), 2.14-2.04 (m, 1 H), 1.16 (t, J = 7.1 Hz, 3 H); 13C NMR (500 MHz) δ 171.4, 
171.1, 138.1, 133.7, 126.7, 122.5, 120.4, 118.4, 111.8, 109.5, 75.4, 74.3, 62.6, 55.9, 50.9, 
  209
40.3, 39.9, 39.8, 36.3, 36.0, 35.0, 20.7, 14,0; IR (neat) 2981, 2921, 1719, 1650, 1460, 
1412, 1304, 1213, 1214, 1106, 1063, 1024, 912, cm-1; mass spectrum (CI) m/z 461.1556 
[C23H29N2O4S2 (M+1) requires 461.1569], 417, 429, 461 (base), 475. 
 NMR Assignments. 1H NMR (400 MHz) δ 7.49 (d, J = 7.7 Hz, 1 H, C5-H), 7.41 
(d, J = 7.9 Hz, 1 H, C-8H), 7.26-7.19 (m, 1 H, C6-H), 7.18-7.11 (m, 1 H, C6-H), 5.43 (s, 
2 H, C22-H), 5.01 (dd, J = 9.5, 3.7 Hz, 1 H, C11-H), 4.94-4.83 (m, 1H, C2-H), 4.21 (q, J 
= 7.1 Hz, 2H, C19-H), 3.51-3.33 (comp, 4H, C16-H & C17-H), 3.27 (s, 3H, C23-H) 
3.08-2.93 (m, 1 H, C13-H), 2.91-2.74 (comp, 4 H, C1-H & C2-H & C14-H), 2.63 (dd, J = 
15.4, 11.3 Hz, 1 H, C14-H), 2.45 (ddd, J = 14.4, 4.4, 3.7 Hz, 1 H, C12-H), 2.14-2.04 (m, 
1 H, C12-H), 1.16 (t, J = 7.1 Hz, 3 H, C18-H).  13C NMR (500 MHz) δ 171.4 (C15), 
171.1 (C20), 138.1 (C9), 133.7 (C10), 126.7 (C4), 122.5 (C7), 120.4 (C6), 118.4 (C5), 
111.8 (C3), 109.5 (C8), 75.4 (C22), 74.3 (C21), 62.6 (C19), 55.9 (C23), 50.9 (C11), 40.3 
(C16 or C17), 39.9 (C16 or C17), 39.8 (C2), 36.3 (C13), 36.0 (C14), 35.0 (C12), 20.7 






























hexahydro-2H indolo [2,3-a]quinolizine-12-carboxylic acid tert-butyl ester (2.31) 
(mp1-252) .  A solution of 2.16 (550 mg, 1.32 mmol), Boc2O (1.14 g, 5.28 mmol) and 
dimethylaminopyridine (DMAP) (16 mg, 0.13 mmol) in CH2Cl2 (40 mL) was stirred at 
room temperature for 4 h. The reaction mixture was concentrated under reduced pressure, 
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and the residue was purified by flash column-chromatography eluting with 
hexanes/EtOAc (1:2) to give 2.31 (578 mg, 85%) as a white solid. Mp 115-118 °C; 
1NMR (500 MHz) δ 7.99 (d, J = 8.1 Hz, 1 H), 7.42 (d, J = 8.1 Hz, 1 H), 7.28 (m, 1 H), 
7.23 (m, 1 H), 5.30-5.26 (m, 1 H), 4.96-4.94 (m, 1H) 4.23-4.10 (m, 1 H), 3.41-3.25 
(comp, 4 H), 2.88 (app td, J = 11.8, 3.6 Hz, 1 H), 2.84-2.79 (m, 1 H), 2.79-2.73 (m, 1 H), 
2.71-2.65 (comp, 2 H), 2.42 (dd, J = 14.7, 11.6 Hz, 1 H), 2.99 (ddd, J = 14.1, 8.8, 6.0 Hz, 
1 H), 2.21-2.15 (m, 1 H), 1.66 (s, 9 H), 1.17 (t, J = 7.0 Hz, 3 H); 13C NMR (125 MHz) δ 
171.2, 171.1, 150.1, 136.7, 134.9, 128.7, 124.6, 123.0, 118.9, 118.3, 115.4, 84.4, 74.6, 
62.5, 53.5, 40.5, 40.2, 39.9, 37.1, 35.8, 33.3, 28.2, 21.3, 13.9; IR (neat) 2980, 2924, 1723, 
1649, 1453, 1413, 1311, 1214, 1141, 754 cm-1; mass spectrum (CI) m/z 517.1830 
[C26H32N2O5S2 (M+1) requires 517.1831], 417, 461, 517 (base). 
 NMR Assignments. 1NMR (500 MHz) δ 7.99 (d, J = 8.1 Hz, 1 H, C9-H), 7.42 
(d, J = 8.1 Hz, 1 H, C12-H), 7.28 (m, 1 H, C10-H), 7.23 (m, 1 H, C11-H), 5.30-5.26 (m, 
1 H, C3-H), 4.96-4.91 (m, 1H, C6-H) 4.23-4.10 (m, 1 H, C21-H), 3.41-3.25 (comp, 4 H, 
C18-H & C19-H), 2.88 (app td, J = 11.8, 3.6 Hz, 1 H, C6-H), 2.84-2.79 (m, 1 H, C5-H), 
2.79-2.73 (m, 1 H, C16-H), 2.71-2.65 (comp, 2 H, C5-H & C15-H), 2.42 (dd, J = 14.7, 
11.6 Hz, 1 H, C16-H), 2.99 (ddd, J = 14.1, 8.8, 6.0 Hz, 1 H, C14-H), 2.21-2.15 (m, 1 H, 
C14-H), 1.66 (s, 9 H, C26-H), 1.17 (t, J = 7.0 Hz, 3 H, C20-H); 13C NMR (500 MHz) δ 
171.2 (C17), 171.1 (C22), 150.1 (C24), 136.7 (C13), 134.9 (C2), 128.7 (C8), 124.6 
(C10), 123.0 (C11), 118.9 (C7), 118.3 (C12), 115.4 (C9), 84.4 (C25), 74.6 (C23), 62.5 
(C20), 53.5 (C3), 40.5 (C18 or C19), 40.2 (C6), 39.9 (C18 or C19), 37.1 (C15), 35.8 


































 (3R*, 15S*, 24S*)-3-Acetyl-2-(2-ethoxycarbonyl-[1,3dithiolane-2-yl)-4-oxo-
1,3,4,6,7,12b-hexahydro-2H-indolo[2,3-α]quinolizine-12-carboxylic acid tert-butyl 
ester (2.30) (mp1-226). A solution of potassium hexamethyldisilazide in toluene (0.58 
mL of 0.5 M, 0.291 mmol) was added dropwise over 10 min to a solution of 2.31 (50 mg, 
0.097 mmol) and MgBr2·OEt2 (27 mg, 0.101 mmol) in THF (1 mL, degassed by three 
freeze-pump-thaw cycles) at -78 °C.  The reaction was stirred at -78 °C for 2 h 
whereupon a solution of freshly distilled acetyl chloride (23 mg, 21 μL, 0.291 mmol) in 
degassed THF (1 mL) cooled to -78 °C was added via cannula.  The solution was stirred 
at -78 °C for 2 h, whereupon a saturated aqueous solution of NH4Cl (0.2 mL) was added. 
The cooling bath was removed and the mixture was stirred at room temperature for 40 
min.  The slurry was diluted with EtOAc (5 mL) and poured into a separatory funnel 
containing 0.5 M HCl (3 mL).  The layers were separated, and the aqueous layer was 
extracted with EtOAc (2 x 5 mL).  The combined organic layers were dried (MgSO4) and 
concentrated under reduced pressure.  Purification of the residue by flash 
chromatography eluting with hexanes/EtOAc (1:2) to give 32 mg (60%, dr > 95:5) of 
2.30 as a pale yellow solid: mp 141-144 °C; 1NMR (500 MHz) δ 7.90 (d, J = 8.2 Hz, 1 
H), 7.43-7.39 (m, 1 H), 7.28-7.25 (m, 1 H), 7.24-7.20 (m, 1 H), 5.45-5.41 (m, 1 H), 5.10-
5.05 (m, 1H) 4.29-4.23 (comp, 2 H), 4.03 (d, J = 4.0 Hz, 1 H), 3.54-3.43 (comp, 2 H), 
3.39-3.27 (comp, 3 H), 2.85-2.78 (m, 1 H),  2.73-2.67 (m, 1 H), 2.67-2.57 (m, 1 H), 2.43 
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(s, 3 H), 1.93 (ddd, J = 14.7, 11.0, 6.4 Hz, 1 H), 1.67 (s, 9 H), 1.29 (t, J = 7.2 Hz, 3 H); 
13C NMR (500 MHz) δ 205.1, 170.9, 166.9, 150.3, 136.3, 134.9, 128.7, 124.5, 122.9, 
118.5, 118.3, 115.5, 84.3, 74.3, 62.4, 56.6, 52.7, 41.4, 39.4, 39.1, 38.2, 31.3, 30.8, 28.2, 
21.6, 13.9; IR (neat) 2975, 2923, 1723, 1635, 1453, 1422, 1365, 1308, 1219, 1136, 1022, 
747 cm-1; mass spectrum (CI) m/z 559.1939 [C28H35N2O6S2 (M+1) requires 559.1937], 
279, 381, 459, 517, 559 (base). 
NMR Assignments. 1NMR (500 MHz) δ 7.90 (d, J = 8.2 Hz, 1 H, C9-H), 7.43-
7.39 (m, 1 H, C12-H), 7.28-7.25 (m, 1 H, C10-H), 7.24-7.20 (m, 1 H, C11-H), 5.45-5.41 
(m, 1 H, C3-H), 5.10-5.05 (m, 1 H, C6-H) 4.29-4.23 (comp, 2 H, C20-H), 4.03 (d, J = 4.0 
Hz, 1H, C24-H), 3.54-3.43 (comp, 2 H, C17-H, C18-H), 3.39-3.27 (comp, 3 H, C17-H, 
C18-H, C15-H), 2.85-2.78 (m, 1 H, C6-H),  2.73-2.67 (m, 1 H, C14-H), 2.67-2.57 (m, 1 
H, C14-H), 2.43 (s, 3 H, C22-H), 1.93 (ddd, J = 14.7, 11.0, 6.4 Hz, 1 H, C14-H), 1.67 (s, 
9 H) , C28-H, 1.29 (t, J = 7.23 Hz, 3 H, C21-H); 13C NMR (500 MHz) δ 205.1 (C23), 
170.9 (C25), 166.9 (C19), 150.3 (C26), 136.3 (C13), 134.9 (C2), 128.7 (C8), 124.5 
(C10), 122.9 (C11), 118.5 (C7), 118.3 (C12), 115.5 (C9), 84.3 (C27), 74.3 (C16), 62.4 
(C20), 56.6 (C24), 52.7 (C3), 41.4 (C17 or C18), 39.4 (C6), 39.1 (C17 or C18), 38.2 
(C15), 31.3 (C14), 30.8 (C22), 28.2 (C28), 21.6 (C5), 13.9 (C21). 
































1,3,4,6,7,12b-hexa hydro-2H-indolo[2,3-α]quinolizine-12-carboxylic acid tert-butyl 
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ester (2.33) (mp2-120). A solution of sodium hexamethyldisilazide in THF (0.39 mL, 2.0 
M, 0.774 mmol) was added dropwise over 12 min to a solution of 2.31 (200 mg, 0.387 
mmol) in degassed THF (2.5 mL) at –78 °C.  The mixture was stirred at –78 °C for 1 h, 
whereupon it was cooled –100 °C. 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)- pyrimidone 
(DMPU) (74 mg, 70 µL, 0.58 mmol) was added followed by ethyl triflate (276 mg, 0.20 
mL, 1.55 mmol).  The mixture was stirred at –100 °C for 2.5 h, whereupon benzylamine 
(249 mg, 0.25 mL, 2.32 mmol) and ethanol (0.2 mL) were added.  The flask was 
transferred to a –78 °C bath and stirring was continued for 45 min.  A saturated aqueous 
solution of NH4Cl (2 mL) was added and the cold bath was removed. After allowing the 
reaction to warm to room temperature, the mixture was poured into a separatory funnel 
containing 0.5 M HCl (10 mL) and EtOAc (10 mL).  The layers were separated, and the 
aqueous layer was extracted with EtOAc (2 × 10 mL).  The combined organic layers were 
dried (Na2SO4) and concentrated under reduced pressure.  The residue was purified by 
flash column-chromatography eluting with pentane/acetone (2:1) to give 39 mg (20%) of 
recovered 2.31 and 142 mg (67%, dr > 95:5) of 2.33 as a colorless foam that could be 
recrystallized from CH2Cl2/heptane. mp 151-153 °C; 1NMR (500 MHz) δ 7.91-7.87 (m, 
1 H), 7.43-7.40 (m, 1 H), 7.27-7.20 (comp, 2 H), 5.41-5.35 (m, 1 H), 5.18-5.12 (m, 1H), 
4.32 (q, J = 7.2 Hz, 2 H), 3.50-3.44 (comp, 2 H), 3.34-3.25 (comp, 3 H), 2.86-2.65 
(comp, 6 H), 1.97-1.88 (m, 1 H), 1.76 (ddd, J = 14.3, 11.8, 4.8 Hz, 1 H), 1.67 (s, 9 H), 
1.60-1.50 (m, 1H), 1.34 (t, J = 7.2 Hz, 3 H), 1.00 (t, J = 7.4 Hz, 3 H); 13C NMR (125 
MHz) δ 172.7, 171.3, 150.3, 136.5, 135.9, 128.9, 124.4, 122.9, 118.5, 118.3, 115.5, 84.2, 
74.1, 62.2, 53.0, 44.6, 41.7, 39.5, 39.2, 38.7, 28.5, 28.2, 27.2, 22.0, 13.9, 12.1; IR (neat) 
2975, 2923, 1723, 1635, 1453, 1417, 1370, 1303, 1219, 1136, 1022, 731 cm-1; mass 
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spectrum (CI) m/z 545.2143 [C28H37N2O5S2 (M+1) requires 545.2144], 233, 339, 445, 
545 (base).  
NMR Assignments. 1NMR (500 MHz) δ 7.91-7.87 (m, 1 H, C9-H), 7.43-7.40 
(m, 1 H, C12-H), 7.27-7.20 (comp, 2 H, C10-H, C11-H), 5.41-5.35 (m, 1 H, C3-H), 5.18-
5.12 (m, 1H, C6-H), 4.32 (q, J = 7.2 Hz, 2 H, C20-H), 3.50-3.44 (comp, 2 H, C17-H, 
C18-H), 3.34-3.25 (comp, 3 H, C15-H, C17-H, C18-H), 2.86-2.65 (comp, 6 H, C5-H, C6-
H, C14-H, C24-H), 1.97-1.88 (m, 1 H, C23-H), 1.76 (ddd, J = 14.3, 11.8, 4.8 Hz, 1 H, 
C23-H), 1.67 (s, 9 H, C14-H), 1.60-1.50 (m, 1H, C23-H), 1.34 (t, J = 7.2 Hz, 3 H, C21-
H), 1.00 (t, J = 7.4 Hz, 3 H, C22-H); 13C NMR (125 MHz) δ 172.7 (C25), 171.3 (C19), 
150.3 (C26), 136.5 (C13), 135.9 (C2), 128.9 (C8), 124.4 (C10), 122.9 (C11), 118.5 (C7), 
118.3 (C12), 115.5 (C9), 84.2 (C27), 74.1 (C16), 62.2 (C20), 53.0 (C3), 44.6 (C24), 41.7 
(C17 or C18), 39.5 (C15), 39.2 (C6), 38.7 (C17 or C18), 28.5 (C14), 28.2 (C28), 27.2 
(C23), 22.0 (C5), 13.9 (C21), 12.1 (C22); IR (neat) 2975, 2923, 1723, 1635, 1453, 1417, 
1370, 1303, 1219, 1136, 1022, 731 cm-1; mass spectrum (CI) m/z 545.2143 





























(3R*, 15S*, 22S*)-2-(2-Ethoxycarbonyl-3-ethyl-4-oxo-1,3,4,6,7,12b-hexa 
hydro-2H-indolo [2,3-α]quinolizine-12-carboxylic acid tert-butyl ester (45) (mp2-
125). A slurry of Raney-Nickel in water (2.9 g) was added to a solution of 2.33 (312 mg, 
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0.57 mmol) in EtOH (20 mL), and the reaction was stirred at room temperature for 4 h. 
EtOAc (20 mL) was added and the mixture was dried (Na2SO4) and filtered through 
Celite.  The solids were washed with EtOAc (20 mL) and the filtrate was concentrated 
under reduced pressure. Purification of the residue by flash column-chromatography 
eluting with hexane/EtOAc (1:1) gave 242 mg (93%) of 2.36 as a clear colorless oil; 
1NMR (125 MHz) δ 7.94-7.90 (m, 1 H), 7.44-7.39 (m, 1 H), 7.30-7.20 (comp, 2 H), 5.21-
5.18 (m, 1 H), 5.06-5.03 (m, 1 H), 4.15 (q, J = 7.0 Hz, 2 H),  2.83-2.76 (m, 1 H), 2.72-
2.67 (comp, 2 H), 2.61 (dd, J = 15.9, 7.4 Hz, 1 H), 2.52 (dd, J = 15.9, 7.4 Hz, 1 H), 2.48-
2.37 (comp, 3 H), 2.21-2.15 (m, 1 H), 1.87-1.79 (m, 1 H), 1.75-1.64 (comp, 10 H), 1.56-
1.52 (m, 1 H), 1.27 (t, J = 7.0 Hz, 3 H), 0.98 (t, J = 7.4 Hz, 3 H); 13C NMR (500 MHz) δ 
172.2, 172.0, 150.3, 136.5, 135.7, 128.8, 124.4, 122.9, 118.4, 118.3, 115.5, 84.3, 60.5, 
51.8, 47.6, 39.2, 38,1, 30.5, 29.7, 28.2, 25.5, 21.7, 14.2, 12.1; IR (neat) 2970, 2927, 1728, 
1656, 1640, 1455, 1414, 1368, 1311, 1249, 1219, 1158, 1136, 1116, 745 cm-1; mass 
spectrum (CI) m/z 455.2559 [C26H35N2O5 (M+1) requires 455.2546], 355, 399, 455 
(base).  
 NMR Assignments. 1NMR (500 MHz) δ 7.94-7.90 (m, 1 H, C9-H), 7.44-7.39 
(m, 1 H, C12-H), 7.30-7.20 (comp, 2 H, C10-H, C11-H), 5.21-5.18 (m, 1 H, C3-H), 5.06-
5.03 (m, 1 H, C6-H), 4.15 (q, J = 7.0 Hz, 2 H, C18-H),  2.83-2.76 (m, 1 H, C6-H), 2.72-
2.67 (comp, 2 H, C5-H), 2.61 (dd, J = 15.9, 7.4 Hz, 1 H, C16-H), 2.52 (dd, J = 15.9, 7.4 
Hz, 1 H, C16-H), 2.48-2.37 (comp, 3 H, C14-H, C15-H), 2.21-2.15 (m, 1 H, C20-H), 
1.87-1.79 (m, 1 H, C21-H), 1.75-1.64 (comp, 10 H, C14-H, C26-H), 1.56-1.52 (m, 1 H, 
C21-H), 1.27 (t, J = 7.0 Hz, 3 H, C19-H), 0.98 (t, J = 7.4 Hz, 3 H, C22-H); 13C NMR 
(500 MHz) δ 172.2 (C23), 172.0 (C17), 150.3 (C24), 136.5 (C13), 135.7 (C2), 128.8 
(C8), 124.4 (C10), 122.9 (C11), 118.4 (C7), 118.3 (C12), 115.5 (C9), 84.3 (C25), 60.5 
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(C18), 51.8 (C3), 47.6 (C20), 39.2 (C6), 38.1 (C16), 30.5 (C14), 29.7 (C15), 28.2 (C26), 

























α]quinolizine-2-yl]-acetic acid methyl ester (2.39) (mp2-127). A solution of 4.4 M 
NaOMe (1.20 mL, 5.28 mmol), which was freshly prepared by the addition of sodium 
(404 mg, 17.6 mmol) to degassed methanol (4 mL), was added to a solution of 2.36 (240 
mg, 0.53 mmol) in degassed THF (5 mL) at 0 °C.  The ice bath was removed, and the 
reaction was stirred at room temperature for 1 h, whereupon the reaction was cooled to 0 
°C, and a saturated aqueous solution of NH4Cl (3 mL) and water (15 mL) were added. 
The mixture was poured into a separatory funnel containing EtOAc (20 mL) and the 
layers were separated. The aqueous layer was extracted with EtOAc (2 × 15 mL) and the 
combined organic extracts were dried (Na2SO4) and concentrated under reduced 
pressure.  The residue was recrystallized from CH2Cl2/ether and the mother liquor was 
purified by flash chromatography eluting with hexane/EtOAc (1:1) to afford a total of 
155 mg (86%) of 2.39 as a white solid: mp 186-189 °C decomp.; 1NMR (500 MHz, 
CDCl3) δ 7.92 (br s, 1H), 7.48 (d, J = 7.6 Hz, 1 H), 7.33 (d, J = 8.0 Hz, 1 H), 7.19-7.15 
(m, 1 H), 7.12-7.09 (m, 1 H), 5.14-5.08 (m, 1 H), 4.83 (dd, J = 9.4, 5.2 Hz, 1 H), 3.72 (s, 
3 H), 2.89-2.81 (comp, 2 H), 2.77-2.70 (m, 1 H), 2.55-2.38 (comp, 3 H), 2.25-2.19 
(comp, 2 H), 2.17-2.11 (m, 1 H), 1.82-1.74 (m, 1 H), 1.64-1.55 (m, 1 H), 0.92 (t, J = 7.4 
Hz, 3 H); 13C NMR (125 MHz) δ 172.5, 171.0, 136.2, 133.1, 127.0, 122.2, 119.9, 118.3, 
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111.0, 110.0, 51.8, 50.7, 48.2, 40.7, 37.3, 29.4, 28.6, 24.9, 21.1, 11.8; IR (neat) 3255, 
2962, 2930, 1733, 1612, 1466, 1434, 1351, 1304, 1262, 1236, 1199, 1168, 739 cm-1; 
340.1777 [C20H24N2O3 S2 (M+) requires 340.1787], 241, 273, 305, 341 (base), 369.   
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.92 (br s, 1H, NH), 7.48 (d, 
J = 7.6 Hz, 1 H, C9-H or C12-H), 7.33 (d, J = 8.0 Hz, 1 H, C9-H or C12-H), 7.19-7.15 
(m, 1 H, C10-H or C11-H), 7.12-7.09 (m, 1 H, C10-H or C11-H), 5.14-5.08 (m, 1 H, C6-
H), 4.83 (dd, J = 9.4, 5.2 Hz, 1 H, C3-H), 3.72 (s, 3 H, C18-H), 2.89-2.81 (comp, 2 H, 
C5-H and C6-H), 2.77-2.70 (m, 1 H, C5-H), 2.55-2.38 (comp, 3 H, C15-H and C16-H), 
2.25-2.19 (comp, 2 H, C14-H and C20-H), 2.17-2.11 (m, 1 H, C14-H), 1.82-1.74 (m, 1 H, 
C21-H), 1.64-1.55 (m, 1 H, C21-H), 0.92 (t, J = 7.4 Hz, 3 H, C22-H); 13C NMR (125 
MHz) δ 172.5 (C17), 171.0 (C19), 136.2 (C13), 133.1 (C2), 127.0 (C8), 122.2 (C10 or 
C11), 119.9 (C10 or C11), 118.3 (C9 or C12), 111.0 (C9 or C12), 110.0 (C7), 51.8 (C18), 
50.7 (C3), 48.2 (C20), 40.7 (C6), 37.3 (C16), 29.4 (C15), 28.6 (C14), 24.9 (C21), 21.1 
























a]quinolizine-2-yl]-acetic acid methyl ester (2.4) (mp2-131).  A slurry of 2.39 (72 mg, 
0.21 mmol), trimethyloxonium tetrafluoroborate (83 mg, 0.56 mmol) and 2,6-di-tert-
butylpyridine (118 mg, 0.14 mL, 0.619 mmol) in CH2Cl2  (7 mL) was stirred at room 
temperature for 21 h during which time a homogenous yellow solution was produced. 
The reaction mixture was cooled to 0 °C, and anhydrous MeOH (2.5 mL) was added. 
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After 15 min, NaBH4 (83 mg, 2.18 mmol) was added, and the reaction mixture was 
stirred for an additional 20 min.  Saturated NaHCO3 (5 mL) and CH2Cl2 (10 mL) were 
added and the layers separated.  The aqueous layer was extracted with CH2Cl2 (2 × 8 
mL).  The combined organic fractions were dried (Na2SO4), and the volatiles were 
removed under reduced pressure.  The residue was purified by flash chromatography 
eluting with 2.5%−10% MeOH in CH2Cl2 to afford 56 mg (81%) of 2.4 as a foam.  
1NMR (500 MHz, CDCl3) δ 8.00 (br s, 1H), 7.50 (d, J = 7.4 Hz, 1 H), 7.40-7.38 (m, 1 
H), 7.18 (app td, J = 7.4, 1.2 Hz, 1 H), 7.12 (app td, J = 7.4, 1.2 Hz, 1 H), 4.13 (br s, 1 H), 
3.75 (s, 3 H), 3.23 (dd, J = 11.9, 5.2 Hz, 1 H), 3.10 (dd, J = 11.9, 4.4 Hz, 1 H), 3.08-2.99 
(m, 1 H), 2.76 (dd, J = 11.4, 3.4 Hz, 1 H), 2.69-2.64 (m, 1 H), 2.63 (dd, J = 16.3, 4.4 Hz, 
1 H), 2.56 (dd, J = 11.4, 8.0 Hz, 1 H), 2.31-2.24 (comp, 2 H), 1.82-1.74 (comp, 2 H), 
1.58-1.49 (m, 1 H), 1.46-1.38 (m, 1 H), 1.27-1.19 (m, 1 H), 0.87 (t, J = 7.4 Hz, 3 H); 13C 
NMR (125 MHz) δ 173.7, 136.0, 133.2, 127.6, 121.4, 119.4, 118.0, 111.1, 107.8, 54.3, 
51.9, 51.6, 51.4, 41.2, 36.9, 32,8, 32.2, 24.1, 18.5, 11.5; IR (neat) 3397, 3245, 2941, 
1731, 1452, 1168, 1004, 732 cm-1; mass spectrum (CI) m/z 327.2076 [C20H27N2O2 
(M+1) requires 327.2073], 325, 327 (base), 326, 341.  
NMR Assignments. 1NMR (500 MHz) δ 8.00 (br s, 1H, NH), 7.50 (d, J = 7.4 Hz, 
1 H, C9-H or C12-H), 7.40-7.38 (m, 1 H, C9-H or C12-H), 7.18 (app dt, J = 7.4, 1.2 Hz, 
1 H, C10-H or C11-H), 7.12 (app dt, J = 7.4, 1.2 Hz, 1 H, C10-H or C11-H), 4.13 (br s, 1 
H, C3-H), 3.75 (s, 3 H, C18-H), 3.23 (dd, J = 11.9, 5.2 Hz, 1 H, C6-H), 3.10 (dd, J = 
11.9, 4.4 Hz, 1 H, C6-H), 3.08-2.99 (m, 1 H, C5-H), 2.76 (dd, J = 11.4, 3.4 Hz, 1 H, C19-
H), 2.69-2.64 (m, 1 H, C5-H), 2.63 (dd, J = 16.3, 4.4 Hz, 1 H, C16-H), 2.56 (dd, J = 11.4, 
8.0 Hz, 1 H, C19-H), 2.31-2.24 (comp, 2 H, C14-H and C16-H), 1.82-1.74 (comp, 2 H, 
C14-H and C-15), 1.58-1.49 (m, 1 H, C21-H), 1.46-1.38 (m, 1 H, C20-H), 1.27-1.19 (m, 
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1 H, C21-H), 0.87 (t, J = 7.4 Hz, 3 H, C22-H); 13C NMR (125 MHz) δ 173.7 (C17), 
136.0 (C13), 133.2 (C2), 127.6 (C8), 121.4 (C10 or C11), 119.4 (C10 or C11), 118.0 (C9 
or C12), 111.1 (C9 or C12), 107.8 (C7), 54.3 (C3), 51.9 (C6), 51.6 (C18), 51.4 (C19), 



















Spirooxindoles epi-2.3 and 2.3 (mp2-146, mp2-147, mp2-149).  A solution of t-
BuOCl in CCl4 (0.5 M, 0.50 mL, 0.25 mmol) was added to a solution of 2.4 (51 mg, 0.16 
mmol) in CH2Cl2 (11 mL) at −20 °C. The reaction mixture was stirred at −20 °C for 0.5 
h, and the volatiles were removed under reduced pressure. The yellow residue was 
dissolved in MeOH (7 mL) and a freshly prepared solution of NaOCH3 (3.5 M, 0.9 mL, 
3.15 mmol) was added.  The reaction mixture was stirred for 4 h at room temperature, 
whereupon saturated aqueous NaHCO3 (6 mL) and brine (6 mL) were added.  The 
aqueous mixture was extracted with Et2O (3 x 10 mL), and the combined organic layers 
were dried (Na2SO4).  The volatiles were evaporated under reduced pressure, and the 
residue was dissolved in CH2Cl2 (13 mL). Water (2.2 mL) was added, the mixture was 
cooled to 0 °C, and CF3SO3H (0.14 mL, 1.56 mmol) was added via syringe.  The 
reaction was stirred at 0 °C for 1 h and then for an additional 5 h at room temperature. A 
saturated aqueous solution of NaHCO3 (4 mL) was added and the layers were separated.  
The aqueous layer was extracted with CH2Cl2 (2 x 10 mL), and the combined organic 
layers were dried (Na2SO4) and concentrated under reduced pressure.  From the 1H NMR 
of the crude product a dr = 45:55 of epi-3/3 was determined. The crude mixture was 
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separated by flash chromatography eluting with EtOAc/hexanes (2:1 → 100% EtOAc) 
then 1% → 2 % MeOH in EtOAc to give 18 mg (35%) of epi-2.3 (less polar) as a yellow 
oil and 22 mg (41%) 2.3 (more polar) as a colorless solid; mp = 172-174 °C 
(Et2O/pentane); Lit.
27 167-168 °C. epi-2.3: 1NMR (500 MHz, DMSO d6) δ 10.32 (s, 1 
H), 7.21 (d, J = 7.4 Hz, 1 H), 7.14 (td, J = 7.6, 1.2 Hz, 1 H), 6.94 (td, J = 7.4, 0.8 Hz, 1 
H), 6.80 (d, J = 7.6, Hz, 1 H), 3.46 (s, 3 H), 3.24-3.17 (comp, 2 H), 2.45 (dd, J = 15.5, 3.8 
Hz, 1 H), 2.30 (app q, J = 8.7 Hz, 1 H) 2.22 (dd, J = 11.3, 2.3 Hz, 1 H), 2.16 (ddd, J = 
12.8, 9.5, 2.4 Hz, 1 H), 1.90-1.79 (comp, 2 H), 1.69 (app t, J = 10.9 Hz, 1 H), 1.52-1.44 
(m, 1 H), 1.42-1.34 (m, 1 H), 1.20-1.12 (m, 1 H), 1.08-0.98 (comp, 2 H), 0.82 (t, J = 7.4 
Hz, 3 H), 0.60 (app q, J = 11.9, 1 H); 13C NMR (125 MHz, DMSO d6) δ 179.9, 172.6, 
141.4, 133.5, 127.4, 124.3, 121.4, 109.1, 70.9, 56.9, 55.9, 53.2, 51.1, 40.5, 37.3, 36.6, 
34.6, 31.5, 22.7, 10.7; IR (neat) , 3208, 2932, 2804, 1726, 1708, 1619, 1470, 1342, 1223, 
1167, 754 cm-1; mass spectrum (CI) m/z  343.2032 [C20H26N2O3 (M+1) requires 
343.2022], 197, 311, 343  (base). 2.3 : 1NMR (500 MHz, DMSO d6) δ 10.15 (s, 1 H, 
NH), 7.23 (d, J = 9.2 Hz, 1 H), 7.14 (t, J = 7.3, Hz, 1 H), 6.95 (t, J = 7.4, Hz, 1 H), 6.77 
(d, J = 7.6, Hz, 1 H), 3.48 (s, 3 H), 3.16-3.12 (comp, 2 H), 2.51-2.47 (multiplicity 
obscured by DMSO peak, 1 H), 2.40-2.34 (m, 1 H) 2.18-2.10 (comp, 2 H), 2.00 (dd, J = 
15.5, 8.6 Hz, 1 H), 1.85 (dd, J = 12.4, 7.4 Hz, 1 H), 1.64 (app t, J = 10.7 Hz, 1 H), 1.54-
1.45 (m, 1 H), 1.36-1.08 (comp, 4 H), 1.04-0.96 (m, 1 H), 0.81 (t, J = 7.4 Hz); 13C NMR 
(125 MHz, DMSO d6) δ 179.6, 172.7, 141.8, 133.8, 127.7, 123.1, 121.6, 108.8, 73.8, 
56.4, 55.1, 54.0, 51.1, 37.4, 36.9, 34.3, 30.8, 22.8, 10.7; IR (neat) , 3233, 2935, 2779, 
1727, 1619, 1476, 1333, 1219, 1178, 758 cm-1; mass spectrum (CI) m/z  343.2018 
[C20H26N2O3 (M+1) requires 343.2022], 343  (base), 371.  
NMR Assignments. epi-2.3: 1NMR (500 MHz, DMSO d6) δ 10.32 (s, 1 H, NH), 
7.21 (d, J = 7.4 Hz, 1 H,  C9-H), 7.14 (td, J = 7.6, 1.2 Hz, 1 H,  C11-H), 6.94 (td, J = 7.4, 
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0.8 Hz, 1 H,  10-H), 6.80 (d, J = 7.6, Hz, 1 H,  C12-H), 3.46 (s, 3 H,  C22-H), 3.24-3.17 
(comp, 2 H,  C5-H,  C21-H), 2.45 (dd, J = 15.5, 3.8 Hz, 1 H,  C16-H), 2.30 (app q, J = 
8.7 Hz, 1 H,  C5-H) 2.22 (dd, J = 11.3, 2.3 Hz, 1 H,  C3-H), 2.16 (ddd, J = 12.8, 9.5, 2.4 
Hz, 1 H,  C6-H), 1.90-1.79 (comp, 2 H,  C6-H,  C16-H), 1.69 (app t, J = 10.9 Hz, 1 H,  
C21-H), 1.52-1.44 (m, 1 H,  C19-H), 1.42-1.34 (m, 1 H,  C15-H), 1.20-1.12 (m, 1 H,  
C20-H), 1.08-0.98 (comp, 2 H,  C14-H,  C19-H), 0.82 (t, J = 7.4 Hz, 3 H,  C18-H), 0.60 
(app q, J = 11.9, 1 H,  C14-H); 13C NMR (125 MHz, DMSO d6) δ 179.9 (C2), 172.6 
(C17), 141.4 (C13), 133.5 (C8), 127.4 (C11), 124.3 (C9), 121.4 (C10), 109.1 (C12), 70.9 
(C3), 56.9 (C21), 55.9 (C7), 53.2 (C5), 51.1 (C22), 40.5 (C20), 37.3 (C16), 36.6 (C15), 
34.6 (C6), 31.5 (C14), 22.7 (C19), 10.7 (C18). 2.3: 1NMR (500 MHz, DMSO d6) δ 10.15 
(s, 1 H, NH), 7.23 (d, J = 9.2 Hz, 1 H,  C9-H), 7.14 (t, J = 7.3, Hz, 1 H,  C11-H), 6.95 (t, 
J = 7.4, Hz, 1 H,  C10-H), 6.77 (d, J = 7.6, Hz, 1 H,  C12-H), 3.48 (s, 3 H,  C22-H), 3.16-
3.12 (comp, 2 H,  C5-H, C21-H), 2.51-2.47 (multiplicity obscured by DMSO peak, 1 H,  
C16-H), 2.40-2.34 (m, 1 H,  C5-H) 2.18-2.10 (comp, 2 H,  C3-H,  C6-H), 2.00 (dd, J = 
15.5, 8.6 Hz, 1 H,  C16-H), 1.85 (dd, J = 12.4, 7.4 Hz, 1 H,  C6-H), 1.64 (app t, J = 10.7 
Hz, 1 H,  C21-H), 1.54-1.45 (m, 1 H,  C19-H), 1.36-1.08 (comp, 4 H,  C14-H,  C15-H,  
C20-H), 1.04-0.96 (m, 1 H,  C19-H), 0.81 (t, J = 7.4 Hz,  C18-H); 13C NMR (125 MHz, 
DMSO d6) δ 179.6 (C2), 172.7 (C17), 141.8 (C13), 133.8 (C28), 127.7 (C11), 123.1 
(C9), 121.6 (C10), 108.8 (C12), 73.8 (C3), 56.4 (C21), 55.1 (C7), 54.0 (C5), 51.1 (C22), 























tert-butyl ester (2.36) (mp1-300).  A solution of 2.17 (1.10 g, 4.62 mmol), Boc2O (4.97 
g, 23.1 mmol) and dimethylaminopyridine (DMAP) (113 mg, 0.92 mmol) in THF (100 
mL) was stirred at room temperature for 4 h, whereupon the reaction was concentrated 
under reduced pressure. The residue was purified by flash column-chromatography 
eluting with hexanes/EtOAc (1:1−1:2 ) to give 1.54 g (99%) of 2.36 as a white solid: mp 
181-183 °C; 1NMR (500 MHz) δ 8.06 (d, J = 8.2 Hz, 1 H), 7.47-7.45 (m, 1 H), 7.32-7.28 
(m, 1 H), 7.27-7.24 (m, 1 H), 6.67 (ddd, J = 9.6, 6.5, 2.1 Hz, 1 H), 6.07 (dd, J = 9.6, 2.9 
Hz, 1 H) 5.26-5.21 (m, 1 H), 5.00 (ddd, J = 12.7, 4.6, 1.6 Hz, 1 H), 3.01 (ddd, J = 17.1, 
6.5, 3.6 Hz, 1 H),  2.87-2.79 (comp, 3 H), 2.15 (dddd, J = 17.1, 13.1, 2.9, 2.1,  Hz, 1 H), 
1.67 (s, 9 H); 13C NMR (125 MHz) δ 164.8, 150.0, 139.1, 136.6, 134.1, 128.5, 125.4, 
124.7, 123.1, 118.4, 118.0, 115.8, 84.5, 53.3, 37.6, 31.6, 28.2, 21.5; IR (CDCl3) 2982, 
2919, 1727, 1659, 1607, 1423, 1366, 1308, 1146, 1052, 817, 718 cm-1; mass spectrum 
(CI) m/z 339.1721 [C20H23N2O3 (M+1) requires 339.1709], 283, 311, 339 (base), 367, 
422. 
 NMR Assignments. ; 1NMR (500 MHz) δ 8.06 (d, J = 8.2 Hz, 1 H, C9-H), 7.47-
7.45 (m, 1 H, C12-H), 7.32-7.28 (m, 1 H, C10-H), 7.27-7.24 (m, 1 H, C11-H), 6.67 (ddd, 
J = 9.6, 6.5, 2.1 Hz, 1 H, C15-H), 6.07 (dd, J = 9.6, 2.9 Hz, 1 H, C16-H) 5.26-5.21 (m, 1 
H, C3-H), 5.00 (ddd, J = 12.7, 4.6, 1.6 Hz, 1 H, C6-H), 3.01 (ddd, J = 17.1, 6.5, 3.6 Hz, 1 
H, C14-H),  2.87-2.79 (comp, 3 H, C6-H, C5-H), 2.15 (dddd, J = 17.1, 13.1, 2.9, 2.1 Hz, 
1 H, C14-H), 1.67 (s, 9 H, C20-H); 13C NMR (500 MHz) δ 164.8 (C17),  150.0 (C18),  
139.1 (C15),  136.6 (C13),  134.1 (C2),  128.5 (C8),  125.4 (C16),  124.7 (C10),  123.1 
(C11),   118.4 (C7),  118.0 (C12),  115.8 (C9),  84.5 (C19),  53.3 (C3),  37.6 (C6),  31.6 























butyl ester (2.36) (mp2-046). To a degassed solution of Grubbs’ first-generation catalyst 
(18 mg, 0.02 mmol, 4 mol%) in CH2Cl2 (25 mL) was added a solution of 2.17 (149 mg, 
0.56 mmol) in degassed CH2Cl2 (7 mL) via cannula.  The reaction mixture was stirred at 
room temperature for 24 h, whereupon Boc2O (603 mg, 2.80 mmol) and 
dimethylaminopyridine (DMAP) (14 mg, 0.11 mmol) were added.  The reaction mixture 
was stirred for 1.5 h, whereupon ethanol (0.2 mL) and activated carbon (180 mg) were 
added. After stirring for 20 h, the reaction was filtered through a plug of Celite, and the 
filtrate was concentrated under reduced pressure. The residue was purified by flash 
column-chromatography eluting with hexanes/EtOAc (1:1−1:2) to give 175 mg (93%) of 
2.36 as a white solid.  The 1H NMR spectrum was identical to that previously reported 































  (3R*,  15R*)-2-(-4-Oxo-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-
yl)-[1,3] dithiolane-2-carboxylic acid ethyl ester (2.32) (mp1-303). A solution of n-
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BuLi (0.28 mL, 0.67 mmol) in hexanes (2.40 M) was added to a solution of i-Pr2NH (75 
mg, 98 μL, 0.74 mmol) in THF (16 mL) at –78 °C.  After stirring at –78 °C for 15 min, 
the flask was transferred to an ice/water bath and stirring was continued for 15 min. The 
mixture was then recooled to –78 °C. Neat ethyl-1,3-dithiolane-2-carboxylate (180 mg, 
0.144 mL, 1.01 mmol) was added, and the resulting solution was stirred at –78 °C for 30 
min. A solution of 2.36 (114 mg, 0.336 mmol) in THF (16 mL) at -78 °C was added via 
cannula. The dry ice/acetone bath was removed, and the reaction was stirred for 3 h at 
room temperature whereupon NH4Cl (1.0 mL) was added and 50% of the volatiles were 
removed under reduced pressure.  The mixture was poured into a separatory funnel 
containing 0.5 M HCl (30 mL) and extracted with EtOAc (3 x 20 mL). The combined 
organic layers were dried (MgSO4) and concentrated under reduced pressure.  The 
residue was purified by flash chromatography eluting with hexanes/EtOAc  (1:2 → 1:3) 
to give 123 mg (71%, dr > 95:5) of 2.32 as a white solid: mp 150-151 °C: 1NMR (500 
MHz, CDCl3) δ 8.01 (d, J = 8.2 Hz, 1 H), 7.42-7.40 (m, 1 H), 7.30-7.27 (m, 1 H), 7.24-
7.21 (m, 1 H), 5.16-5.08 (comp, 2 H), 4.23 (app dq, J = 7.2, 1.1 Hz, 2 H), 3.38-3.31 
(comp, 2 H), 3.30-3.23 (comp, 2 H), 2.97 (ddt, J = 11.9, 5.51, 2.6 Hz, 1 H), 2.87-2.81 
(comp, 3 H), 2.81-2.65 (comp, 2 H), 2.50 (dd, J = 17.5, 11.6 Hz, 1 H), 1.68 (s, 9 H), 1.44-
1.37 (m, 1 H), 1.31 (t, J = 7.2 Hz, 3 H); 13C NMR (500 MHz) δ 171.2, 168.7, 150.2, 
136.8, 134.7, 128.6, 124.7, 123.0, 118.6, 118.3, 115.5, 84.5, 74.2, 62.5, 54.4, 40.2, 40.0, 
39.0, 38.3, 35.8, 33.7, 28.1, 21.6, 13.9; IR (neat) 2974, 2923, 1727, 1640, 1457, 1431, 
1411, 1365, 1314, 1222, 1141, 1023, 906, 728 cm-1; mass spectrum (CI) m/z 516.1747 
[C26H32N2O5 S2 (M+) requires 516.1753], 237, 289, 339, 362, 391, 517 (base).   
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 8.01 (d, J = 8.2 Hz, 1 H, C9-
H or C12-H), 7.42-7.40 (m, 1 H, C9-H or C12-H), 7.30-7.27 (m, 1 H, C10-H or C11-H), 
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7.24-7.21 (m, 1 H, C10-H or C11-H), 5.16-5.08 (comp, 2 H, C3-H and C6-H), 4.23 (app 
dq, J = 7.2, 1.1 Hz, 2 H, C21-H), 3.38-3.31 (comp, 2 H, C18-H or C19-H), 3.30-3.23 
(comp, 2 H, C18-H or C19-H), 2.97 (ddt, J = 11.9, 5.51, 2.6 Hz, 1 H, C15-H), 2.87-2.81 
(comp, 3 H, C6-H, C14-H, C16-H), 2.81-2.65 (comp, 2H, C5-H), 2.50 (dd, J = 17.5, 11.6 
Hz, 1 H, C16-H), 1.68 (s, 9 H, C26-H), 1.44-1.37 (m, 1 H, C14-H), 1.20 (t, J = 7.2 Hz, 3 
H, C20-H); 13C NMR (500 MHz) δ 171.2 (C17), 168.7 (C22), 150.2 (C24), 136.8 (C13), 
134.7 (C2), 128.6 (C8), 124.7 (C10 or C11 ),  123.0 (C10 or C11), 118.6 (C7), 118.3 
(C12), 115.5 (C9), 84.5 (C25), 74.2 (C23), 62.5 (C21), 54.4 (C3), 40.2 (C18 or C19), 





























(3R*, 15R*, 2R*)-2-(2-Ethoxycarbonyl-3-ethyl-4-oxo-1,3,4,6,7,12b-hexa 
hydro-2H-indolo [2,3-α]quinolizine-12-carboxylic acid tert-butyl ester (2.42) (mp2-
054, mp2-058). A solution of sodium hexamethyldisilazide in THF (0.25 mL, 2.0 M, 
0.50 mmol) was added dropwise over 7 min to a solution of 2.32 (130 mg, 0.252 mmol) 
in a mixture of degassed THF (2.3 mL) and toluene (1.0 mL) at -78 °C.  The reaction 
stirred at -78 °C for 1 h, whereupon freshly distilled ethyl iodide (156 mg, 80 μL, 1.00 
mmol) was added dropwise.  The reaction was stirred at -78 °C for 4 h, whereupon EtOH 
(0.1 mL) and a saturated aqueous solution of NH4Cl (1 mL) were added. The cooling 
bath was removed, the mixture was allowed to warm to room temperature, and the slurry 
was poured into a separatory funnel containing 0.5 M HCl (10 mL). The resulting 
aqueous mixture was extracted with EtOAc (3 x 10 mL), and the combined organic layers 
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were dried (Na2SO4) and concentrated under reduced pressure.  The residue was purified 
by flash chromatography eluting with pentane/acetone (2:1) to give a crude oil that was 
dissolved in EtOH (1.5 mL).  Raney Ni (200 mg as a slurry in water) was added, and the 
reaction was stirred at room temperature for 3 h, whereupon EtOH (3 mL) was added.  
The reaction was dried (Na2SO4), filtered through celite, and the solids were washed with 
EtOAc (10 mL). The volatiles were removed under reduced pressure, and the resulting 
residue was purified by flash chromatography eluting with hexanes/EtOAc (1:1) to give 
16 mg (20%, dr > 95:5) of 2.42 as a colorless oil:  1NMR (500 MHz, CDCl3 δ 8.05 (d, J 
= 7.9 Hz, 1 H), 7.43-7.40 (m, 1 H), 7.30-7.26 (m, 1 H), 7.25-7.20 (m, 1 H), 5.12-5.07 
(comp, 2 H), 4.14-4.07 (comp, 2 H), 2.84-2.74 (m, 1 H), 2.73-2.68 (comp, 2 H),  2.66-
2.61 (m, 1 H) 2.50 (dd, J = 15.4, 3.8 Hz, 1 H), 2.42-2.31 (m, 1 H), 2.22-1.06 (comp, 3 H), 
1.80-1.59 (comp, 2 H), 1.68 (s, 9 H), 1.24 (t, J = 7.2 Hz, 3 H), 0.93 (t, J = 7.5 Hz, 3 H); 
IR (neat) 2966, 2922, 1732, 1644, 1458, 1414, 1370, 1310, 1157, 751 cm-1; mass 
spectrum (CI) m/z 455.2537 [C26H35N2O5 (M+1) requires 455.2546], 354, 399, 455 
(base), 483.   
NMR Assignments. 1NMR (500 MHz, CDCl3 δ 8.05 (d, J = 7.9 Hz, 1 H, C9-H 
or C12-H), 7.43-7.40 (m, 1 H, C9-H, C12-H), 7.30-7.26 (m, 1 H, C10-H, C11-H), 7.25-
7.20 (m, 1 H, C10-H, C11-H), 5.12-5.07 (comp, 2 H, C3-H, C6-H), 4.14-4.07 (comp, 2 
H, C22-H), 2.84-2.74 (m, 1 H, C6-H), 2.73-2.68 (comp, 2 H, C5-H),  2.66-2.61 (m, 1 H, 
C16-H) 2.50 (dd, J = 15.4, 3.8 Hz, 1 H, C16-H), 2.42-2.31 (m, 1 H, C14-H), 2.22-1.06 
(comp, 3 H, C15-H, C19-H, C20-H), 1.80-1.59 (comp, 2 H, C14-H, C19-H), 1.68 (s, 9 










3-Hydroxy-2,2-dimethylcyclopentanone (4.17) (mp2-216). A solution of 
sucrose (10 g) in water (130 mL) was warmed to 35 ˚C and Baker’s yeast (7 g) was 
added.  The mixture was vigorously stirred at 35 ˚C for 15 min, whereupon a solution of 
4.16 (650 mg, 5.16 mmol) in water (20 mL) was added. The temperature was reduced to 
30 ˚C, and the reaction was stirred overnight. Sucrose (10 g) was added, and the reaction 
was stirred overnight, whereupon another portion of sucrose (10 g) was added.  The 
mixture was stirred over night whereupon it was filtered through celite and the solids 
were washed with water (50 mL).  The filtrate was saturated with NaCl, extracted with 
ether (5 x 200 mL) and the combined organic layers were dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
eluting with EtOAc/hexanes (2:1) to give 431 mg (65%) of 4.17 as a clear colorless 














222). TBSCl (2.36 g, 15.7 mmol) was added to a solution of imidazole (2.00 g, 29.5 
mmol) and 4.17 (1.18 g, 9.21 mmol) in DMF (18 mL).  The solution was stirred at room 
temperature overnight, whereupon it was poured into a separatory funnel containing 
saturated aqueous NH4Cl (40 mL) and water (40 mL). The mixture was extracted with 
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Et2O (3 x 40 mL). The combined organic layers were dried (Na2SO4) and concentrated 
under reduced pressure, and the residue was purified by flash chromatography eluting 
with 5% → 10% → 20% Et2O in pentane to give 1.94 g (87%) of 4.18 as a clear 





















cyclopent-1-enyl ester (4.19) (mp2-226). A solution of sodium hexamethyldisilazide 
(1.24 mmol) in THF (0.620 mL) was added to a solution of 4.18 (200 mg, 0.825 mmol) in 
THF (8.5 mL) at 0 ˚C. The reaction was stirred at 0 ˚C for 1 h, whereupon a solution of 
N-phenyltriflamide (340 mg, 0.908 mmol) in THF (2.5 mL) was added.  The reaction was 
stirred at 0 ˚C for 1 h, whereupon a saturated aqueous NaHCO3 (10 mL) was added. The 
mixture was poured into a separatory funnel containing Et2O (30 mL).  The layers were 
separated, and the organic layer was washed with a saturated aqueous NaHCO3 (15 mL), 
50% saturated aqueous NaCl (15 mL), brine (15 mL), dried (Na2SO4) and concentrated 
under reduced pressure. The residue was purified by flash chromatography eluting with 
1% ether in pentane to give 286 mg (93%) of 4.19 as a clear colorless liquid. 1NMR (500 
MHz) 5.41 (dd, J = 3.1, 2.2 Hz, 1 H), 3.98 (dd, J = 7.2, 6.7 Hz 1 H) 2.52 (ddd, J = 15.5, 
7.2, 3.1 Hz, 1 H), 2.19 (ddd, J = 15.5, 6.7, 2.2 Hz, 1 H)  1.06 (s, 3 H), 1.00 (s, 3 H), 0.88 
(s, 9H), 0.05 (s, 3 H), 0.04 (s, 3 H); 13C NMR (125 MHz) δ 154.0, 109.9, 78.1, 46.3, 
35.6, 25.7, 23.6, 18.4, 18.0, -4.6, -4.9; IR (neat) 2957, 2930, 2858, 1651, 1464, 1420, 
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1249, 1218, 1142, 1064, 838, 601 cm-1; mass spectrum (CI) m/z 375.1269 
[C14H26O4SSiF3 (M+1) requires 375.1273], 225, 243, 375 (base).  
NMR Assignments. 1NMR (500 MHz) 5.41 (dd, J = 3.1, 2.2 Hz, 1 H, C7-H), 
3.98 (dd, J = 7.2, 6.7 Hz, 1 H, C5-H) 2.52 (ddd, J = 15.5, 7.2, 3.1 Hz, 1 H, C6-H), 2.19 
(ddd, J = 15.5, 6.7, 2.2 Hz, 1 H, C6-H)  1.06 (s, 3 H, C4-H or C3-H), 1.00 (s, 3 H, C4-H 
or C3-H), 0.88 (s, 9 H, C11-H), 0.05 (s, 3 H, C9-H or C8-H), 0.04 (s, 3 H, C9-H or C8-
H); 13C NMR (125 MHz) δ 154.0 (C1), 109.9 (C12 and C7), 78.1 (C5), 46.3 (C2), 35.6 
(C6), 25.7 (C11), 23.6 (C4 or C3), 18.4 (C4 or C3), 18.0 (C10), -4.6 (C9 or C8), -4.9 (C9 






















triisopropylphenyl)hydrazine (4.25) (mp2-245). Trisyl hydrazide (370 mg, 1.237 
mmol) was added to a solution of 4.19 (200 mg, 0.825 mmol) in CH2Cl2 (5 mL) and the 
mixture was stirred at room temperature overnight.  The solvent was evaporated under 
reduced pressure, and the residue was purified by flash chromatography eluting with 5% 
→ 10% EtOAc in hexanes to give 405 mg (94%) of 4.19 as a white solid; mp 145-147 
°C; 1NMR (400 MHz) 7.12 (s, 1 H), 6.94 (s, 1 H, NH), 4.17 (h, J = 6.8 Hz, 2 H) 3.69 
(app t, J = 5.3 Hz, 1 H), 2.87 (h, J = 6.8 Hz, 1 H), 2.26 (ddd, J = 17.8, 9.2, 5.7 Hz, 1 H), 
2.10 (ddd, J = 17.8, 9.2, 6.2 Hz, 1 H) 2.00-1.92 (m, 1 H), 1.72-1.64 (m, 1 H), 1.26-1.21 
(comp, 18 H), 0.91 (s, 3 H), 0.81 (s, 3 H), 0.79 (s, 9 H) -0.02 (s, 3 H), -0.03 (s, 3 H); IR 
(neat) 3228, 2959, 2860, 1600, 1462, 1383, 1256, 1165, 1030, 837, 775 cm-1; mass 
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spectrum (CI) m/z 523.3390 [C28H51N2O3SiS (M+1) requires 523.3390], 521, 523 
(base).  
NMR Assignments. 1NMR (400 MHz) 7.12 (s, 1 H, C19-H), 6.94 (s, 1 H, NH), 
4.17 (h, J = 6.8 Hz, 2 H, C18-H) 3.69 (app t, J = 5.3 Hz, 1 H, C5-H), 2.87 (h, J = 6.8 Hz, 
1 H, C16-H), 2.26 (ddd, J = 17.8, 9.2, 5.7 Hz, 1 H, C7-H), 2.10 (ddd, J = 17.8, 9.2, 6.2 
Hz, 1 H, C7-H), 2.00-1.92 (m, 1 H, C6-H), 1.72-1.64 (m, 1 H), 1.26-1.21 (comp, 18 H, 
C19-H, C17-H), 0.91 (s, 3 H or C4-H or C3-H), 0.81 (s, 3 H, C4-H or C3-H), 0.79 (s, 9 
















(4.26) (mp-234). n-BuLi (0.52 mmol) in hexanes (0.22 mL) was added to a solution of 
4.25 (100 mg, 0.191 mmol) in hexanes (6.7 mL) containing N,N,N’,N’-
tetramethylethylenediamine (TMEDA) (0.87 mL) cooled to –78 °C.  The reaction was 
stirred at –78 °C for 25 min, whereupon the cooling bath was replaced with an ice/water 
bath and stirring continued for 25 min.  The reaction was recooled to –78 °C, and a 
solution of dimethylformamide (42 mg, 44 μL, 0.57 mmol) in TMEDA (0.9 mL) was 
added. The mixture was stirred at –78 °C for 30 min, whereupon the cold bath was 
removed and stirring continued 1.5 h at room temperature.  A 10% solution of phosphoric 
acid (3 mL) was added, and the mixture was poured into a separatory funnel containing 
Et2O (30 mL) and 10% phosphoric acid (20 mL). The layers were separated, and the 
organic layer was washed with brine (20 mL), dried (Na2SO4) and concentrated under 
reduced pressure. The residue was purified by flash chromatography eluting with 5% 
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ether in pentane to give 32 mg (67%) of 4.26 as a clear colorless oil: 1NMR (500 MHz, 
CDCl3) δ 9.63 (s, 1 H), 6.61 (dd, J = 3.1, 2.4 Hz, 1 H), 3.98 (app t, J = 6.8 Hz, 1 H), 2.68 
(ddd, J = 18.5, 6.8, 3.1 Hz, 1 H), 2.34 (ddd, J = 18.5, 6.8, 2.4 Hz, 1 H), 1.19 (s, 3 H),  
1.06 (s, 3 H), 0.88 (s, 9 H), 0.05 (s, 3 H) 0.04 (s, 3 H); 13C NMR (125 MHz) δ 190.5, 
152.6, 149.4, 110.0, 47.0, 40.0, 26.0, 25.0, 19.4, -4.3, -4.7. IR (neat) 2955, 2858, 1687, 
1256, 1148, 1124, 883, 837, 776 cm-1; mass spectrum (CI) m/z 255.1782 [C14H27O2Si 
(M+1) requires 255.1780], 198, (base), 219, 255, 289.  
NMR Assignments. 1NMR (500 MHz) δ 9.63 (s, 1 H, C12-H), 6.61 (dd, J = 3.1, 
2.4 Hz, 1 H, C7-H), 3.98 (app t, J = 6.8 Hz, 1 H, C5-H), 2.68 (ddd, J = 18.5, 6.8, 3.1 Hz, 
1 H, C6-H), 2.34 (ddd, J = 18.5, 6.8, 2.4 Hz, 1 H, C6-H), 1.19 (s, 3 H, C3-H or C4-H),  
1.06 (s, 3 H, C3-H or C4-H), 0.88 (s, 9 H, C11-H), 0.05 (s, 3 H, C9-H or C8-H) 0.04 (s, 3 
H, C9-H or C8-H); 13C NMR (125 MHz) δ 190.5 (C12), 152.6 (C1), 149.4 (C7), 110.0 
(C5), 47.0 (C2), 40.0 (C6), 26.0 (C11), 25.0 (C4 and C3), 19.4 (C10), -4.3 (C9 or C8), -






















phenylmethanol (4.28) (mp2-267). A solution of n-BuLi in hexanes (1.04 mL, 2.37 M, 
2.49 mmol) was added to a solution of 4.25 (520 mg, 1.00 mmol) in THF (10 mL) cooled 
to –78 °C.  The reaction was stirred at –78 °C for 30 min, whereupon the cooling bath 
was replaced with an ice/water bath, and stirring was continued for 10 min.  The reaction 
was recooled to –78 °C, and a solution of o-azidobenzaldehyde (439 mg, 2.98 mmol) in 
THF (7.8 mL + 2.6 mL rinse) was added. The mixture was stirred at –78 °C for 20 min, 
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whereupon the cold bath was removed, and stirring was continued for 1 h at room 
temperature.  Saturated aqueous NH4Cl (10 mL) was added, and the mixture was poured 
into a separatory funnel containing Et2O (50 mL) and water (5 mL). The layers were 
separated, and the aqueous layer was extracted with Et2O (50 mL). The combined 
organic extracts were washed with brine (30 mL), dried (Na2SO4), and concentrated 
under reduced pressure. The residue was purified by flash chromatography eluting with 
EtOAc/hexanes (1:5) to give 287 mg (77%) of 4.28 as a pale yellow oil: 1NMR (500 
MHz, mixture of diastereomers) δ 7.45-7.41 (comp, 1 H), 7.32-7.28 (comp, 1 H), 7.14-
7.10 (comp, 2 H), 5.44-5.40 (m, 1 H), 5.37-5.35 (m, 0.44 H), 5.28-5.26 (m, 0.56 H), 3.91 
(app t, J = 6.9 Hz, 0.44 H), 3.86 (app t, J = 7.3 Hz, 0.56 H),  2.42-2.32 (comp, 1 H), 2.15-
2.08 (comp, 1 H), 2.06-2.00 (comp, 1 H), 1.10 (s, 1.32 H), 1.04 (s, 1.68 H), 0.88-0.86 
(comp, 12 H), 0.72 (s, 1.32 H), 0.03-0.01 (comp, 6 H); 13C NMR (125 MHz, mixture of 
diastereomers) δ 151.8, 151.7, 137.1, 137.0, 133.94, 133.87, 128.9, 128.83, 128.80, 
128.7, 128.5, 124.8, 123.0, 122.7, 118.1, 118.0, 81.5, 84.4, 66.9, 66.7, 48.0, 47.8, 37.9, 
37.8, 25.82, 25.79, 25.3, 24.6, 20.15, 19.59, 18.08, 18.05, -4.46, -4.48, -4.93, -4.95. 
NMR Assignments. 1NMR (500 MHz, mixture of diastereomers) δ 7.45-7.41 
(comp, 1 H, Ar-H), 7.32-7.28 (comp, 1 H, Ar-H), 7.14-7.10 (comp, 2 H, Ar-H), 5.44-5.40 
(m, 1 H, C12-H), 5.37-5.35 (m, 0.44 H, C7-H), 5.28-5.26 (m, 0.56 H, C7-H), 3.91 (app t, 
J = 6.9 Hz, 0.44 H, C5-H), 3.86 (app t, J = 7.3 Hz, 0.56 H, C5-H),  2.42-2.32 (comp, 1 H, 
C6-H), 2.15-2.08 (comp, 1 H, C6-H), 2.06-2.00 (comp, 1 H, OH), 1.10 (s, 1.32 H, C3-H 
or C4-H), 1.04 (s, 1.68 H, C3-H or C4-H), 0.88-0.86 (comp, 12 H, C11-H, C3-H or C4-
H), 0.72 (s, 1.32 H, C3-H or C4-H), 0.03-0.01 (comp, 6 H, C8-H, C9-H); 13C NMR (125 
MHz, mixture of diastereomers) δ 151.8 (C1), 151.7 (C1), 137.1 (Ar-C), 137.0 (Ar-C), 
133.94 (Ar-C), 133.87 (Ar-C), 128.9 (Ar-C), 128.83 (Ar-C), 128.80 (Ar-C), 128.7 (Ar-
C), 128.5 (Ar-C), 124.8 (Ar-C), 123.0 (C7), 122.7 (C7), 118.1 (Ar-C), 118.0 (Ar-C), 81.5 
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(C5), 84.4 (C5), 66.9 (C12), 66.7 (C12), 48.0 (C2), 47.8 (C2), 37.9 (C6), 37.8 (C6), 25.82 
(C11), 25.79 (C11), 25.3 (C4 or C3), 24.6 (C4 or C3), 20.15 (C4 or C3), 19.59 (C4 or 
C3), 18.08 (C10), 18.05 (C10), -4.46 (C9 or C8), -4.48 (C9 or C8), -4.93 (C9 or C8), -
























hydroxymethyl}-phenyl)-carbamic acid tert-butyl ester (4.9) (mp2-268 and mp2-269) 
Tributyl phosphine (0.59 mL, 2.35 mmol) was added to a solution of 4.28 (293 mg, 0.78 
mmol) in H2O (0.21 mL) and THF (8 mL). The mixture was stirred at room temperature 
for 1 h, whereupon it was poured into CH2Cl2 (50 mL) and washed with a saturated 
aqueous solution of NaHCO3 (50 mL) and H2O (50 mL). The organic layer was dried 
(Na2SO4) and concentrated under reduced pressure. The residue was dissolved in THF (8 
mL) and DMAP (10 mg, 0.08 mmol) and Boc2O (0.5 mL, 2.35 mmol) were added. The 
reaction was stirred at room temperature for 2 h, whereupon it was poured into a 
separatory funnel containing Et2O (50 mL) and 0.5 M HCl (50 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (50 mL). The combined organic 
extracts were, dried (Na2SO4), and concentrated under reduced pressure. The residue was 
purified by flash chromatography eluting with 10% → 20% Et2O in hexanes to give 168 
mg (48%) of 4.9 as a pale yellow oil: 1NMR (500 MHz, mixture of diastereomers) δ 
7.61-7.59 (m, 0.55 H), 7.55-7.52 (m, 0.45 H), 7.37-7.32 (comp, 1 H), 7.20-7.13 (comp, 
1.45 H), 7.11-7.09 (m, 0.55 H), 5.64 (d, J = 1.7 Hz, 0.55 H), 5.63 (s, 0.46 H), 5.22-5.20 
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(m, 0.45 H), 5.11 (app pent, J = 1.7 Hz, 0.55 H), 3.94 (app t, J = 6.2 Hz, 0.45 H), 3.89 
(dd, J = 8.0, 7.1 Hz, 0.55 H),   2.42-2.36 (m, 0.45 H), 2.31-2.25 (m, 0.55 H), 2.11-2.03 
(m, 1 H), 1.53 (s, 9 H), 1.73 (s, 3 H), 1.08 (s, 1.65 H), 1.01 (s, 1.35 H), 0.88 (s, 4.95 H), 
0.87 (s, 4.05 H), 0.04 (s, 4.05 H), 0.01 (s, 4.95 H); 13C NMR (125 MHz, mixture of 
diastereomers) δ 150.1, 150.0, 149.9, 149.8, 146.6, 145.9, 135.04, 135.01, 128.7, 128.6, 
128.1, 128.0, 125.3, 125.2, 125.14, 125.10, 121.8, 121.6, 84.30, 84.29, 81.4, 76.3, 76.2, 
48.7, 47.7, 38.4, 37.6, 27.8, 25.8, 24.1, 19.9, 19.4, 18.1, 18.0, -4.49, -4.56, -4.93; IR 
(neat) 2931, 2857, 1742, 1463, 1369, 1301, 1154 cm-1; mass spectrum (CI) m/z 446.2725 
[C25H40O4Si (M-1) requires 446.2727], 372, 429 (base), 446.  
NMR Assignments. 1NMR (500 MHz, mixture of diastereomers) δ 7.61-7.59 (m, 
0.55 H, Ar-H), 7.55-7.52 (m, 0.45 H, Ar-H), 7.37-7.32 (comp, 1 H, Ar-H), 7.20-7.13 
(comp, 1.45 H, Ar-H), 7.11-7.09 (m, 0.55 H, Ar-H), 5.64 (d, J = 1.7 Hz, 0.55 H, C12-H), 
5.63 (s, 0.46 H, C12-H), 5.22-5.20 (m, 0.45 H, C7-H), 5.11 (app pent, J = 1.7 Hz, 0.55 H, 
C7-H), 3.94 (app t, J = 6.2 Hz, 0.45 H, C5-H), 3.89 (dd, J = 8.0, 7.1 Hz, 0.55 H, C5-H),   
2.42-2.36 (m, 0.45 H, C6-H), 2.31-2.25 (m, 0.55 H, C6-H), 2.11-2.03 (m, 1 H, C6-H), 
1.53 (s, 9 H, C21-H), 1.73 (s, 3 H, C3-H or C4-H), 1.08 (s, 1.65 H, C3-H or C4-H), 1.01 
(s, 1.35 H, C3-H or C4-H), 0.88 (s, 4.95 H, C11-H), 0.87 (s, 4.05 H, C11-H), 0.04 (s, 
4.05 H, C8-H, C9-H), 0.01 (s, 4.95 H, C8-H, C9-H); 13C NMR (125 MHz, mixture of 
diastereomers) δ 150.1 (C1), 150.0 (C1), 149.9 (C19), 149.8 (C19), 146.6 (Ar-C), 145.9 
(Ar-C), 135.04 (Ar-C), 135.01 (Ar-C), 128.7 (Ar-C), 128.6 (Ar-C), 128.1 (C7), 128.0 
(C7), 125.3 (Ar-C), 125.2 (Ar-C), 125.14 (Ar-C), 125.10 (Ar-C), 121.8 (C17 or C14), 
121.6 (C17 or C14), 84.30 (C20), 84.29 (C20), 81.4 (C5), 76.3 (C12), 76.2 (C12), 48.7 
(C2), 47.7 (C2), 38.4 (C6), 37.6 (C6), 27.8 (C21), 25.8 (C11), 24.1 (C4 or C3), 19.9 (C4 
or C3), 19.4 (C4 or C3), 18.1 (C10), 18.0 (C10), -4.49 (C9 or C8), -4.56 (C9 or C8), -4.93 

























benzyl)-2,5-dioxo pyrrolidine-3-yl ester (4.38) (mp2-172). A flask equipped with a 
Dean-Stark trap was charged with L-tartaric acid (4.36) (2.50 g, 16.7 mmol) and 4-
methoxybenzyl alcohol (2.40 mL, 18.3 mmol) in xylenes (50 mL) was heated under 
reflux for 1 h. The mixture was allowed to cool to room temperature. The precipitate was 
filtered, and the solids were washed with xylenes (50 mL) and Et2O (30 mL).  The solid 
was dried under high vacuum, and 50% wt of the crude material was dissolved in 
pyridine (30 mL) and 4-dimethylamino pyridine (DMAP) (10 mg, 0.083 mmol) was 
added.  The mixture was cooled to 0 °C and pivaloyl chloride (5.97 g, 6.10 mL, 49.8 
mmol) was added dropwise.  The cooling bath was removed, and the reaction was stirred 
overnight, whereupon it was poured into 1 M HCl (100 mL) and EtOAc (200 mL). The 
layers were separated, and the organic layer was washed with 1 M HCl (4 x 50 mL), 
saturated aqueous NaHCO3 (75 mL) and brine (50 mL). The organic layer was dried 
(Na2SO4), and concentrated under reduced pressure, and the residue was purified by flash 
chromatography eluting with EtOAc/hexanes (1:9) to give 2.00 g (57%) of 4.38 as a clear 
colorless oil: 1NMR (500 MHz, CDCl3) δ 7.34-7.31 (m, 2 H), 6.85-6.82 (m, 2 H), 5.48 
(s, 2 H), 4.68 (d, J = 14.1 Hz, 1 H), 4.61 (d, J = 14.1 Hz, 1 H), 3.77 (s, 3 H), 1.23 (s, 18 
H); 13C NMR (125 MHz) δ 177.3, 169.3, 159.5, 130.5, 126.9, 114.1, 72.7, 55.3, 42.5, 
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38.8, 26.9; IR (CDCl3) 2977, 1729, 1514, 1340, 1250, 1154, 1127, 1034 cm-1; mass 
spectrum (CI) m/z 420.2022 [C22H30NO7 (M+1) requires 420.2022], 318, 336, 420, 
(base), 448.  
NMR Assignments. 1NMR (500 MHz) δ 7.34-7.31 (m, 2 H, C9-H), 6.85-6.82 
(m, 2 H, C10-H), 5.48 (s, 2 H, C3-H), 4.68 (d, J = 14.1 Hz, 1 H, C7-H), 4.61 (d, J = 14.1 
Hz, 1 H, C7-H), 3.77 (s, 3 H, C12-H), 1.23 (s, 18 H, C6-H); 13C NMR (125 MHz) δ 
177.3 (C4), 169.3 (C2), 159.5 (C8), 130.5 (C9), 126.9 (C11), 114.1 (C10), 72.7 (C3), 


















-3-yl ester (4.39) (mp2-174). A solution of ceric ammonium nitrate (4.45 g, 8.11 mmol) 
in H2O (40 mL) was added dropwise to a solution of 4.38 (1.62 g, 3.86 mmol) in CH3CN 
(40 mL).  The cooling bath was removed, and the reaction was stirred at room 
temperature for 3 h, whereupon brine (75 mL) and EtOAc (75 mL) were added.  The 
mixture was extracted with EtOAc (3 x 75 mL). The combined organic layers were 
washed with a saturated aqueous solution of NaHCO3 (75 mL) and brine (50 mL), dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with EtOAc/hexanes (6:1 → 4:1) to give 562 mg ( 49%) of 4.39 
as a white solid: mp 163-165 °C 1NMR (500 MHz, CDCl3) δ 8.33 (s, 1 H), 5.48 (s, 2 H), 
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1.24 (s, 18 H); 13C NMR (125 MHz) δ 177.5, 168.7, 73.4, 38.8, 26.9; IR (CDCl3) 3261, 
2975, 1810, 1745, 1218, 1156, 1130, cm-1; mass spectrum (CI) m/z 300.1436 
[C14H22NO6 (M+1) requires 300.1447], 198, 216, 300, (base), 328, 340.  
NMR Assignments. 1NMR (500 MHz) δ 8.33 (s, 1 H, NH), 5.48 (s, 2 H, C3-H), 
1.24 (s, 18 H, C6-H); 13C NMR (125 MHz) δ 177.5 (C4), 168.7 (C2), 73.4 (C3), 38.8 



















dioxopyrrolidin-3-yl ester (4.40) (mp2-203). Sulfuric acid (conc.) (28 μL, 0.50 mmol) 
was added to a solution of 4.39 (200 mg, 0.668 mmol) in CH3CO2H (2 mL) and H2O 
(0.4 mL) followed by NaBrO3 (100 mg, 0.663 mmol) and NaBr (69 mg, 0.448 mmol). 
The reaction was stirred at room temperature for 30 min, whereupon a white precipitate 
formed.  The mixture was diluted with water (2 mL) and filtered.  The solid was rinsed 
with water (2 mL) and dried under high vacuum to afford 226 mg (79%) of 4.40 as a 
white solid: mp 151-153 °C; 1NMR (500 MHz, CDCl3) δ 5.73 (s, 2 H), 1.24 (s, 18 H); 
13C NMR (125 MHz) δ 177.3, 166.6, 72.9, 38.8, 26.8; IR (CH2Cl2) 2978, 1750, 1480, 
1273, 1121, 763, 716 cm-1; mass spectrum (CI) m/z 300.1436 [C14H22NO6 (M+1) 
requires 300.1447], 198, 216, 300, (base), 328, 340.  
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NMR Assignments. 1NMR (500 MHz) δ 5.73 (s, 2 H, C3-H), 1.24 (s, 18 H, C6-


















3-Oxo-1,2,3,4-tetrahydrocarbazole-9-carboxylic acid tert-butyl ester (4.46) 
(mp2-182). DMAP (4 mg, 0.032 mmol) and di-tert-butyl dicarbonate (279 mg, 0.27 mL, 
1.30 mmol) was added to a solution of 4.45 (60 mg, 0.324 mmol) in CH2Cl2 (5 mL).  The 
mixture was stirred at room temperature for 3 h, whereupon a saturated NH4Cl (5 mL) 
and H2O (10 mL) were added.  The mixture was extracted with EtOAc (3 x 10 mL), and 
the combined organic fractions were washed with brine (10 mL), dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
eluting with EtOAc/hexanes (2:1) to give 88 mg ( 95%) of 4.46 as a white solid: mp 89-
91 °C; 1NMR (500 MHz, CDCl3) δ 8.11-8.09 (m, 1 H), 7.34-7.32 (m, 1 H), 7.30-7.27 (m, 
1 H), 7.24-7.21 (m, 1 H), 3.52 (t, J = 1.6 Hz, 2 H), 3.47 (tt, J = 6.8 Hz, 1.6, 1 H), 2.77 (t, 
J = 6.8 Hz, 2 H), 1.66 (s, 9 H) 13C NMR (125 MHz) δ 208.4, 150.4, 136.4, 133.5, 128.4, 
124.3, 122.9, 117.5, 115.7, 114.0, 84.1, 39.0, 36.1, 28.3, 25.2; IR (neat) 2976, 1724, 
1456, 1359, 1138, 746 cm-1; 285.1368 [C17H19NO3 (M+) requires 285, 1365], 186, 231, 
286 (base), 331.   
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 8.11-8.09 (m, 1 H, C9-H or 
C12-H), 7.34-7.32 (m, 1 H, C9-H or C12-H) 7.30-7.27 (m, 1 H, C10-H or C11-H) 7.24-
7.21 (m, 1 H, C10-H or C11-H), 3.52 (t, J = 1.6 Hz, 2 H, C6-H), 3.47 (tt, J = 6.8 Hz, 1.6, 
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1 H, C4-H), 2.77 (t, J = 6.8 Hz, 2 H, C3-H), 1.66 (s, 9 H, C16-H) 13C NMR (125 MHz) δ 
208.4 (C5), 150.4 (C14), 136.4 (C13), 133.5 (C2), 128.4 (C8), 124.3 (C10 or C11), 122.9 
(C10 or C11), 117.5 (C9 or C12), 115.7 (C9 or C12), 114.0 (C7), 84.1 (C15), 39.0 (C3), 




















1’-Benzoyl-1H-spiro[indole-3,3’-pyrrolidin]-2-one (4.52) (mp2-206). N-
Bromosuccinimide (18 mg, 0.11 mmol) was added to a solution of 4.51 (27 mg, 0.098 
mmol) in a mixture of THF (0.75 mL), CH3CO2H (0.75 mL) and water (0.75 mL) at 0 
˚C. The reaction was stirred at 0 ˚C for 1 h, and the cold bath was removed. Stirring 
continued for 15 min, whereupon Na2SO3 (90 mg) was added followed by saturated 
aqueous Na2CO3 (5 mL) and water (2 mL). The mixture was extracted with CH2Cl2 (3 x 
5 mL), and the combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure. The residue was purified by flash chromatography eluting with 
EtOAc/hexanes (4:1) to give 25.5 mg (89%) of 4.52 as a foam. 1H NMR (400 MHz, 
CDCl3, rotamers) δ 8.78 (br s, 0.6 H), δ 8.73 (br s, 0.4 H), 7.61 (br s, 0.6 H), 7.52-7.48 
(comp, 1.4 H) 7.47-7.29 (comp, 3 H), 7.26-7.00 (comp, 3 H), 6.94-6.87 (m, 1 H), 4.19-
3.88 (comp, 3 H, C6-H), 3.83-3.75 (m, 0.4 H), 3.56 (d, J = 10.6 Hz, 0.6 H), 2.59-2.51 (m, 
0.6 H), 2.42-2.32 (m, 0.4 H), 2.19-2.12 (m, 1 H). 
NMR Assignments. 1H NMR (400 MHz, CDCl3, rotamers) δ 8.78 (br s, 0.6 H, 
NH), δ 8.73 (br s, 0.4 H, NH), 7.61 (br s, 0.6 H, Ar-H), 7.52-7.48 (comp, 1.4 H, Ar-H) 
7.47-7.29 (comp, 3 H, Ar-H), 7.26-7.00 (comp, 3 H, Ar-H), 6.94-6.87 (m, 1 H, Ar-H), 
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4.19-3.88 (comp, 3 H, C6-H, C4-H), 3.83-3.75 (m, 0.4 H, C4-H), 3.56 (d, J = 10.6 Hz, 





















1’-Benzoyl-1H-spiro[indole-3,3’-pyrrolidin]-2-one (60) (mp2-207). Chiral 
succinamide 4.40 (41 mg, 0.11 mmol) was added to a solution of 4.51 (27 mg, 0.098 
mmol) in a mixture of THF (0.75 mL), CH3CO2H (0.75 mL) and water (0.75 mL) at 0 
˚C. The reaction was stirred at 0 ˚C for 1 h, and the cold bath was removed. Stirring 
continued for 15 min, whereupon Na2SO3 (90 mg) was added followed by saturated 
aqueous Na2CO3 (5 mL) and water (2 mL).  The mixture was extracted with CH2Cl2 (3 x 
5 mL), and the combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure. The residue was purified by flash chromatography eluting with 
EtOAc/hexanes (4:1) to give 28 mg (94%) of 4.52 as a foam. The 1H NMR spectrum was 


















Indole 4.56 (mp2-293) NaH (60% dispersion in mineral oil, 83 mg, 2.1 mmol) 
was added to a solution of 4.44 (160 mg, 0.70 mmol) in DMF (7 mL) cooled to 0 °C. The 
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mixture was stirred for 5 min at 0 °C, whereupon acetyl chloride (220 mg, 0.20 mL, 2.8 
mmol) was added. The ice bath was removed and the reaction was stirred 1 h where upon 
saturated aqueous NH4Cl (2.0 mL) was added. The mixture was poured into a separatory 
funnel containing water (40 mL), and was extracted with EtOAc (3 x 30 mL). The 
combined organic extracts were dried (Na2SO4) and concentrated under reduced 
pressure, and the residue was purified by flash chromatography eluting with 
EtOAc/hexanes (1:2) to give 97 mg (36%) of 4.56 as a clear colorless oil: 1H NMR (500 
MHz, CDCl3) δ 7.99-7.96 (m, 1 H, C9-H or C12-H), 7.35-7.33 (m, 1 H, C9-H or C12-H) 
7.26-7.19 (comp, 2 H, C10-H, C11-H), 4.07-4.01 (comp, 4 H, C16-H, C17-H), 3.21 (tt, J 
= 6.5, 1.8 Hz, 2 H, C3-H), 2.81 (m, 2 H, C6-H), 2.67 (s, 3 H, C15-H), 2.04 (t, J = 6.5 Hz, 
2 H, C4-H), 13C NMR (125 MHz) δ 169.7, 136.4, 133.9, 129.8, 124.1, 123.0, 117.7, 
116.3, 115.3, 107.9, 64.7, 32.1, 31.9, 37.1, 24.9; IR (neat) 2884, 1697, 1454, 1389, 1312, 
1106, 1061, 748 cm-1; mass spectrum (CI) m/z 272.1288 [C16H18NO3 (M+1) requires 
272.1287], 159 (base), 201, 259, 272.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.99-7.96 (m, 1 H, C9-H or 
C12-H), 7.35-7.33 (m, 1 H, C9-H or C12-H) 7.26-7.19 (comp, 2 H, C10-H, C11-H), 
4.07-4.01 (comp, 4 H, C16-H, C17-H), 3.21 (tt, J = 6.5, 1.8 Hz, 2 H, C3-H), 2.81 (m, 2 
H, C6-H), 2.67 (s, 3 H, C15-H), 2.04 (t, J = 6.5 Hz, 2 H, C4-H), 13C NMR (125 MHz) δ 
169.7 (C14), 136.4 (C2 or C8 or C13 ), 133.9 (C2 or C8 or C13), 129.8 (C2 or C8 or 
C13), 124.1 (C10 or C11), 123.0 (C10 or C11), 117.7 (C9 or C12), 116.3 (C5), 115.3 (C9 























Spirooxindole 4.57 (mp2-298) A solution of DMDO in acetone (2.9 mL, 0.08 M, 
0.23 mmol) was added to a solution of 4.56 (48 mg, 0.18 mmol) in CH2Cl2 (2.3 mL) at –
78 ˚C. The reaction was stirred at –78 ˚C for 30 min, whereupon the cold bath was 
removed and the reaction was concentrated under reduced pressure. 1H NMR of the 
crude reaction mixture indicated that 60% starting material still remained. The crude 
material was re-dissolved in CH2Cl2 (2.3 mL), cooled to –78 ˚C, and a solution of 
DMDO in acetone (4.4 mL, 0.08 M, 0.35 mmol) was added. The mixture was stirred for 
30 min at –78 ˚C, whereupon the cold bath was removed and the reaction was 
concentrated under reduced pressure. The residue was purified by flash chromatography 
eluting with EtOAc/hexanes (1:2 → 1:1) to give 35 mg (69%) of 4.57 as a clear colorless 
oil: 1H NMR (500 MHz, CDCl3) δ 8.19-8.16 (m, 1 H), 7.50-7.47 (m, 1 H), 7.28-7.25 (m, 
1 H), 7.21-7.17 (dt, J = 7.6, 1.2 Hz, 1 H), 4.04-3.95 (comp, 4 H), 2.66 (s, 3 H), 2.53 (d, J 
= 13.4 Hz, 1 H), 2.34-2.23 (comp, 2 H), 1.13-1.99 (comp, 3 H); 13C NMR (125 MHz) δ 
182.3, 171.0, 138.9, 134.7, 128.1, 125.6, 123.0, 117.7, 116.2, 65.0, 64.4, 51.7, 46.9, 37.8, 
36.2, 26.6; IR (neat) 2943, 1750, 1710, 1465, 1372, 1343, 1275, 1014, 760 cm-1; mass 
spectrum (CI) m/z 288.1237 [C16H18NO4 (M+1) requires 288.1236], 217, 245, 259, 288 
(base).  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 8.19-8.16 (m, 1 H, C12-H), 
7.50-7.47 (m, 1 H, C9-H), 7.28-7.25 (m, 1 H, C10-H), 7.21-7.17 (dt, J = 7.6, 1.2 Hz, 1 H, 
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C11-H), 4.04-3.95 (comp, 4 H, C16-H, C17-H), 2.66 (s, 3 H, C15-H), 2.53 (d, J = 13.4 
Hz, 1 H, C7-H), 2.34-2.23 (comp, 2 H, C4-H, C5-H), 1.13-1.99 (comp, 3 H, C4-H, C5-H 
C7-H); 13C NMR (125 MHz) δ 182.3 (C2), 171.0 (C14 ), 138.9 (C8 or C13), 134.7 (C8 
or C13), 128.1 (C10), 125.6 (C11), 123.0 (C9), 117.7 (C6), 116.2 (C12), 65.0 (C16 or 























Spirooxindole 4.57 (mp2-301). A mixture of oxone (544 mg, 0.89 mmol) and 
NaHCO3 (230 mg, 2.74 mmol) were added in small portions over 50 min to a solution of 
4.56 (48 mg, 0.18 mmol), Bu4NOH (5 mg, 0.01 mmol) in CH3CN (2.7 mL) and 1 x 10-4 
M EDTA (1.8 mL) at 0 °C. Simultaneously, D-epoxone (137 mg, 0.53 mmol) was added 
in small portions to the reaction mixture over 1 h, whereupon H2O (8 mL) was added. 
The mixture was extracted with EtOAc (3 x 10 mL), and the combined organic extracts 
were dried (Na2SO4) and concentrated under reduced pressure. The residue was purified 
by flash chromatography eluting with EtOAc / hexanes (1:2 → 1:1) to give 42 mg (87%) 
4.56 and 4 mg (7%) of 4.57 as a clear colorless oil: The 1H NMR spectrum was 



















Indole 4.65 (mp3-155). Phenyl hydrazine (1.04 g, 1.03 mL, 9.61 mmol) was 
added to a solution of 4.64 (1.61 g, 8.74 mmol) in MeOH (44 mL). The mixture was 
stirred at room temperature for 40 min, whereupon it was concentration under reduced 
pressure and the residue was dissolved in EtOAc (100 mL) and washed with H2O (100 
mL). The organic layer was dried (Na2SO4) and concentrated under reduced pressure. 
The residue was co-evaporated with toluene (3 x 30 mL) and dissolved in toluene (55mL) 
and transferred via cannula to a flask containing freshly fused and powdered ZnCl2 (2.38 
g, 17.5 mmol). The mixture was heated to reflux for 4 h, whereupon it was allowed to 
cool to room temperature and was poured into a separatory funnel containing aqueous 
saturated NaHCO3 (150 ml). The mixture was extracted with EtOAc (3 x 100 mL) and 
the combined organic extracts were dried (Na2SO4) and concentrated under reduced 
pressure. The residue was purified by flash chromatography eluting with Et2O/pentane 
(3:7) to give 1.06 g (47% over two steps) of 4.65 as a pale yellow solid: 1H NMR (500 
MHz, CDCl3) δ 7.68 (br s, 1H), 7.43 (d, J = 7.6 Hz, 1 H), 7.27-7.25 (m, 1 H) 7.11-7.08 
(m, 1 H), 7.06-7.03 (m, 1 H), 4.09-3.99 (comp, 4 H), 2.82 (t, J = 6.4 Hz, 2 H), 2.04 (t, J = 
6.4 Hz, 2 H), 1.37 (s, 6 H); 13C NMR (125 MHz) δ 140.5, 136.3, 127.3, 121.2, 119.2, 
118.2, 112.4, 110.5, 107.3, 65.3, 40.6, 27.8, 23.9, 18.6; IR (neat) 3414, 2967, 2884, 1460, 
1297, 1126, 1096, 743 cm-1; mass spectrum (CI) m/z 258.1495 [C16H20NO2 (M+1) 
requires 258.1494], 171, 196, 257, 258 (base).  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.68 (br s, 1H, NH), 7.43 (d, 
J = 7.6 Hz, 1 H, C9-H or C12-H), 7.27-7.25 (m, 1 H, C9-H or C12-H) 7.11-7.08 (m, 1 H, 
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C10-H or C11-H), 7.06-7.03 (m, 1 H, C10-H or C11-H), 4.09-3.99 (comp, 4 H, C16-H, 
C17-H), 2.82 (t, J = 6.4 Hz, 2 H, C6-H), 2.04 (t, J = 6.4 Hz, 2 H, C5-H), 1.37 (s, 6 H, 
C14-H, C15-H); 13C NMR (125 MHz) δ 140.5 (C2 or C8 or C13 ), 136.3 (C2 or C8 or 
C13), 127.3 (C2 or C8 or C13), 121.2 (C10 or C11), 119.2 (C10 or C11), 118.2 (C9 or 
C12), 112.4 (C4), 110.5 (C9 or C12), 107.3 (C7), 65.3 (C16, C17), 40.6 (C3), 27.8 (C5), 





















Indole 4.66 (mp3-126). Freshly powdered NaOH (331 mg, 8.28 mmol) was 
added to a solution of 4.65 (195 mg, 0.76 mmol) and Bu4NHSO4 (28 mg, 0.08 mmol) in 
CH2Cl2 (5.5 mL) cooled to 0 ˚C. The mixture was stirred for 5 min, whereupon acetyl 
chloride (320 mg, 0.29 mL, 4.1 mmol) was added. The reaction was stirred at 0 ˚C for 30 
min, whereupon the ice bath was removed and stirring was continued for 3 h. Saturated 
aqueous NH4Cl (2 mL) was added and the mixture was poured into a separatory funnel 
containing water (15 ml), and extracted with EtOAc (2 x 15 mL). The combined organic 
extracts were dried (Na2SO4) and concentrated under reduced pressure, and the residue 
was purified by flash chromatography eluting with Et2O/pentane (1:4 → 3:7) to give 71 
mg (31%) of 4.66 as a clear colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.47-7.45 (m, 1 
H), 7.41-7.38 (m, 1 H) 7.23-7.19 (m, 1 H), 7.18 (app t, J = 1.0 Hz, 1 H), 4.05-3.99 (comp, 
4 H), 2.78 (s, 3 H), 2.77 (t, J = 6.5 Hz, 2 H), 2.07 (t, J = 6.5 Hz, 2 H), 1.45 (s, 6 H); 13C 
NMR (125 MHz) δ 171.6, 142.6, 136.2, 129.3, 123.6, 122.2, 118.8, 116.5, 113.5, 113.0, 
65.3, 43.3, 27.8, 26.0, 21.8, 19.0; IR (neat) 2883, 1713, 1458, 1365, 1295, 1091, 919, 743 
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cm-1; mass spectrum (CI) m/z 299.1518 [C18H21NO3 (M+) requires 299.1521], 238, 258, 
300 (base), 328.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.47-7.45 (m, 1 H, C9-H or 
C12-H), 7.41-7.38 (m, 1 H, C9-H or C12-H) 7.23-7.19 (m, 1 H, C10-H or C11-H), 7.18 
(app t, J = 1.0 Hz, 1 H, C10-H or C11-H), 4.05-3.99 (comp, 4 H, C16-H, C17-H), 2.78 (s, 
3 H, C19-H), 2.77 (t, J = 6.5 Hz, 2 H, C6-H), 2.07 (t, J = 6.5 Hz, 2 H, C5-H), 1.45 (s, 6 
H, C14-H, C15-H); 13C NMR (125 MHz) δ 171.6 (C18), 142.6 (C2 or C8 or C13 ), 136.2 
(C2 or C8 or C13), 129.3 (C2 or C8 or C13), 123.6 (C10 or C11), 122.2 (C10 or C11), 
118.8 (C9 or C12), 116.5 (C4), 113.5 (C7), 113.0 (C9 or C12), 65.3 (C16, C17), 43.3 





















Indole 4.67 (mp3-120). A solution of sodium hexamethyldisilazide in THF (0.21 
mL, 2.0 M, 0.43 mmol) was added to a solution of 4.65 (100 mg, 0.39 mmol) in THF (4 
mL) cooled to –78 ˚C. The reaction was stirred at –78 ˚C for 40 min, whereupon 
methylchloroformate (73 mg, 60 μL, 0.78 mmol) was added. The reaction was stirred at –
78 ˚C for 10 min, whereupon the cooling bath was removed, and stirring was continued 
for 1.5 h. Saturated aqueous NH4Cl (0.5 mL) was added, and the mixture was poured into 
a separatory funnel containing 0.5 M HCl (10 ml), and extracted with EtOAc (2 x 10 
mL). The combined organic extracts were dried (Na2SO4) and concentrated under 
reduced pressure, and the residue was purified by flash chromatography eluting with 
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Et2O/pentane (1:4 → 3:7) to give 114 mg (93%) of 4.67 as a clear colorless oil: 1H NMR 
(500 MHz, CDCl3) δ 7.89-7.86 (m, 1 H), 7.38-7.35 (m, 1 H) 7.25-7.16 (comp, 2 H), 4.05-
3.99 (comp, 7 H), 2.76 (t, J = 6.5 Hz, 2 H), 2.07 (t, J = 6.5 Hz, 2 H), 1.53 (s, 6 H); 13C 
NMR (125 MHz) δ 152.8, 141.1, 137.1, 128.8, 124.0, 122.5, 118.1, 116.8, 114.9, 113.4, 
65.2, 53.4, 43.2, 26.0, 21.4, 19.0; IR (neat) 2954, 2884, 1744, 1456, 1358, 1321, 1219, 
1092, 1039, 746 cm-1; mass spectrum (CI) m/z 316.1537 [C18H22NO4 (M+1) requires 
316.1549], 229, 254 (base), 282, 316.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.89-7.86 (m, 1 H, C9-H or 
C12-H), 7.38-7.35 (m, 1 H, C9-H or C12-H) 7.25-7.16 (comp, 2 H, C10-H, C11-H), 
4.05-3.99 (comp, 7 H, C15-H, C16-H, C17-H), 2.76 (t, J = 6.5 Hz, 2 H, C6-H), 2.07 (t, J 
= 6.5 Hz, 2 H, C5-H), 1.53 (s, 6 H, C18-H, C19-H); 13C NMR (125 MHz) δ 152.8 (C14), 
141.1 (C2 or C8 or C13 ), 137.1 (C2 or C8 or C13), 128.8 (C2 or C8 or C13), 124.0 (C10 
or C11), 122.5 (C10 or C11), 118.1 (C9 or C12), 116.8 (C4), 114.9 (C9 or C12), 113.4 

























Spirooxindole 4.68 (mp3-128). D-epoxone (72 mg, 0.28 mmol) was added to a 
solution of 4.66 (28 mg, 0.09 mmol), Bu4NHSO4 (16 mg, 0.05 mmol) and Na2B4O7⋅H2O 
(15 mg, 0.05 mmol) in CH3CN (1.5 mL) and 1 x 10-4 M EDTA (1.0 mL). A solution of 
oxone (305 mg, 0.47 mmol) in 1 x 10-4 M EDTA (0.6 mL) and a solution of K2CO3 (271 
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mg, 1.96 mmol) in H2O (0.9 mL) were added simultaneously in aliquots over 1.5 h. The 
reaction was stirred at room temperature for an additional 30 min, whereupon it was 
poured into H2O (15 mL) and extracted with EtOAc (3 x 15 mL). The combined organic 
extracts were dried (Na2SO4) and concentrated under reduced pressure. The residue was 
purified by flash chromatography eluting with 30% Et2O in pentane to give 11 mg (40%) 
of recovered 4.66 and 6 mg (20%) of 4.68 an inseparable mixture: 1H NMR (400 MHz, 
CDCl3) δ 8.18-8.15 (m, 1 H), 7.53-7.51 (m, 1 H) 7.27-7.13 (comp, 2 H), 3.98-3.93 
(comp, 4 H), 2.63 (s, 3 H), 2.33-2.28 (comp, 2 H), 2.10-2.03 (comp, 2 H), 1.09 (s, 3 H), 
0.64 (s, 3 H); mass spectrum (CI) m/z 213, 238, 299 (base), 316. 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 8.18-8.15 (m, 1 H, C9-H or 
C12-H), 7.53-7.51 (m, 1 H, C9-H or C12-H) 7.27-7.13 (comp, 2 H, C10-H, C11-H), 
3.98-3.93 (comp, 4 H, C16-H, C17-H), 2.63 (s, 3 H, C19-H), 2.33-2.28 (comp, 2 H, C5-






























Indole 4.71 (mp3-135). A solution of sodium hexamethyldisilazide in THF (0.96 
mL, 2.0 M, 1.9 mmol) was added to a solution of 4.65 (450 mg, 1.75 mmol) in THF (20 
mL) cooled to –78 ˚C. The reaction was stirred at –78 ˚C for 40 min, whereupon 
menthylchloroformate (763 mg, 0.74 mL, 3.5 mmol) was added dropwise over 5 min. 
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The reaction was stirred at –78 ˚C for an additional 5 min, whereupon the cooling bath 
was removed, and stirring was continued for 2 h. Saturated aqueous NH4Cl (1 mL) was 
added, and the mixture was poured into a separatory funnel containing 50% saturated 
aqueous NH4Cl (10 ml), and extracted with EtOAc (3 x 20 mL). The combined organic 
extracts were dried (Na2SO4) and concentrated under reduced pressure, and the residue 
was purified by flash chromatography eluting with 5%→10% Et2O/pentane to give 614 
mg (80%) of 4.71 as a white solid: mp 84-87 °C; 1NMR (500 MHz, CDCl3) δ 7.87-7.85 
(m, 1 H), 7.37-7.35 (m, 1 H), 7.24-7.19 (m, 1 H), 7.16 (app td, J = 7.3, 1.1 Hz, 1 H), 4.98 
(app td, J = 11.0, 4.4 Hz, 1 H), 4.05-3.95 (comp, 4 H), 2.78-2.74 (comp, 2 H), 2.24-2.19 
(m, 1 H), 2.18-2.12 (m, 1 H), 2.05-1.96 (comp, 2 H), 1.78-1.71 (comp, 2 H), 1.67-1.63 
(m, 1 H), 1.61 (s, 3 H), 1.59-1.53 (m, 1 H), 1.46 (s, 3 H), 1.28 (app q, J = 11.7, Hz, 1 H),  
1.18-1.09 (m, 1 H), 1.01-0.92 (m, 1 H), 0.95 (d, J = 6.6 Hz, 3 H), 0.89 (d, J = 7.0 Hz, 3 
H), 0.81 (d, J = 7.0 Hz, 3 H); 13C NMR (125 MHz) δ 152.1, 141.4, 137.0, 128.8, 123.8, 
122.3, 118.1, 116.4, 115.1, 113.5, 77.8, 65.3, 65.2, 47.3, 43.2, 41.2, 34.2, 31.6, 26.3, 26.1, 
23.5, 22.9, 22.0, 20.7, 19.7, 19.0, 16.3; IR (neat) 2956, 2873, 1733, 1456, 1369, 1304, 
1217, 1092, 1034, 743 cm-1; mass spectrum (CI) m/z 439.2720 [C27H37NO4 (M+) 
requires 439.2723], 302, 378, 438, 440 (base).  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.87-7.85 (m, 1 H, C9-H or 
C12-H), 7.37-7.35 (m, 1 H, C9-H or C12-H), 7.24-7.19 (m, 1 H, C10-H or C11-H), 7.16 
(app td, J = 7.3, 1.1 Hz, 1 H, C10-H or C11-H), 4.98 (app td, J = 11.0, 4.4 Hz, 1 H, C19-
H), 4.05-3.95 (comp, 4 H, C16-H, C17-H), 2.78-2.74 (comp, 2 H, C6-H), 2.24-2.19 (m, 1 
H, C20-H), 2.18-2.12 (m, 1 H, C5-H), 2.05-1.96 (comp, 2 H, C5-H, C26-H), 1.78-1.71 
(comp, 2 H, C22-H, C23-H), 1.67-1.63 (m, 1 H, C24-H), 1.61 (s, 3 H, C14-H or C15-H), 
1.59-1.53 (m, 1 H, C21-H), 1.46 (s, 3 H, C14-H or C15-H), 1.28 (app q, J = 11.7, Hz, 1 
H, C20-H),  1.18-1.09 (m, 1 H, C23-H), 1.01-0.92 (m, 1 H, C22-H), 0.95 (d, J = 6.6 Hz, 3 
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H, C25-H), 0.89 (d, J = 7.0 Hz, 3 H, C27-H or C28-H), 0.81 (d, J = 7.0 Hz, 3 H, C27-H 
or C28-H); 13C NMR (125 MHz) δ 152.1 (C18), 141.4 (C2 or C8 or C13 ), 137.0 (C2 or 
C8 or C13), 128.8 (C2 or C8 or C13), 123.8 (C10 or C11), 122.3 (C10 or C11), 118.1 (C9 
or C12), 116.4 (C4), 115.1 (C9 or C12), 113.5 (C7), 77.8 (C19), 65.3 (C16 or C17), 65.2 
(C16 or C17), 47.3 (C24), 43.2 (C3), 41.2 (C20), 34.2 (C22), 31.6 (C21), 26.3 (C26), 
26.1 (C5), 23.5 (C23), 22.9 (C14 or C15), 22.0 (C25), 20.7 (C27 or C28), 19.7 (C14 or 































Indole 4.72 (mp3-144). A solution of sodium hexamethyldisilazide in THF (0.30 
mL, 2.0 M, 0.60 mmol) was added to a solution of 4.65 (140 mg, 0.54 mmol) in THF 
(2.75 mL) cooled to –78 ˚C. The reaction was stirred at –78 ˚C for 45 min, whereupon a 
solution of 8-phenylmenthyl chloroformate (241 mg, 0.82 mmol) in THF (0.4 mL) was 
added dropwise over 5 min. The reaction was stirred at –78 ˚C for an additional 15 min, 
whereupon the cooling bath was removed, and stirring was continued for 1.5 h. A 
solution of 0.5 M HCl (1 mL) was added, and the mixture was poured into a separatory 
funnel containing 0.5 M HCl (8 mL), EtOAc (8 mL). The layers were separated and the 
aqueous layer was extracted with EtOAc (2 x 8 mL). The combined organic extracts were 
dried (Na2SO4), and concentrated under reduced pressure, and the residue was purified 
by flash chromatography eluting with 20% Et2O/pentane to give 176 mg (63%) of 4.72 as 
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a pale yellow foam; 1H NMR (500 MHz, CDCl3) δ 7.76-7.73 (m, 1 H), 7.35-7.33 (m, 1 
H), 7.24-7.20 (comp, 2 H), 7.19-7.14 (comp, 2 H), 7.09-7.05 (comp, 2H), 6.93-6.89 (m, 1 
H), 5.09 (app td, J = 11.0, 4.4 Hz, 1 H), 4.10-3.94 (comp, 4 H), 2.77-2.74 (comp, 2 H), 
2.24-2.11 (comp, 3 H), 1.92 (app td, J = 13.2, 4.4 Hz, 1 H), 1.67 (s, 3H), 1.64-1.59 (m, 1 
H), 1.58-1.47 (comp, 2 H), 1.45 (s, 3 H), 1.34 (s, 3 H), 1.33 (s, 3 H), 1.27 (app q, J = 11.9 
Hz, 1 H), 1.08 (qd, J = 13.2, 3.4 Hz, 1 H), 0.94-0.85 (m, 1 H) 0.89 (d, J = 6.6 Hz, 3 H); 
13C NMR (125 MHz) δ 151.5, 150.3, 141.3, 137.0, 128.8, 127.9, 125.5, 125.1, 123.7, 
122.2, 117.9, 116.7, 115.3, 113.5, 78.3, 65.3, 65.1, 51.3, 43.2, 42.2, 40.2, 34.5, 31.6, 28.5, 
27.2, 26.1, 25.3, 24.4, 21.7, 19.0, 18.5; IR (neat) 2956, 1731, 1456, 1364, 1217, 1092, 
1034, 920, 735 cm-1; mass spectrum (CI) m/z 515.3033 [C33H41NO4 (M+) requires 
515.3036], 302, 515 (base), 557, 620.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.76-7.73 (m, 1 H, C9-H or 
C12-H), 7.35-7.33 (m, 1 H, C9-H or C12-H), 7.24-7.20 (comp, 2 H, Ar-H), 7.19-7.14 
(comp, 2 H, C10-H, C11-H), 7.09-7.05 (comp, 2H, Ar-H), 6.93-6.89 (m, 1 H, Ar-H), 5.09 
(app td, J = 11.0, 4.4 Hz, 1 H, C19-H), 4.10-3.94 (comp, 4 H, C16-H, C17-H), 2.77-2.74 
(comp, 2 H, C6-H), 2.24-2.11 (comp, 3 H, C5-H, C20-H, C24-H), 1.92 (app td, J = 13.2, 
4.4 Hz, 1 H, C5-H), 1.67 (s, 3H, C14-H or C15-H), 1.64-1.59 (m, 1 H, C22-H), 1.58-1.47 
(comp, 2 H, C21-H, C23-H), 1.45 (s, 3 H, C14-H or C-15), 1.34 (s, 3 H, C27-H or C28-
H), 1.33 (s, 3 H, C27-H or C28-H), 1.27 (app q, J = 11.9 Hz, 1 H, C20-H), 1.08 (qd, J = 
13.2, 3.4 Hz, 1 H, C23-H), 0.94-0.85 (m, 1 H, C22-H) 0.89 (d, J = 6.6 Hz, 3 H, C25-H); 
13C NMR (125 MHz) δ 151.5 (C18), 150.3 (C29), 141.3 (C2 or C8 or C13 ), 137.0 (C2 
or C8 or C13), 128.8 (C2 or C8 or C13), 127.9 (Ar-C), 125.5 (Ar-C), 125.1 (Ar-C), 123.7 
(C10 or C11), 122.2 (C10 or C11), 117.9 (C9 or C12), 116.7 (C4), 115.3 (C9 or C12), 
113.5 (C7), 78.3 (C19), 65.3 (C16 or C17), 65.1 (C16 or C17), 51.3 (C24), 43.2 (C3), 
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42.2 (C20), 40.2 (C26), 34.5 (22), 31.6 (C21), 28.5 (C27 or C28), 27.2 (C23), 26.1 (C5), 
































Spirooxindole 4.75 (mp4-260). A solution of DMDO in acetone (3.3 mL, 0.08 
M, 0.26 mmol) was added to a solution of 4.71 (50 mg, 0.11 mmol) in acetone (2 mL) at 
0 ˚C. The reaction was stirred at 0 ˚C for 1 h and then concentrated under reduced 
pressure. The residue was dissolved in CH2Cl2 (4 mL), and silica gel (400 mg) was 
added. The slurry was stirred at room temperature for 3.5 h, whereupon it was filtered 
through celite. The solids were washed with EtOAc (10 mL), and the filtrate and 
washings were removed under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / EtOAc (4:1) to give 41 mg (78%, dr = 2:1) of 
4.75 as a clear colorless oil: 1H NMR (500 MHz, CDCl3, mixture of diastereomers) δ 
7.82-7.79 (comp, 1 H), 7.56-7.53 (comp, 1 H), 7.25-7.21 (comp, 1 H), 7.12-7.08 (comp, 1 
H), 4.90-4.83 (comp, 1 H), 4.01-3.88 (comp, 4 H), 2.37-2.23 (comp, 2 H), 2.20-1.09 
(comp, 2 H), 2.04-1.93 (comp, 3 H), 1.74-1.67 (comp, 2 H), 1.63-1.48 (comp, 2 H), 1.19-
1.12 (comp, 1 H), 1.13 (s, 2H), 1.12 (s, 1H), 0.95-0.86 (comp, 2 H), 0.99-0.89 (comp, 6 
H), 0.79 (d, J = 6.8 Hz, 3 H), 0.78 (d, J = 6.8 Hz, 3 H), 0.60 (s, 1 H), 0.59 (s, 2 H); 13C 
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NMR (125 MHz) δ 178.5, 178.4, 150.8, 150.7, 139.09, 139.06, 132.7, 132.5, 127.70, 
127.67, 126.2, 125.5, 123.7, 123.6, 119.1, 114.09, 114.05,  77.7, 77.6, 65.2, 64.1, 59.2, 
59.1, 50.9, 46.9, 46.8, 40.8, 40.7, 34.1, 33.7, 33.6, 31.53, 31.50, 31.0, 26.5, 25.9, 23.7, 
23.5, 23.3, 23.2, 21.98, 21.96, 20.9, 20.7, 20.3, 20.2, 16.6, 16.1. IR (neat) 2955, 2872, 
1766, 1725, 1467, 1356, 1290, 1242, 1150 cm-1; mass spectrum (CI) m/z 456.2748 
[C27H38NO5 (M+1) requires 456.2750], 274, 318, 456 (base).  
NMR Assignments. 1H NMR (500 MHz, CDCl3, mixture of diastereomers) δ 
7.82-7.79 (comp, 1 H, C9-H or C12-H), 7.56-7.53 (comp, 1 H, C9-H or C12-H), 7.25-
7.21 (comp, 1 H, C10-H or C11-H), 7.12-7.08 (comp, 1 H, C10-H or C11-H), 4.90-4.83 
(comp, 1 H, 17-H), 4.01-3.88 (comp, 4 H, C27-H, C28-H), 2.37-2.23 (comp, 2 H, C4-H, 
C5-H), 2.20-1.09 (comp, 2 H, C18-H, C23-H), 2.04-1.93 (comp, 3 H, C4-H, C5-H, C23-
H), 1.74-1.67 (comp, 2 H, C20-H, C21-H), 1.63-1.48 (comp, 2 H, C19-H, C22-H), 1.19-
1.12 (comp, 1 H, C18-H), 1.13 (s, 2H, C15-H or C16-H), 1.12 (s, 1H, C15-H or C16-H), 
0.95-0.86 (comp, 2 H, C20-H, C21-H), 0.99-0.89 (comp, 6 H, C24-H, C25-H or C26-H), 
0.79 (d, J = 6.8 Hz, 3 H, C24 or C25), 0.78 (d, J = 6.8 Hz, 3 H, C24 or C25), 0.60 (s, 1 H, 
C15-H or C16-H), 0.59 (s, 2 H, C15-H or C16-H); 13C NMR (125 MHz) δ 178.5 (C2), 
178.4 (C2), 150.8 (C14), 150.7 (C14), 139.09 (C13), 139.06 (C13), 132.7 (C8), 132.5 
(C8), 127.70 (C10 or C11), 127.67 (C10 or C11), 126.2 (C9 or C12), 125.5 (C28), 123.7 
(C10 or C11), 123.6 (C10 or C11), 119.1 (C6), 114.09 (C9 or C12), 114.05 (C9 or C12),  
77.7 (C17), 77.6 (C17), 65.2 (C27 or C28), 64.1 (C27 or C28), 59.2 (C3), 59.1 (C3), 50.9 
(C7), 46.9 (C22), 46.8 (C22), 40.8 (C18), 40.7 (C18), 34.1 (C20), 33.7 (C4 or C5), 33.6 
(C4 or C5), 31.53 (C19), 31.50 (C4 or C5), 31.0 (C4 or C5), 26.5 (C23), 25.9 (C23), 23.7 
(C21), 23.5 (C15 or C16), 23.3 (C21), 23.2 (C15 or C16), 21.98 (C24 or C25), 21.96 
(C24 or C25), 20.9 (C26), 20.7 (C26), 20.3 (C15 or C16), 20.2 (C15 or C16), 16.6 (C24 




































Spirooxindole 4.76 (mp4-259). A solution of DMDO in acetone (2.5 mL, 0.08 
M, 0.20 mmol) was added to a solution of 4.72 (45 mg, 0.09 mmol) in acetone (1.5 mL) 
at 0 ˚C. The reaction was stirred at 0 ˚C for 1 h and then concentrated under reduced 
pressure. The residue was dissolved in CH2Cl2 (3 mL), and silica gel (300 mg) was 
added. The slurry was stirred at room temperature for 3.5 h, whereupon it was filtered 
through celite. The solids were washed with EtOAc (10 mL), and the combined filtrate 
and washings were removed under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / EtOAc (4:1) to give 36 mg (78%, dr = 12:1) of 
4.76 as a clear colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.68-7.65 (m, 1 H), 7.54-7.51 
(m, 1 H), 7.25 (dd, J = 8.5, 1.2 Hz, 2 H), 7.23-7.19 (m, 1 H), 7.10 (td, J = 7.5, 1.2 Hz, 1 
H), 7.07-7.03 (comp, 2H), 6.88 (tt, J = 7.4, 1.0 Hz, 1 H), 5.09 (td, J = 10.6, 4.6 Hz, 1 H), 
3.99-3.88 (comp, 4 H), 2.31-2.24 (comp, 2 H), 2.14 (ddd, J = 12.3, 10.6, 3.4 Hz, 1 H), 
2.01-1.96 (comp, 3 H), 1.65-1.57 (comp, 2 H), 1.51-1.42 (m, 1 H), 1.36 (s, 3H), 1.28 (s, 
3H), 1.26-1.18 (m, 1 H), 1.13-1.56 (m, 1 H), 1.09 (s, 3 H), 0.91-0.82 (m, 1 H), 0.87 (d, J 
= 6.6 Hz, 3 H), 0.56 (s, 3 H); 13C NMR (125 MHz) δ 177.5, 150.7, 150.0, 139.1, 132.4, 
127.8, 127.5, 126.1, 125.5, 125.0, 123.5, 119.1, 114.2, 65.2, 64.8, 58.9, 50.9, 50.6, 41.9, 
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40.0, 34.3, 33.6, 31.45, 31.38, 26.8, 26.64, 26.57, 23.4, 21.7, 20.4; IR (neat) 2955, 2882, 
1766, 1721, 1478, 1465, 1358, 1292, 1243, 1149 cm-1; mass spectrum (CI) m/z 531.2978 
[C33H41NO5 (M+) requires 531.2985], 274, (base), 516, 532.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.68-7.65 (m, 1 H, C9-H or 
C12-H), 7.54-7.51 (m, 1 H, C9-H or C12-H), 7.25 (dd, J = 8.5, 1.2 Hz, 2 H, C28), 7.23-
7.19 (m, 1 H, C10-H or C11-H), 7.10 (td, J = 7.5, 1.2 Hz, 1 H, C10-H or C11-H), 7.07-
7.03 (comp, 2H, C29-H), 6.88 (tt, J = 7.4, 1.0 Hz, 1 H, C30-H), 5.09 (td, J = 10.6, 4.6 Hz, 
1 H, C17-H), 3.99-3.88 (comp, 4 H, C31-H, C32-H), 2.31-2.24 (comp, 2 H, C4-H, C5-
H), 2.14 (ddd, J = 12.3, 10.6, 3.4 Hz, 1 H, C22-H), 2.01-1.96 (comp, 3 H, C18-H, C5-H 
C4-H), 1.65-1.57 (comp, 2 H, C20-H, C21-H), 1.51-1.42 (m, 1 H, C19-H), 1.36 (s, 3H, 
C24-H or C25-H), 1.28 (s, 3H, C15-H or C16-H), 1.26-1.18 (m, 1 H, C18-H), 1.13-1.56 
(m, 1 H, C21-H), 1.09 (s, 3 H, C24-H or C-25), 0.91-0.82 (m, 1 H, C20-H), 0.87 (d, J = 
6.6 Hz, 3 H, C26-H), 0.56 (s, 3 H, C15-H or C16-H); 13C NMR (125 MHz) δ 177.5 (C2), 
150.7 (C14), 150.0 (C27), 139.1 (C13), 132.4 (C8), 127.8 (C29), 127.5 (C10 or C11), 
126.1 (C9 or C12), 125.5 (C28), 125.0 (C30), 123.5 (C10 or C11), 119.1 (C6), 114.2 (C9 
or C12), 65.2 (C31 or C32), 64.8 (C31 or C32), 58.9 (C3), 50.9 (C7), 50.6 (C22), 41.9 
(C18), 40.0 (C23), 34.3 (C20), 33.6 (C4 or C5), 31.45 (C4 or C5), 31.38 (C19), 26.8 
(C21), 26.64 (C15 or C16), 26.57 (C24 or C25), 23.4 (C24 or C25), 21.7 (C26), 20.4 



































Ketone 4.77 (mp5-072, mp5-073, mp5-074). A solution of DMDO in acetone 
(58 mL, 0.08 M, 4.64 mmol) was added to a solution of 4.72 (1.00 g, 1.94 mmol) in 
acetone (34 mL) at 0 ˚C. The reaction was stirred at 0 ˚C for 1.25 h and then concentrated 
under reduced pressure. The residue was dissolved in CH2Cl2 (60 mL), and silica gel (6.6 
g) was added. The slurry was stirred at room temperature for 3.5 h, whereupon it was 
filtered through celite. The solids were washed with EtOAc (100 mL), and the combined 
filtrate and washings were removed under reduced pressure. The residue was dissolved in 
acetone (50 mL) and TsOH·H2O (369 mg, 1.94 mmol) was added. The reaction was 
heated under reflux for 1 h, whereupon it was allowed to cool to room temperature. The 
solvent was removed under reduced pressure, and the residue was purified by flash 
chromatography eluting with hexanes / EtOAc (4:1 → 3:1) to give 692 mg (73%, dr = 
12:1) of 4.77 as a white foam; [α]D −62.5 (CH2Cl2);  1H NMR (500 MHz, CDCl3) δ 7.78-
7.76 (m, 1 H), 7.33 (ddd, J = 8.2, 5.6, 3.2 Hz, 1 H), 7.26-7.23 (comp, 2 H), 7.18-7.16 
(comp, 2 H), 7.05-7.01 (comp, 2H), 6.88-6.84 (m, 1 H), 5.08 (td, J = 10.8, 4.6 Hz, 1 H), 
2.84 (dt, J = 19.4, 9.8 Hz, 1 H), 2.55 (ddd, J = 19.4, 8.6, 4.4 Hz, 1 H), 2.27-2.22 (comp, 2 
H), 2.17 (ddd, J = 12.5, 10.8, 3.6 Hz, 1 H), 1.96- 1.91 (m, 1 H), 1.74 (dq, J = 13.6, 3.6 
Hz, 1 H), 1.66-1.60 (m, 1 H), 1.52-1.43 (m, 1 H),  1.35 (s, 3H), 1.26-1.21 (m, 1 H), 1.25 
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(s, 3 H), 1.18-1.09 (m, 1 H), 1.06 (s, 3 H), 0.93-0.85 (m, 1 H), 0.87 (d, J = 6.6 Hz, 3 H), 
0.82 (s, 3 H); 13C NMR (125 MHz) δ 218.0, 177.1, 151.0, 150.0, 140.0, 128.7, 127.8, 
127.4, 125.4, 124.9, 124.4, 124.1, 115.1, 77.5, 57.9, 53.1, 50.5, 41.7, 39.8, 34.2, 33.2, 
31.4, 28.3, 27.8, 26.6, 25.0, 21.7, 21.3, 17.9. IR (neat) 2965, 1760, 1745, 1725, 1464, 
1357, 1293, 1244, 1163 cm-1; mass spectrum (CI) m/z 487.2720 [C31H37NO4 (M+) 
requires 487.2723], 267, 488 (base). 
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.78-7.76 (m, 1 H, C9-H or 
C12-H), 7.33 (ddd, J = 8.2, 5.6, 3.2 Hz, 1 H, C10-H or C11-H), 7.26-7.23 (comp, 2 H, 
C28-H), 7.18-7.16 (comp, 2 H, C10-H or C11-H, C9-H or C12-H), 7.05-7.01 (comp, 2H, 
C29-H), 6.88-6.84 (m, 1 H, C30-H), 5.08 (td, J = 10.8, 4.6 Hz, 1 H, C17-H), 2.84 (dt, J = 
19.4, 9.8 Hz, 1 H, C5-H), 2.55 (ddd, J = 19.4, 8.6, 4.4 Hz, 1 H, C5-H), 2.27-2.22 (comp, 
2 H, C4-H), 2.17 (ddd, J = 12.5, 10.8, 3.6 Hz, 1 H, C22-H), 1.96- 1.91 (m, 1 H, C18-H), 
1.74 (dq, J = 13.6, 3.6 Hz, 1 H, C21-H), 1.66-1.60 (m, 1 H, C20-H), 1.52-1.43 (m, 1 H, 
C19-H),  1.35 (s, 3H, C24-H or C25-H), 1.26-1.21 (m, 1 H, C18-H), 1.25 (s, 3 H, C15-H 
or C-16), 1.18-1.09 (m, 1 H, C21-H), 1.06 (s, 3 H, C24-H or C25-H), 0.93-0.85 (m, 1 H, 
C20-H), 0.87 (d, J = 6.6 Hz, 3 H, C26-H), 0.82 (s, 3 H, C15-H or C16-H); 13C NMR 
(125 MHz) δ 218.0 (C6), 177.1 (C2), 151.0 (C14), 150.0 (C27), 140.0 (C13 ), 128.7 (C10 
or C11), 127.8 (C29), 127.4 (C8), 125.4 (C28), 124.9 (C30), 124.4 (C10 or C11), 124.1 
(C9 or C12), 115.1 (C9 or C12), 77.5 (C17), 57.9 (C3), 53.1 (C7), 50.5 (C22), 41.7 
(C18), 39.8 (C23), 34.2 (C20), 33.2 (5), 31.4 (C19), 28.3 (C4), 27.8 (C15 or C16), 26.6 




































Ketone 4.78 (mp4-091). NaBH4 (5 mg, 0.12 mmol) was added to a solution of 
4.77 (40 mg, 0.08 mmol) in MeOH (0.4 mL) at 0 °C. The reaction was stirred at 0 °C for 
15 min, whereupon a saturated aqueous solution of NH4Cl (2 mL) was added. The ice 
bath was removed and the mixture was stirred for 3 min, whereupon it was poured in 
H2O (10 mL). The mixture was extracted with EtOAc (3 × 10 mL), and the combined 
organic phases were dried (Na2SO4). The solvent was removed under reduced pressure, 
and the residue was purified by flash chromatography eluting with hexanes / EtOAc (4:1) 
to give 28 mg (69%) of 4.78 as a white solid; 1H NMR (500 MHz, DMSO d6, 100 ˚C) δ 
7.69 (d, J = 6.8, Hz, 1 H), 7.34 (dd, J = 8.5, 1.1 Hz, 2 H), 7.26-7.22 (comp, 2 H), 7.17 (td, 
J = 7.5, 1.3 Hz, 1 H), 7.13-7.10 (m, 1 H), 6.91 (td, J = 7.5, 1.1 Hz, 1 H), 6.68 (d, J = 7.5, 
Hz, 1 H), 5.21 (br s), 4.89 (td, J = 10.6, 4.5 Hz, 1 H), 2.52-2.44 (m, 1 H), 2.25-2.13 
(comp, 3 H), 1.93-1.88 (m, 1 H), 1.61-1.57 (m, 1 H), 1.56-1.50 (m, 1 H), 1.49-1.35 
(comp, 2 H, C6-H), 1.36 (s, 3H), 1.26 (s, 3H), 1.28-1.23 (m, 1 H), 1.22 (s, 3 H), 1.11-1.03 
(m, 1 H), 1.10 (s, 3 H), 0.89-0.81 (m, 1 H), 0.87 (d, J = 6.5 Hz, 3 H); 13C NMR (125 
MHz, DMSO d6, 100 ˚C) δ 219.4, 151.2, 150.5, 139.9, 134.2, 127.3, 126.8, 124.9, 124.6, 
122.9, 121.4, 114.5, 89.4, 75.0, 57.2, 49.2, 48.9, 41.0, 33.7, 32.3, 31.3, 30.4, 26.7, 26.1, 
25.1, 21.1, 20.2, 19.1. 
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NMR Assignments. 1H NMR (500 MHz, DMSO d6, 100 ˚C) δ 7.69 (d, J = 6.8, 
Hz, 1 H, C9-H or C12-H), 7.34 (dd, J = 8.5, 1.1 Hz, 2 H, C28-H), 7.26-7.22 (comp, 2 H, 
C29-H), 7.17 (td, J = 7.5, 1.3 Hz, 1 H, C10-H or C11-H), 7.13-7.10 (m, 1 H, C30-H), 
6.91 (td, J = 7.5, 1.1 Hz, 1 H, C10-H or C11-H), 6.68 (d, J = 7.5, Hz, 1 H, C9-H or C12-
H), 5.21 (br s, 1 H, C2-H), 4.89 (td, J = 10.6, 4.5 Hz, 1 H, C17-H), 2.52-2.44 (m, 1 H, 
C5-H), 2.25-2.13 (comp, 3 H C5-H, C6-H, C22-H), 1.93-1.88 (m, 1 H, C18-H), 1.61-1.57 
(m, 1 H, C20-H), 1.56-1.50 (m, 1 H, C21-H), 1.49-1.35 (comp, 2 H, C6-H, C19-H), 1.36 
(s, 3H, C15-H or C16-H), 1.26 (s, 3H, C15-H or C16-H), 1.28-1.23 (m, 1 H, C18-H), 
1.22 (s, 3 H, C24-H or C-25), 1.11-1.03 (m, 1 H, C21-H), 1.10 (s, 3 H, C24-H or C25-H), 
0.89-0.81 (m, 1 H, C20-H), 0.87 (d, J = 6.5 Hz, 3 H, C26-H); 13C NMR (125 MHz, 
DMSO d6, 100 ˚C) δ 219.4 (C6), 151.2 (C14), 150.5 (C27), 139.9 (C13 ), 134.2 (C8), 
127.3 (C29), 126.8 (C10 or C11), 124.9 (C28), 124.6 (30), 122.9 (C9 or C12), 121.4 (C10 
or C11), 114.5 (C9 or C12), 89.4 (C2), 75.0 (C17), 57.2 (C3 or C7), 49.2 (C3 or C7), 48.9 
(C22), 41.0 (C18), 33.7 (C20), 32.3 (C5), 31.3 (C6), 30.4 (C19), 26.7 (C15 or C16), 26.1 





































Ketoester 4.79 (mp5-081). A solution of n-BuLi (1.22 mL, 2.23 M, 2.73 mmol) 
in hexanes was added to a solution of i-Pr2NH (0.42 mL, 3.00 mmol) in THF (3.8 mL) at 
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−78 °C. The solution was stirred at −78 °C for 15 min, whereupon the dry ice/acetone 
bath was replaced with an ice bath, and the reaction was stirred at 0 °C for 15 min. The 
LDA solution was added dropwise via cannula to a stirred solution of 4.77 (605 mg, 1.24 
mmol) in THF (12.4 mL) at −78 °C, and the reaction mixture was stirred for 20 min. 
CH3OCOCN (0.39 mL, 4.96 mmol) was added, the reaction was stirred at −78 °C for 1 h 
and at −40 °C for 1 h, and saturated aqueous 0.5 M HCl (5 mL) was added. The cold bath 
was removed, and the reaction mixture was allowed to warm to room temperature and 
poured in 0.5 M HCl (100 mL). The mixture was extracted with EtOAc (3 × 100 mL), 
and the combined organic phases were dried (Na2SO4). The solvent was removed under 
reduced pressure, and the residue was purified by flash chromatography eluting with 
hexanes / EtOAc (4:1) to give 542 mg (80%) of 4.79 as a foam; 1H NMR (500 MHz, 
CDCl3) δ 7.86-7.76 (m, 1 H), 7.38-7.34 (m, 1 H), 7.29-7.27 (m, 1 H), 7.23 (dd, J = 8.5, 
1.1 Hz, 2 H), 7.20 (td, J = 7.5, 1.1 Hz, 1 H), 7.03-7.00 (comp, 2 H), 6.86-82 (m, 1 H), 
5.08 (td, J = 10.8, 4.6 Hz, 1 H), 3.99 (dd, J = 10.7, 9.3 Hz, 1 H), 3.80 (s, 3 H), 2.77 (dd, J 
= 13.8, 10.7 Hz, 1 H), 2.39 (dd, J = 13.8, 9.3 Hz, 1 H), 2.17 (ddd, J = 12.2, 10.8, 3.5 Hz, 
1 H), 1.95-1.90 (m, 1 H), 1.79-1.74 (m, 1 H), 1.66-1.62 (m, 1 H), 1.52-1.42 (m, 1 H),  
1.34 (s, 3H), 1.24 (s, 3 H), 1.26-1.10 (comp, 2 H), 1.15 (s, 3H), 0.88 (d, J = 6.6 Hz, 3 H), 
0.80 (s, 3 H); 13C NMR (125 MHz) δ 210.1, 177.2, 169.9, 151.1, 149.7, 140.2, 129.0, 
127.8, 125.9, 125.4, 124.9, 124.8, 124.3, 115.2, 77.6, 56.6, 53.7, 52.9, 50.9, 50.5, 41.7, 
39.7, 34.2, 31.9, 31.4, 28.1, 26.5, 24.7, 21.7, 20.9, 18.0; IR (neat) 2955, 1760, 1727, 
1464, 1284, 1245, 1160 cm-1; mass spectrum (CI) m/z 546.2855 [C33H40NO6 (M+1) 
requires 546.2856], 530, 546 (base), 574. 
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.86-7.76 (m, 1 H, C9-H or 
C12-H), 7.38-7.34 (m, 1 H, C10-H or C11-H), 7.29-7.27 (m, 1 H, C9-H or C12-H), 7.23 
(dd, J = 8.5, 1.1 Hz, 2 H, C28-H), 7.20 (td, J = 7.5, 1.1 Hz, 1 H, C10-H or C11-H), 7.03-
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7.00 (comp, 2 H, C29-H), 6.86-82 (m, 1 H, C30-H), 5.08 (td, J = 10.8, 4.6 Hz, 1 H, C17-
H), 3.99 (dd, J = 10.7, 9.3 Hz, 1 H, C5-H), 3.80 (s, 3 H, C32-H), 2.77 (dd, J = 13.8, 10.7 
Hz, 1 H, C4-H), 2.39 (dd, J = 13.8, 9.3 Hz, 1 H, C4-H), 2.17 (ddd, J = 12.2, 10.8, 3.5 Hz, 
1 H, C22-H), 1.95-1.90 (m, 1 H, C18-H), 1.79-1.74 (m, 1 H, C21-H), 1.66-1.62 (m, 1 H, 
C20-H), 1.52-1.42 (m, 1 H, C19-H),  1.34 (s, 3H, C24-H or C25-H), 1.24 (s, 3 H, C15-H 
or C-16), 1.26-1.10 (comp, 2 H, C18-H, C21-H), 1.15 (s, 3H, C24-H or C25-H), 0.88 (d, 
J = 6.6 Hz, 3 H, C26-H), 0.80 (s, 3 H, C15-H or C16-H); 13C NMR (125 MHz) δ 210.1 
(C6), 177.2 (C2), 169.9 (C31), 151.1 (C14), 149.7 (C27), 140.2 (C13), 129.0 (C10 or 
C11), 127.8 (C29), 125.9 (C8), 125.4 (C28), 124.9 (C9 or C12), 124.8 (C30), 124.3 (C10 
or C11), 115.2 (C9 or C12), 77.6 (C17), 56.6 (C3), 53.7 (C7), 52.9 (C32), 50.9 (C22), 
50.5 (C5), 41.7 (C18), 39.7 (C23), 34.2 (C20), 31.9 (C4), 31.4 (C19), 28.1 (C15 or C16), 












































Triflate 4.80 (mp5-082). A solution of potassium hexamethyldisilazide (4.0 mL, 
0.5 M, 1.98 mmol) in toluene was added to a stirred solution of 4.79 (542 mg, 0.99 
mmol) in toluene (10 mL) at –78 ˚C. The reaction was stirred for 20 min, whereupon 
Tf2O (0.67 mL, 3.96 mmol) was added. The cold bath removed, and the reaction was 
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stirred 2 h, whereupon it was poured into a separatory funnel containing saturated 
aqueous NaHCO3 (75 mL). The mixture was extracted with EtOAc (3 x 70 mL), and the 
combined organic layers were dried (Na2SO4). The solvent was removed under reduced 
pressure, and the residue was purified by flash chromatography eluting with hexanes / 
EtOAc (4:1) to give 509 mg (76%) of 4.80 as a tan oil; 1H NMR (500 MHz, CDCl3) δ 
7.73 (d, J = 7.8 Hz, 1 H), 7.34-7.30 (m, 1 H), 7.29-7.27 (m, 1 H), 7.24-7.22 (comp, 2 H), 
7.14 (td, J = 7.6, 1.0 Hz, 1 H), 7.00-6.96 (comp, 2 H), 6.85-6.81 (m, 1 H), 5.10 (td, J = 
10.7, 4.6 Hz, 1 H), 3.84 (s, 3 H), 3.13 (d, J = 16.3 Hz, 1 H), 2.90 (d, J = 16.3 Hz, 1 H), 
2.18 (ddd, J = 12.2, 10.7, 3.6 Hz, 1 H), 1.96-1.91 (m, 1 H), 1.78 (dq, J = 13.4, 3.6 Hz, 1 
H), 1.68-1.63 (m, 1 H), 1.52-1.44 (m, 1 H),  1.35 (s, 3H), 1.24 (s, 3 H), 1.17-1.11 (comp, 
1 H), 1.14 (s, 3H), 0.96-0.90 (m, 1 H), 0.93 (s, 3 H), 0.87 (d, J = 6.6 Hz, 3 H); 13C NMR 
(125 MHz) δ 173.8, 162.2, 155.9, 151.0, 149,7, 139.2, 129.9, 128.0, 127.8, 125.4, 124.9, 
124.4, 123.9, 119.4, 115.1, 77.4, 56.4, 52.1, 52.0, 50.6, 41.7, 39.7, 37.1, 34.2, 31.5, 28.3, 
26.5, 24.6, 21.8, 21.7, 21.2; IR (neat) 2957, 1769, 1727, 1428, 1241, 1214, 1138, 1088, 
845, 765 cm-1; mass spectrum (CI) m/z 678.2345 [C34H39F3NO8 S(M+1) requires 
678.2348], 388,420, 678 (base).   
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 7.8 Hz, 1 H, C9-
H or C12-H), 7.34-7.30 (m, 1 H, C10-H or C11-H), 7.29-7.27 (m, 1 H, C9-H or C12-H), 
7.24-7.22 (comp, 2 H, C28-H), 7.14 (td, J = 7.6, 1.0 Hz, 1 H, C10-H or C11-H), 7.00-
6.96 (comp, 2 H, C29-H), 6.85-6.81 (m, 1 H, C30-H), 5.10 (td, J = 10.7, 4.6 Hz, 1 H, 
C17-H), 3.84 (s, 3 H, C32-H), 3.13 (d, J = 16.3 Hz, 1 H, C4-H), 2.90 (d, J = 16.3 Hz, 1 
H, C4-H), 2.18 (ddd, J = 12.2, 10.7, 3.6 Hz, 1 H, C22-H), 1.96-1.91 (m, 1 H, C18-H), 
1.78 (dq, J = 13.4, 3.6 Hz, 1 H, C21-H), 1.68-1.63 (m, 1 H, C20-H), 1.52-1.44 (m, 1 H, 
C19-H),  1.35 (s, 3H, C24-H or C25-H), 1.24 (s, 3 H, C15-H or C-16), 1.17-1.11 (comp, 
1 H, C21-H), 1.14 (s, 3H, C24-H or C25-H), 0.96-0.90 (m, 1 H, C20-H), 0.93 (s, 3 H, 
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C15-H or C16-H), 0.87 (d, J = 6.6 Hz, 3 H, C26-H); 13C NMR (125 MHz) δ 173.8 (C2), 
162.2 (C31), 155.9 (C6), 151.0 (C14), 149,7 (C27), 139.2 (C13), 129.9 (C10 or C11), 
128.0 (C8), 127.8 (C29), 125.4 (C28), 124.9 (C30), 124.4 (C10 or C11), 123.9 (C9 or 
C10), 119.4 (C5), 115.1 (C9 or C12), 77.4 (C17), 56.4 (C3), 52.1 (C7), 52.0 (C32), 50.6 
(C22), 41.7 (C18), 39.7 (C23), 37.1 (C4), 34.2 (C20), 31.5 (C19), 28.3 (C15 or C16), 









































Enoate 4.84 (mp4-023). Dibromoethane (13 mg, 6 μL, 0.07 mmol) was added to 
a suspension of zinc (124 mg, 1.89 mmol) in THF (0.2 mL), and the resulting mixture 
was heated to 65 ˚C for 1 min. The mixture was allowed to cool to room temperature, and 
TMSCl (6 mg, 7 μg, 0.06 mmol) was added. The mixture was stirred for 15 min, 
whereupon a solution of 4-chloro-1-iodobutane (393 mg, 0.22 mL, 1.80 mmol) in THF (1 
mL) was added, and the reaction was stirred over night at 35 ˚C. The opaque supernate 
was transferred via cannula to a separate flask leaving unreacted zinc behind, and the 
solids were washed with THF (2 x 0.5 mL). The solution was cooled to –78 ˚C, and a 
solution of MeLi (1.10 mL, 1.56 M, 1.72 mmol) was added followed by a solution of 
CuCN (95 mg, 1.06 mmol) and LiCl (89 mg, 2.11 mmol) in THF (2.1 mL). The mixture 
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was stirred at –78 ˚C for 10 min, whereupon a solution of 4.80 (41 mg, 0.06 mmol) in 
THF (1.5 mL) was added. The cold bath was removed, and the reaction was stirred 1 h, 
whereupon a mixture of saturated aqueous NH4Cl/NH4OH (9:1, 5 mL) was added, and 
resulting slurry was stirred for 30 min. The layers were separated, and the aqueous layer 
was extracted with Et2O (3 x 10 mL). The combined organic extracts were dried 
(Na2SO4), and the solvent was removed under reduced pressure. The residue was purified 
by flash chromatography eluting with hexanes / EtOAc (2:1) to provide 29 mg (77%) of 
4.84 as a pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.70-7.68 (m, Hz, 1 H), 7.28-
7.26 (m, 1 H), 7.25-7.23 (comp, 2 H), 7.19 (dd, J = 7.6, 1.8 Hz, 1 H), 7.08 (td, J = 7.4, 
1.0 Hz, 1 H), 7.01 (t, J = 7.4, 1.0 Hz 2 H), 6.87-6.84 (m, 1 H), 5.10 (td, J = 10.8, 4.6 Hz, 
1 H), 3.75 (s, 3 H), 3.57 (td, J = 6.6, 1.2 Hz, 1 H), 3.08 (d, J = 16.3 Hz, 1 H), 2.80 (d, J = 
16.3 Hz, 1 H), 2.48-2.37 (comp, 2 H), 2.17 (ddd, J = 14.3, 10.6, 3.6 Hz, 1 H), 1.99-1.94 
(m, 1 H), 1.96-1.85 (comp, 2 H), 1.74-1.60 (comp, 4 H), 1.51-1.43 (m, 1 H), 1.35 (s, 3H), 
1.25 (s, 3 H), 1.28-1.22 (m, 1 H), 1.18-1.09 (m, 1 H), 1.03 (s, 3H), 0.88 (d, J = 6.4 Hz, 3 
H), 0.84 (s, 3H); 13C NMR (125 MHz) δ 175.2, 165.5, 163.6, 150.9, 149.9, 139.1, 130.0, 
128.2, 127.8, 125.4, 125.0, 124.9, 123.9, 123.7, 114.8, 72.9, 58.7, 56.2, 51.3, 50.6, 44.6, 
41.8, 40.6, 39.8, 34.3, 33.1, 31.5, 27.7, 26.6, 26.5, 26.4, 25.3, 23.2, 22.2, 21.7; IR (neat) 
2956, 1767, 1716, 1358, 1293, 1250 cm-1; mass spectrum (CI) m/z 619.3069 
[C37H46NO5Cl(M+) requires 619.3069], 585, 620, 621 (base), 623, 624. 
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.70-7.68 (m, Hz, 1 H, C9-H 
or C12-H), 7.28-7.26 (m, 1 H, C10-H or C11-H), 7.25-7.23 (comp, 2 H, C28-H), 7.19 
(dd, J = 7.6, 1.8 Hz, 1 H, C9-H or C12-H), 7.08 (td, J = 7.4, 1.0 Hz, 1 H, C10-H or C11-
H), 7.01 (t, J = 7.4, 1.0 Hz 2 H, C29-H), 6.87-6.84 (m, 1 H, C30-H), 5.10 (td, J = 10.8, 
4.6 Hz, 1 H, C17-H), 3.75 (s, 3 H, C32-H), 3.57 (td, J = 6.6, 1.2 Hz, 1 H, C33-H), 3.08 
(d, J = 16.3 Hz, 1 H, C4-H), 2.80 (d, J = 16.3 Hz, 1 H, C4-H), 2.48-2.37 (comp, 2 H, 
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C36-H), 2.17 (ddd, J = 14.3, 10.6, 3.6 Hz, 1 H, C22-H), 1.99-1.94 (m, 1 H, C18-H), 1.96-
1.85 (comp, 2 H, C34-H), 1.74-1.60 (comp, 4 H, C20-H, C21-H, C35-H), 1.51-1.43 (m, 1 
H, C19-H), 1.35 (s, 3H, C24-H or C25-H), 1.25 (s, 3 H, C15-H or C-16), 1.28-1.22 (m, 1 
H, C18-H), 1.18-1.09 (m, 1 H, C21-H), 1.03 (s, 3H, C15-H or C16-H), 0.88 (d, J = 6.4 
Hz, 3 H, C26-H), 0.84 (s, 3H, C15-H or C16-H); 13C NMR (125 MHz) δ 175.2 (C2), 
165.5 (C31), 163.6 (C6), 150.9 (C14), 149.9 (C27), 139.1 (C13), 130.0 (C5), 128.2 (C10 
or C11), 127.8 (C29), 125.4 (C28), 125.0 (C30), 124.9 (C8), 123.9 (C10 or C11), 123.7 
(C9 or C12), 114.8 (C9 or C12), 72.9 (C17), 58.7 (C3), 56.2 (C7), 51.3 (C32), 50.6 
(C22), 44.6 (C33), 41.8 (C18), 40.6 (C4), 39.8, (C23), 34.3 (C20), 33.1 (C34), 31.5 
(C19), 27.7 (C15 or C16), 26.6 (C21 or C35 or C36), 26.5 (C21 or C35 or C36), 26.4 









(1-Methyl-3-oxopropyl)carbamic acid benzyl ester (4.90) (mp3-224, mp3-225, 
mp3-226). A solution of SO3⋅Py (9.0 g, 57.0 mmol) in DMSO (60 mL) was added to a 
solution of 4.88 (4.0 g, 19.1 mmol) and Et3N (7.9 mL, 57.0 mmol) in CH2Cl2 (60 mL) at 
−10 °C. The cold bath was removed and the reaction was stirred for 15 min, whereupon it 
was poured into brine (200 mL) and crushed ice (200 mL). The aqueous mixture was 
extracted with Et2O (3 x 200 mL), and the combined organic layers were washed with 
10% citric acid (100 mL) and brine (100 mL). The organic layer was dried (Na2SO4) and 
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concentrated under reduced pressure to give the crude 4.89, which was used in the next 
step without further purification. In a separate flask NaHMDS (13.4 mL, 2.0 M, 26.7 
mmol) was added to a slurry of (methoxymethyl)triphenylphosphonium bromide (9.15 g, 
26.7 mmol) in THF (60 mL) at −78 °C. The cold bath was replaced with a 0 °C ice bath, 
and the reaction was stirred at this temperature for 40 min. The reaction was cooled to 
−78 °C, and a solution of the crude 4.89 in THF (40 mL) was added drop wise. The cold 
bath was replaced with a 0 °C ice bath, and the reaction was stirred at this temperature for 
40 min and then at room temperature for 30 min. The reaction was diluted in Et2O (200 
mL) and filtered through celite. The solids were washed with Et2O (100 mL), and the 
combined washings and filtrate were washed with 1 M HCl (3 x 100 mL) and a 50% 
saturated aqueous solution of NaHCO3 (100 mL). The organic layer was dried (Na2SO4) 
and concentrated under reduced pressure. The residue was filtered through a pug of silica 
eluting with Et2O, and the volatiles were removed under reduced pressure. The residue 
was dissolved in acetone (50 mL), and TsOH⋅H2O (1.82 g, 9.55 mmol) was added. The 
reaction was stirred at room temperature over night, whereupon the solvent was removed 
under reduced pressure. The residue was dissolved in EtOAc (200 mL) and washed with 
a saturated aqueous solution of NaHCO3 (100 mL). The organic layer was dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes/EtOAc (2:1) to 1.82 g (43%) of 4.90 as a clear 


















N-(3-Hydoxy-1-methyl-hex-5-enyl)-3-phenylpropionamide (4.91) (mp3-092). 
A solution of allylmagnesium bromide (0.35 mL, 1.0 M, 0.35 mmol) was added to a 
solution of (-)-DIP-Cl (134 mg, 0.42 mmol) in Et2O (2 mL) cooled to –78 ˚C. The 
reaction was stirred at –78 ˚C for 5 min, whereupon the cold bath was replaced with and 
ice water bath and the mixture was stirred for 1 h. The reaction was cooled to –78 ˚C, 
whereupon a solution of aldehyde 4.90 (70 mg, 0.32 mmol) in Et2O (0.7 mL + 0.3 mL 
rinse) was added via canula. Stirring was continued for 1 h, whereupon phosphate buffer 
(2 mL) and MeOH (2 mL) were added and the cold bath was removed. After stirring for 
30 min, the reaction was poured into a separatory funnel containing saturated aqueous 
NaHCO3 (10 mL), and extracted with ether (3 x 10 mL). The combined organic extracts 
were dried (Na2SO4) and concentrated under reduced pressure, and the residue was 
purified by flash chromatography eluting with hexanes/EtOAc (2:1 → 1:1) to 55 mg 
(66%) of 4.91 as a clear colorless oil; 1NMR (500 MHz) δ 7.34-7.27 (comp, 5 H), 5.82-
5.73 (m, 1 H), 5.12-5.04 (comp, 4 H), 4.98 (br s, 1 H), 3.87-3.80 (m, 1 H),  3.74-3.69 (m, 
1 H), 2.31-2.22 (m,  H), 2.18-2.11 (m, H), 1.63-1.52 (comp, 2 H), 1.17 (d, J = 6.6 Hz, 3 
H); 13C NMR (125 MHz) δ 156.0, 136.6, 134.4, 128.5, 128.0, 118.3, 68.8, 66.5, 45.7, 
43.7, 42.3, 21.6; IR (neat) 3325, 3069, 2973, 2932, 1694, 1537, 1257, 1088, 915, 697 cm-
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1; mass spectrum (CI) m/z 264.1597 [C15H22NO3 (M+1) requires 264.1600], 220, 246, 
264 (base), 354.  
NMR Assignments. 1NMR (500 MHz) δ 7.34-7.27 (comp, 5 H, C11-H, C12-H, 
C13-H), 5.82-5.73 (m, 1 H, C6-H), 5.12-5.04 (comp, 4 H, C7-H, C9-H), 4.98 (br s, 1 H, 
NH), 3.87-3.80 (m, 1 H, C1-H),  3.74-3.69 (m, 1 H, C4-H), 2.31-2.22 (m,  H, C5-H), 
2.18-2.11 (m, H, C5-H), 1.63-1.52 (comp, 2 H, C3-H), 1.17 (d, J = 6.6 Hz, 3 H, C2-H); 
13C NMR (125 MHz) δ 156.0 (C8), 136.6 (C10), 134.4 (C6), 128.5 (Ar-C), 128.0 (Ar-C), 





















(4.92) (mp3-106). 2,6-lutidine (83 mg, 90 μL, 0.76 mmol) followed by TIPSOTf (171 
mg, 0.15 mL, 0.57 mmol) were added to a solution of 4.91 (100 mg, 0.38 mmol) in 
CH2Cl2 (3.8 mL) cooled to 0 ˚C. The reaction was stirred at 0 ˚C for 40 min, whereupon 
MeOH (0.5 mL) was added and the reaction. Stirring was continued for 5 min, 
whereupon the reaction mixture was poured into a separatory funnel containing 0.5 M 
HCl (15 mL), and extracted with ether (3 x 15 mL). The combined organic extracts were 
dried (Na2SO4) and concentrated under reduced pressure, and the residue was purified by 
flash chromatography eluting with 10% Et2O/pentane to give 159 mg (99%) of 4.92 as a 
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white solid: mp = 45-47 ˚C; 1NMR (500 MHz) δ 7.35-7.27 (comp, 5 H), 5.85-5.79 (m, 1 
H), 5.07-5.03 (comp, 4 H), 4.66 (d, J = 6.8 Hz, 1 H), 3.95-3.92 (m, 1 H),  3.83-3.77 (m, 1 
H), 2.58-2.30 (comp, 2 H), 1.68-1.52 (comp, 2 H), 1.15 (d, J = 6.4 Hz, 3 H), 1.05-0.97 
(m, 3 H) 1.03 (s, 18 H); 13C NMR (125 MHz) δ 155.6, 136.7, 134.4, 128.5, 128.1, 128.0, 
117.4, 69.8, 66.4, 44.8, 43.8, 41.3, 22.2, 18.15, 18.13, 12.6; IR (neat) 3315, 2942, 2866, 
1696, 1536, 1462, 1254, 1088, 1056 cm-1; mass spectrum (CI) m/z 420.2932 
[C24H42NO3Si (M+1) requires 420. 2934], 246, 376 (base), 420.  
NMR Assignments. 1NMR (500 MHz) δ 7.35-7.27 (comp, 5 H, C11-H, C12-H, 
C13-H), 5.85-5.79 (m, 1 H, C6-H), 5.07-5.03 (comp, 4 H, C7-H, C9-H), 4.66 (d, J = 6.8 
Hz, 1 H, NH), 3.95-3.92 (m, 1 H, C4-H),  3.83-3.77 (m, 1 H, C1-H), 2.58-2.30 (comp, 2 
H, C5-H), 1.68-1.52 (comp, 2 H, C3-H), 1.15 (d, J = 6.4 Hz, 3 H, C2-H), 1.05-0.97 (m, 3 
H, C15-H) 1.03 (s, 18 H, C14-H); 13C NMR (125 MHz) δ 155.6 (C8), 136.7 (C10), 134.4 
(C6), 128.5 (Ar-C), 128.1 (Ar-C), 128.0 (Ar-C), 117.4 (C7), 69.8 (C4), 66.4 (C9), 44.8 


















(4.95) (mp3-202, mp3-213). Hg(OAc)2 (57 mg, 0.18 mmol) was added to a solution of 
4.92 (30 mg, 0.07 mmol) in THF (2.1 mL) and the reaction was stirred at room 
temperature for 2 days. A saturated aqueous solution of KBr was added and the mixture 
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was stirred for 1.5 h, whereupon it was poured into H2O (10 mL) and extracted with 
EtOAc (3 x 10 mL). The combined organic extracts were dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
eluting with 20% Et2O/pentane to give 35 mg (70%) of 4.94, which was dissolved in 
CH2Cl2 (1 mL). Iodine (19 mg, 0.15 mmol) was added and the reaction was heated to 45 
°C for 2 h, whereupon the reaction was allowed to cool to room temperature. A saturated 
aqueous solution of Na2S2O3 (0.5 mL) was added, and the slurry was poured into H2O (4 
mL) and extracted with CH2Cl2 (2 x 4 mL). The combined organic extracts were dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with EtOAc/hexanes (1:3) to give 10 mg (61%) of 4.95, as a 
white solid: 1NMR (400 MHz) δ 4.31 (t, J = 7.9 Hz, 1 H), 4.31-4.27 (m, 1 H), 4.03 (dtd, J 
= 11.3, 7.9, 3.1 Hz, 1 H), 3.75 (t, J = 7.9 Hz, 1 H), 3.72-3.63 (m, 1 H), 1.88-1.82 (m, 1 
H), 1.74-1.72 (m, 1 H), 1.56 (d, J = 6.5 Hz, 3 H), 1.52-1.43 (comp, 2 H), 1.11-0.99 
(comp, 21 H). 
NMR Assignments. 1NMR (400 MHz) δ 4.31 (t, J = 7.9 Hz, 1 H, C7-H), 4.31-
4.27 (m, 1 H, C4-H), 4.03 (dtd, J = 11.3, 7.9, 3.1 Hz, 1 H, C6-H), 3.75 (t, J = 7.9 Hz, 1 H, 
C7-H), 3.72-3.63 (m, 1 H, C2-H), 1.88-1.82 (m, 1 H, C3-H or C5-H), 1.74-1.72 (m, 1 H, 
C3-H or C5-H), 1.56 (d, J = 6.5 Hz, 3 H, C9-H), 1.52-1.43 (comp, 2 H, C3-H or C5-H), 


















N-(3-Hydoxy-1-methyl-hex-5-enyl)-3-phenylpropionamide (mp3-227). A 
solution of allylmagnesium bromide (9.1 mL, 1.0 M, 9.1 mmol) was added to a stirred 
solution of (-)-DIP-Cl (3.50 g, 10.9 mmol) in Et2O (50 mL) at –78 ˚C. The reaction was 
stirred at –78 ˚C for 5 min, whereupon the cold bath was replaced with an ice water bath, 
and the mixture was stirred for 1 h. The reaction was cooled to –78 ˚C, whereupon a 
solution of aldehyde 4.90 (1.82 g, 8.23 mmol) in Et2O (20 mL + 5 mL rinse) was added 
via canula. Stirring was and for 1 h, whereupon phosphate buffer (40 mL), MeOH (40 
mL), and a 30% aqueous solution of H2O2 (20 mL) were added. The cold bath was 
removed, and stirring was continued for 30 min. The reaction was poured into a 
separatory funnel containing saturated aqueous NaHCO3 (100 mL), and the mixture was 
extracted with Et2O (3 x 100 mL). The combined organic extracts were dried (Na2SO4), 
and the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography, eluting with hexanes/EtOAc (2:1) to 1.46 g (67%) of the title compound 
as a clear colorless oil; 1NMR (500 MHz) δ 7.40-7.32 (comp, 5 H), 5.90-5.81 (m, 1 H), 
5.14-5.09 (comp, 4 H), 4.82 (br d, J =7.4 Hz, 1 H), 4.08-3.98 (m, 1 H),  3.76-3.68 (m, 1 
H), 2.31-2.18 (comp, 2 H), 1.58 (ddd, J = 14.1, 10.6, 3.2 Hz, 1 H), 1.42 (ddd, J = 14.1, 
10.4, 2.2 Hz, 1 H), 1.22 (d, J = 6.6 Hz, 3 H); 13C NMR (125 MHz) δ 157.0, 136.4, 135.1, 
128.5, 128.2, 128.1, 117.3, 67.2, 66.9, 44.9, 44.1, 41.6, 21.4; IR (neat) 3322, 2972, 2932, 
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1537, 1693, 1255, 1043 cm-1; mass spectrum (CI) m/z 264.1600 [C15H22NO3 (M+1) 
requires 264.1600], 220, 246, 264 (base).        
NMR Assignments. 1NMR (500 MHz) δ 7.40-7.32 (comp, 5 H, C12-H, C13-H, 
C14-H), 5.90-5.81 (m, 1 H, C7-H), 5.14-5.09 (comp, 4 H, C8-H, C10-H), 4.82 (br d, J 
=7.4 Hz, 1 H, NH), 4.08-3.98 (m, 1 H, C2-H),  3.76-3.68 (m, 1 H, C5-H), 2.31-2.18 
(comp, 2 H, C6-H), 1.58 (ddd, J = 14.1, 10.6, 3.2 Hz, 1 H, C4-H), 1.42 (ddd, J = 14.1, 
10.4, 2.2 Hz, 1 H, C4-H), 1.22 (d, J = 6.6 Hz, 3 H, C3-H); 13C NMR (125 MHz) δ 157.0 
(C9), 136.4 (C11), 135.1 (C7), 128.5 (Ar-C), 128.2 (Ar-C), 128.1 (Ar-C), 117.3 (C8), 






















(4.97) (mp3-228). 2,6-Lutidine (1.19 g, 1.29 mL, 11.1 mmol) and TIPSOTf (2.55 g, 2.23 
mL, 8.31 mmol) were added to a stirred solution of N-(3-hydoxy-1-methyl-hex-5-enyl)-3-
phenylpropionamide (1.46 g, 5.54 mmol) in CH2Cl2 (50 mL) at 0 ˚C. The reaction was 
stirred at 0 ˚C for 1.5 h, whereupon MeOH (2 mL) was added. Stirring was continued for 
5 min, whereupon the reaction mixture was poured into a separatory funnel containing 
0.5 M HCl (50 mL). The mixture was extracted with ether (3 x 50 mL), and the combined 
organic extracts were washed with brine (50 mL), dried (Na2SO4) and concentrated 
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under reduced pressure. The residue was purified by flash chromatography eluting with 
10% → 20% Et2O in pentane in water give 1.50 g (66%) of 4.97 as colorless oil; 1NMR 
(500 MHz) δ 7.33-7.25 (comp, 5 H), 5.73 (ddt, J = 17.3, 10.2, 7.1 Hz, 1 H), 5.32, (br s, 1 
H), 5.08-5.02 (comp, 4 H), 4.01-3.96 (m, 1 H), 3.86-3.80 (m, 1 H),  2.34-2.29 (comp, 2 
H), 1.68-1.54 (comp, 2 H), 1.17 (d, J = 5.5 Hz, 3 H), 1.07-1.0 (comp, 21 H); 13C NMR 
(125 MHz) δ 155.8, 136.8, 134.2, 128.4, 127.92, 127.88, 117.6, 70.2, 66.3, 44.5, 42.2, 
41.3, 21.8, 18.2, 18.1, 12.6, 12.3; IR (neat) 3338, 2942, 2866 1701, 1463, 1259, 1060, 
883 cm-1 mass spectrum (CI) m/z 420.2932 [C24H42NO3Si (M+1) requires 420. 2934], 
246, 376 (base), 420.  
NMR Assignments. 1NMR (500 MHz) δ 7.33-7.25 (comp, 5 H, C12-H, C13-H, 
C14-H), 5.73 (ddt, J = 17.3, 10.2, 7.1 Hz, 1 H, C7-H), 5.32, (br s, 1 H, NH), 5.08-5.02 
(comp, 4 H, C8-H, C10-H), 4.01-3.96 (m, 1 H, C5-H), 3.86-3.80 (m, 1 H, C2-H),  2.34-
2.29 (comp, 2 H, C6-H), 1.68-1.54 (comp, 2 H, C4-H), 1.17 (d, J = 5.5 Hz, 3 H, C3-H), 
1.07-1.0 (comp, 21 H, C15-H, C16-H); 13C NMR (125 MHz) δ 155.8 (C9), 136.8 (C11), 
134.2 (C7), 128.4 (Ar-C), 127.92 (Ar-C), 127.88 (Ar-C), 117.6 (C8), 70.2 (C5), 66.3 





























silanyloxy)-propionic acid methyl ester (4.105), (mp4-035, mp4-036, mp4-039). A 
solution of 4.103 (2.00 g, 12.9 mmol), TBSCl (2.90 g, 19.4 mmol) and imidazole (3.10 g, 
45.2 mmol) in CH2Cl2 (64 mL) was stirred at room temperature for 4 h, whereupon it 
was poured into EtOAc (300 mL). The mixture was washed with 0.5 M HCl (2 x 100 
mL), and the organic layer was dried (Na2SO4). The solvent was removed under reduced 
pressure, and the residue was dissolved in CH2Cl2 (60 mL). Et3N (6.3 mL, 45.2 mmol) 
and NsCl (4.30 g, 19.4 mmol) were added, and the reaction was stirred at room 
temperature for 1 h, whereupon it was poured into EtOAc (300 mL) and washed with a 
saturated aqueous solution of NaHCO3 (100 mL), 1 M KHSO4 (2 x 50 mL), 0.5 M HCl 
(100 mL) and brine (100 mL).  The organic layer was dried (Na2SO4) and concentrated 
under reduced pressure. The residue was purified by flash chromatography eluting with 
EtOAc / hexanes (1:1) to give 5.2 g (96%) of 4.104 as a yellow oil. DEAD (3.00 mL, 
19.1 mmol) was added dropwise over 10 min to a solution of 4.104 (4.00 g, 9.56 mmol) 
and PPh3 (6.00 g, 22.9 mmol) in THF (50 mL) at 0 °C. The ice bath was removed, and 
the reaction was stirred overnight. The solvent was removed under reduced pressure, and 
the residue was purified by flash chromatography eluting with EtOAc / hexanes (1:2) to 
give 3.7 g (82%) of 4.105 as a yellow oil. 1NMR (400 MHz) δ 8.08-8.05 (m, 1 H), 7.68-
7.63 (comp, 2 H), 7.58-7.54 (m, 1 H), 5.75-5.64 (m, 1 H), 5.06-4.98 (comp, 2 H), 4.77 
(dd, J = 5.5, 2.7 Hz, 1 H), 4.22 (dd, J = 11.0, 5.5 Hz, 1 H), 4.04 (dd, J = 11.0, 2.7 Hz, 1 
H), 3.60 (s, 3 H), 3.58-3.41 (comp, 2 H), 0.83 (s, 9), 0.04 (s, 3 H), 0.03 (s, 3 H). 
NMR Assignments. 1NMR (400 MHz) δ 8.08-8.05 (m, 1 H, C15-H), 7.68-7.63 
(comp, 2 H, C16-H, C17-H), 7.58-7.54 (m, 1 H, C18-H), 5.75-5.64 (m, 1 H, C3-H), 5.06-
4.98 (comp, 2 H, C4-H), 4.77 (dd, J = 5.5, 2.7 Hz, 1 H, C5-H), 4.22 (dd, J = 11.0, 5.5 Hz, 
1 H, C8-H), 4.04 (dd, J = 11.0, 2.7 Hz, 1 H, C8-H), 3.60 (s, 3 H, C7-H), 3.58-3.41 (comp, 
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propionic acid methyl ester (4.106), (mp4-040, mp4-041). K2CO3 (3.16 g, 22.9 mmol) 
was added to a solution of 4.105 (3.6 g, 6.62 mmol) and thiophenol (0.95 mL, 9.14 
mmol) in DMF (20 mL) at 0 °C. The reaction was stirred at 0 °C for 1 h, whereupon it 
was poured into Et2O (150 mL) and washed with brine (75 mL). The organic layer was 
dried (Na2SO4) and concentrated under reduced pressure. The residue was dissolved in 
THF (40 mL) and Boc2O (2.4 mL) and DMAP (93 mg, 0.76 mmol) were added. The 
reaction was stirred at room temperature overnight, whereupon it was concentrated under 
reduced pressure. The residue was purified by flash chromatography eluting with EtOAc 
/ hexanes (1:8) to give 1.3 g (52%) of 4.106 as a pale yellow oil; 1NMR (500 MHz) δ 
5.78-5.72 (m, 1 H), 5.09-5.00 (comp, 2 H), 4.40 (dd, J = 7.5, 3.8 Hz, 0.6 H), 4.34 (dd, J = 
7.5, 4.1 Hz, 0.4 H), 4.17-4.04 (comp, 2 H), 3.64-3.48 (m, 1 H), 3.71 (s, 3 H), 3.37-3.29 
(m, 1 H), 2.45-2.35 (comp, 2 H), 1.51 (s, 5.4 H), 1.49 (s, 3.6 H), 0.86 (s, 3.6 H), 0.85 (s, 
5.4 H), 0.05-0.03 (comp, 3 H). 
NMR Assignments. 1NMR (500 MHz) δ 5.78-5.72 (m, 1 H, C3-H), 5.09-5.00 
(comp, 2 H, C4-H), 4.40 (dd, J = 7.5, 3.8 Hz, 0.6 H, C5-H), 4.34 (dd, J = 7.5, 4.1 Hz, 0.4 
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H, C5-H), 4.17-4.04 (comp, 2 H, C8-H), 3.64-3.48 (m, 1 H, C1-H), 3.71 (s, 3 H, C7-H), 
3.37-3.29 (m, 1 H, C1-H), 2.45-2.35 (comp, 2 H, C2-H), 1.51 (s, 5.4 H, C15-H), 1.49 (s, 
























butyl ester (4.102) (mp4-057, mp4-058). A mixture of K2CO3 (642 mg, 4.65 mmol) and 
4.114 (940 mg, 4.65 mmol) in CH3CN (20 mL), was stirred at room temperature for 30 
min. 4-Bromo-1-butene (630 mg, 0.47 mL, 4.65 mmol) was added, and the reaction was 
heated under reflux overnight.  The reaction was allowed to cool to room temperature and 
the solids were removed by filtration through celite. The solids were rinsed with CH2Cl2 
(50 mL), and the solvent was removed in vacuo. The residue was dissolved in CH2Cl2 
(80 mL) and poured into aqueous saturated NaHCO3 (50 mL). The layers were separated, 
and the aqueous layer was extracted with CH2Cl2 (2 x 50 mL). The combined organic 
layers were dried (Na2SO4) and concentrated under reduced pressure, and the residue 
was dissolved in THF (18 mL) and cooled to 0 ˚C. Et3N (1.25 g, 1.70 mL, 12.3 mmol) 
was added, and then Boc2O (1.33 g, 1.30 mL, 6.05 mmol) was added slowly dropwise 
over 15 min. The ice bath was removed, and the reaction was stirred for 1.5 h, whereupon 
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additional Boc2O (0.50 g, 0.50 mL, 2.33 mmol) and DMAP (catalytic amount) were 
added. The reaction was stirred for 1 h, whereupon the solvent was removed in vacuo. 
The residue was dissolved in Et2O (100 mL) and poured into 0.5 M HCl (50 mL). The 
layers were separated, and the aqueous layer was extracted with Et2O (2 x 50 mL). The 
combined organic layers were washed with brine (50 mL), dried (Na2SO4) and 
concentrated under reduced pressure, and the residue was purified by flash 
chromatography eluting with hexanes / Et2O (19:1 → 9:1) to give 841 mg (51 %) of 
4.102 as a pale yellow oil; 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 5.91-5.84 (m, 1 H), 
5.77 (ddt, J = 17.1, 10.2, 6.8 Hz, 1 H), 5.18-5.13 (comp, 2 H), 5.04-4.97 (comp, 2 H), 
4.25 (app q, J = 6.4 Hz, 1 H), 3.80 (dd, J = 10.3, 7.5 Hz, 1 H), 3.72 (dd, J = 10.3, 5.9 Hz, 
1 H), 3.24-3.11 (comp, 2 H), 2.27 (app q, J = 7.3 Hz, 1 H), 1.42 (s, 9 H), 0.89 (s, 9 H), 
0.05 (s, 6 H); 13C NMR (125 MHz, DMSO d6, 100 ˚C) δ 154.1, 135.5, 134.9, 116.1, 
115.2, 78.1, 62.8, 60.4, 44.8, 33.0, 27.6, 25.1, 17.2, -6.03, -6.07; IR (neat) 2030, 2858, 
1694, 1472, 1409, 1366, 1255, 1175, 1110 cm-1 mass spectrum (CI) m/z 356.2629 
[C19H38NO3Si (M+1) requires 356.2621], 256, 356 (base).  
NMR Assignments. 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 5.91-5.84 (m, 1 H, 
C11-H), 5.77 (ddt, J = 17.1, 10.2, 6.8 Hz, 1 H, C15-H), 5.18-5.13 (comp, 2 H, C12-H), 
5.04-4.97 (comp, 2 H, C16-H), 4.25 (app q, J = 6.4 Hz, 1 H, C5-H), 3.80 (dd, J = 10.3, 
7.5 Hz, 1 H, C6-H), 3.72 (dd, J = 10.3, 5.9 Hz, 1 H, C6-H), 3.24-3.11 (comp, 2 H, C13-
H), 2.27 (app q, J = 7.3 Hz, 1 H, C14-H), 1.42 (s, 9 H, C4-H), 0.89 (s, 9 H, C9-H), 0.05 
(s, 6 H, C7-H, C8-H); 13C NMR (125 MHz, DMSO d6, 100 ˚C) δ 154.1 (C2), 135.5 
(C15), 134.9 (C11), 116.1 (C12), 115.2 (C11), 78.1 (C3), 62.8 (C6), 60.4 (C5), 44.8 






















carboxylic acid tert-butyl ester (4.101) (mp4-059). A degassed solution of Grubbs I 
catalyst (88 mg, 0.11 mmol) and 4.102 (760 mL, 2.14 mmol) in CH2Cl2 (45 mL) was 
stirred at room temperature overnight. The solvent was removed in vacuo, and the residue 
was purified by flash chromatography eluting with hexanes / Et2O (9:1) to give 524 mg 
(75 %) of 4.101 as a clear colorless oil; 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 5.93-5.80 
(m, 1 H), 5.73-5.70 (m, 1 H), 4.29 (br s, 1H), 3.98 (dd, J = 12.9, 5.6 Hz, 1 H), 3.69-3.63 
(comp, 2 H), 3.00-2.89 (m, 1 H), 2.09-1.92 (comp, 2 H), 1.42 (s, 9 H), 0.88 (s, 9 H), 0.04 
(s, 6 H); 13C NMR (125 MHz, DMSO d6, 100 ˚C) δ 153.3, 125.9, 125.7, 78.1, 63.6, 52.7, 
37.1, 27.7, 25.2, 23.9, 17.3, -5.99, -6.02; IR (neat) 2962, 1761, 1521, 1347, 1257, 1217 
cm-1 mass spectrum (CI) m/z 328.2309 [C17H34NO3Si (M+1) requires 328.2308], 228, 
272, 328 (base). 
NMR Assignments. 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 5.93-5.80 (m, 1 H, 
C12-H), 5.73-5.70 (m, 1 H, C11-H), 4.29 (br s, 1H, C5-H), 3.98 (dd, J = 12.9, 5.6 Hz, 1 
H, C14-H), 3.69-3.63 (comp, 2 H, C6-H), 3.00-2.89 (m, 1 H, C14-H), 2.09-1.92 (comp, 2 
H, C13-H), 1.42 (s, 9 H, C4-H), 0.88 (s, 9 H, C9-H), 0.04 (s, 6 H, C7-H, C8-H); 13C 
NMR (125 MHz, DMSO d6, 100 ˚C) δ 153.3 (C2), 125.9 (C12), 125.7 (C11), 78.1 (C3), 
63.6 (C6), 52.7 (C5), 37.1 (C14), 27.7 (C4), 25.2 (C9), 23.9 (C13), 17.3 (C10), -5.99 (C7 
























acid tert-butyl ester (4.117) (mp4-075). 9-BBN (775 mg, 6.35 mmol) was added to a 
solution 4.101 (520 mg, 1.59 mmol) in THF (8 mL), and the mixture was heated under 
reflux for 18 h. The reaction was cooled to 0 ˚C, and a 2 M solution of NaOH (13 mL) 
and 30% aqueous H2O2 (13 mL) were added. The mixture was stirred at 0 ˚C for 1.5, 
whereupon it was poured into Et2O (60 mL). The layers were separated, and the aqueous 
layer was extracted with Et2O (2 x 40 mL). The combined organic layers were dried 
(Na2SO4), and the solvent was removed under reduced pressure to give a residue that was 
purified by flash chromatography eluting with hexanes / EtOAc (2:1 → 1:1) to give 350 
mg (64 %) of 4.117 as a clear colorless oil; 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 4.20-
4.13 (m, 1H), 3.93-3.87 (m, 1 H), 3.77-3.71 (m, 1 H), 3.66-3.56 (comp, 2 H), 3.47-3.40 
(m, 1 H), 2.81 (td, J = 13.3, 2.8 Hz, 1 H), 2.00-1.95 (m, 1 H), 1.79-1.75 (m, 1 H), 1.40 (s, 
9 H), 1.29-1.21 (m, 1 H), 1.19-1.11 (m, 1 H), 0.89 (s, 9 H), 0.05 (s, 6 H, C7-H); 13C 
NMR (125 MHz, DMSO d6, 100 ˚C) δ 153.7, 78.0, 62.8, 61.7, 51.9, 31.3, 34.3, 33.9, 
27.7, 25.3, 17.3, -6.0; IR (neat) 3440, 2930, 2857, 1693, 1671, 1419, 1365, 1253, 1175 
cm-1 mass spectrum (CI) m/z 346.2418 [C17H36NO4Si (M+1) requires 346.2414], 246, 
290, 346, (base).  
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NMR Assignments. 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 4.20-4.13 (m, 1H, 
C5-H), 3.93-3.87 (m, 1 H, C14-H), 3.77-3.71 (m, 1 H, C12-H), 3.66-3.56 (comp, 2 H, 
C6-H), 3.47-3.40 (m, 1 H, C14-H), 2.81 (td, J = 13.3, 2.8 Hz, 1 H, C14-H), 2.00-1.95 (m, 
1 H, C11-H), 1.79-1.75 (m, 1 H, C13-H), 1.40 (s, 9 H, C4-H), 1.29-1.21 (m, 1 H, C11-H), 
1.19-1.11 (m, 1 H, C13-H), 0.89 (s, 9 H, C9-H), 0.05 (s, 6 H, C7-H, C8-H); 13C NMR 
(125 MHz, DMSO d6, 100 ˚C) δ 153.7 (C2), 78.0 (C3), 62.8 (C12), 61.7 (C6), 51.9 (C5), 






























piperidine-1-caroxylic acid tert-butyl ester (4.118) (mp4-076).  A solution of tert-
butyldiphenylchlorosilane (354 mg, 0.34 mL, 1.29 mmol), imidazole (176 mg, 2.59 
mmol), and 4.117 (298 mg, 0.86 mmol) in DMF (4.5 mL) was stirred at 50 ˚C overnight. 
The reaction was allowed to cool to room temperature, and was poured into Et2O (40 
mL). The solution was washed with H2O (2 x 20 mL) and brine (20 mL), and the organic 
layer was dried (Na2SO4). The solvent was removed under reduced pressure, and the 
residue was purified by flash chromatography eluting with hexanes / Et2O (5:1) to give 
398 mg (81%) of 4.118 as a clear colorless oil; 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 
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7.64-7.59 (comp 4 H), 7.45-7.34 (comp, 6 H), 4.26 (br s, 1H), 4.16-4.13 (m, 1 H), 3.99-
3.93 (m, 1 H), 3.59 (dd, J = 10.3, 8.5 Hz, 1 H), 3.48 (dd, J = 10.3, 5.9 Hz, 1 H), 2.80-2.72 
(m, 1 H), 1.93-1.84 (m, 1 H), 1.56-1.47 (comp, 2 H), 1.40 (s, 9 H), 1.38-1.32 (m 1 H), 
1.06 (s, 9 H), 0.79 (s, 9 H), -0.042 (s, 3 H), -0.046 (s, 3 H); 13C NMR (125 MHz, DMSO 
d6, 100 ˚C) δ 154.1, 134.7, 134.6, 133.6, 133.3, 129.08, 129.07, 127.01, 127.00, 77.8, 
65.5, 60.3, 58.8, 27.6, 26.4, 25.9, 25.1, 18.4, 18.1, 17.2, -6.14, -6.19; IR (neat) 2930, 
2857, 1694, 1111, 838 cm-1; mass spectrum (CI) m/z 584.3591 [C33H53NO4Si2 (M-CH3) 
requires 584.3591], 470, 484, 584 (base).  
NMR Assignments. 1NMR (500 MHz, DMSO d6, 100 ˚C) δ 7.64-7.59 (comp 4 
H, Ar-H), 7.45-7.34 (comp, 6 H, Ar-H), 4.26 (br s, 1H, C5-H), 4.16-4.13 (m, 1 H, C12-
H), 3.99-3.93 (m, 1 H, C14-H), 3.59 (dd, J = 10.3, 8.5 Hz, 1 H, C6-H), 3.48 (dd, J = 10.3, 
5.9 Hz, 1 H, C6-H), 2.80-2.72 (m, 1 H, C14-H), 1.93-1.84 (m, 1 H, C13-H), 1.56-1.47 
(comp, 2 H, C11-H), 1.40 (s, 9 H, C4-H), 1.38-1.32 (m 1 H, C13-H), 1.06 (s, 9 H, C15-
H), 0.79 (s, 9 H, C9-H), -0.042 (s, 3 H, C7-H or C8-H), -0.046 (s, 3 H, C7-H or C8-H); 
13C NMR (125 MHz, DMSO d6, 100 ˚C) δ 154.1 (C2), 134.7 (Ar-C), 134.6 (Ar-C), 
133.6 (C17 or C21), 133.3 (C17 or C21), 129.08 (Ar-C), 129.07 (Ar-C), 127.01 (Ar-C), 
127.00 (Ar-C), 77.8 (C3), 65.5 (C12), 60.3 (C6), 58.8 (C5), 27.6 (C4), 26.4 (C15), 25.9 
(C11), 25.1 (C9), 18.4 (C10 or C16), 18.1 (C13), 17.2 (C10 or C16), -6.14 (C7 or C8), -































methylpiperidine-1-carboxylic acid tert-butyl ester (4.119) (mp4-079-1). N,N.N’,N’-
Tetramethylethylenediamine (TMEDA) (73 mg, 94 μL, 0.63 mmol) was added to a 
solution 4.118 (270 mg, 0.47 mmol) in Et2O (1.9 mL) at –78 ˚C. A solution of sec-BuLi 
(0.47 mL, 0.63 mmol, 1.34 M) in hexanes was added dropwise, and the mixture was 
stirred at –78 ˚C for 2 h and 45 min, whereupon MeI (201 mg, 88 μL, 1.4 mmol) was 
added. The cold bath was removed, and the reaction was stirred for 1 h, whereupon H2O 
(2 mL) was added. The mixture was poured into a separatory funnel containing Et2O (20 
mL) and H2O (20 mL). The layers were separated, and the aqueous layer was extracted 
with Et2O (2 x 20 mL). The combined organic extracts were dried (Na2SO4), and the 
solvent was removed under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / Et2O (5:1) to give 150 mg (54%) of 4.119 as a 
clear colorless oil. NMR Assignments. 1NMR (400 MHz, CDCl3) δ 7.66-7.63 (comp 4 
H), 7.41-7.31 (comp, 6 H), 4.29-24 (m, 1H), 4.08-4.02 (m, 1 H), 3.88-3.80 (m, 1 H), 3.47 
(dd, J = 9.4, 4.6 Hz, 1 H), 3.38 (app t, J = 9.4, Hz, 1 H), 1.81-1.59 (comp, 4 H), 1.49 (d, J 
= 6.5 Hz, 3 H), 1.45 (s, 9 H), 1.06 (s, 9 H), 0.72 (s, 9 H), -0.13 (s, 6 H); IR (neat) 2930, 
2857, 1692, 1365, 1111, 838 cm-1. 
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NMR Assignments. 1NMR (400 MHz, CDCl3) δ 7.66-7.63 (comp 4 H, Ar-H), 
7.41-7.31 (comp, 6 H, Ar-H), 4.29-24 (m, 1H, C5-H), 4.08-4.02 (m, 1 H, C12-H), 3.88-
3.80 (m, 1 H, C14-H), 3.47 (dd, J = 9.4, 4.6 Hz, 1 H, C6-H), 3.38 (app t, J = 9.4, Hz, 1 H, 
C6-H), 1.81-1.59 (comp, 4 H, C4-H), 1.49 (d, J = 6.5 Hz, 3 H, C15-H), 1.45 (s, 9 H, C4-























methylpiperidine-1-carboxylic acid tert-butyl ester (4.121) (mp4-078, mp4-080). 
TBAF (336 mg, 1.28 mmol) was added to a solution of 4.119 (150 mg, 0.26 mmol) in 
THF (2.6 mL), and the reaction was stirred at room temperature 1.3 h. The reaction was 
poured into H2O (20 mL) and extracted with EtOAc (3 x 20 mL). The combined organic 
extracts were dried (Na2SO4), and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography eluting with EtOAc / hexanes (1:1 → 2:1) 
to give 56 mg (89%) of 4.120 as a clear colorless oil. DMAP (53 mg, 0.44 mmol) and 
pNO2BzCl (85 mg, 0.46 mmol) were added to a solution of 4.120 (56 mg, 0.22 mmol) in 
CH2Cl2 (2.3 mL), and the reaction was stirred at room temperature 1.5 h. The reaction 
was cooled to 0 °C and Et3N (0.06 mL, 0.44 mmol) and pNO2BzCl (85 mg, 0.46 mmol) 
were added. The reaction was stirred for 30 min at 0 °C, whereupon it was poured into 
H2O (20 mL) and extracted with EtOAc (3 x 20 mL). The combined organic extracts 
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were dried (Na2SO4), and the solvent was removed under reduced pressure. The residue 
was purified by flash chromatography eluting with EtOAc / hexanes (1:1) to give 32 mg 
(46%) of 4.121 as a white crystalline solid: mp 182-183 °C; 1NMR (500 MHz, CHCl3) δ 
8.27 (d, J = 9.3 Hz, 2 H), 7.37 (d, J = 9.3 Hz, 2 H), 4.57-4.52 (m, 1 H), 4.44 (dd, J = 9.2, 
8.0 Hz, 1 H), 4.21 (dd, J = 9.2, 5.5 Hz, 1 H), 4.19-4.14 (m, 1 H), 3.86 (ddd, J = 9.7, 8.0, 
5.5 Hz, 1 H), 2.24-2.19 (m, 1 H), 1.92-1.78 (comp, 2 H), 1.71-1.66 (m, 1 H), 1.25 (d, J = 
7.0 Hz, 3 H); 13C NMR (125 MHz, CHCl3) δ 156.2, 155.1, 151.7, 145.6, 125.4, 121.6, 
77.6, 66.1, 53.3, 44.3, 27.9, 24.2, 15.9; IR (neat) 2947, 1761, 1521, 1259, 1217, 1057 cm-
1 mass spectrum (CI) m/z 321.1089 [C15H17N2O6 (M+1) requires 321.1087], 307 (base), 
321, 325.  
NMR Assignments. 1NMR (500 MHz, CHCl3) δ 8.27 (d, J = 9.3 Hz, 2 H, C13-
H), 7.37 (d, J = 9.3 Hz, 2 H, C12-H), 4.57-4.52 (m, 1 H, C5-H), 4.44 (dd, J = 9.2, 8.0 Hz, 
1 H, C7-H), 4.21 (dd, J = 9.2, 5.5 Hz, 1 H, C7-H), 4.19-4.14 (m, 1 H, C2-H), 3.86 (ddd, J 
= 9.7, 8.0, 5.5 Hz, 1 H, C6-H), 2.24-2.19 (m, 1 H, C4-H), 1.92-1.78 (comp, 2 H, C3-H, 
C4-H), 1.71-1.66 (m, 1 H, C3-H), 1.25 (d, J = 7.0 Hz, 3 H, C9-H); 13C NMR (125 MHz, 
CHCl3) δ 156.2 (C10 or C8), 155.1 (C10 or C8), 151.7 (C14), 145.6 (C11), 125.4 (C13), 
















2-Methyl-4-oxopiperidine-1-carboxylic acid benzyl ester (4.132) (mp4-100). 
CBz-Cl (2.80 mL, 19.7 mmol) was added to a solution of 4.130 (2.00 mL, 19.7 mmol) in 
THF (100 mL) at −25 °C. The reaction was stirred at −25 °C for 20 min, whereupon a 
solution of methyl magnesium bromide (7.80 mL, 3 M, 23.6 mmol) in ether was added. 
The reaction was stirred at −25 °C for 30 min, whereupon the cold bath was removed, 
and stirring was continued for 40 min. A 3 M aqueous solution of HCl (40 mL) was 
added, and stirring was continued for 20 min. The slurry was extracted with Et2O (3 x 40 
mL), and the combined organic phases were dried (Na2SO4). The solvent was removed 
under reduced pressure. The residue was dissolved in THF (75 mL), cooled to −78 °C, 
and a solution of L-selectride (16.5 mL, 1 M, 16.5 mmol) in THF was added. The 
reaction was stirred at −78 °C for 15 min, whereupon the cold bath was removed, and 
stirring was continued for 45 min. Water (4 mL) was added, and the volatiles were 
removed under reduced pressure. The residue was dissolved in water (100 mL) and the 
aqueous solution was extracted with EtOAc (2 x 100 mL). The combined organic layers 
were dried (Na2SO4), and the solvent was removed under reduced pressure. The residue 
was purified by flash chromatography eluting with hexanes / EtOAc (7:3) to give 3.09 g 
(61 %, 2 steps) of 4.132 as a clear colorless oil; 1NMR (500 MHz, CDCl3) δ 7.38-7.28 
(comp, 5 H), 5.15 (s, 2 H), 5.48-4.75 (m, 1 H), 4.34-4.25 (m, 1 H), 3.37 (ddd, J = 14.0, 
11.3, 4.1 Hz, 1 H), 2.66 (dd, J = 14.7, 6.8 Hz, 1 H), 2.47 (ddd, J = 15.4, 11.3, 6.8 Hz, 1 
H), 2.36-2.31 (m, 1 H), 2.27-2.22 (m, 1H), 1.18 (d, J = 6.8 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 208.0, 155.3, 136.6, 128.8, 128.5, 128.2, 67.8, 48.5, 46.8, 40.8, 39.0, 
38.8. 19.0; IR (neat) 2966, 1698, 1419, 1331, 1219, 1185, 1120, 1066 cm-1; mass 
spectrum (HRMS:CI; LRMS:ESI) m/z 248.1291 [C14H18NO3 (M+1) requires 248.1287] 
242, 248, 265 (base), 384. 
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NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.38-7.28 (comp, 5 H, Ar-H), 
5.15 (s, 2 H, C9-H), 5.48-4.75 (m, 1 H, C2-H), 4.34-4.25 (m, 1 H, C6-H), 3.37 (ddd, J = 
14.0, 11.3, 4.1 Hz, 1 H, C6-H), 2.66 (dd, J = 14.7, 6.8 Hz, 1 H, C3-H), 2.47 (ddd, J = 
15.4, 11.3, 6.8 Hz, 1 H, C5-H), 2.36-2.31 (m, 1 H, C5-H), 2.27-2.22 (m, 1H, C3-H), 1.18 
(d, J = 6.8 Hz, 3 H, C7-H); 13C NMR (125 MHz, CDCl3) δ 208.0 (C4), 155.3 (C8), 136.6 
(C10), 128.8 (Ar-C), 128.5 (Ar-C), 128.2 (Ar-C), 67.8 (C9), 48.5 (C2 or C3 or C5 or C6), 















2-Methyl-4-oxopiperidine-1-carboxylic acid tert-butyl ester (4.133) (mp4-
101). A solution of 4.132 (3.09 g, 11.7 mmol) and 10 wt % Pd/C (300 mg) in EtOH (60 
mL) was stirred at room temperature over night, whereupon Boc2O (3.7 mL, 17.5 mmol) 
was added. The reaction was stirred for an additional 2 h and filtered through celite. The 
solids were washed with EtOH (20 mL) and filtrate and washings were removed under 
reduced pressure. The residue was purified by flash chromatography eluting with hexanes 
/ EtOAc (8:2 → 7:3) to give 2.20 g (77%) of 4.133 as a clear colorless oil; 1NMR (500 
MHz, CDCl3) δ 4.66-4.61 (m, 1 H), 4.20 (ddd, J = 13.7, 6.8, 2.7 Hz, 1 H), 3.28 (ddd, J = 
13.7, 11.3, 3.8 Hz, 1 H), 2.65 (dd, J = 14.4, 6.8 Hz, 1 H), 2.45 (ddd, J = 15.4, 11.3, 6.8 
Hz, 1 H), 2.34-2.27 (m, 1 H), 2.22 (ddd, J = 14.4, 2.7, 1.7 Hz, 1 H), 1.46 (s, 9 H), 1.15 (d, 
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J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 208.7, 154.7, 80.5, 46.8, 40.8, 39.9, 
38.3, 30.0, 28.6; IR (neat) 2975, 1693, 1404, 1366, 1249, 1165 cm-1; mass spectrum 
(HRMS:CI; LRMS:ESI) m/z 214.1447 [C11H19NO3 (M+1) requires 214.1443] 214, 236, 
242 (base), 265. 
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 4.66-4.61 (m, 1 H, C2-H), 4.20 
(ddd, J = 13.7, 6.8, 2.7 Hz, 1 H, C6-H), 3.28 (ddd, J = 13.7, 11.3, 3.8 Hz, 1 H, C6-H), 
2.65 (dd, J = 14.4, 6.8 Hz, 1 H, C3-H), 2.45 (ddd, J = 15.4, 11.3, 6.8 Hz, 1 H, C5-H), 
2.34-2.27 (m, 1 H, C5-H), 2.22 (ddd, J = 14.4, 2.7, 1.7 Hz, 1 H, C3-H), 1.46 (s, 9 H, C10-
H), 1.15 (d, J = 6.8 Hz, 3 H, C7-H); 13C NMR (125 MHz, CDCl3) δ 208.7 (C4), 154.7 
(C8), 80.5 (C9), 46.8 (C3), 40.8 (C2 or C5 or C6), 39.9 (C2 or C5 or C6), 38.3 (C2 or C5 














4-Hydroxy-2-methylpiperidine-1-carboxylic acid tert-butyl ester (4.134) 
(mp4-107). A solution of L-selectride (5.20 mL, 1 M, 5.16 mmol) in THF was added to a 
solution of 4.133 (1.10 g, 4.48 mmol) in THF (80 mL) at −78 °C. The reaction was 
stirred at −78 °C for 10 min, whereupon MeOH (10 mL) was added, and the cold bath 
was removed. Stirring was continued for 40 min, the reaction was poured into a 
separatory funnel containing water (200 mL) and the aqueous mixture was extracted with 
CH2Cl2 (200 mL and 2 x 100 mL). The combined organic layers were washed with brine 
(50 mL) and dried (Na2SO4), and the solvent was removed under reduced pressure. The 
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residue was purified by flash chromatography eluting with hexanes / EtOAc (3:1 → 2:1) 
to give 837 mg (75 %) of 4.134 as a clear colorless oil; 1NMR (500 MHz, CDCl3) δ 4.25 
(pent d, J = 7.0, 1.8 Hz, 1 H), 4.13 (pent, J = 3.3 Hz, 1 H), 3.78 (ddd, J = 13.6, 4.5, 2.8 
Hz, 1H), 3.22 (ddd, J = 13.6, 12.0, 4.0 Hz, 1 H), 1.81 (ddd, J = 14.5, 6.8, 3.3 Hz, 1 H), 
1.72-1.55 (comp, 3 H), 1.43 (s, 9 H), 1.29 (d, J = 7.0 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 154.9, 79.2, 64.9, 45.4, 36.4, 33.2, 32.4, 28.5, 19.1; IR (neat) 3436, 2972, 2930, 
1691, 1665, 1419, 1365, 1173, 1078 cm-1;  
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 4.25 (pent d, J = 7.0, 1.8 Hz, 1 
H, C2-H), 4.13 (pent, J = 3.3 Hz, 1 H, C4-H), 3.78 (ddd, J = 13.6, 4.5, 2.8 Hz, 1H, C6-
H), 3.22 (ddd, J = 13.6, 12.0, 4.0 Hz, 1 H, C6-H), 1.81 (ddd, J = 14.5, 6.8, 3.3 Hz, 1 H, 
C3-H), 1.72-1.55 (comp, 3 H, C3-H, C5-H), 1.43 (s, 9 H, C10-H), 1.29 (d, J = 7.0 Hz, 3 
H, C7-H); 13C NMR (125 MHz, CDCl3) δ 154.9 (C8), 79.2 (C9), 64.9 (C4), 45.4 (C2), 



















butyl ester (4.135) (mp4-109). A solution of 4.134 (837 mg, 3.38 mmol), TBDPSCl 
(1.32 mL, 5.08 mmol) and imidazole (690 mg, 10.1 mmol) in DMF (17 mL) was heated 
at 50 °C overnight. The reaction was allowed to cool to room temperature, whereupon it 
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was diluted with Et2O (200 mL). The solution was washed with H2O (2 x 100 mL), 0.5 
M aqueous HCl (100 mL), and brine (100 mL), and the organic layer was dried 
(Na2SO4), and the solvent was removed under reduced pressure. The residue was purified 
by flash chromatography eluting with hexanes / EtOAc (3:1 → 2:1) to give 837 mg (75 
%) of 4.135 as a clear colorless oil; 1NMR (500 MHz, CDCl3) δ 7.66-7.62 (comp, 4 H), 
7.44-7.39 (comp, 2 H), 7.38-7.33 (comp, 4 H), 4.30-4.23 (m, 1 H), 4.08 (pent, J = 3.1 Hz, 
1 H), 3.78 (ddd, J = 13.2, 4.4, 2.4 Hz, 1 H), 3.35 (td, J = 13.2, 3.0, Hz, 1 H), 1.64-1.61 
(comp, 2 H), 1.49-1.34 (comp, 2 H), 1.43 (s, 9 H), 1.42 (d, J = 7.1 Hz), 1.07 (s, 9 H); 13C 
NMR (125 MHz, CDCl3) δ 155.0, 135.8, 134.04, 133.95, 129.7, 127.6, 79.1, 66.2, 45.6, 
36.3, 33.4, 32.5, 28.5, 27.0, 19.3, 19.1; IR (neat) 2963, 2858, 1692, 1412, 1363, 1174, 
1111, 1053, 702 cm-1. 
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.66-7.62 (comp, 4 H, Ar-H), 
7.44-7.39 (comp, 2 H, Ar-H), 7.38-7.33 (comp, 4 H, Ar-H), 4.30-4.23 (m, 1 H, C2-H), 
4.08 (pent, J = 3.1 Hz, 1 H, C4-H), 3.78 (ddd, J = 13.2, 4.4, 2.4 Hz, 1 H, C6-H), 3.35 (td, 
J = 13.2, 3.0, Hz, 1 H, C6-H), 1.64-1.61 (comp, 2 H, C3-H), 1.49-1.34 (comp, 2 H, C5-
H), 1.43 (s, 9 H, C10-H), 1.42 (d, J = 7.1 Hz, 3 H, C7-H), 1.07 (s, 9 H, C16-H); 13C 
NMR (125 MHz, CDCl3) δ 155.0 (C8), 135.8 (Ar-C), 134.04 (Ar-C), 133.95 (Ar-C), 
129.7 (Ar-C), 127.6 (Ar-C), 79.1 (C9), 66.2 (C4), 45.6 (C2), 36.3 (C3), 33.4 (C6), 32.5 






















acid tert-butyl ester (4.136) (mp4-113) A solution of sec-BuLi (3.10 mL, 1.39 M, 4.27 
mmol) in cyclohexane was added dropwise over 15 min to a solution of 4.135 (1.49 g, 
3.28 mmol) and tetramethylethylenediamine (TMEDA) (0.64 mL, 4.27 mmol) in Et2O 
(13 mL) at −78 °C. The solution was stirred at −78 °C for 1 h, whereupon DMF (0.51 
mL, 6.56 mmol) was added. Stirring was continued at −78 °C for 1 h, and a saturated 
aqueous solution of NH4Cl (8 mL) was added. The cold bath was removed, and the slurry 
was allowed to warm to room temperature and poured into a separatory funnel containing 
H2O (75 mL). The mixture was extracted with EtOAc (3 x 75 mL), and the combined 
organic layers were dried (Na2SO4). The solvent was removed under reduced pressure, 
and the residue was purified by flash chromatography eluting with hexanes / EtOAc 
(10:1) to give 1.47 g (92%, dr = 94:6) of 4.136 as a pale yellow oil; 1NMR (500 MHz, 
CDCl3) δ 9.34 (d, J = 2.8 Hz, 1 H), 7.65-7.60 (comp, 4 H), 7.44-7.39 (comp, 2 H), 7.38-
7.34 (comp, 4 H), 4.23-4.16 (m, 1 H), 4.12 (app pent, J = 3.5 Hz, 1 H), 4.07 (td, J = 10.7, 
3.3, Hz, 1 H), 1.74-1.68 (m, 1 H), 1.65-1.61 (comp, 2 H), 1.57-1.42 (m, 1 H), 1.45 (d, J = 
6.9 Hz, 3 H), 1.43 (s, 9 H), 1.06 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 196.7, 156.1, 
135.77, 135.75, 133.6, 133.3, 129.9, 129.8, 127.75, 127.68, 81.3, 65.0, 55.9, 47.3, 36.0, 
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32.5, 28.2, 27.0, 20.2, 12.0; IR (neat) 2965, 2991, 1732, 1683, 1367, 1302, 1104, 702 cm-
1; mass spectrum (ESI) m/z 482.2706 [C28H39NO4Si (M+1) requires 482.2721]. 
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 9.34 (d, J = 2.8 Hz, 1 H, C17-
H), 7.65-7.60 (comp, 4 H, Ar-H), 7.44-7.39 (comp, 2 H, Ar-H), 7.38-7.34 (comp, 4 H, 
Ar-H), 4.23-4.16 (m, 1 H, C2-H), 4.12 (app pent, J = 3.5 Hz, 1 H, C4-H), 4.07 (td, J = 
10.7, 3.3, Hz, 1 H, C6-H), 1.74-1.68 (m, 1 H, C5-H), 1.65-1.61 (comp, 2 H, C3-H), 1.57-
1.42 (m, 1 H, C5-H), 1.45 (d, J = 6.9 Hz, 3 H, C7-H), 1.43 (s, 9 H, C10-H), 1.06 (s, 9 H, 
C16-H); 13C NMR (125 MHz, CDCl3) δ 196.7 (C17), 156.1 (C8), 135.77 (Ar-C), 135.75 
(Ar-C), 133.6 (Ar-C), 133.3 (Ar-C), 129.9 (Ar-C), 129.8 (Ar-C), 127.75 (Ar-C), 127.68 
(Ar-C), 81.3 (C9), 65.0 (C4), 55.9 (C6), 47.3 (C2), 36.0 (C3), 32.5 (C5), 28.2 (C10), 27.0 






















carboxylic acid tert-butyl ester (4.137) (mp4-114). NaBH4 (459 mg, 12.1 mmol) was 
added to a solution of 4.136 (1.46 g, 3.03 mmol) in MeOH (30 mL) at 0 °C. The reaction 
was stirred at 0 °C for 1 h and 15 min, whereupon a saturated aqueous solution of NH4Cl 
(10 mL) was added. The mixture was poured into H2O (100 mL), and the mixture was 
extracted with EtOAc (3 x 100 mL). The organic layer was dried (Na2SO4), and the 
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solvent was removed under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / EtOAc (4:1) to give 1.33 g (91 %) of 4.137 as a 
clear colorless oil; 1NMR (500 MHz, CDCl3) δ 7.65-7.60 (comp, 4 H), 7.43-7.39 (comp, 
2 H), 7.38-7.33 (comp, 4 H), 4.15-4.07 (comp, 2 H), 3.93 (app hept, J = 3.7 Hz, 1 H), 
3.63-3.55 (comp, 2 H), 1.80-1.74 (comp, 2 H), 1.72-1.67 (m, 1 H), 1.63-1.59 (m, 1 H), 
1.44 (d, J = 7.1 Hz, 3 H), 1.42 (s, 9 H), 1.05 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 
156.2, 135.8, 135.7, 133.9, 129.8, 129.7, 127.65, 127.64, 80.1, 65.8, 65.6, 51.3, 48.2, 
36.9, 34.8, 28.4, 26.9, 20.8, 19.0; IR (neat) 3435, 2963, 2932, 1683, 1428, 1322, 1366, 
1111, 1072, 702 cm-1; mass spectrum (ESI) m/z 484.2895 [C28H42NO4Si (M+1) requires 
484.2878]. 
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.65-7.60 (comp, 4 H, Ar-H), 
7.43-7.39 (comp, 2 H, Ar-H), 7.38-7.33 (comp, 4 H, Ar-H), 4.15-4.07 (comp, 2 H, C4-H, 
C2-H), 3.93 (app hept, J = 3.7 Hz, 1 H, C6-H), 3.63-3.55 (comp, 2 H, C7-H), 1.80-1.74 
(comp, 2 H, C5-H, C3-H), 1.72-1.67 (m, 1 H, C5-H or C3-H), 1.63-1.59 (m, 1 H, C5-H 
or C3-H), 1.44 (d, J = 7.1 Hz, 3 H, C8-H), 1.42 (s, 9 H, C11-H), 1.05 (s, 9 H, C17-H); 
13C NMR (125 MHz, CDCl3) δ 156.2 (C9), 135.8 (Ar-C), 135.7 (Ar-C), 133.9 (Ar-C), 
129.8 (Ar-C), 129.7 (Ar-C), 127.65 (Ar-C), 127.64 (Ar-C), 80.1 (C10), 65.8 (C7), 65.6 
(C2), 51.3 (C6), 48.2 (C4), 36.9 (C5 or C3), 34.8 (C5 or C3), 28.4 (C11), 26.9 (C17), 























butyl ester (4.139) (mp4-242 and mp4-241). A solution of allylmagnesium bromide 
(16.0 mL, 1.0 M, 16.0 mmol) was added to a stirred solution of (-)-DIP-Cl (6.00 g, 18.7 
mmol) in Et2O (93 mL) at –78 ˚C. The reaction was stirred at –78 ˚C for 5 min, 
whereupon the cold bath was replaced with an ice water bath, and the mixture was stirred 
for 1 h. The reaction was cooled to –78 ˚C, whereupon a solution of aldehyde 4.138 (2.50 
g, 13.4 mmol) in Et2O (25 mL, and 5 mL rinse) was added dropwise via cannula over 20 
min. Stirring was continued at –78 ˚C for 1 h, whereupon a saturate aqueous solution of 
NaHCO3 (20 mL) was added. The cold bath was removed, and stirring was continued for 
30 min. The reaction was poured into a separatory funnel containing saturated aqueous 
NaHCO3 (300 mL), and the mixture was extracted with Et2O (3 x 300 mL). The 
combined organic extracts were dried (Na2SO4), and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography, eluting with 
hexanes / EtOAc (3:1) to give a clear colorless oil, which was redissolved in DMF (54 
mL). TBDPSCl (4.80 mL, 18.3 mmol) and imidazole (2.35 g, 34.5 mmol) were added 
and the reaction was stirred at 50 ˚C overnight. The reaction was diluted with Et2O (400 
mL), and the solution was washed with H2O (2 x 200 mL), 0.5 M aqueous HCl (200 mL) 
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and brine (200 mL). The organic layer was dried (Na2SO4), and the solvent was removed 
under reduced pressure. The residue was purified by flash chromatography eluting with 
hexanes / EtOAc (9:1) to give 1.92 g (31%, 2 steps) of 4.139 as a clear colorless oil; 
1NMR (500 MHz) δ 7.71-7.66 (comp, 4 H), 7.44-7.34 (comp, 6 H), 5.60-5.51 (m, 1 H), 
4.92-4.82 (comp, 2 H), 3.85-3.81 (comp, 1 H), 3.73-3.65 (m, 1 H), 2.23-2.16 (m, 1 H), 
2.15-2.09 (comp, 1 H), 1.68-1.60 (m, 1 H), 1.54-1.47 (m, 1 H), 1.42 (s, 9 H), 1.05 (s, 9 
H), 1.02 (d, J = 6.35 Hz, 3 H); 13C NMR (125 MHz) δ 155.3, 135.91, 135.88, 134.8, 
134.25, 134.18, 133.6, 129.7, 129.6, 127.6, 127.5, 117.4, 78.8, 71.3, 43.9, 41.9, 40.8, 
28.5, 27.0, 21.6, 19.3; IR (neat) 3430, 2965, 2931, 1703, 1501, 1365, 1174, 1112, 1054 
cm-1; mass spectrum (CI) m/z 468.2934 [C28H42NO3Si (M+1) requires 468.2934], 231, 
305, 335, 468 (base).  
NMR Assignments. 1NMR (500 MHz) δ 7.71-7.66 (comp, 4 H, Ar-H), 7.44-7.34 
(comp, 6 H, Ar-H), 5.60-5.51 (m, 1 H, C6-H), 4.92-4.82 (comp, 2 H, C7-H), 3.85-3.81 
(comp, 1 H, C4-H), 3.73-3.65 (m, 1 H, C1-H), 2.23-2.16 (m, 1 H, C6-H), 2.15-2.09 
(comp, 1 H, C6-H), 1.68-1.60 (m, 1 H, C3-H), 1.54-1.47 (m, 1 H, C3-H), 1.42 (s, 9 H, 
C10-H), 1.05 (s, 9 H, C16-H), 1.02 (d, J = 6.35 Hz, 3 H, C2-H); 13C NMR (125 MHz) δ 
155.3 (C8), 135.91 (Ar-C), 135.88 (Ar-C), 134.8 (Ar-C), 134.25 (C6), 134.18 (Ar-C), 
133.6 (C6), 129.7 (Ar-C), 129.6 (Ar-C), 127.6 (Ar-C), 127.5 (Ar-C), 117.4 (C7), 78.8 























tert-butyl ester (4.140) (mp4-244). A stream of ozone was passed through a solution of 
4.139 (1.20 g, 2.56 mmol) at –78 ˚C for 10 min. The blue solution was then sparged with 
N2 for 15 min, whereupon NaBH4 (970 mg, 25.6 mmol) was added and the cold bath 
removed. Stirring was continued for 25 min, and a saturated aqueous solution of NH4Cl 
(30 mL) was added. The volatiles were removed under reduced pressure, and the 
remaining aqueous residue was diluted with brine (100 mL). The resulting slurry was 
extracted with EtOAc (3 x 400 mL) and washed with H2O (2 x 200 mL), 0.5 M aqueous 
HCl (200 mL, and brine (200 mL). The organic layer was dried (Na2SO4), the solvent 
was removed under reduced pressure, and the residue was purified by flash 
chromatography eluting with hexanes / EtOAc (2:1 → 1:1) to give 1.07 g (88%) of 4.140 
as a clear colorless oil; 1NMR (500 MHz) δ 7.70-7.68 (comp, 4 H), 7.44-7.34 (comp, 6 
H), 4.63 (br s, 1 H), 3.99-3.94 (m, 1 H), 3.70-3.57 (comp, 2 H), 3.52-3.42 (m, 1 H), 1.85-
1.73 (comp, 2 H), 1.70-1.64 (m, 1 H), 1.46-1.36 (m, 1 H), 1.39 (s, 9 H), 1.04 (s, 9 H), 
0.84 (d, J = 6.3 Hz, 3 H); 13C NMR (125 MHz) δ 155.2, 135.92, 135.88, 133.6, 129.9, 
129.8, 127.70, 129.69, 70.0, 59.4, 43.9, 42.9, 37.8, 28.4, 27.0, 20.9, 19.2; IR (neat) 3351, 
  296
2964, 2931, 1692, 1504, 1427, 1366, 1173, 1111, 1060 cm-1; mass spectrum (CI) m/z 
472.3886 [C27H42NO4Si (M+1) requires 472.2883 ], 315, 373, 472 (base).  
NMR Assignments. 1NMR (500 MHz) δ 7.70-7.68 (comp, 4 H, Ar-H), 7.44-7.34 
(comp, 6 H, Ar-H), 4.63 (br s, 1 H, NH), 3.99-3.94 (m, 1 H, C4-H), 3.70-3.57 (comp, 2 
H, C6-H), 3.52-3.42 (m, 1 H, C1-H), 1.85-1.73 (comp, 2 H, C3-H or C5-H, OH), 1.70-
1.64 (m, 1 H, C3-H or C5-H), 1.46-1.36 (m, 1 H, C3-H or C5-H), 1.39 (s, 9 H, C15-H), 
1.04 (s, 9 H, C16-H), 0.84 (d, J = 6.3 Hz, 3 H, C2-H); 13C NMR (125 MHz) δ 155.2 
(C8), 135.92 (Ar-C), 135.88 (Ar-C), 133.6 (Ar-C), 129.9 (Ar-C), 129.8 (Ar-C), 127.70 
(Ar-C), 129.69 (Ar-C), 70.0 (C4), 59.4 (C6), 43.9 (C1), 42.9 (C3 or C5), 37.8 (C3 or C5), 
















 4-(tert-Butyldiphenylsilanyloxy)-2-methylpiperidine-1-carboxylic acid tert-
butyl ester (4.135) (mp4-237, mp4-235). MsCl (29 μL, 0.29 mmol) was added to a 
solution 4.140 (69 mg, 0.15 mmol) and Et3N (45 μL) in CH2Cl2 (1.8 mL) and stirred at 
room temperature for 30 min. The mixture was poured into a separatory funnel 
containing H2O (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The combined organic 
layers were dried (Na2SO4), and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography eluting with hexanes / EtOAc (2:1) to give 
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69 mg (88 %) of 4.141 as a yellow oil. KOtBu (12 mg, 0.11 mmol) was added to a 
solution 4.141 (30 mg, 0.05 mmol) in THF (1.1 mL) at 0 ˚C, and the reaction was stirred 
at 0 ˚C for 20 min, whereupon a saturated aqueous solution of NH4Cl (1 mL) was added. 
The mixture was poured into a separatory funnel containing H2O (10 mL), and the 
aqueous mixture was extracted with EtOAc (3 x 10 mL). The combined organic layers 
were dried (Na2SO4), and the solvent was removed under reduced pressure. The residue 
was purified by flash chromatography eluting with hexanes / EtOAc (8:1) to give 24 mg 
(98 %) of 4.135 as a clear colorless oil; The 1H NMR spectrum was identical to that 























(4.143) (mp4-106). MsCl (14 μL, 0.18 mmol) was added to a solution of 4.137 (44 mg, 
0.09 mmol) and Et3N (38 μL, 0.27 mmol) in CH2Cl2 (0.9 mL) at 0 °C. The reaction was 
stirred at 0 °C for 1 h, whereupon a saturated aqueous solution of NH4Cl (1 mL) was 
added. The mixture was poured into H2O (10 mL) and extracted with EtOAc (3 x 10 
mL). The combined organic extracts were washed with 0.5 M HCl (5 mL) and dried 
(Na2SO4). The solvent was removed under reduced pressure, and the residue was 
recrystallized from Et2O/heptane to give 19 mg (51%) of 4.143 as a white solid; 1NMR 
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(400 MHz, CHCl3) δ 7.64-7.61 (comp, 4 H), 7.46-7.34 (comp, 6 H), 4.40 (app t, J = 8.2 
Hz, 1 H), 4.31-4.21 (comp, 2 H), 4.13-4.05 (m, 1 H), 3.77 (dd, J = 8.2, 6.2 Hz, 1 H), 
1.73-1.59 (comp, 3 H), 1.50 (d, J = 7.2 Hz, 3 H), 1.30-1.20 (m, 1 H), 1.08 (s, 9 H). 
NMR Assignments. 1NMR (400 MHz, CHCl3) δ 7.64-7.61 (comp, 4 H, Ar-H), 
7.46-7.34 (comp, 6 H, Ar-H), 4.40 (app t, J = 8.2 Hz, 1 H, C7-H), 4.31-4.21 (comp, 2 H, 
C4-H, C6-H), 4.13-4.05 (m, 1 H, C2-H), 3.77 (dd, J = 8.2, 6.2 Hz, 1 H, C6-H), 1.73-1.59 
(comp, 3 H, C3-H, C5-H), 1.50 (d, J = 7.2 Hz, 3 H, C9-H), 1.30-1.20 (m, 1 H, C3-H or 













1 8  
 [4-(tert-Butyldiphenylsilanyloxy)-6-methylpiperidine-2-yl]-methanol (mp4-
125). TFA (8.5 mL) was added to a solution of 4.137 (683 mg, 1.41 mmol) in CH2Cl2 
(8.5 mL) at 0 °C. The reaction was stirred at 0°C for 2 h, whereupon the volatiles were 
removed under reduced pressure. A saturated aqueous solution of NaHCO3 was added, 
and the mixture was extracted with CH2Cl2 (3 x 60 mL). The organic layer was dried 
(Na2SO4), and the solvent was removed under reduced pressure to give 540 mg (99%) of 
the title compound as a pale yellow oil; 1NMR (500 MHz, CDCl3) δ 7.65-7.59 (comp, 4 
H), 7.44-7.39 (comp, 2 H), 7.38-7.33 (comp, 4 H, Ar-H), 5.08 (br s, 1H), 3.93-3.88 (m, 1 
H), 3.48-3.43 (m, 1 H), 3.89-3.36 (comp, 2 H), 3.21-3.16 (m, 1 H), 1.86 (td, J = 13.8, 3.9 
Hz, 1 H), 1.55-1.52 (comp, 2 H), 1.49-1.43 (m, 1 H), 1.35 (d, J = 6.8 Hz, 1 H), 1.04 (s, 9 
H); 13C NMR (125 MHz, CDCl3) δ 135.6, 133.5, 133.4, 130.0, 129.9, 127.8, 127.7, 65.5, 
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61.1, 50.9, 46.4, 38.4, 33.6, 26.9, 19.0. IR (neat) 3326, 2932, 2858, 1675, 1428, 1203, 
1112, 702 cm-1; (HRMS: CI; LRMS: ESI) m/z 384.2357 [C23H34NO2Si (M+1) requires 
384.2359] 384 (base), 440, 583. 
 NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.65-7.59 (comp, 4 H, Ar-H), 
7.44-7.39 (comp, 2 H, Ar-H), 7.38-7.33 (comp, 4 H, Ar-H), 5.08 (br s, 1H, NH), 3.93-
3.88 (m, 1 H, C4-H), 3.48-3.43 (m, 1 H, C6-H), 3.89-3.36 (comp, 2 H, C7-H), 3.21-3.16 
(m, 1 H, C2-H), 1.86 (td, J = 13.8, 3.9 Hz, 1 H, C3-H), 1.55-1.52 (comp, 2 H, C5-H), 
1.49-1.43 (m, 1 H, C3-H), 1.35 (d, J = 6.8 Hz, 1 H, C8-H), 1.04 (s, 9 H, C14-H); 13C 
NMR (125 MHz, CDCl3) δ 135.6 (Ar-C), 133.5 (Ar-C), 133.4 (Ar-C), 130.0 (Ar-C), 
129.9 (Ar-C), 127.8 (Ar-C), 127.7 (Ar-C), 65.5 (C4), 61.1 (C7), 50.9 (C6), 46.4 (C2), 




















methylpiperidine (4.144) (mp4-185). A solution of [4-(tert-Butyldiphenylsilanyloxy)-6-
methylpiperidine-2-yl]-methanol (470 mg, 1.23 mmol), TBSCl (454 mg, 3.00 mmol) and 
imidazole (335 mg, 4.92 mmol) in CH2Cl2 (10 mL) was stirred at room temperature 
overnight. The reaction was poured into a separatory funnel containing brine (60 mL), 
and the aqueous mixture was extracted with CH2Cl2 (3 x 40 mL). The organic layer was 
dried (Na2SO4), the solvent was removed under reduced pressure, and the residue was 
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purified by flash chromatography eluting with 2% NH4OH (20% aqueous solution) and 
40% EtOAc in hexanes to give 457 mg (75 %) of 4.144 as a pale yellow oil; 1NMR (500 
MHz, CDCl3) δ 7.66-7.63 (comp, 4 H), 7.42-7.38 (comp, 2 H), 7.37-7.32 (comp, 4 H), 
3.73 (app hept, J = 4.3 Hz, 1 H), 3.35 (t, J = 9.3 Hz, 3 H), 3.12-3.04 (comp, 2 H), 2.78-
2.72 (m, 1 H), 1.77-1.73 (m, 1 H), 1.61 (ddd, J = 13.0, 10.0, 5.2 Hz, 1 H), 1.49-1.44 (m, 1 
H), 1.27 (dt, J = 12.4, 10.0 Hz, 1 H), 1.05 (d, J = 6.2 Hz, 1 H), 1.02 (s, 9 H), 0.82 (s, 9 
H), -0.048 (s, 3H), -0.054 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 135.78, 135.76, 134.5, 
134.4, 129.5, 127.5, 67.5, 62.8, 53.0, 44.2, 42.7, 35.1, 26.93, 25.86, 22.7, 19.1, 18.2, -5.4, 
-5.5; IR (neat) 3071, 2954, 2857, 1472, 1428, 1256, 1104, 836, 702 cm-1; mass spectrum 
(ESI) m/z 498.3221 [C29H48NO2Si2 (M+1) requires 498.3218]. 
 NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.66-7.63 (comp, 4 H, Ar-H), 
7.42-7.38 (comp, 2 H, Ar-H), 7.37-7.32 (comp, 4 H, Ar-H), 3.73 (app hept, J = 4.3 Hz, 1 
H, C4-H), ), 3.35 (t, J = 9.3 Hz, 3 H, C7-H), 3.12-3.04 (comp, 2 H, C7-H, C6-H), 2.78-
2.72 (m, 1 H, C2-H), 1.77-1.73 (m, 1 H, C3-H), 1.61 (ddd, J = 13.0, 10.0, 5.2 Hz, 1 H, 
C5-H), 1.49-1.44 (m, 1 H, C5-H), 1.27 (dt, J = 12.4, 10.0 Hz, 1 H, C3-H), 1.05 (d, J = 6.2 
Hz, 1 H, C8-H), 1.02 (s, 9 H, C12-H), 0.82 (s, 9 H, C18-H), -0.048 (s, 3H, C10-H or C9-
H), -0.054 (s, 3H, C10-H or C9-H); 13C NMR (125 MHz, CDCl3) δ 135.78 (Ar-C), 
135.76 (Ar-C), 134.5 (Ar-C), 134.4 (Ar-C), 129.5 (Ar-C), 127.5 (Ar-C), 67.5 (C4), 62.8 
(C7), 53.0 (C6), 44.2 (C2), 42.7 (C3), 35.1 (C5), 26.93 (C12), 25.86 (C18), 22.7 (C8), 


























methyl-1-(toluene-4-sulfonyl)-piperidine (4.145) (mp5-044). Toluenesulfonyl chloride 
(153 mg, 0.80 mmol) was added to a solution of 4.144 (200 mg, 0.40 mmol), Et3N (0.17 
mL, 1.21 mmol) and a catalytic amount of DMAP. The reaction was stirred at room 
temperature overnight, whereupon it was poured into EtOAc (50 mL) and washed with 
0.5 M HCl (2 x 20 mL) and brine (20 mL). The organic layer was dried (Na2SO4), and 
the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / EtOAc (5:1) to give 249 mg (95%) of 4.145 as a 
clear colorless oil; 1NMR (500 MHz, CDCl3) δ 1NMR (500 MHz, CDCl3) δ 7.24-7.70 
(comp, 2 H), 7.63-7.60 (comp, 4 H), 7.42-7.37 (comp, 2 H), 7.35-7.32 (comp, 4 H), 7.22-
7.19 (comp, 2 H), 4.31-4.26 (m, 1 H), 4.00-3.94 (m, 1 H), 3.65 (dd, J = 10.3, 6.1 Hz, 1 
H), 3.53-3.45 (m, 1 H), 3.45 (dd, J = 10.3, 6.1 Hz, 1 H), 2.38 (s, 3 H), 1.92 (app dt, J = 
13.4, 4.0, Hz, 1 H), 1.73 (ddd, J = 13.4, 9.5, 5.2, Hz, 1 H), 1.66 (app dt, J = 13.3, 3.5, Hz, 
1 H), 1.57-1.52 (m, 1 H), 1.20 (d, J = 6.9, Hz, 1 H), 1.03 (s, 9 H), 0.80 (s, 9 H), -0.05 (s, 3 
H), -0.06 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 142.6, 141.2, 135.75, 135.72, 134.2, 
134.1, 129.7, 129.6, 129.3. 127.58, 127.56, 126.9, 66.5, 63.5, 55.5, 50.0, 41.6, 35.2, 26.9, 
25.9, 24.1, 20.4, 19.1, 18.2, -5.47, -5.54; IR (neat) 2929, 2856, 1472, 1318, 1152, 1110, 
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1087 cm-1; mass spectrum (CI) m/z 652.3312 [C36H54NO4Si2S(M+1) requires 
652.3312], 396, 498, 574, 594, 652 (base).  
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.24-7.70 (comp, 2 H, Ar-H), 
7.63-7.60 (comp, 4 H, Ar-H), 7.42-7.37 (comp, 2 H, Ar-H), 7.35-7.32 (comp, 4 H, Ar-H), 
7.22-7.19 (comp, 2 H, Ar-H), 4.31-4.26 (m, 1 H, C6-H), 4.00-3.94 (m, 1 H, C4-H), 3.65 
(dd, J = 10.3, 6.1 Hz, 1 H, C7-H), 3.53-3.45 (m, 1 H, C2-H), 3.45 (dd, J = 10.3, 6.1 Hz, 1 
H, C7-H), 2.38 (s, 3 H, C13-H), 1.92 (app dt, J = 13.4, 4.0, Hz, 1 H, C5-H), 1.73 (ddd, J 
= 13.4, 9.5, 5.2, Hz, 1 H, C5-H), 1.66 (app dt, J = 13.3, 3.5, Hz, 1 H, C3-H), 1.57-1.52 
(m, 1 H, C3-H), 1.20 (d, J = 6.9, Hz, 1 H, C8-H), 1.03 (s, 9 H, C19-H), 0.80 (s, 9 H, C23-
H), -0.05 (s, 3 H, C20-H or C21-H), -0.06 (s, 3 H, C20-H or C21-H); 13C NMR (125 
MHz, CDCl3) δ 142.6 (Ar-C), 141.2 (Ar-C), 135.75 (Ar-C), 135.72 (Ar-C), 134.2 (Ar-C), 
134.1 (Ar-C), 129.7 (Ar-C), 129.6 (Ar-C), 129.3 (Ar-C), 127.58 (Ar-C), 127.56 (Ar-C), 
126.9 (Ar-C), 66.5 (C4), 63.5 (C7), 55.5 (C6), 50.0 (C2), 41.6 (C3), 35.2 (C5), 26.9 
(C13), 25.9 (C8), 24.1 (C19), 20.4 (C23), 19.1 (C18 or C22), 18.2 (C18 or C22), -5.47 























2-yl]-methanol (4.146) (mp5-045). A solution of 4.145 (199 mg, 0.31 mmol) and 
camphorsulfonic acid (21 mg, 0.09 mmol) in MeOH (3 mL) and CH2Cl2 (3 mL) was 
stirred at 0 °C for 1 h, whereupon the ice bath was removed and the reaction stirred for an 
additional 30 min. Additional camphorsulfonic acid (70 mg, 0.31 mmol) was added, and 
the reaction was stirred at room temperature for 40 min, whereupon an aqueous saturated 
solution of NaHCO3 (1 mL) was added. The mixture was poured into a saturated aqueous 
solution of NaHCO3 and extracted with EtOAc (3 x 30 mL). The combined organic 
layers were dried (Na2SO4), and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography eluting with hexanes / EtOAc (2:1) to give 
158 mg (96%) of 4.146 as a clear colorless oil; 1NMR (500 MHz, CDCl3) δ 1NMR (500 
MHz, CDCl3) δ 7.70-7.67 (comp, 2 H), 7.59-7.56 (comp, 4 H), 7.43-7.39 (comp, 2 H), 
7.36-7.32 (comp, 4 H), 7.23-7.21 (comp, 2 H), 4.20 (hept, J = 4.2, Hz, 1 H), 3.90-3.86 
(m, 1 H), 3.84-3.75 (comp, 2 H, C2-H), 3.54 (ddd, J = 12.4, 8.0, 4.5 Hz, 1 H), 2.66 (dd, J 
= 8.0, 6.1 Hz, 1 H, OH), 2.37 (s, 3 H), 1.60 (app dt, J = 13.7, 4.2, Hz, 1 H), 1.54-1.46 
(comp, 2 H), 1.43 (ddd, J = 13.8, 6.6, 4.1 Hz, 1 H), 1.37 (d, J = 6.9 Hz, 1 H), 1.02 (s, 9 
H); 13C NMR (125 MHz, CDCl3) δ 143.2, 139.8, 135.7, 133.8, 133.7, 129.85, 129.80, 
129.67, 127.68, 127.67, 126.9, 66.6, 63.2, 54.5, 50.6, 38.4, 34.9, 26.9, 21.5, 20.5, 19.0; 
IR (neat) 3530, 2931, 1428, 1316, 1150, 1111, 1086, 818, 703 cm-1. mass spectrum (CI) 
m/z 538.2449 [C30H40NO4SSi(M+1) requires 538.2447], 282, 352 (base), 384, 460, 538.  
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.70-7.67 (comp, 2 H, Ar-H), 
7.59-7.56 (comp, 4 H, Ar-H), 7.43-7.39 (comp, 2 H, Ar-H), 7.36-7.32 (comp, 4 H, Ar-H), 
7.23-7.21 (comp, 2 H, Ar-H), 4.20 (hept, J = 4.2, Hz, 1 H, C6-H), 3.90-3.86 (m, 1 H, C4-
H), 3.84-3.75 (comp, 2 H, C2-H, C7-H), 3.54 (ddd, J = 12.4, 8.0, 4.5 Hz, 1 H, C7-H), 
2.66 (dd, J = 8.0, 6.1 Hz, 1 H, OH), 2.37 (s, 3 H, C13-H), 1.60 (app dt, J = 13.7, 4.2, Hz, 
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1 H, C3-H), 1.54-1.46 (comp, 2 H, C3-H, C5-H), 1.43 (ddd, J = 13.8, 6.6, 4.1 Hz, 1 H, 
C5-H), 1.37 (d, J = 6.9 Hz, 1 H, C8-H), 1.02 (s, 9 H, C19-H); 13C NMR (125 MHz, 
CDCl3) δ 143.2 (Ar-C), 139.8 (Ar-C), 135.7 (Ar-C), 133.8 (Ar-C), 133.7 (Ar-C), 129.85 
(Ar-C), 129.80 (Ar-C), 129.67 (Ar-C), 127.68 (Ar-C), 127.67 (Ar-C), 126.9 (Ar-C), 66.6 
(C4), 63.2 (C7), 54.5 (C6), 50.6 (C2), 38.4 (C3), 34.9 (C5), 26.9 (C19), 21.5 (C13), 20.5 






















sulfonyl)-piperidine (4.147) (mp5-045). Iodine (94 mg, 0.74 mmol) was added to a 
solution of 4.146 (66 mg, 0.12 mmol), PPh3 (241 mg, 0.92 mmol), and imidazole (63 mg, 
0.92 mmol) in CH2Cl2 (1.2 mL). The reaction was stirred at room temperature overnight, 
whereupon it was concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / EtOAc (20:1 → 4:1) to give 55 mg (69%) of 
4.147 as a clear colorless oil; 1NMR (500 MHz, CDCl3) δ 7.73-7.71 (comp, 2 H), 7.65-
7.61 (comp, 4 H), 7.45-7.33 (comp, 6 H), 7.25-7.23 (comp, 2 H), 4.48-4.43 (m, 1H), 3.92 
(hept, J = 4.4, Hz, 1 H), 3.45-3.40 (m, 1 H), 3.35 (dd, J = 9.9, 5.7, Hz, 1 H), 3.10 (app t, J 
= 9.9, Hz, 1 H), 2.39 (s, 3 H), 2.18 (dtd, J = 13.7, 4.4, 1.1 Hz, 1 H), 1.80 (ddd, J = 13.7, 
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9.7, 4.4 Hz, 1 H), 1.73-1.66 (m, 1 H), 1.58-1.53 (m, 1 H), 1.21 (d, J = 6.8 Hz, 1 H), 1.03 
(s, 9 H); 13C NMR (125 MHz, CDCl3) δ 143.1, 140.4, 135.8, 135.7, 133.9, 133.7, 
129.83, 129.76, 129.5, 127.8, 127.7, 127.1, 65.7, 55.8, 49.6, 41.3, 36.3, 26.9, 21.5, 20.5, 
19.0, 6.2; IR (neat) 2929, 1427, 1317, 1151, 1112, 1088, 703 cm-1; mass spectrum (CI) 
m/z 648.1467 [C30H39NO3SSiI (M+1) requires 648.1465], 352, 458 (base), 570, 648.  
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.73-7.71 (comp, 2 H, Ar-H), 
7.65-7.61 (comp, 4 H, Ar-H), 7.45-7.33 (comp, 6 H, Ar-H), 7.25-7.23 (comp, 2 H, Ar-H), 
4.48-4.43 (m, 1H, C6-H), 3.92 (hept, J = 4.4, Hz, 1 H, C4-H), 3.45-3.40 (m, 1 H, C2-H), 
3.35 (dd, J = 9.9, 5.7, Hz, 1 H, C7-H), 3.10 (app t, J = 9.9, Hz, 1 H, C7-H), 2.39 (s, 3 H, 
C13-H), 2.18 (dtd, J = 13.7, 4.4, 1.1 Hz, 1 H, C5-H), 1.80 (ddd, J = 13.7, 9.7, 4.4 Hz, 1 
H, C5-H), 1.73-1.66 (m, 1 H, C3-H), 1.58-1.53 (m, 1 H, C3-H), 1.21 (d, J = 6.8 Hz, 1 H, 
C8-H), 1.03 (s, 9 H, C19-H); 13C NMR (125 MHz, CDCl3) δ 143.1 (Ar-C), 140.4 (Ar-
C), 135.8 (Ar-C), 135.7 (Ar-C), 133.9 (Ar-C), 133.7 (Ar-C), 129.83 (Ar-C), 129.76 (Ar-
C), 129.5 (Ar-C), 127.8 (C11), 127.7 (Ar-C), 127.1 (Ar-10), 65.7 (C4), 55.8 (C6), 49.6 
















1-Benzy-2-iodomethylpiperidine (4.143), (mp4-277-1) Iodine (1.24 g, 9.74 
mmol) was added to a solution of 4.152 (1.0 g, 4.87 mmol), PPh3 (3.29 g, 12.2 mmol) 
and imidazole (830 mg, 12.2 mmol) in benzene (80 mL). The mixture was stirred at room 
temperature shielded from light for 20 min, whereupon a solution of Na2S2O3 (10 g) in 
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saturated aqueous NaHCO3 (100 mL) was added. The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (2 x 60 mL). The combined organic layers 
were dried (Na2SO4), and the solvent was removed under reduced pressure. The residue 
was purified by flash chromatography eluting with hexanes / EtOAc (20:1 → 15:1) to 
give 589 mg (38%) of 4.153 as a yellow oil; 1NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.5, 
Hz, 1 H), 7.31-7.28 (comp, 2 H), 7.24-7.21 (m, 1 H), 3.94 (d, J = 13.0 Hz, 1 H), 3.49 (dd, 
J = 10.5, 6.3 Hz, 1 H), 3.36 (dd, J = 10.5, 2.3 Hz, 1 H), 3.15 (d, J = 13.0, Hz, 1 H), 2.75-
2.71 (m, 1 H), 2.11-2.02 (comp, 2 H), 1.74-1.63 (comp, 2 H), 1.50-1.36 (comp, 3 H) 13C 
NMR (125 MHz, CDCl3) δ 138.9, 129.0, 128.2, 126.9, 59.8, 58.0, 50.8, 31.5, 25.3, 22.7, 
13.4. 
NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.5, Hz, 1 H, C9-
H), 7.31-7.28 (comp, 2 H, C10-H), 7.24-7.21 (m, 1 H, C11-H), 3.94 (d, J = 13.0 Hz, 1 H, 
C7-H), 3.49 (dd, J = 10.5, 6.3 Hz, 1 H, C12-H), 3.36 (dd, J = 10.5, 2.3 Hz, 1 H, C12-H), 
3.15 (d, J = 13.0, Hz, 1 H, C7-H), 2.75-2.71 (m, 1 H, C6-H), 2.11-2.02 (comp, 2 H, C2-
H, C6-H), 1.74-1.63 (comp, 2 H, C3-H, C4-H), 1.50-1.36 (comp, 3 H, C5-H, C3-H or 
C4-H) 13C NMR (125 MHz, CDCl3) δ 138.9 (C8), 129.0 (C9), 128.2 (C10), 126.9 (C11), 
59.8 (C2), 58.0 (C7), 50.8 (C6), 31.5 (C3 or C4 or C5), 25.3 (C3 or C4 or C5), 22.7 (C3 

















acid tert-butyl ester (4.159), (mp5-066, mp5-067, mp5-070). A solution of 4.156 (2.00 
g, 13.3 mmol), TBSCl (3.00 g, 19.9 mmol) and imidazole (1.81 g, 26.6 mmol) in CH2Cl2 
(30 mL) was stirred at room temperature for 3 h. MeOH (2 mL) was added and the 
reaction was stirred for 10 min, whereupon it was poured into EtOAc (150 mL) and 
washed with 0.5 M HCl (2 x 50 mL). The organic layer was dried (Na2SO4), and the 
solvent was removed under reduced pressure. The residue was dissolved in DMF (12 mL) 
and cooled to 0 °C. NaH (676 mg, 16.9 mmol) was added and the reaction was stirred at 
0 °C for 10 min, whereupon allyl bromide (1.46 mL, 16.9 mmol) was added. The reaction 
was stirred over night, and NaH (484 mg, 12.1 mmol) and allyl bromide (1.05 mL, 12.1 
mmol) were added. The reaction was stirred at room temperature for 3 h, whereupon it 
was poured into brine (80 mL) and extracted Et2O (3 x 70 mL). The combined organic 
extracts were washed with brine (2 x 30 mL), and dried (Na2SO4). The solvent was 
removed under reduced pressure, and the residue was purified by flash chromatography 
eluting with hexanes / EtOAc (20:1 → 15:1 → 10:1) to give 1.77 g (44%) of 4.158 as a 
clear colorless oil. TBAF (2.08 g, 7.95 mmol) was added to a solution of 4.158 (1.77 g, 
5.3 mmol) in THF (50 mL) and the reaction was stirred at room temperature for 2 h. The 
reaction was poured into H2O (150 mL) and extracted with EtOAc (3 x 100 mL). The 
combined organic layers were dried (Na2SO4), and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography eluting with hexanes 
/ EtOAc (2:1) to give 1.01 g (89%) of 4.159 as a clear colorless oil; 1NMR (500 MHz, 
CDCl3) 5.87-5.57 (m, 1 H), 5.14-5.06 (comp, 2 H), 3.97 (br s, 1 H), 3.73 (br, s, 2 H), 3.57 
(d, J = 5.6, Hz, 1 H), 2.49 (br s, 1 H), 1.43 (s, 9 H), 1.13 (d, J = 6.1 Hz, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 156.5, 135.6, 116.0, 80.0, 65.6, 54.2, 47.2, 28.4, 14.7; IR (neat) 
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3435, 2977, 1672, 1454, 1407, 1366 cm-1. mass spectrum (CI) m/z 216.1609 
[C11H22NO3 (M+1) requires 216.1600], 184, 216 (base).  
NMR Assignments. 1NMR (500 MHz, CDCl3) 5.87-5.57 (m, 1 H, C5-H), 5.14-
5.06 (comp, 2 H, C6-H), 3.97 (br s, 1 H, C1-H), 3.73 (br, s, 2 H, C4-H), 3.57 (d, J = 5.6, 
Hz, 1 H, C2-H), 2.49 (br s, 1 H, OH), 1.43 (s, 9 H, C9-H), 1.13 (d, J = 6.1 Hz, 3 H, C3-
H); 13C NMR (125 MHz, CDCl3) δ 156.5 (C7), 135.6 (C5), 116.0 (C6), 80.0 (C8), 65.6 













3-But-3-enyl-4-methyloxazolidine-2-one (4.161), mp5-071). Iodine (88 mg, 
0.67 mmol) was added to a solution of 4.159 (100 mg, 0.46 mmol), PPh3 (250 mg, 0.93 
mmol) and imidazole (63 mg, 0.93 mmol) in CH2Cl2 (4.6 mL). The reaction was stirred 
at room temperature overnight, whereupon it was concentrated under reduced pressure. 
The residue was purified by flash chromatography eluting with hexanes / EtOAc (1:1) to 
give 48 mg (73%) of 4.161 as a clear colorless oil; 1NMR (500 MHz, CDCl3) 5.77-5.68 
(m, 1 H), 5.23-5.16 (comp, 2 H), 4.36 (app t, J = 7.8, Hz, 1 H), 4.09-4.04 (m, 1 H), 3.87-
3.78 (m, 1 H), 3.78 (app t, J = 7.8 Hz, 1 H), 3.61-3.56 (m, 1 H), 1.21 (d, J = 5.9 Hz, 3 H); 
13C NMR (125 MHz, CDCl3) δ 157.9, 132.2, 118.4, 68.9, 50.6, 44.4, 18.0; IR (neat) 
2975, 1747, 1412, 1254 cm-1; mass spectrum (CI) m/z 142.0871 [C7H12NO2 (M+1) 
requires 142.0868] 116, 142 (base).  
NMR Assignments. 1NMR (500 MHz, CDCl3) 5.77-5.68 (m, 1 H, C3-H), 5.23-
5.16 (comp, 2 H, C4-H), 4.36 (app t, J = 7.8, Hz, 1 H, C7-H), 4.09-4.04 (m, 1 H, C2-H), 
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3.87-3.78 (m, 1 H, C6-H), 3.78 (app t, J = 7.8 Hz, 1 H, C7-H), 3.61-3.56 (m, 1 H, C2-H), 
1.21 (d, J = 5.9 Hz, 3 H, C5-H); 13C NMR (125 MHz, CDCl3) δ 157.9 (C8), 132.2 (C3), 












(2-Iodo-1-methylethyl)carbamic acid tert-butyl ester (4.163), (mp5-132). 
Iodine (728 mg, 5.74 mmol) was added to a solution of 4.131 (500 mg, 2.87 mmol), PPh3 
(1.93 g, 7.17 mmol) and imidazole (488 mg, 7.16 mmol) in CH2Cl2 (15 mL) at 0 °C. The 
reaction was stirred at 0 °C for 45 min, whereupon the cold bath was removed and the 
reaction was stirred at room temperature for 7 h. The reaction was poured into H2O (50 
mL) and the aqueous mixture was extracted with CH2Cl2 (2 x 40 mL). The combined 
organic layers were dried (MgSO4), and the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography eluting with hexanes / 
EtOAc (7:1) to give 386 mg (47%) of 4.163 as a brown oil; 1NMR (500 MHz, CDCl3) 
4.62-4.59 (m, 1 H), 3.53-3.45 (m, 1 H), 3.41-3.32 (m, 1 H), 3.26 (dd, J = 9.9, 3.8 Hz, 1 
H), 1.41 (s, 9 H), 1.16 (d, J = 6.6 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 154.8, 79.6, 
45.9, 28.3, 21.1, 15. 
NMR Assignments. 1NMR (500 MHz, CDCl3) 4.62-4.59 (m, 1 H, NH), 3.53-
3.45 (m, 1 H, C1-H), 3.41-3.32 (m, 1 H, C2-H), 3.26 (dd, J = 9.9, 3.8 Hz, 1 H, C2-H), 
1.41 (s, 9 H, C6-H), 1.16 (d, J = 6.6 Hz, 3 H, C3-H); 13C NMR (125 MHz, CDCl3) δ 
























methylpiperidine-1-yl]-acetonitrile (4.172) (mp4-193). Iodoacetonitrile (81 μL, 1.60 
mmol) was added to a solution of 4.144 (250 mg, 0.50 mmol) and i-Pr2EtN (0.35 mL, 
2.00 mmol) in THF (5 mL). The mixture was stirred at room temperature overnight, 
whereupon it was diluted with EtOAc (75 mL). The solution was washed with a saturated 
aqueous solution of NaHCO3 (30 mL) and brine (30 mL). The organic layer was dried 
(Na2SO4), the solvent was removed under reduced pressure, and the residue was purified 
by flash chromatography eluting with hexanes / EtOAc (6:1) to give 250 mg (93%) of 
4.172 as a clear yellow oil; 1NMR (500 MHz, CDCl3) δ 7.65-7.62 (comp, 4 H), 7.43-7.33 
(comp, 6 H), 3.79 (d, J = 17.4, Hz, 1 H), 3.78-3.73 (m, 1 H), 3.68 (dd, J = 10.9, 6.5 Hz, 1 
H), 3.51 (d, J = 17.4 Hz, 1 H), 3.15 (dd, J = 10.9, 4.4, Hz, 1 H), 3.07-3.02 (m, 1 H), 2.89-
2.82 (m, 1 H), 1.80-1.75 (m, 1 H), 1.69-1.64 (m, 1 H), 1.58 (ddd, J = 12.8, 9.9, 4.9 Hz, 1 
H), 1.40 (dt, J = 12.7, 9.7 Hz, 1 H), 1.14 (d, J = 6.3 Hz, 3 H), 1.04 (s, 9 H), 0.82 (s, 9 H), 
-0.05 (s, 3 H), -0.06 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 135.8, 135.7, 134.3, 134.2, 
129.6, 127.6, 117.6, 66.5, 61.9, 60.8, 49.5, 42.5, 40.4, 37.4, 26.9, 25.9, 19.8, 19.1, 18.1, -
5.55, -5.62; IR (neat) 2938, 2856, 1472, 1427, 1256, 1105, 837, 702 cm-1; mass spectrum 
(ESI) m/z 537.3334 [C31H49N2O2Si2 (M+1) requires 537.3327], 498, 537 (base), 559.  
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NMR Assignments. 1NMR (500 MHz, CDCl3) δ 7.65-7.62 (comp, 4 H, Ar-H), 
7.43-7.33 (comp, 6 H, Ar-H), 3.79 (d, J = 17.4, Hz, 1 H, C19-H), 3.78-3.73 (m, 1 H, C4-
H), 3.68 (dd, J = 10.9, 6.5 Hz, 1 H, C7-H), 3.51 (d, J = 17.4 Hz, 1 H, C19-H), 3.15 (dd, J 
= 10.9, 4.4, Hz, 1 H, C7-H), 3.07-3.02 (m, 1 H, C6-H), 2.89-2.82 (m, 1 H, C2-H), 1.80-
1.75 (m, 1 H, C3-H), 1.69-1.64 (m, 1 H, C5-H), 1.58 (ddd, J = 12.8, 9.9, 4.9 Hz, 1 H, C5-
H), 1.40 (dt, J = 12.7, 9.7 Hz, 1 H, C3-H), 1.14 (d, J = 6.3 Hz, 3 H, C8-H), 1.04 (s, 9 H, 
C12-H), 0.82 (s, 9 H, C18-H), -0.05 (s, 3 H, C9-H or C10-H), -0.06 (s, 3 H, C9-H or 
C10-H); 13C NMR (125 MHz, CDCl3) δ 135.8 (Ar-C), 135.7 (Ar-C), 134.3 (Ar-C), 134.2 
(Ar-C), 129.6 (Ar-C), 127.6 (Ar-C), 117.6 (C-20), 66.5 (C4), 61.9 (C7), 60.8 (C6), 49.5 
(C2), 42.5 (C3), 40.4 (C9), 37.4 (C5), 26.9 (C12), 25.9 (C18), 19.8 (C8), 19.1 (C17 or 






































Ketone 4.175 (mp4-192). LDA (0.25 mL, 0.4 M, 0.10 mmol) was added to a 
solution of 4.77 (40 mg, 0.08 mmol) in THF (1 mL) at −78 °C. The reaction was stirred 
at −78 °C for 30 min, whereupon a solution of Eschenmoser salt (46 mg, 0.25 mmol) in 
THF (0.5 mL) was added. The cold bath was removed and the reaction was stirred for 1 
h, whereupon a saturated aqueous solution of NH4Cl (1 mL) was added. The mixture was 
poured into H2O (10 mL) and extracted with EtOAc (3 x 10 mL). The combined organic 
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layers were dried (Na2SO4), and the solvent was removed under reduced pressure. The 
residue was dissolved in MeOH (0.2 mL), and MeI (60 μL, 1.0 mmol) was added. The 
reaction was stirred at room temperature overnight, whereupon it was poured into H2O 
(10 mL) and extracted with EtOAc (3 x 10 mL). The combined organic layers were dried 
(Na2SO4), and the solvent was removed under reduced pressure. The residue was purified 
by flash chromatography eluting with hexanes / EtOAc (3:1) to give 7 mg (17%) of 4.77 
and 24 mg (58%) of 4.175 as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J 
= 8.2 Hz, 1 H), 7.32 (td, J = 8.5, 1.4 Hz, 1 H), 7.24 (d, J = 7.4 Hz, 2 H), 7.16-7.09 (comp, 
2 H), 7.02 (t, J = 7.4 Hz, 2 H), 6.85 (t, J = 7.4 Hz), 6.25 (t, J = 2.3 Hz, 1 H), 5.50 (t, J = 
2.4 Hz, 1 H), 5.08 (td, J = 10.6, 4.8 Hz, 1 H), 3.00 (dt, J = 17.4, 2.4 Hz, 1 H), 2.89 (dt, J 
= 17.4, 2.4 Hz, 1 H), 1.96-1.90 (m, 1 H), 1.96-1.90 (m, 1 H), 1.77-1.69 (m, 1 H), 1.66-
1.60 (m, 1 H), 1.51-1.41 (m, 1 H), 1.34 (s, 3H), 1.32-1.24 (m, 1 H), 1.24 (s, 3 H), 1.18-
1.07 (m, 1 H), 0.99 (s, 3 H), 0.99 (s, 3 H), 0.93-0.83 (m, 1 H), 0.87 (d, J = 6.5 Hz, 3 H); 
mass spectrum (CI) m/z 215 (base), 286, 499 (M+1), 528, 488. 
NMR Assignments. 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.2 Hz, 1 H, C9-
H or C12-H), 7.32 (td, J = 8.5, 1.4 Hz, 1 H, C10-H or C11-H), 7.24 (d, J = 7.4 Hz, 2 H, 
C28-H), 7.16-7.09 (comp, 2 H, C10-H or C11-H, C9-H or C12-H), 7.02 (t, J = 7.4 Hz, 2 
H, C29-H), 6.85 (t, J = 7.4 Hz, C30-H), 6.25 (t, J = 2.3 Hz, 1 H, C31-H or C32-H), 5.50 
(t, J = 2.4 Hz, 1 H, C31-H or C32-H), 5.08 (td, J = 10.6, 4.8 Hz, 1 H, C17-H), 3.00 (dt, J 
= 17.4, 2.4 Hz, 1 H, C4-H), 2.89 (dt, J = 17.4, 2.4 Hz, 1 H, C4-H), 1.96-1.90 (m, 1 H, 
C22-H), 1.96-1.90 (m, 1 H, C18-H), 1.77-1.69 (m, 1 H, C21-H), 1.66-1.60 (m, 1 H, C20-
H), 1.51-1.41 (m, 1 H, C19-H), 1.34 (s, 3H, C15-H or C16-H), 1.32-1.24 (m, 1 H, C18-
H), 1.24 (s, 3 H, C15-H or C-16), 1.18-1.07 (m, 1 H, C21-H), 0.99 (s, 3 H, C24-H or 
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C25-H), 0.99 (s, 3 H, C24-H or C25-H), 0.93-0.83 (m, 1 H, C20-H), 0.87 (d, J = 6.5 Hz, 







































 Aldehyde 4.179 (mp4-299, mp4-302). Pd2(dba)3 (99 mg, 0.11 mmol) was added 
to a solution of 4.80 (364 mg, 0.54 mmol) and Ph3As (131 mg, 0.43) in degassed 
DMF/THF 2:1 (11 mL), and the mixture was stirred at room temperature for 15 min. 
Tributylvinyltin (0.47 mL, 1.61 mmol) was added, and the reaction was stirred at room 
temperature for 6.5 h, whereupon it was poured into a separatory funnel containing brine 
(40 mL). The mixture was extracted with Et2O (3 x 40 mL), and the combined organic 
layers were dried (Na2SO4), the solvent was removed under reduced pressure, and the 
residue was purified by flash chromatography eluting with hexanes / EtOAc (4:1) to give 
4.178 as a clear colorless oil. The purified alkene was dissolved in dioxane (4 mL). 2,6-
lutidine (0.25 mL, 2.15 mmol), H2O (1.3 mL), and a 2.5% wt solution of OsO4 in t-butyl 
alcohol (0. 27 mL, 0.02 mmol) was added followed by NaIO4 (920 mg, 4.30 mmol). The 
reaction was stirred at room temperature for 2 h, whereupon it was poured into a 
separatory funnel containing H2O (40 mL) and extracted with CH2Cl2 (3 x 40 mL). The 
combined organic layers were dried (Na2SO4), the solvent was removed under reduced 
pressure, and the residue was purified by flash chromatography eluting with hexanes / 
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EtOAc (5:1) to give 190 mg (63%, 2 steps) of 4.179 as a dark grey oil; 1H NMR (500 
MHz, CDCl3) δ 10.45 (s, 1 H), 7.77 (d, J = 8.2 Hz, 1 H), 7.33-7.29 (m, 1 H), 7.25-7.20 
(comp, 3 H), 7.13 (td, J = 7.6, 1.1 Hz, 1 H), 7.03-7.00 (comp, 2 H), 6.89-6.85 (m, 1 H), 
5.08 (td, J = 10.9, 4.8 Hz, 1 H), 3.87 (s, 3 H), 3.18 (d, J = 18.5 Hz, 1 H), 3.01 (d, J = 18.5 
Hz, 1 H), 2.18-2.13 (m, 1 H), 1.95-1.91 (m, 1 H), 1.72 (dq, J = 13.5, 3.5 Hz, 1 H), 1.65-
1.60 (m, 1 H), 1.50-1.43 (m, 1 H), 1.35 (s, 3H), 1.52 (s, 3 H), 1.22-1.18 (m, 1 H), 1.14 (s, 
3H), 1.11 (s, 3H), 1.17-1.08 (m, 1 H), 0.90-0.83 (m, 1 H), 0.87 (d, J = 6.5 Hz, 3 H); 13C 
NMR (125 MHz) δ 190.7, 175.6, 163.9, 153.4, 151.0, 149.8, 143.4, 139.8, 128.8, 127.8, 
127.2, 125.4, 124.9, 124.4, 124.0, 115.0, 59.1, 54.7, 52.5, 50.6, 41.8, 41.1, 39.8, 34.3, 
31.5, 27.8, 26.6, 25.2, 24.4, 21.7, 21.2; IR (neat) 2955, 1769, 1722, 1677, 1464, 1242 cm-
1; mass spectrum (CI) m/z 558.2855 [C34H40NO6 (M+1) requires 558.2855], 260, (base), 
371, 557, 558. 
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 10.45 (s, 1H), 7.77 (d, J = 
8.2 Hz, 1 H, C9-H or C12-H), 7.33-7.29 (m, 1 H, C10-H or C11-H), 7.25-7.20 (comp, 3 
H, C9-H or C12-H, C28-H), 7.13 (td, J = 7.6, 1.1 Hz, 1 H, C10-H or C11-H), 7.03-7.00 
(comp, 2 H, C29-H), 6.89-6.85 (m, 1 H, C30-H), 5.08 (td, J = 10.9, 4.8 Hz, 1 H, C17-H), 
3.87 (s, 3 H, C32-H), 3.18 (d, J = 18.5 Hz, 1 H, C4-H), 3.01 (d, J = 18.5 Hz, 1 H, C4-H), 
2.18-2.13 (m, 1 H, C22-H), 1.95-1.91 (m, 1 H, C18-H), 1.72 (dq, J = 13.5, 3.5 Hz, 1 H, 
C21-H), 1.65-1.60 (m, 1 H, C22-H), 1.50-1.43 (m, 1 H, C19-H), 1.35 (s, 3H, C24-H or 
C25-H), 1.52 (s, 3 H, C15-H or C-16), 1.22-1.18 (m, 1 H, C18-H), 1.14 (s, 3H, C24-H or 
C25-H), 1.11 (s, 3H, C15-H or C16-H), 1.17-1.08 (m, 1 H, C21-H), 0.90-0.83 (m, 1 H, 
C21-H), 0.87 (d, J = 6.5 Hz, 3 H, C26-H); 13C NMR (125 MHz) δ 190.7 (C33), 175.6 
(C2), 163.9 (C31), 153.4 (C6), 151.0 (C14), 149.8 (C27), 143.4 (C13), 139.8 (C5), 128.8 
(C10 or C11), 127.8 (C29), 127.2 (C8), 125.4 (C28), 124.9 (C30), 124.4 (C9 or C12), 
124.0 (C10 or C11), 115.0 (C9 or C12), 59.1 (C3), 54.7 (C7), 52.5 (C32), 50.6 (C22), 
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41.8 (C18), 41.1 (C4), 39.8 (C23), 34.3 (C20), 31.5 (C19), 27.8 (C15 or C16), 26.6 







































Allyl bromide 4.181 (mp5-029, mp5-033).  A solution of NaBH4 (0.2 M, 1.36 
mL, 0.27 mmol) in EtOH was added to a solution of 4.179 (117 mg, 0.21 mmol) in 
CH2Cl2 (2.8 mL) at −78 °C. The reaction was stirred at −78 °C for 2 h, whereupon a 
saturated aqueous solution of NH4Cl (2 mL) was added and the cold bath removed. 
Stirring was continued for 15 min, and the reaction was poured into a separatory funnel 
containing water (50 mL). The aqueous mixture was extracted with EtOAc (3 x 50 mL). 
The combined organic layers were dried (Na2SO4), and the solvent was removed under 
reduced pressure The residue was purified by flash chromatography eluting with hexanes 
/ EtOAc (2:1) to give 95 mg (81%) of 4.180 as a clear colorless oil. CBr4 (35 mg, 0.11 
mmol), was added to a solution of 4.180 (45 mg, 0.08 mmol), and PPh3 (28 mg, 0.11 
mmol) in CH2Cl2 (0.8 mL). The reaction was stirred at room temperature for 30 min, 
whereupon it was concentrated under reduced pressure. The residue was purified by flash 
chromatography eluting with hexanes / EtOAc (5:1) to give 43 mg (73%) of 4.181 as a 
clear colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 7.8 Hz, 1 H), 7.29-7.23 
(comp, 4 H), 7.10 (d, J = 7.5 Hz, 1 H), 7.03-7.00 (comp, 2 H), 6.87-6.84 (m, 1 H), 5.01 
  316
(td, J = 10.9, 4.7 Hz, 1 H), 4.75 (d, J = 9.5 Hz, 1 H), 4.02 (d, J = 9.5 Hz, 1 H),  3.82 (s, 3 
H), 3.18 (d, J = 17.0 Hz, 1 H), 2.84 (d, J = 17.0 Hz, 1 H), 2.20-2.14 (m, 1 H), 1.98-1.94 
(m, 1 H), 1.73 (dq, J = 13.6, 3.4 Hz, 1 H), 1.66-1.61 (m, 1 H), 1.52-1.45 (m, 1 H), 1.35 (s, 
3H), 1.29-1.22 (m, 1 H), 1.25 (s, 3 H), 1.19-1.10 (m, 1 H), 1.13 (s, 3 H), 0.99 (s, 3H), 
0.93-0.86 (m, 1 H), 0.88 (d, J = 6.5 Hz, 3 H); 13C NMR (125 MHz) δ 175.0, 164.5, 
156.0, 150.9, 149.9, 139.0, 129.7, 129.5, 128.5, 127.8, 125.4, 125.0, 124.1, 123.8, 114.9, 
58.8, 55.6, 51.8, 50.6, 41.8, 40.9, 39.8, 34.3, 31.5, 27.8, 26.6, 25.1, 23.3, 22.8, 22.1, 21.2; 
IR (neat) 2954, 1767, 1716, 1479, 1464, 1261 cm-1; mass spectrum (CI) m/z 622.2157 
[C34H41NO5Br (M+1) requires 622.2168], 251 (base), 364, 408, 542, 622 ,624.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 7.8 Hz, 1 H, C9-
H or C12-H), 7.29-7.23 (comp, 4 H, C10-H or C11-H, C9-H or C12-H, C28), 7.10 (d, J = 
7.5 Hz, 1 H, C10-H or C11-H), 7.03-7.00 (comp, 2 H, C29-H), 6.87-6.84 (m, 1 H, C30-
H), 5.01 (td, J = 10.9, 4.7 Hz, 1 H, C17-H), 4.75 (d, J = 9.5 Hz, 1 H, C33-H), 4.02 (d, J = 
9.5 Hz, 1 H, C4-H),  3.82 (s, 3 H, C32-H), 3.18 (d, J = 17.0 Hz, 1 H, C4-H), 2.84 (d, J = 
17.0 Hz, 1 H, C4-H), 2.20-2.14 (m, 1 H, C22-H), 1.98-1.94 (m, 1 H, C18-H), 1.73 (dq, J 
= 13.6, 3.4 Hz, 1 H, C21-H), 1.66-1.61 (m, 1 H, C20-H), 1.52-1.45 (m, 1 H, C19-H), 1.35 
(s, 3H, C24-H or C25-H), 1.29-1.22 (m, 1 H, C18-H), 1.25 (s, 3 H, C15-H or C-16), 1.19-
1.10 (m, 1 H, C21-H), 1.13 (s, 3 H, C24-H or C25-H), 0.99 (s, 3H, C15-H or C16-H), 
0.93-0.86 (m, 1 H, C20-H), 0.88 (d, J = 6.5 Hz, 3 H, C26-H); 13C NMR (125 MHz) δ 
175.0 (C2), 164.5 (C31), 156.0 (C6), 150.9 (C14), 149.9 (C27), 139.0 (C13), 129.7 (C5), 
129.5 (C8), 128.5 (C10 or C11), 127.8 (C29), 125.4 (C28), 125.0 (C30), 124.1 (C10 or 
C11), 123.8 (C9 or C12), 114.9 (C9 or C12), 58.8 (C3), 55.6 (C7), 51.8 (C32), 50.6 
(C22), 41.8 (C18), 40.9 (C4), 39.8 (C23), 34.3 (C20), 31.5 (C19), 27.8 (C15 or C16), 












































Oxindole 4.185 (mp4-285, mp4-298). A solution of sec-BuLi (1.66 M, 34 μL, 
0.06 mmol) was added to a solution of 4.135 (31 mg, 0.07 mmol) in Et2O (0.5 mL) and 
TMEDA (9 μL. 0.06 mmol) at −78 °C, and the reaction was stirred for 2.75 h. This 
solution was then added via cannula to a solution of 4.179 (29 mg, 0.05 mmol) in Et2O 
(0.5 mL) at −100 °C, and the reaction was stirred at −100 °C for 30 min, whereupon the 
cold bath was replaced with a  −78 °C bath. The reaction was stirred at this temperature 
for 1 h, whereupon the cold bath was removed. After stirring for 10 min, a saturated 
aqueous solution of NH4Cl (1 mL) was added. The slurry was poured into H2O (10 mL), 
and the mixture was extracted with EtOAc (3 x 10 mL). The combined organic layers 
were dried (Na2SO4), and the solvent was removed under reduced pressure. The residue 
was purified by flash chromatography eluting with hexanes / EtOAc (3:1) to give 7 mg 
(24%) of recovered 4.179 and 7 mg (12%) of 4.184 as a clear colorless oil. K2CO3 (10 
mg, 0.076 mmol) was added to a solution of 4.184 (7 mg, 0.006 mmol) in MeOH (0.5 
mL), and the reaction was stirred at room temperature for 20 min, whereupon a saturated 
aqueous solution of NH4Cl (1 mL) and H2O (1 mL) were added. The aqueous mixture 
was extracted with EtOAc (2 x 4 mL), and the combined organic layers were dried 
(Na2SO4). The solvent was removed under reduced pressure, and the residue was purified 
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by flash chromatography eluting with hexanes / EtOAc (3:1) to give 3 mg (70%) of 4.185 
as a clear colorless oil.1H NMR (500 MHz, CDCl3) δ 7.67-7.64 (comp, 2 H), 7.61-7.58 
(comp, 2 H), 7.45-7.35 (comp, 6 H), 7.27-7.24 (m, 1 H), 7.08 (d, J = 7.6, 1 H), 7.01 (td, J 
= 7.6, 1.0 Hz,1 H), 6.83 (d, J = 7.6 Hz,1 H), 5.28-5.26 (m, 1 H), 4.22 (q, J = 6.9 Hz 1 H), 
4.18-4.16 (m, 1 H), 4.08-4.02 (m, 1 H), 2.80 (dd, J = 16.1, 2.6 Hz, 1 H), 2.62 (dd, J = 
16.1, 2.6 Hz, 1 H), 2.46-2.40 (m, 1 H), 1.81-1.75 (comp, 2 H, C18-H), 1.44 (s, 9H), 1.42-
1.35 (comp, 3 H), 1.20 (s, 3 H), 1.06 (s, 9 H), 0.91 (s, 3H). ; IR (neat) 3252, 2971, 2922, 
1766, 1709, 1679, 1471, 1391, 1370, 1106, 1058 cm-1; mass spectrum (CI) m/z 721.3671 
[C43H53N2O6Si (M+1) requires 721.3673], 575, 619, 720 (base, M-1), 722.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.67-7.64 (comp, 2 H, Ar-H), 
7.61-7.58 (comp, 2 H, Ar-H), 7.45-7.35 (comp, 6 H, Ar-H), 7.27-7.24 (m, 1 H, C10-H or 
C11-H), 7.08 (d, J = 7.6, 1 H, C9-H or C12-H), 7.01 (td, J = 7.6, 1.0 Hz,1 H, C10-H or 
C11-H), 6.83 (d, J = 7.6 Hz,1 H, C9-H or C12-H), 5.28-5.26 (m, 1 H, C16-H), 4.22 (q, J 
= 6.9 Hz 1 H, C19-H), 4.18-4.16 (m, 1 H, C17-H), 4.08-4.02 (m, 1 H, C21-H), 2.80 (dd, J 
= 16.1, 2.6 Hz, 1 H, C4-H), 2.62 (dd, J = 16.1, 2.6 Hz, 1 H, C4-H), 2.46-2.40 (m, 1 H, 
C18-H), 1.81-1.75 (comp, 2 H, C18-H, C20-H), 1.44 (s, 9H, C25-H), 1.42-1.35 (comp, 3 
H, C22-H, C20-H), 1.20 (s, 3 H, C14-H or C-15), 1.06 (s, 9 H, C27-H), 0.91 (s, 3H, C14-









































Enoate 4.200 (mp5-098). Pd2(dba)3 (25 mg, 0.03 mmol) was added to a solution 
of 4.80 (88 mg, 0.14 mmol) and Ph3As (33 mg, 0.11) in degassed DMF/THF 2:1 (2.8 
mL), and the mixture was stirred at room temperature for 15 min. Allyltributyltin (0.11 
mL, 0.39 mmol) was added, and the reaction was stirred at 50 °C overnight, whereupon it 
was allowed to cool to room temperature and poured into a separatory funnel containing 
brine (20 mL). The mixture was extracted with Et2O (3 x 20 mL), and the combined 
organic layers were dried (MgSO4). The solvent was removed under reduced pressure, 
and the residue was purified by flash chromatography eluting with hexanes / EtOAc 
(10:1) to give 49 mg (64%) of 4.200 as a clear colorless oil; 1H NMR (500 MHz, CDCl3) 
δ 7.70 (d, J = 8.2 Hz, 1 H), 7.27-7.23 (comp, 3 H), 7.19 (dd, J = 7.5, 1.0 Hz,1 H), 7.07 
(td, J = 7.5, 1.0 Hz, 1 H), 7.02 (t, J = 7.4 Hz, 2 H), 6.86 (t, J = 7.4 Hz, 1 H),  5.84 (ddt, J 
= 16.9, 10.1, 6.6 Hz, 1 H), 5.13 (dd, J = 16.9, 1.6 Hz, 1 H),  5.09 (td, J = 10.7, 4.5 Hz, 1 
H), 5.02 (dd, J = 10.1, 1.6 Hz, 1 H), 3.76 (s, 3 H), 3.37 (d, J = 13.8, 6.8 Hz, 1 H), 3.18 
(dd, J = 13.8, 6.8 Hz, 1 H), 3.12 (d, J = 16.1 Hz, 1 H), 2.82 (d, J = 16.1 Hz, 1 H), 2.19-
2.14 (m, 1 H), 1.99-1.93 (m, 1 H), 1.72 (dq, J = 13.6, 3.3 Hz, 1 H), 1.52-1.43 (m, 1 H), 
1.35 (s, 3H), 1.30-1.20 (m, 1 H), 1.26 (s, 3 H), 1.17-1.09 (m, 1 H), 1.05 (s, 3 H), 0.93-
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0.85 (m, 1 H), 0.88 (d, J = 6.5 Hz, 3 H), 0.83 (s, 3H); 13C NMR (125 MHz) δ 175.5, 
165.5, 160.5, 150.9, 149.9, 139.1, 135.2, 130.1, 128.2, 127.8, 125.39, 125.36, 125.0, 
123.9, 123.7, 116.5, 114.8, 77.1, 58.8, 56.4, 51.3, 50.6, 41.8, 40.7, 39.8, 34.3, 31.7, 31.4, 
27.6, 26.6, 25.3, 23.4, 22.4, 21.7; IR (neat) 2957, 1769, 1768, 1465, 1358, 1292, 1250 
cm-1; mass spectrum (CI) m/z 570.3216 [C36H44NO5 (M+1) requires 570.3219], 538, 
554, 570 (base), 598.  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.2 Hz, 1 H, C9-
H or C12-H), 7.27-7.23 (comp, 3 H, C10-H or C11-H, C28-H), 7.19 (dd, J = 7.5, 1.0 
Hz,1 H, C9-H or C12-H), 7.07 (td, J = 7.5, 1.0 Hz, 1 H, C10-H or C11-H), 7.02 (t, J = 7.4 
Hz, 2 H, C29-H), 6.86 (t, J = 7.4 Hz, 1 H, C30-H),  5.84 (ddt, J = 16.9, 10.1, 6.6 Hz, 1 H, 
C34-H), 5.13 (dd, J = 16.9, 1.6 Hz, 1 H, C35-H),  5.09 (td, J = 10.7, 4.5 Hz, 1 H, C17-H), 
5.02 (dd, J = 10.1, 1.6 Hz, 1 H, C35-H), 3.76 (s, 3 H, C32-H), 3.37 (d, J = 13.8, 6.8 Hz, 1 
H, C33-H), 3.18 (dd, J = 13.8, 6.8 Hz, 1 H, C33-H), 3.12 (d, J = 16.1 Hz, 1 H, C4-H), 
2.82 (d, J = 16.1 Hz, 1 H, C4-H), 2.19-2.14 (m, 1 H, C22-H), 1.99-1.93 (m, 1 H, C18-H), 
1.72 (dq, J = 13.6, 3.3 Hz, 1 H, C21-H), 1.52-1.43 (m, 1 H, C19-H), 1.35 (s, 3H, C24-H 
or C25-H), 1.30-1.20 (m, 1 H, C18-H), 1.26 (s, 3 H, C15-H or C-16), 1.17-1.09 (m, 1 H, 
C21-H), 1.05 (s, 3 H, C24-H or C25-H), 0.93-0.85 (m, 1 H, C20-H), 0.88 (d, J = 6.5 Hz, 
3 H, C26-H), 0.83 (s, 3H, C15-H or C16-H); 13C NMR (125 MHz) δ 175.5 (C2), 165.5 
(C31), 160.5 (C6), 150.9 (C14), 149.9 (C27), 139.1 (C13), 135.2 (C34), 130.1 (C5), 
128.2 (C10 or C11), 127.8 (C29), 125.39 (C8), 125.36 (C28), 125.0 (C30), 123.9 (C10 or 
C11), 123.7 (C9 or C12), 116.5 (C35), 114.8 (C9 or C12), 77.1 (C17), 58.8 (C3), 56.4 
(C7), 51.3 (C32), 50.6 (C22), 41.8 (C18), 40.7 (C4), 39.8 (C23), 34.3 (C20), 31.7 (C33), 
31.4 (C19), 27.6 (C15 or C16), 26.6 (C21), 25.3 (C24 or C25), 23.4 (C15 or C16), 22.4 











































Aldehyde 4.193 (mp5-100). A solution of OsO4 (a 2.5% wt, 41 μL, 0.003 mmol) 
in t-butyl alcohol was added to a solution of 4.200 (46 mg, 0.08 mmol) in dioxane (0.8 
mL), H20 (0.2 mL) containing 2,6-lutidine (38 μL, 0.03 mmol). NaIO4 (140 mg, 0.66 
mmol) was added, and the reaction was stirred at room temperature for 2 h, whereupon it 
was poured into a separatory funnel containing H2O (10 mL) and was extracted with 
CH2Cl2 (3 x 10 mL). The combined organic layers were dried (Na2SO4), and the solvent 
was removed under reduced pressure. The residue was purified by flash chromatography 
eluting with hexanes / EtOAc (4:1) to give 26 mg (57%) of 4.193 as a pale yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 9.64 (t, J = 1.5 Hz, 1 H), 7.71 (d, J = 7.9 Hz, 1 H), 7.32 (dd, J 
= 7.6, 0.9 Hz, 1 H), 7.30-7.26 (m, 1 H), 7.25-7.22 (comp, 2 H), 7.12 (td, J = 7.6, 1.0 Hz,1 
H), 7.02-6.99 (comp, 2 H), 6.87-6.83 (m, 1 H), 5.10 (dt, J = 10.9, 4.7 Hz, 1 H), 3.76 (s, 3 
H), 3.69 (dd, J = 16.3, 1.3 Hz, 1 H), 3.45 (dd, J = 16.3, 0.8 Hz, 1 H), 3.15 (d, J = 16.4 Hz, 
1 H), 2.18 (d, J = 16.4 Hz, 1 H), 2.20-2.14 (m, 1 H), 1.97-1.92 (m, 1 H), 1.74 (dq, J = 
13.7, 3.4 Hz, 1 H), 1.66-1.61 (m, 1 H), 1.52-1.43 (m, 1 H), 1.35 (s, 3H), 1.28-1.21 (m, 1 
H), 1.25 (s, 3 H), 1.17-1.11 (m, 1 H), 0.98 (s, 3 H), 0.93-0.86 (m, 1 H), 0.88 (d, J = 6.5 
Hz, 3 H), 0.81 (s, 3H); 13C NMR (125 MHz) δ 197.7, 175.5, 165.2, 153.8, 150.9, 149.8, 
139.2, 129.3, 128.6, 128.4, 127.8, 125.4, 125.0, 124.10, 124.08, 114.8, 58.8, 55.5, 51.6, 
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50.6, 42.1, 41.8, 40.6, 39.8, 34.3, 31.5, 27.8, 26.6, 25.1, 23.2, 21.9, 21.7; IR (neat) 2957, 
1770, 1716, 1464, 1292, 1252 cm-1; mass spectrum (CI) m/z 572.3008 [C35H42NO6 
(M+1) requires 572.3012], 403, 559, 570 (base M-1).  
NMR Assignments. 1H NMR (500 MHz, CDCl3) δ 9.64 (t, J = 1.5 Hz, 1 H, C34-
H), 7.71 (d, J = 7.9 Hz, 1 H, C9-H or C12-H), 7.32 (dd, J = 7.6, 0.9 Hz, 1 H, C9-H or 
C12-H), 7.30-7.26 (m, 1 H, C10-H or C11-H), 7.25-7.22 (comp, 2 H, C28-H), 7.12 (td, J 
= 7.6, 1.0 Hz,1 H, C10-H or C11-H), 7.02-6.99 (comp, 2 H, C29-H), 6.87-6.83 (m, 1 H, 
C30-H), 5.10 (dt, J = 10.9, 4.7 Hz, 1 H, C17-H), 3.76 (s, 3 H, C32-H), 3.69 (dd, J = 16.3, 
1.3 Hz, 1 H, C33-H), 3.45 (dd, J = 16.3, 0.8 Hz, 1 H, C33-H), 3.15 (d, J = 16.4 Hz, 1 H, 
C4-H), 2.18 (d, J = 16.4 Hz, 1 H, C4-H), 2.20-2.14 (m, 1 H, C22-H), 1.97-1.92 (m, 1 H, 
C18-H), 1.74 (dq, J = 13.7, 3.4 Hz, 1 H, C21-H), 1.66-1.61 (m, 1 H, C20-H), 1.52-1.43 
(m, 1 H, C19-H), 1.35 (s, 3H, C24-H or C25-H), 1.28-1.21 (m, 1 H, C18-H), 1.25 (s, 3 H, 
C15-H or C-16), 1.17-1.11 (m, 1 H, C21-H), 0.98 (s, 3 H, C24-H or C25-H), 0.93-0.86 
(m, 1 H, C20-H), 0.88 (d, J = 6.5 Hz, 3 H, C26-H), 0.81 (s, 3H, C15-H or C16-H); 13C 
NMR (125 MHz) δ 197.7 (C34), 175.5 (C2), 165.2 (C31), 153.8 (C6), 150.9 (C14), 149.8 
(C27), 139.2 (C13), 129.3 (C5 or C8), 128.6 (C5 or C8), 128.4 (C10 or C11), 127.8 
(C29), 125.4 (C28), 125.0 (C30), 124.10 (C10 or C11), 124.08 (C9 or C12), 114.8 (C9 or 
C12), 58.8 (C3), 55.5 (C7), 51.6 (C32), 50.6 (C22), 42.1 (C33), 41.8 (C18), 40.6 (C4), 
39.8 (C23), 34.3 (C20), 31.5 (C19), 27.8 (C15 or C16), 26.6 (C21), 25.1 (C24 or C25), 
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